{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03421496_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>SCREENING  PERIOD</td>\n<td colspan=\"5\" rowspan=\"1\">INITIAL TREATMENT PERIOD</td>\n<td colspan=\"3\" rowspan=\"1\">EXTENDED TREATMENT  PERIOD</td>\n<td></td>\n<td>Taper  Period </td>\n<td>Follow-up  Period </td>\n</tr>\n<tr>\n<td>Visit </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td colspan=\"1\" rowspan=\"2\">Early  Withdrawal   m </td>\n<td colspan=\"1\" rowspan=\"2\">6 days </td>\n<td colspan=\"1\" rowspan=\"2\">30 days </td>\n</tr>\n<tr>\n<td>Day </td>\n<td>-14 to -1 </td>\n<td>Titration  Days 1 </td>\n<td>Titration  Day 4 </td>\n<td> Day 7</td>\n<td>Day  14   a </td>\n<td>Day 15  EOS  (+ 5  days)   b </td>\n<td>Week 6 </td>\n<td>Week  10 </td>\n<td>Week  13  EOS   b </td>\n</tr>\n<tr>\n<td>Signed ICF </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Video-EEG </td>\n<td>X   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"2\" rowspan=\"1\">X  X   c,c </td>\n<td colspan=\"3\" rowspan=\"1\">--------------X  ----------   c </td>\n<td>X   c </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of  inclusion/exclusion  criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Assessment of  current AETs </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Medical/surgical  history </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Seizure History   d </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant  medications </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Vital Signs   e </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical Labs </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical Exam  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Height/Weight </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Head  Circumference </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03421496_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>SCREENING  PERIOD</td>\n<td colspan=\"5\" rowspan=\"1\">INITIAL TREATMENT PERIOD</td>\n<td colspan=\"3\" rowspan=\"1\">EXTENDED TREATMENT  PERIOD</td>\n<td></td>\n<td>Taper  Period </td>\n<td>Follow-up  Period </td>\n</tr>\n<tr>\n<td>Visit </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td colspan=\"1\" rowspan=\"2\">Early  Withdrawal   m </td>\n<td colspan=\"1\" rowspan=\"2\">6 days </td>\n<td colspan=\"1\" rowspan=\"2\">30 days </td>\n</tr>\n<tr>\n<td>Day </td>\n<td>-14 to -1 </td>\n<td>Titration  Days 1 </td>\n<td>Titration  Day 4 </td>\n<td> Day 7</td>\n<td>Day  14   a </td>\n<td>Day 15  EOS  (+ 5  days)   b </td>\n<td>Week 6 </td>\n<td>Week  10 </td>\n<td>Week  13  EOS   b </td>\n</tr>\n<tr>\n<td>Neurological  Exam   f </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Study Drug Dosing </td>\n<td></td>\n<td>X   g </td>\n<td>X   h </td>\n<td> X   h </td>\n<td> X    h </td>\n<td>X   i </td>\n<td>X   i </td>\n<td>X   i </td>\n<td>X   i </td>\n<td>X   i </td>\n<td>X   j </td>\n<td></td>\n</tr>\n<tr>\n<td>Assess AEs </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PK blood  sampling   k </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Investigator CGI-S </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Investigator CGI-I </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Seizure Diary   l </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Meal Diary   n </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03428100_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Period 1:   Screening</td>\n<td colspan=\"12\" rowspan=\"1\">Period 2:  Double-blind Treatment Period</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3:  Long-Term Extension</td>\n<td colspan=\"6\" rowspan=\"1\">Period 4: Bridging Extension</td>\n<td>PTFU</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>22</td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27</td>\n<td>28/  ET   a </td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from  Randomization</td>\n<td>-8 to -35  days</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>48</td>\n<td>52</td>\n<td>56</td>\n<td>60</td>\n<td>64</td>\n<td>68</td>\n<td>76</td>\n<td>84</td>\n<td>92</td>\n<td>104</td>\n<td>120</td>\n<td>136</td>\n<td>152</td>\n<td>168</td>\n<td>184</td>\n<td>200</td>\n<td>204</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td></td>\n<td>0</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>28±4</td>\n</tr>\n<tr>\n<td>Inclusion and  exclusion review</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical  Assessments</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Substance Use  (alcohol, tobacco)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Previous and current  AD treatments</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs (BP and  Pulse)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Physical  examination</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Symptom-directed  physical  examination   b </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead ECG  (single)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chest x-ray  (posterior–anterior  view)  c </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TB test   d </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03428100_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Period 1:   Screening</td>\n<td colspan=\"12\" rowspan=\"1\">Period 2:  Double-blind Treatment Period</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3:  Long-Term Extension</td>\n<td colspan=\"6\" rowspan=\"1\">Period 4: Bridging Extension</td>\n<td>PTFU</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>22</td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27</td>\n<td>28/  ET   a </td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from  Randomization</td>\n<td>-8 to -35  days</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>48</td>\n<td>52</td>\n<td>56</td>\n<td>60</td>\n<td>64</td>\n<td>68</td>\n<td>76</td>\n<td>84</td>\n<td>92</td>\n<td>104</td>\n<td>120</td>\n<td>136</td>\n<td>152</td>\n<td>168</td>\n<td>184</td>\n<td>200</td>\n<td>204</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td></td>\n<td>0</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>28±4</td>\n</tr>\n<tr>\n<td>Read PPD if  applicable (48 to 72  hours after PPD)</td>\n<td>X   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pre-existing  Conditions</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse Events</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant  Medications</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>ePRO (patient diary)  dispensed</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ePRO (patient diary)  returned</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization/ rerandomization   g </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IWRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>IP Dispensed</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP Returned and  Compliance  Assessed</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Weigh and dispense  background TCS  (tubes with cap)   q </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weigh and record  returned background  TCS (tubes with  cap)   q </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td></td>\n</tr>\n<tr>\n<td>Scales</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IGA</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>EASI</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>SCORAD</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Health Outcomes  Measures and  Other  </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03428100_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Period 1:   Screening</td>\n<td colspan=\"12\" rowspan=\"1\">Period 2:  Double-blind Treatment Period</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3:  Long-Term Extension</td>\n<td colspan=\"6\" rowspan=\"1\">Period 4: Bridging Extension</td>\n<td>PTFU</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>22</td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27</td>\n<td>28/  ET   a </td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from  Randomization</td>\n<td>-8 to -35  days</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>48</td>\n<td>52</td>\n<td>56</td>\n<td>60</td>\n<td>64</td>\n<td>68</td>\n<td>76</td>\n<td>84</td>\n<td>92</td>\n<td>104</td>\n<td>120</td>\n<td>136</td>\n<td>152</td>\n<td>168</td>\n<td>184</td>\n<td>200</td>\n<td>204</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td></td>\n<td>0</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>28±4</td>\n</tr>\n<tr>\n<td>Questionnaires   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Itch NRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n</tr>\n<tr>\n<td>Skin Pain NRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n</tr>\n<tr>\n<td>ADSS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n</tr>\n<tr>\n<td>PGI-S-AD</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n</tr>\n<tr>\n<td>POEM</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>DLQI</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>HADS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td>X   r </td>\n</tr>\n<tr>\n<td>EQ-5D-5L</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td>X   r </td>\n</tr>\n<tr>\n<td>WPAI-AD</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td>X   r </td>\n</tr>\n<tr>\n<td>SF-36</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td>X   r </td>\n</tr>\n<tr>\n<td>C-SSRS and Self-Harm Supplement   i </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Self-Harm Follow-Up Form   j </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Laboratory  Assessments</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Lipids (Fasting  Visit)   k </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical Chemistry   l </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Serum Pregnancy   m </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FSH   n </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TSH</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HIV</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HCV Antibody   o </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV testing</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV DNA   p </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03428100_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Period 1:   Screening</td>\n<td colspan=\"12\" rowspan=\"1\">Period 2:  Double-blind Treatment Period</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3:  Long-Term Extension</td>\n<td colspan=\"6\" rowspan=\"1\">Period 4: Bridging Extension</td>\n<td>PTFU</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>22</td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27</td>\n<td>28/  ET   a </td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from  Randomization</td>\n<td>-8 to -35  days</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>48</td>\n<td>52</td>\n<td>56</td>\n<td>60</td>\n<td>64</td>\n<td>68</td>\n<td>76</td>\n<td>84</td>\n<td>92</td>\n<td>104</td>\n<td>120</td>\n<td>136</td>\n<td>152</td>\n<td>168</td>\n<td>184</td>\n<td>200</td>\n<td>204</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td></td>\n<td>0</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>28±4</td>\n</tr>\n<tr>\n<td>Urinalysis</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td>X   r </td>\n</tr>\n<tr>\n<td>Urine Pregnancy   m </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pharmacogenetics:   blood</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum  immunoglobulin  (IgE)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td></td>\n</tr>\n<tr>\n<td>Exploratory storage  samples (serum and  plasma)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td></td>\n</tr>\n<tr>\n<td>RNA and  biomarkers:  blood</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03428100_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Period 1:   Screening</td>\n<td colspan=\"12\" rowspan=\"1\">Period 2:  Double-blind Treatment Period</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3:  Long-Term Extension</td>\n<td colspan=\"6\" rowspan=\"1\">Period 4: Bridging Extension</td>\n<td>PTFU</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>22/  ET   a </td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27</td>\n<td>28/  ET   a </td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from  Randomization</td>\n<td>-8 to -35  days</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>48</td>\n<td>52</td>\n<td>56</td>\n<td>60</td>\n<td>64</td>\n<td>68</td>\n<td>76</td>\n<td>84</td>\n<td>92</td>\n<td>104</td>\n<td>120</td>\n<td>136</td>\n<td>152</td>\n<td>168</td>\n<td>184</td>\n<td>200</td>\n<td>10820 4</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td></td>\n<td>0</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>28±4</td>\n</tr>\n<tr>\n<td>Inclusion and  exclusion review</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical  Assessments</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Substance Use  (alcohol, tobacco)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Previous and current  AD treatments</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs (BP and  Pulse)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Physical  examination</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Symptom-directed  physical  examination   b </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead ECG  (single)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chest x-ray  (posterior–anterior  view)  c </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TB test   d </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Read PPD if  applicable (48 to 72  </td>\n<td>X   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03428100_SOA_table_5.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Period 1:   Screening</td>\n<td colspan=\"12\" rowspan=\"1\">Period 2:  Double-blind Treatment Period</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3:  Long-Term Extension</td>\n<td colspan=\"6\" rowspan=\"1\">Period 4: Bridging Extension</td>\n<td>PTFU</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>22/  ET   a </td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27</td>\n<td>28/  ET   a </td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from  Randomization</td>\n<td>-8 to -35  days</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>48</td>\n<td>52</td>\n<td>56</td>\n<td>60</td>\n<td>64</td>\n<td>68</td>\n<td>76</td>\n<td>84</td>\n<td>92</td>\n<td>104</td>\n<td>120</td>\n<td>136</td>\n<td>152</td>\n<td>168</td>\n<td>184</td>\n<td>200</td>\n<td>10820 4</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td></td>\n<td>0</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>28±4</td>\n</tr>\n<tr>\n<td>hours after PPD)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pre-existing  Conditions</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse Events</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant  Medications</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>ePRO (patient diary)  dispensed</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ePRO (patient diary)  returned</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization/ rerandomization   g </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IWRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>IP Dispensed</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP Returned and  Compliance  Assessed</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Weigh and dispense  background TCS  (tubes with cap)   q </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weigh and record  returned background  TCS (tubes with  cap)   q </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td></td>\n</tr>\n<tr>\n<td>Scales</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IGA</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>EASI</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>SCORAD</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03428100_SOA_table_6.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Period 1:   Screening</td>\n<td colspan=\"12\" rowspan=\"1\">Period 2:  Double-blind Treatment Period</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3:  Long-Term Extension</td>\n<td colspan=\"6\" rowspan=\"1\">Period 4: Bridging Extension</td>\n<td>PTFU</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>22/  ET   a </td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27</td>\n<td>28/  ET   a </td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from  Randomization</td>\n<td>-8 to -35  days</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>48</td>\n<td>52</td>\n<td>56</td>\n<td>60</td>\n<td>64</td>\n<td>68</td>\n<td>76</td>\n<td>84</td>\n<td>92</td>\n<td>104</td>\n<td>120</td>\n<td>136</td>\n<td>152</td>\n<td>168</td>\n<td>184</td>\n<td>200</td>\n<td>10820 4</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td></td>\n<td>0</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>28±4</td>\n</tr>\n<tr>\n<td>Health Outcomes  Measures and  Other  Questionnaires   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Itch NRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n</tr>\n<tr>\n<td>Skin Pain NRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n</tr>\n<tr>\n<td>ADSS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n</tr>\n<tr>\n<td>PGI-S-AD</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   f </td>\n<td></td>\n</tr>\n<tr>\n<td>POEM</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>DLQI</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>HADS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td>X   r </td>\n</tr>\n<tr>\n<td>EQ-5D-5L</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td>X   r </td>\n</tr>\n<tr>\n<td>WPAI-AD</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td>X   r </td>\n</tr>\n<tr>\n<td>SF-36</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td>X   r </td>\n</tr>\n<tr>\n<td>C-SSRS and Self-Harm Supplement   i </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Self-Harm Follow-Up Form   j </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Laboratory  Assessments</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Lipids (Fasting  Visit)   k </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical Chemistry   l </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Serum Pregnancy   m </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FSH   n </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TSH</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03428100_SOA_table_7.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Period 1:   Screening</td>\n<td colspan=\"12\" rowspan=\"1\">Period 2:  Double-blind Treatment Period</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3:  Long-Term Extension</td>\n<td colspan=\"6\" rowspan=\"1\">Period 4: Bridging Extension</td>\n<td>PTFU</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>22/  ET   a </td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27</td>\n<td>28/  ET   a </td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from  Randomization</td>\n<td>-8 to -35  days</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>48</td>\n<td>52</td>\n<td>56</td>\n<td>60</td>\n<td>64</td>\n<td>68</td>\n<td>76</td>\n<td>84</td>\n<td>92</td>\n<td>104</td>\n<td>120</td>\n<td>136</td>\n<td>152</td>\n<td>168</td>\n<td>184</td>\n<td>200</td>\n<td>10820 4</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td></td>\n<td>0</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±5</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>28±4</td>\n</tr>\n<tr>\n<td>HIV</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HCV Antibody   o </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV testing</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV DNA   p </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urinalysis</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td>X   r </td>\n</tr>\n<tr>\n<td>Urine Pregnancy   m </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pharmacogenetics:   blood</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum  immunoglobulin  (IgE)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td></td>\n</tr>\n<tr>\n<td>Exploratory storage  samples (serum and  plasma)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td></td>\n</tr>\n<tr>\n<td>RNA and  biomarkers:  blood</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   r </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03433755_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td>Baseline </td>\n<td colspan=\"4\" rowspan=\"1\">Treatment Period </td>\n<td>Early  Termination </td>\n<td></td>\n</tr>\n<tr>\n<td>Study Week </td>\n<td>Week -4  (Day -28) to  Day -1 </td>\n<td>Day 1 </td>\n<td>Week 8  ± 3 days </td>\n<td>Week 10  ± 3 days </td>\n<td>Week 12  ± 3 days   a </td>\n<td>Week 14  ± 3 days  Q2W subjects only   a, b </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed Consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Physical Examination </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Weight and waist circumference </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Height </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy Test : Serum   c </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy Test : Urine   d </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chemistry </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Screening placebo injection   e </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HbA1c </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Thyroid Stimulating Hormone </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HCV   f </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Hepatitis C viral load   g </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>hsCRP </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Anti-evolocumab antibodies </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03433755_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td>Baseline </td>\n<td colspan=\"4\" rowspan=\"1\">Treatment Period </td>\n<td>Early  Termination </td>\n<td></td>\n</tr>\n<tr>\n<td>Study Week </td>\n<td>Week -4  (Day -28) to  Day -1 </td>\n<td>Day 1 </td>\n<td>Week 8  ± 3 days </td>\n<td>Week 10  ± 3 days </td>\n<td>Week 12  ± 3 days   a </td>\n<td>Week 14  ± 3 days  Q2W subjects only   a, b </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Fasting Lipids, ApoA1, ApoB,  Lp(a) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>PCSK9 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Safety Data  Collection/Recording/Reporting   h </td>\n<td>X</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant Therapy </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>IP dispensation to subject for  non-clinic administration </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP administration   i </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP reconciliation </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td>Prescreen  &amp; Screening</td>\n<td>Baseline</td>\n<td colspan=\"9\" rowspan=\"1\">Dose Escalation Period</td>\n<td colspan=\"1\" rowspan=\"3\">Unsched  Visit</td>\n</tr>\n<tr>\n<td>Weeks 12 to 1</td>\n<td>Day  1</td>\n<td>Day  4</td>\n<td>Wk  4</td>\n<td>Wk  8</td>\n<td>Wk 12</td>\n<td>Wk  16</td>\n<td>Wk  20</td>\n<td>Wk  24</td>\n<td>Wk  28</td>\n<td>Wk  32</td>\n</tr>\n<tr>\n<td>Dose Number</td>\n<td></td>\n<td>1   a </td>\n<td></td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5   b </td>\n<td>6   b </td>\n<td>7   a </td>\n<td>8   b </td>\n<td>9   b </td>\n</tr>\n<tr>\n<td>Dose level in milligrams (mg)</td>\n<td></td>\n<td>120</td>\n<td></td>\n<td>120</td>\n<td>120</td>\n<td>255</td>\n<td>255</td>\n<td>255</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent(s)   c </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of inclusion and exclusion criteria</td>\n<td>x</td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history, personal status, and demographics</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight and height    t </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Clinical genotyping samples</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical RNA samples</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis   d </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine sample for drugs of abuse   e </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Coagulation (PT)</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Viral serology (HIV, hepatitis B, and hepatitis C)</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FCSRT</td>\n<td>P   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-Lead electrocardiogram   g </td>\n<td>x</td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK plasma sample   h, v </td>\n<td></td>\n<td>B</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Serum chemistry and  hematology   I,j </td>\n<td>x</td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Plasma biomarker sample    u </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x </td>\n</tr>\n<tr>\n<td>Complete physical examination (includes  neurological systems)   k </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td>Prescreen  &amp; Screening</td>\n<td>Baseline</td>\n<td colspan=\"9\" rowspan=\"1\">Dose Escalation Period</td>\n<td colspan=\"1\" rowspan=\"3\">Unsched  Visit</td>\n</tr>\n<tr>\n<td>Weeks 12 to 1</td>\n<td>Day  1</td>\n<td>Day  4</td>\n<td>Wk  4</td>\n<td>Wk  8</td>\n<td>Wk 12</td>\n<td>Wk  16</td>\n<td>Wk  20</td>\n<td>Wk  24</td>\n<td>Wk  28</td>\n<td>Wk  32</td>\n</tr>\n<tr>\n<td>Dose Number</td>\n<td></td>\n<td>1   a </td>\n<td></td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5   b </td>\n<td>6   b </td>\n<td>7   a </td>\n<td>8   b </td>\n<td>9   b </td>\n</tr>\n<tr>\n<td>Dose level in milligrams (mg)</td>\n<td></td>\n<td>120</td>\n<td></td>\n<td>120</td>\n<td>120</td>\n<td>255</td>\n<td>255</td>\n<td>255</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n</tr>\n<tr>\n<td>Limited physical examination   l </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>MRI scan   m, n </td>\n<td>x   o </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>CSF and matching serum sampling or PET scan m, p  m, p </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CDR </td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ADAS-Cog13</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n</tr>\n<tr>\n<td>Verbal Fluency Task</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n</tr>\n<tr>\n<td>Coding</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n</tr>\n<tr>\n<td>ADCS-ADL</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>FAQ</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>MMSE</td>\n<td>P   f </td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n</tr>\n<tr>\n<td>EQ-5D</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>QoL-AD</td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ZCI-AD</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>RUD-Lite</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>NPI-Q</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>C-SSRS BL/SLV</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n</tr>\n<tr>\n<td>Vital signs   q </td>\n<td>x</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Urine pregnancy test   r </td>\n<td>x</td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Study drug administration   h, s </td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_10.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"13\" rowspan=\"1\">Open-Label Extension Treatment Period</td>\n<td colspan=\"1\" rowspan=\"3\">OLE  Early  Term Visit  [m]</td>\n<td colspan=\"1\" rowspan=\"3\">OLE  UV</td>\n</tr>\n<tr>\n<td>OLE  Day 1</td>\n<td>OLE  Day  4</td>\n<td>OLE  Wk 2</td>\n<td>OLE  Wk 4</td>\n<td>OLE  Wk 6</td>\n<td>OLE  Wk 8</td>\n<td>OLE  Wk 10</td>\n<td>OLE  Wk 12</td>\n<td>OLE  Wk 14</td>\n<td>OLE  Wk 16</td>\n<td>OLE  Wk  18</td>\n<td>OLE  Wk  20</td>\n<td>OLE  Wk  22</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>1   a </td>\n<td></td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9    b </td>\n<td>10    b </td>\n<td>11    b </td>\n<td>12    b </td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg) for participants  previously on placebo</td>\n<td colspan=\"3\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg) for participants  previously on active</td>\n<td>510</td>\n<td></td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma biomarker sample   l </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Complete physical  examination (includes  neurological systems)   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Limited physical examination    g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>MRI scan    h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x    n </td>\n<td>x</td>\n</tr>\n<tr>\n<td>CDR</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;SP </td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ADAS-Cog 13</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>MMSE</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Verbal Fluency Test</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Coding</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>ADCS-ADL</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP </td>\n<td>SP</td>\n</tr>\n<tr>\n<td>FAQ</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP </td>\n<td>SP</td>\n</tr>\n<tr>\n<td>EQ-5D</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP  </td>\n<td>SP</td>\n</tr>\n<tr>\n<td>QOL-AD</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ZCI-AD</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP </td>\n<td>SP</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_11.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"13\" rowspan=\"1\">Open-Label Extension Treatment Period</td>\n<td colspan=\"1\" rowspan=\"3\">OLE  Early  Term Visit  [m]</td>\n<td colspan=\"1\" rowspan=\"3\">OLE  UV</td>\n</tr>\n<tr>\n<td>OLE  Day 1</td>\n<td>OLE  Day  4</td>\n<td>OLE  Wk 2</td>\n<td>OLE  Wk 4</td>\n<td>OLE  Wk 6</td>\n<td>OLE  Wk 8</td>\n<td>OLE  Wk 10</td>\n<td>OLE  Wk 12</td>\n<td>OLE  Wk 14</td>\n<td>OLE  Wk 16</td>\n<td>OLE  Wk  18</td>\n<td>OLE  Wk  20</td>\n<td>OLE  Wk  22</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>1   a </td>\n<td></td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9    b </td>\n<td>10    b </td>\n<td>11    b </td>\n<td>12    b </td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg) for participants  previously on placebo</td>\n<td colspan=\"3\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg) for participants  previously on active</td>\n<td>510</td>\n<td></td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>RUD-Lite</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>NPI-Q</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>C-SSRS/SLV</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>CSF and matching serum  sampling (for participants  enrolled based on CSF  eligibility criteria in  double-blind part only)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x    o </td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs    i </td>\n<td>B</td>\n<td>x</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Urine pregnancy test    i </td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Study drug administration    c, k </td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_12.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"7\" rowspan=\"1\">Open-Label Extension Treatment Period</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-up Period for  Participants  Not Enrolling in  Study WN42171</td>\n<td>OLE  Early  Term Visit  [a]</td>\n<td>OLE  Unsched Visit</td>\n</tr>\n<tr>\n<td>OLE  Wk 24</td>\n<td>OLE  Wk  26</td>\n<td>OLE  Wk  28</td>\n<td>OLE  Wk  30</td>\n<td>OLE  Wk  32</td>\n<td>OLE  Wk  34</td>\n<td>OLE  Wk  35</td>\n<td>OLE  Follow  Up 1</td>\n<td>OLE  Follow  Up 2</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>13    a </td>\n<td>14    b </td>\n<td>15    b </td>\n<td>16    b </td>\n<td>17    b </td>\n<td>18    b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in milligrams (mg) for participants  previously on placebo</td>\n<td colspan=\"2\" rowspan=\"1\">510</td>\n<td colspan=\"2\" rowspan=\"1\">510</td>\n<td colspan=\"2\" rowspan=\"1\">510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in milligrams (mg) for participants  previously on active</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent(s)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of inclusion and exclusion criteria</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>12-Lead electrocardiogram</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK plasma sample    c </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Serum chemistry  and hematology    d,e </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Plasma biomarker sample   n </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Complete physical examination (includes  neurological systems)    f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Limited physical examination    g </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_13.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"7\" rowspan=\"1\">Open-Label Extension Treatment Period</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-up Period for  Participants  Not Enrolling in  Study WN42171</td>\n<td>OLE  Early  Term Visit  [a]</td>\n<td>OLE  Unsched Visit</td>\n</tr>\n<tr>\n<td>OLE  Wk 24</td>\n<td>OLE  Wk  26</td>\n<td>OLE  Wk  28</td>\n<td>OLE  Wk  30</td>\n<td>OLE  Wk  32</td>\n<td>OLE  Wk  34</td>\n<td>OLE  Wk  35</td>\n<td>OLE  Follow  Up 1</td>\n<td>OLE  Follow  Up 2</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>13    a </td>\n<td>14    b </td>\n<td>15    b </td>\n<td>16    b </td>\n<td>17    b </td>\n<td>18    b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in milligrams (mg) for participants  previously on placebo</td>\n<td colspan=\"2\" rowspan=\"1\">510</td>\n<td colspan=\"2\" rowspan=\"1\">510</td>\n<td colspan=\"2\" rowspan=\"1\">510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in milligrams (mg) for participants  previously on active</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MRI scan    h </td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x   i </td>\n<td>x</td>\n</tr>\n<tr>\n<td>CDR</td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ADAS-Cog 13</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>MMSE</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Verbal Fluency Test</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Coding</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>ADCS-ADL</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>FAQ</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>EQ-5D</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>QOL-AD</td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ZCI-AD</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>RUD-Lite</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>NPI-Q</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>C-SSRS/SLV</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_14.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"7\" rowspan=\"1\">Open-Label Extension Treatment Period</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-up Period for  Participants  Not Enrolling in  Study WN42171</td>\n<td>OLE  Early  Term Visit  [a]</td>\n<td>OLE  Unsched Visit</td>\n</tr>\n<tr>\n<td>OLE  Wk 24</td>\n<td>OLE  Wk  26</td>\n<td>OLE  Wk  28</td>\n<td>OLE  Wk  30</td>\n<td>OLE  Wk  32</td>\n<td>OLE  Wk  34</td>\n<td>OLE  Wk  35</td>\n<td>OLE  Follow  Up 1</td>\n<td>OLE  Follow  Up 2</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>13    a </td>\n<td>14    b </td>\n<td>15    b </td>\n<td>16    b </td>\n<td>17    b </td>\n<td>18    b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in milligrams (mg) for participants  previously on placebo</td>\n<td colspan=\"2\" rowspan=\"1\">510</td>\n<td colspan=\"2\" rowspan=\"1\">510</td>\n<td colspan=\"2\" rowspan=\"1\">510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in milligrams (mg) for participants  previously on active</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CSF and matching serum sampling (for  participants enrolled based on CSF eligibility  criteria in double-blind part only)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x    j </td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs    k </td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Urine pregnancy test    l </td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Study drug administration    c, m </td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"3\">Assessment/Procedure</td>\n<td colspan=\"11\" rowspan=\"1\"></td>\n<td colspan=\"2\" rowspan=\"1\">Only for  Participants Who  Have Completed  Week 104 when  the 12 week  study extension  is Implemented</td>\n<td colspan=\"1\" rowspan=\"4\">Early  Term Visit  [a]</td>\n<td colspan=\"1\" rowspan=\"4\">Unsched Visit</td>\n</tr>\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Final Efficacy  and Safety  Assessments</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period  for Participants  Not Enrolling in  the OLE</td>\n</tr>\n<tr>\n<td>Wk 36</td>\n<td>Wk  38</td>\n<td>Wk  40</td>\n<td>Wk  41</td>\n<td>Wk 4250</td>\n<td>Wk 52</td>\n<td>Wk 5474</td>\n<td>Wk  76</td>\n<td>Wk 78102</td>\n<td>Wk  103</td>\n<td>Wk  104   a, b </td>\n<td>Wk  116</td>\n<td>Wk  152</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td></td>\n<td>1317    c </td>\n<td>18   a </td>\n<td>1929    c </td>\n<td>30   a </td>\n<td>3143   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-Lead ECG</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK plasma sample   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td>x  (Site  visit)</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>x (Site  visit)</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Clinical RNA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum chemistry and  hematology    e,f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Plasma biomarker  sample   o </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Complete physical  examination (including  neurological systems)   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Limited physical  examination   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Weight</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"3\">Assessment/Procedure</td>\n<td colspan=\"11\" rowspan=\"1\"></td>\n<td colspan=\"2\" rowspan=\"1\">Only for  Participants Who  Have Completed  Week 104 when  the 12 week  study extension  is Implemented</td>\n<td colspan=\"1\" rowspan=\"4\">Early  Term Visit  [a]</td>\n<td colspan=\"1\" rowspan=\"4\">Unsched Visit</td>\n</tr>\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Final Efficacy  and Safety  Assessments</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period  for Participants  Not Enrolling in  the OLE</td>\n</tr>\n<tr>\n<td>Wk 36</td>\n<td>Wk  38</td>\n<td>Wk  40</td>\n<td>Wk  41</td>\n<td>Wk 4250</td>\n<td>Wk 52</td>\n<td>Wk 5474</td>\n<td>Wk  76</td>\n<td>Wk 78102</td>\n<td>Wk  103</td>\n<td>Wk  104   a, b </td>\n<td>Wk  116</td>\n<td>Wk  152</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td></td>\n<td>1317    c </td>\n<td>18   a </td>\n<td>1929    c </td>\n<td>30   a </td>\n<td>3143   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MRI scan   i </td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td>Wk  48   j </td>\n<td></td>\n<td>Wk  60</td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td>x</td>\n</tr>\n<tr>\n<td>CSF and matching  serum sampling (for  participants enrolled  based on CSF eligibility  criteria only)  k </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x    k </td>\n<td></td>\n</tr>\n<tr>\n<td>CDR</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ADAS-Cog13</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Verbal Fluency Task</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Coding</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>ADCS-ADL</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>FAQ</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>MMSE</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>EQ-5D</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>QOL-AD</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ZCI-AD</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>RUD-Lite</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"3\">Assessment/Procedure</td>\n<td colspan=\"11\" rowspan=\"1\"></td>\n<td colspan=\"2\" rowspan=\"1\">Only for  Participants Who  Have Completed  Week 104 when  the 12 week  study extension  is Implemented</td>\n<td colspan=\"1\" rowspan=\"4\">Early  Term Visit  [a]</td>\n<td colspan=\"1\" rowspan=\"4\">Unsched Visit</td>\n</tr>\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Final Efficacy  and Safety  Assessments</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period  for Participants  Not Enrolling in  the OLE</td>\n</tr>\n<tr>\n<td>Wk 36</td>\n<td>Wk  38</td>\n<td>Wk  40</td>\n<td>Wk  41</td>\n<td>Wk 4250</td>\n<td>Wk 52</td>\n<td>Wk 5474</td>\n<td>Wk  76</td>\n<td>Wk 78102</td>\n<td>Wk  103</td>\n<td>Wk  104   a, b </td>\n<td>Wk  116</td>\n<td>Wk  152</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td></td>\n<td>1317    c </td>\n<td>18   a </td>\n<td>1929    c </td>\n<td>30   a </td>\n<td>3143   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>NPI-Q</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>C-SSRS BL/SLV</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Vital signs   l </td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant  medications</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Urine pregnancy test   m </td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Study drug  administration   d, n </td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_5.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"3\" rowspan=\"1\">Treatment Period</td>\n<td>Final Safety  and  Efficacy  Assessmen t</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period for  Participants  Not Enrolling in the OLE</td>\n<td colspan=\"1\" rowspan=\"3\">Early Term  Visit  [a]</td>\n<td colspan=\"1\" rowspan=\"3\">Unsched  Visit</td>\n</tr>\n<tr>\n<td>Wk 104   a </td>\n<td>Wk  106-114   c </td>\n<td>Wk  115</td>\n<td>Wk  116   a, b </td>\n<td>Wk 128</td>\n<td>Wk  164</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>44</td>\n<td>45-49</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-Lead ECG</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK plasma sample   d </td>\n<td></td>\n<td></td>\n<td>x (site visit)</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Clinical RNA sample</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum chemistry and  hematology    e,f </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Plasma biomarker sample    o </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Complete physical examination  (including neurological systems)    g </td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Limited physical  examination   h </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>MRI scan   i </td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td>x</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_6.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"3\" rowspan=\"1\">Treatment Period</td>\n<td>Final Safety  and  Efficacy  Assessmen t</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period for  Participants  Not Enrolling in the OLE</td>\n<td>Early Term  Visit  [a]</td>\n<td>Unsched  Visit</td>\n</tr>\n<tr>\n<td>Wk 104   a </td>\n<td>Wk  106-114   c </td>\n<td>Wk  115</td>\n<td>Wk  116   a, b </td>\n<td>Wk 128</td>\n<td>Wk  164</td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>44</td>\n<td>45-49</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CSF and matching serum  sampling (for participants  enrolled based on CSF eligibility  criteria only)  k </td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x    k </td>\n<td></td>\n</tr>\n<tr>\n<td>CDR</td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ADAS-Cog13</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Verbal Fluency Task</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Coding</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>ADCS-ADL</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>FAQ</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>MMSE</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>EQ-5D</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>QOL-AD</td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ZCI-AD</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>RUD-Lite</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>NPI-Q</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>C-SSRS BL/SLV</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Vital signs   l </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Urine pregnancy test   m </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Study drug administration   d, n </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_7.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"3\" rowspan=\"1\">Treatment Period</td>\n<td>Final Safety  and Efficacy  Assessment</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period for  Participants  Not Enrolling in the OLE</td>\n<td>Early Term  Visit  [a]</td>\n<td>Unsched  Visit</td>\n</tr>\n<tr>\n<td>Wk 104   a </td>\n<td>Wk 106-126   c </td>\n<td>Wk  127</td>\n<td>Wk  128   a, b </td>\n<td>Wk 140</td>\n<td>Wk  176</td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>44</td>\n<td>45-55</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-Lead ECG</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK plasma sample   d </td>\n<td></td>\n<td></td>\n<td>x (site  visit)</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Clinical RNA sample</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum chemistry and  hematology    e,f </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Plasma biomarker sample    o </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Complete physical examination  (including neurological systems)   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Limited physical  examination   h </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>MRI scan   i </td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td>x</td>\n</tr>\n<tr>\n<td>CSF and matching serum sampling  (for participants enrolled based on  CSF eligibility criteria only)  k </td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x    k </td>\n<td></td>\n</tr>\n<tr>\n<td>CDR</td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ADAS-Cog13</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_8.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"3\" rowspan=\"1\">Treatment Period</td>\n<td>Final Safety  and Efficacy  Assessment</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period for  Participants  Not Enrolling in the OLE</td>\n<td>Early Term  Visit  [a]</td>\n<td>Unsched  Visit</td>\n</tr>\n<tr>\n<td>Wk 104   a </td>\n<td>Wk 106-126   c </td>\n<td>Wk  127</td>\n<td>Wk  128   a, b </td>\n<td>Wk 140</td>\n<td>Wk  176</td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>44</td>\n<td>45-55</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Verbal Fluency Task</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Coding</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>ADCS-ADL</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>FAQ</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>MMSE</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>EQ-5D</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>QOL-AD</td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ZCI-AD</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>RUD-Lite</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>NPI-Q</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>C-SSRS BL/SLV</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Vital signs   l </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Urine pregnancy test   m </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Study drug  administration   d, n </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03443973_SOA_table_9.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"13\" rowspan=\"1\">Open-Label Extension Treatment Period</td>\n<td colspan=\"1\" rowspan=\"3\">OLE  Early  Term Visit  [m]</td>\n<td colspan=\"1\" rowspan=\"3\">OLE  UV</td>\n</tr>\n<tr>\n<td>OLE  Day 1</td>\n<td>OLE  Day  4</td>\n<td>OLE  Wk 2</td>\n<td>OLE  Wk 4</td>\n<td>OLE  Wk 6</td>\n<td>OLE  Wk 8</td>\n<td>OLE  Wk 10</td>\n<td>OLE  Wk 12</td>\n<td>OLE  Wk 14</td>\n<td>OLE  Wk 16</td>\n<td>OLE  Wk  18</td>\n<td>OLE  Wk  20</td>\n<td>OLE  Wk  22</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>1   a </td>\n<td></td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9    b </td>\n<td>10    b </td>\n<td>11    b </td>\n<td>12    b </td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg) for participants  previously on placebo</td>\n<td colspan=\"3\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg) for participants  previously on active</td>\n<td>510</td>\n<td></td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent(s)</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of inclusion and  exclusion criteria</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>12-Lead electrocardiogram</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK Plasma Sample    c </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Serum chemistry  and  hematology    d,e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03444870_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td>Prescreen  &amp; Screening</td>\n<td>Baseline</td>\n<td colspan=\"9\" rowspan=\"1\">Dose Escalation Period</td>\n<td colspan=\"1\" rowspan=\"3\">Unsched  Visit</td>\n</tr>\n<tr>\n<td>Weeks 12 to 1</td>\n<td>Day  1</td>\n<td>Day  4</td>\n<td>Wk  4</td>\n<td>Wk  8</td>\n<td>Wk 12</td>\n<td>Wk  16</td>\n<td>Wk  20</td>\n<td>Wk  24</td>\n<td>Wk  28</td>\n<td>Wk  32</td>\n</tr>\n<tr>\n<td>Dose Number</td>\n<td></td>\n<td>1   a </td>\n<td></td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5   b </td>\n<td>6   b </td>\n<td>7   a </td>\n<td>8   b </td>\n<td>9   b </td>\n</tr>\n<tr>\n<td>Dose level in milligrams (mg)</td>\n<td></td>\n<td>120</td>\n<td></td>\n<td>120</td>\n<td>120</td>\n<td>255</td>\n<td>255</td>\n<td>255</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent(s)   c </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of inclusion and exclusion criteria</td>\n<td>x</td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history, personal status, and demographics</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight and height    t </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Clinical genotyping samples</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical RNA samples</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis   d </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine sample for drugs of abuse   e </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Coagulation (PT)</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Viral serology (HIV, hepatitis B, and hepatitis C)</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FCSRT</td>\n<td>P   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-Lead electrocardiogram   g </td>\n<td>x</td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK plasma sample   h, v </td>\n<td></td>\n<td>B</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Serum chemistry and  hematology   I,j </td>\n<td>x</td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Plasma biomarker sample    u </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x </td>\n</tr>\n<tr>\n<td>Complete physical examination (includes  neurological systems)   k </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03444870_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td>Prescreen  &amp; Screening</td>\n<td>Baseline</td>\n<td colspan=\"9\" rowspan=\"1\">Dose Escalation Period</td>\n<td colspan=\"1\" rowspan=\"3\">Unsched  Visit</td>\n</tr>\n<tr>\n<td>Weeks 12 to 1</td>\n<td>Day  1</td>\n<td>Day  4</td>\n<td>Wk  4</td>\n<td>Wk  8</td>\n<td>Wk 12</td>\n<td>Wk  16</td>\n<td>Wk  20</td>\n<td>Wk  24</td>\n<td>Wk  28</td>\n<td>Wk  32</td>\n</tr>\n<tr>\n<td>Dose Number</td>\n<td></td>\n<td>1   a </td>\n<td></td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5   b </td>\n<td>6   b </td>\n<td>7   a </td>\n<td>8   b </td>\n<td>9   b </td>\n</tr>\n<tr>\n<td>Dose level in milligrams (mg)</td>\n<td></td>\n<td>120</td>\n<td></td>\n<td>120</td>\n<td>120</td>\n<td>255</td>\n<td>255</td>\n<td>255</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n</tr>\n<tr>\n<td>Limited physical examination   l </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>MRI scan   m, n </td>\n<td>x   o </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>CSF and matching serum sampling or PET scan m, p  m, p </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CDR </td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ADAS-Cog13</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n</tr>\n<tr>\n<td>Verbal Fluency Task</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n</tr>\n<tr>\n<td>Coding</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n</tr>\n<tr>\n<td>ADCS-ADL</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>FAQ</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>MMSE</td>\n<td>P   f </td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n</tr>\n<tr>\n<td>EQ-5D</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>QoL-AD</td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ZCI-AD</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>RUD-Lite</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>NPI-Q</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n</tr>\n<tr>\n<td>C-SSRS BL/SLV</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n</tr>\n<tr>\n<td>Vital signs   q </td>\n<td>x</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Urine pregnancy test   r </td>\n<td>x</td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Study drug administration   h, s </td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03444870_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"3\">Assessment/Procedure</td>\n<td colspan=\"11\" rowspan=\"1\"></td>\n<td colspan=\"2\" rowspan=\"1\">Only for  Participants Who  Have Completed  Week 104 when  the 12 week  study extension  is Implemented</td>\n<td colspan=\"1\" rowspan=\"4\">Early  Term Visit  [a]</td>\n<td colspan=\"1\" rowspan=\"4\">Unsched Visit</td>\n</tr>\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Final Efficacy  and Safety  Assessments</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period  for Participants  Not Enrolling in  the OLE</td>\n</tr>\n<tr>\n<td>Wk 36</td>\n<td>Wk  38</td>\n<td>Wk  40</td>\n<td>Wk  41</td>\n<td>Wk 4250</td>\n<td>Wk 52</td>\n<td>Wk 5474</td>\n<td>Wk  76</td>\n<td>Wk 78102</td>\n<td>Wk  103</td>\n<td>Wk  104   a, b </td>\n<td>Wk  116</td>\n<td>Wk  152</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td></td>\n<td>1317    c </td>\n<td>18   a </td>\n<td>1929    c </td>\n<td>30   a </td>\n<td>3143   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-Lead ECG</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK plasma sample   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td>x  (Site  visit)</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>x (Site  visit)</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Clinical RNA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum chemistry and  hematology    e,f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Plasma biomarker  sample   o </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Complete physical  examination (including  neurological systems)   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Limited physical  examination   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Weight</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03444870_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"3\">Assessment/Procedure</td>\n<td colspan=\"11\" rowspan=\"1\"></td>\n<td colspan=\"2\" rowspan=\"1\">Only for  Participants Who  Have Completed  Week 104 when  the 12 week  study extension  is Implemented</td>\n<td colspan=\"1\" rowspan=\"4\">Early  Term Visit  [a]</td>\n<td colspan=\"1\" rowspan=\"4\">Unsched Visit</td>\n</tr>\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Final Efficacy  and Safety  Assessments</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period  for Participants  Not Enrolling in  the OLE</td>\n</tr>\n<tr>\n<td>Wk 36</td>\n<td>Wk  38</td>\n<td>Wk  40</td>\n<td>Wk  41</td>\n<td>Wk 4250</td>\n<td>Wk 52</td>\n<td>Wk 5474</td>\n<td>Wk  76</td>\n<td>Wk 78102</td>\n<td>Wk  103</td>\n<td>Wk  104   a, b </td>\n<td>Wk  116</td>\n<td>Wk  152</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td></td>\n<td>1317    c </td>\n<td>18   a </td>\n<td>1929    c </td>\n<td>30   a </td>\n<td>3143   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MRI scan   i </td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td>Wk  48   j </td>\n<td></td>\n<td>Wk  60</td>\n<td>B</td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td>x</td>\n</tr>\n<tr>\n<td>CSF and matching  serum sampling (for  participants enrolled  based on CSF eligibility  criteria only)  k </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x    k </td>\n<td></td>\n</tr>\n<tr>\n<td>CDR</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ADAS-Cog13</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Verbal Fluency Task</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Coding</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>ADCS-ADL</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>FAQ</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>MMSE</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>EQ-5D</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>QoL-AD</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td>P&amp;S P</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ZCI-AD</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>RUD-Lite</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03444870_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"3\">Assessment/Procedure</td>\n<td colspan=\"11\" rowspan=\"1\"></td>\n<td colspan=\"2\" rowspan=\"1\">Only for  Participants Who  Have Completed  Week 104 when  the 12 week  study extension  is Implemented</td>\n<td colspan=\"1\" rowspan=\"4\">Early  Term Visit  [a]</td>\n<td colspan=\"1\" rowspan=\"4\">Unsched Visit</td>\n</tr>\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Final Efficacy  and Safety  Assessments</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period  for Participants  Not Enrolling in  the OLE</td>\n</tr>\n<tr>\n<td>Wk 36</td>\n<td>Wk  38</td>\n<td>Wk  40</td>\n<td>Wk  41</td>\n<td>Wk 4250</td>\n<td>Wk 52</td>\n<td>Wk 5474</td>\n<td>Wk  76</td>\n<td>Wk 78102</td>\n<td>Wk  103</td>\n<td>Wk  104   a, b </td>\n<td>Wk  116</td>\n<td>Wk  152</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td></td>\n<td>1317    c </td>\n<td>18   a </td>\n<td>1929    c </td>\n<td>30   a </td>\n<td>3143   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>NPI-Q</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>C-SSRS BL/SLV</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Vital signs   l </td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant  medications</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Urine pregnancy test   m </td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td></td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td>B</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Study drug  administration   d, n </td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03444870_SOA_table_5.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"3\" rowspan=\"1\">Treatment Period</td>\n<td>Final Safety  and  Efficacy  Assessmen t</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period for  Participants  Not Enrolling in the OLE</td>\n<td>Early Term  Visit  [a]</td>\n<td>Unsched  Visit</td>\n</tr>\n<tr>\n<td>Wk 104   a </td>\n<td>Wk  106-114   c </td>\n<td>Wk  115</td>\n<td>Wk  116   a, b </td>\n<td>Wk 128</td>\n<td>Wk  164</td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>44</td>\n<td>45-49</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-Lead ECG</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK plasma sample   d </td>\n<td></td>\n<td></td>\n<td>x (site visit)</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Clinical RNA sample</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum chemistry and  hematology    e,f </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Plasma biomarker sample    o </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Complete physical examination  (including neurological systems)    g </td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Limited physical  examination   h </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>MRI scan   i </td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td>x</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03444870_SOA_table_6.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"3\" rowspan=\"1\">Treatment Period</td>\n<td>Final Safety  and  Efficacy  Assessmen t</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period for  Participants  Not Enrolling in the OLE</td>\n<td>Early Term  Visit  [a]</td>\n<td>Unsched  Visit</td>\n</tr>\n<tr>\n<td>Wk 104   a </td>\n<td>Wk  106-114   c </td>\n<td>Wk  115</td>\n<td>Wk  116   a, b </td>\n<td>Wk 128</td>\n<td>Wk  164</td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>44</td>\n<td>45-49</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-Lead ECG</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK plasma sample   d </td>\n<td></td>\n<td></td>\n<td>x (site visit)</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Clinical RNA sample</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum chemistry and  hematology    e,f </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Plasma biomarker sample    o </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Complete physical examination  (including neurological systems)    g </td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Limited physical  examination   h </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>MRI scan   i </td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td>x</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03444870_SOA_table_7.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"3\" rowspan=\"1\">Treatment Period</td>\n<td>Final Safety  and Efficacy  Assessment</td>\n<td colspan=\"2\" rowspan=\"1\">Follow-Up Period for  Participants  Not Enrolling in the OLE</td>\n<td>Early Term  Visit  [a]</td>\n<td>Unsched  Visit</td>\n</tr>\n<tr>\n<td>Wk 104   a </td>\n<td>Wk 106-126   c </td>\n<td>Wk  127</td>\n<td>Wk  128   a, b </td>\n<td>Wk 140</td>\n<td>Wk  176</td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>44</td>\n<td>45-55</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-Lead ECG</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK plasma sample   d </td>\n<td></td>\n<td></td>\n<td>x (site  visit)</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Clinical RNA sample</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum chemistry and  hematology    e,f </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Plasma biomarker sample    o </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Complete physical examination  (including neurological systems)   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Limited physical  examination   h </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>MRI scan   i </td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td></td>\n<td></td>\n<td>x   j </td>\n<td>x</td>\n</tr>\n<tr>\n<td>CSF and matching serum sampling  (for participants enrolled based on  CSF eligibility criteria only)  k </td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>x    k </td>\n<td></td>\n</tr>\n<tr>\n<td>CDR</td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ADAS-Cog13</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03444870_SOA_table_8.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td>Treatment Period</td>\n<td></td>\n<td></td>\n<td>Final Safety  and Efficacy  Assessment</td>\n<td>Follow-Up Period for  Participants  Not Enrolling in the OLE</td>\n<td></td>\n<td>Early Term  Visit   a </td>\n<td>Unsched  Visit</td>\n</tr>\n<tr>\n<td>Wk 104   a </td>\n<td>Wk 106-126   c </td>\n<td>Wk  127</td>\n<td>Wk  128   a, b </td>\n<td>Wk 140</td>\n<td>Wk  176</td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>44</td>\n<td>45-55</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg)</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Verbal Fluency Task</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Coding</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>ADCS-ADL</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>FAQ</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>MMSE</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td>P</td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>EQ-5D</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>QoL-AD</td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td></td>\n<td></td>\n<td>P&amp;SP</td>\n<td>P&amp;SP</td>\n</tr>\n<tr>\n<td>ZCI-AD</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>RUD-Lite</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>NPI-Q</td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td></td>\n<td></td>\n<td>SP</td>\n<td>SP</td>\n</tr>\n<tr>\n<td>C-SSRS BL/SLV</td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td></td>\n<td></td>\n<td>P</td>\n<td>P</td>\n</tr>\n<tr>\n<td>Vital signs   l </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Urine pregnancy test   m </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Study drug  administration   d, n </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03444870_SOA_table_9.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment/Procedure</td>\n<td colspan=\"13\" rowspan=\"1\">Open-Label Extension Treatment Period</td>\n<td colspan=\"1\" rowspan=\"2\">OLE  Early  Term Visit  [m]</td>\n<td colspan=\"1\" rowspan=\"2\">OLE  UV</td>\n</tr>\n<tr>\n<td>OLE  Day 1</td>\n<td>OLE  Day  4</td>\n<td>OLE  Wk 2</td>\n<td>OLE  Wk 4</td>\n<td>OLE  Wk 6</td>\n<td>OLE  Wk 8</td>\n<td>OLE  Wk 10</td>\n<td>OLE  Wk 12</td>\n<td>OLE  Wk 14</td>\n<td>OLE  Wk 16</td>\n<td>OLE  Wk  18</td>\n<td>OLE  Wk  20</td>\n<td>OLE  Wk  22</td>\n</tr>\n<tr>\n<td>Dose number</td>\n<td>1   a </td>\n<td></td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9    b </td>\n<td>10    b </td>\n<td>11    b </td>\n<td>12    b </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg) for participants  previously on placebo</td>\n<td colspan=\"3\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">120</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td colspan=\"2\" rowspan=\"1\">255</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose level in  milligrams (mg) for participants  previously on active</td>\n<td>510</td>\n<td></td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td>510</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent(s)</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of inclusion and  exclusion criteria</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>12-Lead electrocardiogram</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>B</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>PK Plasma Sample    c </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Serum chemistry  and  hematology    d,e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td>x</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03461289_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Trial Period</td>\n<td>Screening</td>\n<td colspan=\"4\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"11\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Notes</td>\n</tr>\n<tr>\n<td>Nominal Study Day \n(Visit Relative To Dose)</td>\n<td>\n–30 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60(or month 2)</td>\n<td>72</td>\n<td>90(or month 3)</td>\n<td>Month \n4,5,7,8,10,11,13</td>\n<td>Month \n6,9,12</td>\n<td colspan=\"1\" rowspan=\"2\">End of Trial \n(18 months \nof age or ET)</td>\n<td colspan=\"4\" rowspan=\"3\">Depending on the patient’s age at dosing, \nthe duration of participation can vary from \napproximately 12 months (baby dosed at \napproximately 6 months of age) to \napproximately 18 months (baby dosed near \nbirth, “0 months of age”).</td>\n</tr>\n<tr>\n<td>Visit According To \nMonths of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>14,16,17</td>\n<td>15</td>\n</tr>\n<tr>\n<td>Window</td>\n<td colspan=\"5\" rowspan=\"1\">(No Window)</td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"5\" rowspan=\"1\">± 7 days\n(Except +0–14 days at 14 Months of Age)</td>\n<td>+0–14 days</td>\n</tr>\n<tr>\n<td>Informed Consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 18.3.</td>\n</tr>\n<tr>\n<td>AVXS-101 Infusion</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 10.6. Day 1 assessments will be performed prior to the start of gene replacement therapy infusion</td>\n</tr>\n<tr>\n<td>BSIDv03/WHO Developmental Milestones (with video)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Sections 11.1, 11.2.1, 11.2.2 and 11.3.</td>\n</tr>\n<tr>\n<td>BSIDv03 Gross and Fine Motor Subtests (with video)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Sections 11.1, 11.2.1, 11.2.2 and 11.3.</td>\n</tr>\n<tr>\n<td>CHOP INTEND (with video)</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Sections 11.2.3 and 11.3. Patients who achieve 3 consecutive CHOP INTEND scores ≥ 58 will not continue CHOPINTEND assessments.</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03461289_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Trial Period</td>\n<td>Screening</td>\n<td colspan=\"4\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"11\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Notes</td>\n</tr>\n<tr>\n<td>Nominal Study Day \n(Visit Relative To Dose)</td>\n<td>\n–30 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60(or month 2)</td>\n<td>72</td>\n<td>90(or month 3)</td>\n<td>Month \n4,5,7,8,10,11,13</td>\n<td>Month \n6,9,12</td>\n<td colspan=\"1\" rowspan=\"2\">End of Trial \n(18 months \nof age or ET)</td>\n<td colspan=\"4\" rowspan=\"3\">Depending on the patient’s age at dosing, \nthe duration of participation can vary from \napproximately 12 months (baby dosed at \napproximately 6 months of age) to \napproximately 18 months (baby dosed near \nbirth, “0 months of age”).</td>\n</tr>\n<tr>\n<td>Visit According To \nMonths of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>14,16,17</td>\n<td>15</td>\n</tr>\n<tr>\n<td>Window</td>\n<td colspan=\"5\" rowspan=\"1\">(No Window)</td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"5\" rowspan=\"1\">± 7 days\n(Except +0–14 days at 14 Months of Age)</td>\n<td>+0–14 days</td>\n</tr>\n<tr>\n<td>Demographic/Medical History</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.1.</td>\n</tr>\n<tr>\n<td>Physical Exam</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.2</td>\n</tr>\n<tr>\n<td>Vital Signs/Weight &amp; Length</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>(X)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.3.\n(X): Vital signs will be continuously monitored throughout the infusion of gene replacement therapy and recorded every 15 minutes (+/- 5 minutes) post dose for thefirst 4 hours after the start of infusion, then every hour (+/- 15 minutes) until 24 hours after the start of infusion. Axillary temperature will be recorded pre- and post-infusion.</td>\n</tr>\n<tr>\n<td>12-Lead ECG</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"3\">See Sections 12.1.4, 12.1.5, and 12.1.6.\n(X): Completed every 3 months, starting at \nMonth 3 until 12 months post-dose.</td>\n</tr>\n<tr>\n<td>Echocardiogram</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>X</td>\n</tr>\n<tr>\n<td>24-hour Holter Monitor</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pulmonary Examination</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.7.</td>\n</tr>\n<tr>\n<td>Swallowing Test</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>(X)</td>\n<td>(X)</td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.8</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03461289_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Trial Period</td>\n<td>Screening</td>\n<td colspan=\"4\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"11\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Notes</td>\n</tr>\n<tr>\n<td>Nominal Study Day \n(Visit Relative To Dose)</td>\n<td>\n–30 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60(or month 2)</td>\n<td>72</td>\n<td>90(or month 3)</td>\n<td>Month \n4,5,7,8,10,11,13</td>\n<td>Month \n6,9,12</td>\n<td colspan=\"1\" rowspan=\"2\">End of Trial \n(18 months \nof age or ET)</td>\n<td colspan=\"4\" rowspan=\"3\">Depending on the patient’s age at dosing, \nthe duration of participation can vary from \napproximately 12 months (baby dosed at \napproximately 6 months of age) to \napproximately 18 months (baby dosed near \nbirth, “0 months of age”).</td>\n</tr>\n<tr>\n<td>Visit According To \nMonths of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>14,16,17</td>\n<td>15</td>\n</tr>\n<tr>\n<td>Window</td>\n<td colspan=\"5\" rowspan=\"1\">(No Window)</td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"5\" rowspan=\"1\">± 7 days\n(Except +0–14 days at 14 Months of Age)</td>\n<td>+0–14 days</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">(X): Completed every 6 months, starting at \nMonth 6 through the End of Trial at \n18 months of age.</td>\n</tr>\n<tr>\n<td>Photograph of Infusion Site</td>\n<td></td>\n<td></td>\n<td>(X)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.9.\n(X): Day 1 infusion site photograph will be performed prior to the start of gene replacement therapy infusion.</td>\n</tr>\n<tr>\n<td>Hematology/Chemistry/Urinalysis</td>\n<td>X</td>\n<td>(X)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>(X)*</td>\n<td>X</td>\n<td>(X)*</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Sections 12.1.10.1, 12.1.10.2 and 12.1.10.3.\n(X): Laboratory samples collected on Day -1 to be processed locally, prior to dosing.\n(X)*: Liver function test (AST, ALT, total bilirubin, direct bilirubin, alkaline phosphatase, GGT) only.</td>\n</tr>\n<tr>\n<td>CK-MB or Troponin I</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.10.2.</td>\n</tr>\n<tr>\n<td>Virus Serology</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.10.4.</td>\n</tr>\n<tr>\n<td>Capillary Blood Gas</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.10.5.</td>\n</tr>\n<tr>\n<td>Immunological Testing: ELISA (anti-AAV9/SMN Ab)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.10.6.</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03461289_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Trial Period</td>\n<td>Screening</td>\n<td colspan=\"4\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"11\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Notes</td>\n</tr>\n<tr>\n<td>Nominal Study Day \n(Visit Relative To Dose)</td>\n<td>\n–30 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60(or month 2)</td>\n<td>72</td>\n<td>90(or month 3)</td>\n<td>Month \n4,5,7,8,10,11,13</td>\n<td>Month \n6,9,12</td>\n<td colspan=\"1\" rowspan=\"2\">End of Trial \n(18 months \nof age or ET)</td>\n<td colspan=\"4\" rowspan=\"3\">Depending on the patient’s age at dosing, \nthe duration of participation can vary from \napproximately 12 months (baby dosed at \napproximately 6 months of age) to \napproximately 18 months (baby dosed near \nbirth, “0 months of age”).</td>\n</tr>\n<tr>\n<td>Visit According To \nMonths of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>14,16,17</td>\n<td>15</td>\n</tr>\n<tr>\n<td>Window</td>\n<td colspan=\"5\" rowspan=\"1\">(No Window)</td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"5\" rowspan=\"1\">± 7 days\n(Except +0–14 days at 14 Months of Age)</td>\n<td>+0–14 days</td>\n</tr>\n<tr>\n<td>AAV9 Ab Screen in Biological Mother</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.10.7</td>\n</tr>\n<tr>\n<td>Blood for Diagnostic Confirmation Testing</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.10.8.</td>\n</tr>\n<tr>\n<td>Saliva, Urine, and Stool Samples (for viral shedding)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>(X)</td>\n<td>(X)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.10.9.\n(X): Collected within 24 and 48 hours post dose.</td>\n</tr>\n<tr>\n<td>Prophylactic Prednisolone</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>(X)</td>\n<td>(X)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 9.2.1. \n(X): After 30 days, prednisolone (or equivalent glucocorticoid) can be tapered for patients whose ALT values, and AST values are below the threshold.</td>\n</tr>\n<tr>\n<td>Adverse Events</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Section 13.</td>\n</tr>\n<tr>\n<td>Prior and Concomitant Medications</td>\n<td colspan=\"16\" rowspan=\"1\">Collected from 2 weeks before gene replacement therapy until End of Trial visit</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03505099_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"3\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"10\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Clarification</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>–30 to –2</td>\n<td>–14 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60</td>\n<td>72</td>\n<td></td>\n<td></td>\n<td>End of Study</td>\n<td colspan=\"4\" rowspan=\"1\">Day 1 assessments will be performed prior to the start of gene replacement therapy infusion. Day 7, 14, 21, 30, 44, 60, and 72 visits are timed based on the Day of AVXS-101 dose (Day 1). Visits on Study Days 44 and 72 are for blood chemistry only</td>\n</tr>\n<tr>\n<td>Months of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>3  a</td>\n<td>6, 9, 12, 15, 21</td>\n<td>18, 24, (or ET)</td>\n<td colspan=\"4\" rowspan=\"1\">Please see footnote “a” at the bottom of the Appendix 1 table for guidance on scheduling visits for Study Days 44, 60, 72, and 3 Months of Age.</td>\n</tr>\n<tr>\n<td>Window</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"3\" rowspan=\"1\">± 7 days</td>\n<td>± 14 days</td>\n<td>0–14 days</td>\n<td colspan=\"4\" rowspan=\"1\">The End of Study visit must occur within 0 to 14 days after the date on which the patient reaches 18 or 24 months of age (or ET), depending on the respective cohort. Visits prior to and including the Day 72 visit are timed based on the Day of AVXS-101 dose. Visits following Day 72 are based on the patient’s date of birth.</td>\n</tr>\n<tr>\n<td>Informed Consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 18.3.</td>\n</tr>\n<tr>\n<td>Prophylactic Prednisolone</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>(X)</td>\n<td>(X)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 9.2.1. Prednisolone to be given 24 hours prior to scheduled AVXS-101 dosing and continued as per protocol.\n(X): Taper prednisolone per protocol between 30 and 60 days after AVXS-101 treatment.</td>\n</tr>\n<tr>\n<td>AVXS-101 Infusion</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 10.6.</td>\n</tr>\n<tr>\n<td>Bayley Scales(Fine and Gross Motor Assessment with video)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">The Bayley Gross and Fine Motor Subtests are performed at Screening, Day 30 post-dose, Day 60 post-dose, and then every 3 months from 3 months of age visit. See Sections 11.1, 11.2.1, and 11.3.</td>\n</tr>\n<tr>\n<td>BSIDv03/WHO Developmental</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">Developmental milestones will be assessed as defined by BSIDv03 and WHO Multicentre Growth</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03505099_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"3\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"10\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Clarification</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>–30 to –2</td>\n<td>–14 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60</td>\n<td>72</td>\n<td></td>\n<td></td>\n<td>End of Study</td>\n<td colspan=\"4\" rowspan=\"1\">Day 1 assessments will be performed prior to the start of gene replacement therapy infusion. Day 7, 14, 21, 30, 44, 60, and 72 visits are timed based on the Day of AVXS-101 dose (Day 1). Visits on Study Days 44 and 72 are for blood chemistry only</td>\n</tr>\n<tr>\n<td>Months of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>3  a</td>\n<td>6, 9, 12, 15, 21</td>\n<td>18, 24, (or ET)</td>\n<td colspan=\"4\" rowspan=\"1\">Please see footnote “a” at the bottom of the Appendix 1 table for guidance on scheduling visits for Study Days 44, 60, 72, and 3 Months of Age.</td>\n</tr>\n<tr>\n<td>Window</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"3\" rowspan=\"1\">± 7 days</td>\n<td>± 14 days</td>\n<td>0–14 days</td>\n<td colspan=\"4\" rowspan=\"1\">The End of Study visit must occur within 0 to 14 days after the date on which the patient reaches 18 or 24 months of age (or ET), depending on the respective cohort. Visits prior to and including the Day 72 visit are timed based on the Day of AVXS-101 dose. Visits following Day 72 are based on the patient’s date of birth.</td>\n</tr>\n<tr>\n<td>Milestones (with video)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">Reference Study. Videos may be submitted for review by an independent central reviewer. See Sections 11.1, 11.2.1, and 11.3.</td>\n</tr>\n<tr>\n<td>CHOP INTEND (with video)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">CHOP INTEND will be performed only for patients with 2 copies of SMN2. Patients who achieve 3 consecutive CHOP INTEND scores ≥58 will not continue CHOP INTEND assessments. See Sections 11.2.2 and 11.3.</td>\n</tr>\n<tr>\n<td>CMAP</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">To be completed every 6 months, starting at 6 months of age through and including the EOS. .</td>\n</tr>\n<tr>\n<td>Demographic/Medical History</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.1.</td>\n</tr>\n<tr>\n<td>Physical Exam</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.2</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03505099_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"3\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"10\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Clarification</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>–30 to –2</td>\n<td>–14 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60</td>\n<td>72</td>\n<td></td>\n<td></td>\n<td>End of Study</td>\n<td colspan=\"4\" rowspan=\"1\">Day 1 assessments will be performed prior to the start of gene replacement therapy infusion. Day 7, 14, 21, 30, 44, 60, and 72 visits are timed based on the Day of AVXS-101 dose (Day 1). Visits on Study Days 44 and 72 are for blood chemistry only</td>\n</tr>\n<tr>\n<td>Months of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>3  a</td>\n<td>6, 9, 12, 15, 21</td>\n<td>18, 24, (or ET)</td>\n<td colspan=\"4\" rowspan=\"1\">Please see footnote “a” at the bottom of the Appendix 1 table for guidance on scheduling visits for Study Days 44, 60, 72, and 3 Months of Age.</td>\n</tr>\n<tr>\n<td>Window</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"3\" rowspan=\"1\">± 7 days</td>\n<td>± 14 days</td>\n<td>0–14 days</td>\n<td colspan=\"4\" rowspan=\"1\">The End of Study visit must occur within 0 to 14 days after the date on which the patient reaches 18 or 24 months of age (or ET), depending on the respective cohort. Visits prior to and including the Day 72 visit are timed based on the Day of AVXS-101 dose. Visits following Day 72 are based on the patient’s date of birth.</td>\n</tr>\n<tr>\n<td>Vital Signs/Weight &amp; Length</td>\n<td>(X)</td>\n<td></td>\n<td>X</td>\n<td>(X)*</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.3. Vital signs include blood pressure, respiratory rate, pulse, temperature, and pulse oximetry.\n(X)*: On Day 1, vital signs, with the exception of blood pressure will be recorded pre-dose and then continuously monitored throughout the gene replacement therapy infusion as follows: Every 15 (± 5) minutes from the start of the infusion for the first 1 hour; Every 30 minutes (± 10 minutes) until 2 hours; Every 2 hours (+ 15 minutes) until 6 hours; Every 4 hours (+ 30 minutes) until 24 hours. Blood pressure will be recorded pre-dose and every 8 hours through 24 hours. Additional monitoring of vital signs will be at the discretion of the Investigator.Temperature will be recorded pre- and post infusion. \n(X): Screening weight shall be obtained 14 days prior to Day 1.</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03505099_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"3\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"10\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Clarification</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>–30 to –2</td>\n<td>–14 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60</td>\n<td>72</td>\n<td></td>\n<td></td>\n<td>End of Study</td>\n<td colspan=\"4\" rowspan=\"1\">Day 1 assessments will be performed prior to the start of gene replacement therapy infusion. Day 7, 14, 21, 30, 44, 60, and 72 visits are timed based on the Day of AVXS-101 dose (Day 1). Visits on Study Days 44 and 72 are for blood chemistry only</td>\n</tr>\n<tr>\n<td>Months of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>3  a</td>\n<td>6, 9, 12, 15, 21</td>\n<td>18, 24, (or ET)</td>\n<td colspan=\"4\" rowspan=\"1\">Please see footnote “a” at the bottom of the Appendix 1 table for guidance on scheduling visits for Study Days 44, 60, 72, and 3 Months of Age.</td>\n</tr>\n<tr>\n<td>Window</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"3\" rowspan=\"1\">± 7 days</td>\n<td>± 14 days</td>\n<td>0–14 days</td>\n<td colspan=\"4\" rowspan=\"1\">The End of Study visit must occur within 0 to 14 days after the date on which the patient reaches 18 or 24 months of age (or ET), depending on the respective cohort. Visits prior to and including the Day 72 visit are timed based on the Day of AVXS-101 dose. Visits following Day 72 are based on the patient’s date of birth.</td>\n</tr>\n<tr>\n<td>12-Lead ECG</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"3\">A 12-lead ECG, echocardiogram, and 24-hour Holter Monitor are to be completed at Screening, at 3, 6, 9, and 12 months of age, and every 6 months after 12 months of age. For patients not already undergoing 12-lead ECG/24-Hour Holter monitoring/ECHO from 3 months of age, these testswill be performed when patients are initiallyconsented for them (ICF corresponding to protocol version 3.0 or later), and then according to the Schedule of Assessments. Note that 12-lead ECG and 24-hour Holter monitor are also performed during Days -1, 1, and 2. See Section 12.1.4, 12.1.5, and 12.1.6 for more details</td>\n</tr>\n<tr>\n<td>Echocardiogram</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>24-Hour Holter Monitor</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pulmonary Examination</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Section 12.1.7.</td>\n</tr>\n<tr>\n<td>Swallowing Test</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">Completed every 6 months, starting at 6 months of age through and including the EOS vist. Each test should include consistency tested.See Section 12.1.8.</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03505099_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"3\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"10\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Clarification</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>–30 to –2</td>\n<td>–14 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60</td>\n<td>72</td>\n<td></td>\n<td></td>\n<td>End of Study</td>\n<td colspan=\"4\" rowspan=\"1\">Day 1 assessments will be performed prior to the start of gene replacement therapy infusion. Day 7, 14, 21, 30, 44, 60, and 72 visits are timed based on the Day of AVXS-101 dose (Day 1). Visits on Study Days 44 and 72 are for blood chemistry only</td>\n</tr>\n<tr>\n<td>Months of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>3  a</td>\n<td>6, 9, 12, 15, 21</td>\n<td>18, 24, (or ET)</td>\n<td colspan=\"4\" rowspan=\"1\">Please see footnote “a” at the bottom of the Appendix 1 table for guidance on scheduling visits for Study Days 44, 60, 72, and 3 Months of Age.</td>\n</tr>\n<tr>\n<td>Window</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"3\" rowspan=\"1\">± 7 days</td>\n<td>± 14 days</td>\n<td>0–14 days</td>\n<td colspan=\"4\" rowspan=\"1\">The End of Study visit must occur within 0 to 14 days after the date on which the patient reaches 18 or 24 months of age (or ET), depending on the respective cohort. Visits prior to and including the Day 72 visit are timed based on the Day of AVXS-101 dose. Visits following Day 72 are based on the patient’s date of birth.</td>\n</tr>\n<tr>\n<td>Photographs of Infusion Site</td>\n<td></td>\n<td></td>\n<td></td>\n<td>(X)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">(X): Day 1 photograph of infusion site should be performed after infusion. See Section 12.1.9.</td>\n</tr>\n<tr>\n<td>Hematology/Chemistry/Urinalysis</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>(X)</td>\n<td>X</td>\n<td>(X)#</td>\n<td>X</td>\n<td>(X)#</td>\n<td>(X)#</td>\n<td>X</td>\n<td>(X)#</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">(X): Laboratory samples collected on Day 2 to be processed locally.\n(X)*: Chemisry and urinalysis only. No hematology\n(X)#: Chemistry only. See Sections 0, 12.1.10.2, and 12.1.10.3</td>\n</tr>\n<tr>\n<td>CK-MB or Troponin I</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">CK-MB or troponin-I will be collected at Screening, at the Day 7 and Day 30 visits, and every three months starting at the 6 months of age visit through and including the EOS visit. Patients screened and dosed before IRB/EC approval of Protocol version 2.0 incorporating Amendment 1 will be tested for CK-MB throughout the study. Patients screened before IRB/EC approval of Protocol version 2.0 incorporating Amendment 1 but dosed afterwards, will be tested for CK-MB at screening but for Troponin I at baseline and all subsequent visits. Patients screened after IRB/EC</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03505099_SOA_table_5.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"3\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"10\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Clarification</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>–30 to –2</td>\n<td>–14 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60</td>\n<td>72</td>\n<td></td>\n<td></td>\n<td>End of Study</td>\n<td colspan=\"4\" rowspan=\"1\">Day 1 assessments will be performed prior to the start of gene replacement therapy infusion. Day 7, 14, 21, 30, 44, 60, and 72 visits are timed based on the Day of AVXS-101 dose (Day 1). Visits on Study Days 44 and 72 are for blood chemistry only</td>\n</tr>\n<tr>\n<td>Months of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>3  a</td>\n<td>6, 9, 12, 15, 21</td>\n<td>18, 24, (or ET)</td>\n<td colspan=\"4\" rowspan=\"1\">Please see footnote “a” at the bottom of the Appendix 1 table for guidance on scheduling visits for Study Days 44, 60, 72, and 3 Months of Age.</td>\n</tr>\n<tr>\n<td>Window</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"3\" rowspan=\"1\">± 7 days</td>\n<td>± 14 days</td>\n<td>0–14 days</td>\n<td colspan=\"4\" rowspan=\"1\">The End of Study visit must occur within 0 to 14 days after the date on which the patient reaches 18 or 24 months of age (or ET), depending on the respective cohort. Visits prior to and including the Day 72 visit are timed based on the Day of AVXS-101 dose. Visits following Day 72 are based on the patient’s date of birth.</td>\n</tr>\n<tr>\n<td>Biological Mother Virus/Serology Testing</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Secton 12.1.10.4.</td>\n</tr>\n<tr>\n<td>Anti-AAV9 Ab Screen in Biological Mother</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">Patient samples for anti-AAV9 screening must be collected if biological mother’s titer result is &gt;1:50. See Secton 12.1.10.6.</td>\n</tr>\n<tr>\n<td>Genetic Re-confirmation Testing</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">See Secton 12.1.10.5.</td>\n</tr>\n<tr>\n<td>Adverse Events</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"4\" rowspan=\"1\">See Section 13</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03505099_SOA_table_6.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"3\" rowspan=\"1\">Gene Replacement Therapy (In-patient)</td>\n<td colspan=\"10\" rowspan=\"1\">Follow-up (Outpatient)</td>\n<td colspan=\"4\" rowspan=\"1\">Clarification</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>–30 to –2</td>\n<td>–14 to –2</td>\n<td>-1</td>\n<td>1</td>\n<td>2</td>\n<td>7</td>\n<td>14</td>\n<td>21</td>\n<td>30</td>\n<td>44</td>\n<td>60</td>\n<td>72</td>\n<td></td>\n<td></td>\n<td>End of Study</td>\n<td colspan=\"4\" rowspan=\"1\">Day 1 assessments will be performed prior to the start of gene replacement therapy infusion. Day 7, 14, 21, 30, 44, 60, and 72 visits are timed based on the Day of AVXS-101 dose (Day 1). Visits on Study Days 44 and 72 are for blood chemistry only</td>\n</tr>\n<tr>\n<td>Months of Age</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>3  a</td>\n<td>6, 9, 12, 15, 21</td>\n<td>18, 24, (or ET)</td>\n<td colspan=\"4\" rowspan=\"1\">Please see footnote “a” at the bottom of the Appendix 1 table for guidance on scheduling visits for Study Days 44, 60, 72, and 3 Months of Age.</td>\n</tr>\n<tr>\n<td>Window</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\">± 2 days</td>\n<td colspan=\"3\" rowspan=\"1\">± 7 days</td>\n<td>± 14 days</td>\n<td>0–14 days</td>\n<td colspan=\"4\" rowspan=\"1\">The End of Study visit must occur within 0 to 14 days after the date on which the patient reaches 18 or 24 months of age (or ET), depending on the respective cohort. Visits prior to and including the Day 72 visit are timed based on the Day of AVXS-101 dose. Visits following Day 72 are based on the patient’s date of birth.</td>\n</tr>\n<tr>\n<td>Prior and Concomitant Medications</td>\n<td colspan=\"15\" rowspan=\"1\">Collected from 2 Weeks before gene replacement therapy until End of Study visit</td>\n<td colspan=\"4\" rowspan=\"1\">See Secion 9.2.2</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03520998_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"2\" rowspan=\"1\">Screening/Baseline Vist  [a]</td>\n<td colspan=\"5\" rowspan=\"1\">Treatment   [b]</td>\n<td colspan=\"3\" rowspan=\"1\">Follow-up</td>\n<td colspan=\"5\" rowspan=\"1\">Treatment  [b]</td>\n<td colspan=\"3\" rowspan=\"1\">Follow-up</td>\n<td>End of Study/Early Termination Vist  [a]</td>\n</tr>\n<tr>\n<td>Vist</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n</tr>\n<tr>\n<td>Infusion number</td>\n<td></td>\n<td></td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td></td>\n<td></td>\n<td></td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Day</td>\n<td>Day -28 to -8</td>\n<td>day -7 to -1</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>28 ± 7 days</td>\n<td>56 ± 7 days</td>\n<td>85 ± 7 days</td>\n<td>86</td>\n<td>87</td>\n<td>88</td>\n<td>89</td>\n<td>90</td>\n<td>112 ± 7 days</td>\n<td>140 ± 7 days</td>\n<td>168 ± 7 days</td>\n</tr>\n<tr>\n<td>Week</td>\n<td></td>\n<td></td>\n<td colspan=\"6\" rowspan=\"1\">1</td>\n<td>4</td>\n<td>8</td>\n<td colspan=\"6\" rowspan=\"1\">13</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n</tr>\n<tr>\n<td>Inform Consent/Optional Biomaker Consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X  [2]</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X [1]</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X  [2]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical Exam/Height/Weight</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>GRF 6019 Infusion</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Target Physical Exam/Weight</td>\n<td></td>\n<td></td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant Medication  [a]</td>\n<td>X</td>\n<td>X</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Adverse Event  [a]</td>\n<td></td>\n<td>X</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Labs</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Screening Panel  [c]</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Exit Panel  [d]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Stat Labs(performed onsite)  [e]</td>\n<td></td>\n<td></td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td></td>\n<td></td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Comprehensive Labs   [f]</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X [1]</td>\n<td></td>\n<td>X [1]</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X [1]</td>\n<td></td>\n<td>X [1]</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Interim Safety Labs   [g]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Sample for proteomics/epigenetics/biobanking</td>\n<td></td>\n<td>X</td>\n<td>X [1]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X [1]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Apoe Genotype testing</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Imaging/Lumbar Puncture for CSF Biomakers</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Transthoracic echocardiogram</td>\n<td>X  [*]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MRI Testing</td>\n<td>X  [*]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X [h]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>PET Scan(optional)</td>\n<td>X  [*]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Lumbar Puncture/CSF Fluid Collection(optional)  [i]</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X  [2]</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Congnitive Testing</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MHIS</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MMSE</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Savonix Full Battery(Savonix-8 + Digit Span)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Savonix Brief Battery</td>\n<td></td>\n<td></td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td>X [1]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADAS-Cog/11</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X [1]</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Grooved Pegboard</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>CFT</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>CDR-SOB(subject and trial partner)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>ADCS-ADL(trial partner)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03596762_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening  Visit 1  (Visit 1) </td>\n<td>Screening  Visit 2  (Visit 2) </td>\n<td>Baseline  (Visit 3) </td>\n<td>Week 2  (Visit 4) </td>\n<td>Week 4  (Visit 5) </td>\n<td>Week 8  (Visit 6) </td>\n<td>Week 12  (Visit 7) </td>\n<td>Week 16  Follow-up/Early  Termination visit  (Visit 8)  b</td>\n</tr>\n<tr>\n<td>Visit Day </td>\n<td>-21   a </td>\n<td>-14</td>\n<td>1 </td>\n<td>15 </td>\n<td>29 </td>\n<td>57 </td>\n<td>85 </td>\n<td>113 </td>\n</tr>\n<tr>\n<td>Allowable window </td>\n<td>   a </td>\n<td>±2 days </td>\n<td>0 </td>\n<td>±3 days </td>\n<td>±3 days </td>\n<td>±4 days </td>\n<td>±4 days </td>\n<td>±5 days </td>\n</tr>\n<tr>\n<td>Informed Consent   c </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History/Concomitant Diseases </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demography </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical Exam </td>\n<td></td>\n<td>X </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   d </td>\n</tr>\n<tr>\n<td>Inclusion/Exclusion Criteria </td>\n<td>X </td>\n<td>X   e </td>\n<td>X   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of Concomitant Medications </td>\n<td>       X --------------------------------------------------------------------------------------------------------------------X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs   g </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>12-lead ECG</td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>AE and SAE Recording </td>\n<td>  X --------------------------------------------------------------------------------------------------- X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Issue Paper Diary / Training </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Paper Diary Completion (once daily) </td>\n<td>X-------X   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Issue eDiary / Training / Compliance check </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>eDiary Completion (twice daily) </td>\n<td></td>\n<td>       X---------------------------------------------------------------------------------------------------X   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Study Drug Dispensing/Training </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Placebo Treatment </td>\n<td></td>\n<td>X-------X   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Study Drug Collection/Compliance </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Randomisation </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Daily Dosing (evening before bedtime) </td>\n<td></td>\n<td></td>\n<td>       X ------------------------------------------------------------- X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MenQoL-I </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>HFRDIS </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Pittsburgh Sleep Quality Index </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Insomnia Severity Index </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Columbia Suicide Severity Rating Scale </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Beck Depression Inventory II </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Clinical Chemistry and Haematology </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X   k </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Blood sample for NT-814 concentration</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for bone turnover markers </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urine pregnancy Test </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03600818_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>VISIT </td>\n<td>V1 </td>\n<td>V2 </td>\n<td>V3 </td>\n<td>V4 </td>\n<td>V5 </td>\n<td>V6 </td>\n<td>V7 </td>\n<td>V8 </td>\n<td>V9  </td>\n<td>V10  </td>\n<td>V11 </td>\n<td>V12   (EOT) </td>\n<td>V13  (EOS) </td>\n</tr>\n<tr>\n<td>DAY </td>\n<td>D-28 to  D-1 </td>\n<td>D1 </td>\n<td>D15  (±3) </td>\n<td>D29  (±3) </td>\n<td>D57  (±3) </td>\n<td>D85   (±3) </td>\n<td>D113  (±3) </td>\n<td>D141  (±3) </td>\n<td>D169  (±3) </td>\n<td>D225  (±3) </td>\n<td>D281  (±3) </td>\n<td>D365     (±3) </td>\n<td>D407  (±3) </td>\n</tr>\n<tr>\n<td>WEEK </td>\n<td></td>\n<td>Week 0 </td>\n<td>Week 2 </td>\n<td>Week 4 </td>\n<td>Week 8 </td>\n<td>Week 12 </td>\n<td>Week 16 </td>\n<td>Week 20 </td>\n<td>Week 24 </td>\n<td>Week 32 </td>\n<td>Week 40 </td>\n<td>Week 52 </td>\n<td>Week 58 </td>\n</tr>\n<tr>\n<td>Eligibility </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Written informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria   t </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Ultrasound central reading   v </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Patient demography  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical/surgical/smoking-alcohol  history </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Prior medication history </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Family cardiovascular history </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Full physical examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Targeted physical examination   a </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Confirm eligibility </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Call IRT </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Treatment </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Initial treatment kit assignment (IRT) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IMP administration   b </td>\n<td></td>\n<td>X   w </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X   s </td>\n<td>X   s </td>\n<td>X   s </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medication review </td>\n<td>X   u </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03600818_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>VISIT </td>\n<td>V1 </td>\n<td>V2 </td>\n<td>V3 </td>\n<td>V4 </td>\n<td>V5 </td>\n<td>V6 </td>\n<td>V7 </td>\n<td>V8 </td>\n<td>V9  </td>\n<td>V10  </td>\n<td>V11 </td>\n<td>V12   (EOT) </td>\n<td>V13  (EOS) </td>\n</tr>\n<tr>\n<td>DAY </td>\n<td>D-28 to  D-1 </td>\n<td>D1 </td>\n<td>D15  (±3) </td>\n<td>D29  (±3) </td>\n<td>D57  (±3) </td>\n<td>D85   (±3) </td>\n<td>D113  (±3) </td>\n<td>D141  (±3) </td>\n<td>D169  (±3) </td>\n<td>D225  (±3) </td>\n<td>D281  (±3) </td>\n<td>D365     (±3) </td>\n<td>D407  (±3) </td>\n</tr>\n<tr>\n<td>WEEK </td>\n<td></td>\n<td>Week 0 </td>\n<td>Week 2 </td>\n<td>Week 4 </td>\n<td>Week 8 </td>\n<td>Week 12 </td>\n<td>Week 16 </td>\n<td>Week 20 </td>\n<td>Week 24 </td>\n<td>Week 32 </td>\n<td>Week 40 </td>\n<td>Week 52 </td>\n<td>Week 58 </td>\n</tr>\n<tr>\n<td>Dispense patient diary </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Compliance/review patient diary </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Temperature, heart rate, blood  pressure </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Weight </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Height </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Efficacy</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PMR clinical assessments        (including disease flare) </td>\n<td>X </td>\n<td>X</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Physician global assessment          (MD-VAS) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Patient reported outcomes   c </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Glucocorticoid toxicity index (excl. bone  density assessment) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Bone density assessment   d </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Safety </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>AE/SAE recording </td>\n<td colspan=\"12\" rowspan=\"1\">------------------------------------------------------------------------------------------------------------------------------------------------------</td>\n<td></td>\n</tr>\n<tr>\n<td>Tuberculosis assessment </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>QuantiFERON®</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chest X-ray   e </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Laboratory testing </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology   f </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03600818_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>VISIT </td>\n<td>V1 </td>\n<td>V2 </td>\n<td>V3 </td>\n<td>V4 </td>\n<td>V5 </td>\n<td>V6 </td>\n<td>V7 </td>\n<td>V8 </td>\n<td>V9  </td>\n<td>V10  </td>\n<td>V11 </td>\n<td>V12   (EOT) </td>\n<td>V13  (EOS) </td>\n</tr>\n<tr>\n<td>DAY </td>\n<td>D-28 to  D-1 </td>\n<td>D1 </td>\n<td>D15  (±3) </td>\n<td>D29  (±3) </td>\n<td>D57  (±3) </td>\n<td>D85   (±3) </td>\n<td>D113  (±3) </td>\n<td>D141  (±3) </td>\n<td>D169  (±3) </td>\n<td>D225  (±3) </td>\n<td>D281  (±3) </td>\n<td>D365     (±3) </td>\n<td>D407  (±3) </td>\n</tr>\n<tr>\n<td>WEEK </td>\n<td></td>\n<td>Week 0 </td>\n<td>Week 2 </td>\n<td>Week 4 </td>\n<td>Week 8 </td>\n<td>Week 12 </td>\n<td>Week 16 </td>\n<td>Week 20 </td>\n<td>Week 24 </td>\n<td>Week 32 </td>\n<td>Week 40 </td>\n<td>Week 52 </td>\n<td>Week 58 </td>\n</tr>\n<tr>\n<td>Chemistry   g </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>ANA   h </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Fasting lipids  and fasting  glucose/insulin   i,j </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>HbA1c </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>CRP   k </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>ESR   k </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis   l </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Virology   m </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum pregnancy test   n </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine pregnancy test   n </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum sarilumab   j </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X   r </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Antibodies to sarilumab/ADA   j </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Genotyping and biomarkers   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Biomarkers-IL-6 and sIL-6R </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Immune Cell Phenotyping (Whole  Blood)   o </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Future Use Samples (Serum and  Plasma)  - Optional  l,p </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03600818_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>VISIT </td>\n<td>V1 </td>\n<td>V2 </td>\n<td>V3 </td>\n<td>V4 </td>\n<td>V5 </td>\n<td>V6 </td>\n<td>V7 </td>\n<td>V8 </td>\n<td>V9  </td>\n<td>V10  </td>\n<td>V11 </td>\n<td>V12   (EOT) </td>\n<td>V13  (EOS) </td>\n</tr>\n<tr>\n<td>DAY </td>\n<td>D-28 to  D-1 </td>\n<td>D1 </td>\n<td>D15  (±3) </td>\n<td>D29  (±3) </td>\n<td>D57  (±3) </td>\n<td>D85   (±3) </td>\n<td>D113  (±3) </td>\n<td>D141  (±3) </td>\n<td>D169  (±3) </td>\n<td>D225  (±3) </td>\n<td>D281  (±3) </td>\n<td>D365     (±3) </td>\n<td>D407  (±3) </td>\n</tr>\n<tr>\n<td>WEEK </td>\n<td></td>\n<td>Week 0 </td>\n<td>Week 2 </td>\n<td>Week 4 </td>\n<td>Week 8 </td>\n<td>Week 12 </td>\n<td>Week 16 </td>\n<td>Week 20 </td>\n<td>Week 24 </td>\n<td>Week 32 </td>\n<td>Week 40 </td>\n<td>Week 52 </td>\n<td>Week 58 </td>\n</tr>\n<tr>\n<td>DNA - Optional  q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>RNA - Optional  q </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03605667_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit Number </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 or  Early Term </td>\n<td>10 </td>\n<td></td>\n</tr>\n<tr>\n<td>Study Visit Time Point </td>\n<td>Screening  (within 42  days prior  to baseline) </td>\n<td> Baseline  (Week 0) </td>\n<td> Week 2  (±3 days) </td>\n<td> Week 4  (±7 days) </td>\n<td> Week 8  (±7 days) </td>\n<td> Week 12  (±7 days) </td>\n<td> Week 24  (±7 days) </td>\n<td> Week 36  (±7 days) </td>\n<td> Week 48  (±7 days)   1 </td>\n<td>Follow-Up  Week 52  (±7 days) </td>\n<td>Unscheduled  Visit   2 </td>\n</tr>\n<tr>\n<td>Informed Consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Eligibility Review </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization   3 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Med History/Demographics </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Modified Hachinski Ischemic  Scale </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Height &amp; Weight   4 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Physical Examination </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Neurological Examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs   5 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Concomitant Medication </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Adverse Events   6 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>12-lead ECG (resting) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical Safety Blood Tests   7 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X   8 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>B12 (blood test) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis   9 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HIV, HBsAg, HCV antibody </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ApoE4 (blood test) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood Collection for  Biomarker Banking </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood Collection for  Pharmacokinetics   10 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03605667_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>'Visit Number</td>\n<td>'1</td>\n<td>'2</td>\n<td>'3</td>\n<td>'4</td>\n<td>'5</td>\n<td>'6</td>\n<td>'7</td>\n<td>'8</td>\n<td>'9 or Early Term</td>\n<td>'10</td>\n<td>'</td>\n</tr>\n<tr>\n<td>'Study Visit Time Point</td>\n<td>'Screening (within 42 days prior to baseline)</td>\n<td>'Baseline (Week 0)</td>\n<td>'Week 2 (+3 days)</td>\n<td>'Week 4 (+7 days)</td>\n<td>'Week 8 (+7 days)</td>\n<td>'Week 12 (+7 days)</td>\n<td>'Week 24 (+7 days)</td>\n<td>'Week 36 (+7 days)</td>\n<td>'Week 48 (+7 days)</td>\n<td>Follow-Up week 52 (±7 days)</td>\n<td>'Unscheduled Visit</td>\n</tr>\n<tr>\n<td>'Volumetric MRI</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Lumbar Puncture (LP) 1,12</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'CSF Biomarkers13</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Post-LP Safety Telephone14</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Sheehan Suicidality Tracking</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>'ADAS-Cog 11</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'CDR-SOB</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'NPI</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'ADCS-ADL</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Craft Story 21 Recall</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Benson Complex Figure</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'MINT</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Letter &amp; Category Fluency</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Trail Making Test A &amp; B</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Number Span Test</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'MMSE</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'MoCA</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Research Satisfaction Survey</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Dispense Study Drug</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Study Drug Instruction Phone Call</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Study Drug Accountability</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>'Treatment Blinding Questionnaire17</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03605836_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"11\" rowspan=\"1\">Table 3.7-1 Schedule of Assessments - Screening Through End of Treatment</td>\n</tr>\n<tr>\n<td>Period</td>\n<td>Screening   a </td>\n<td>PBO Run-in   b </td>\n<td colspan=\"7\" rowspan=\"1\">Double-blind Treatment</td>\n<td colspan=\"1\" rowspan=\"2\">NOTES</td>\n</tr>\n<tr>\n<td></td>\n<td>Days −35 to −8</td>\n<td>Day −7</td>\n<td>Baseline Day −1</td>\n<td>Day 7 +1 Day</td>\n<td>Day 14 ±2 Days</td>\n<td>Day 21 ±2 Days</td>\n<td>Day 28 ±2 Days</td>\n<td>Day 35 ±2 Days</td>\n<td>Day 42/ET ±2 Days</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"11\" rowspan=\"1\">ENTRANCE/HISTORY</td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 3.4.1</td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 3.4</td>\n</tr>\n<tr>\n<td>Demography</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medication(s)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ACDS</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Identification of comorbidities using  MINI</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Psychiatric evaluation</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HIV/HBsAg/anti-HCV</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 3.7.5.2</td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 3.6.1</td>\n</tr>\n<tr>\n<td>Urine pregnancy test</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 3.7.5.2 Section 5.7</td>\n</tr>\n<tr>\n<td colspan=\"11\" rowspan=\"1\">EFFICACY</td>\n</tr>\n<tr>\n<td>AISRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 3.7.2.1</td>\n</tr>\n<tr>\n<td>CGI-S</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 3.7.2.2</td>\n</tr>\n<tr>\n<td>CGI Change from Baseline</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 3.7.2.3</td>\n</tr>\n<tr>\n<td colspan=\"11\" rowspan=\"1\">SAFETY</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 5.2</td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>Section 3.7.5.3.1</td>\n</tr>\n<tr>\n<td>Vital signs</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 3.7.5.3.2</td>\n</tr>\n<tr>\n<td>12-lead ECG</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>Section 3.7.5.4</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>Section 3.7.5.2</td>\n</tr>\n<tr>\n<td>SMWQ</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 3.7.5.5.1</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03605836_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"11\" rowspan=\"1\">Table 3.7-1 Schedule of Assessments - Screening Through End of Treatment</td>\n</tr>\n<tr>\n<td>Period</td>\n<td>Screening   a </td>\n<td>PBO Run-in   b </td>\n<td colspan=\"7\" rowspan=\"1\">Double-blind Treatment</td>\n<td colspan=\"1\" rowspan=\"2\">NOTES</td>\n</tr>\n<tr>\n<td></td>\n<td>Days −35 to −8</td>\n<td>Day −7</td>\n<td>Baseline Day −1</td>\n<td>Day 7 +1 Day</td>\n<td>Day 14 ±2 Days</td>\n<td>Day 21 ±2 Days</td>\n<td>Day 28 ±2 Days</td>\n<td>Day 35 ±2 Days</td>\n<td>Day 42/ET ±2 Days</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td></td>\n</tr>\n<tr>\n<td>UDS/alcohol testing via breathalyzer or  blood</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 3.7.5.2</td>\n</tr>\n<tr>\n<td>C-SSRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 3.7.5.5.2</td>\n</tr>\n<tr>\n<td>PHARMACOKINETIC/PHARMACOGENOMIC</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PK blood sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>Section 3.7.6.1</td>\n</tr>\n<tr>\n<td>Pharmacogenomic and FBR samples</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 3.7.6.2 Section 3.7.6.3</td>\n</tr>\n<tr>\n<td colspan=\"11\" rowspan=\"1\">EXPLORATORY</td>\n</tr>\n<tr>\n<td>AIM-A</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>Section 3.7.3.1</td>\n</tr>\n<tr>\n<td>ASRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>Section 3.7.3.4</td>\n</tr>\n<tr>\n<td colspan=\"11\" rowspan=\"1\">OTHER</td>\n</tr>\n<tr>\n<td>IMP/placebo dispensing</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IMP/placebo return and accountability</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.4 Section 3.12</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03605836_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"8\" rowspan=\"1\">Table 3.7-2 Schedule of Assessments - Follow-up</td>\n<td></td>\n</tr>\n<tr>\n<td>Period</td>\n<td colspan=\"6\" rowspan=\"1\">Follow-up   a </td>\n<td colspan=\"1\" rowspan=\"2\">NOTES</td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>1 (+1) day after the last  dose of IMP</td>\n<td>2 (+1)  days  after  the  last  dose of  IMP</td>\n<td>3 (+ 1)  days  after  the last  dose of  IMP</td>\n<td>5 (+ 1)  days  after  the last  dose of  IMP</td>\n<td>7 (+ 2)  days after  the last  dose of  IMP</td>\n<td>10 (+ 2)  days  after the  last dose  of IMP</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"9\" rowspan=\"1\">ENTRANCE/HISTORY</td>\n</tr>\n<tr>\n<td>Concomitant medication(s)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>EFFICACY</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>AISRS</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>Section 3.7.2.1</td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"9\" rowspan=\"1\">SAFETY</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 5.2</td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>Section 3.7.5.3.2</td>\n<td></td>\n</tr>\n<tr>\n<td>SMWQ</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 3.7.5.5.1</td>\n<td></td>\n</tr>\n<tr>\n<td>UDS/alcohol testing via breathalyzer or blood</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>Section 3.7.5.2</td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>Section 3.7.5.5.2</td>\n<td></td>\n</tr>\n<tr>\n<td>PHARMACOKINETIC/PHARMACOGENOMIC</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PK blood sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>Section 3.7.6.1</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03611010_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Phase </td>\n<td>Screen  -ing </td>\n<td>Lead-in </td>\n<td colspan=\"7\" rowspan=\"1\">Treatment </td>\n<td>Follow-up  call </td>\n<td colspan=\"2\" rowspan=\"1\">Optional  SUB-STUDY </td>\n</tr>\n<tr>\n<td>Study Day </td>\n<td>Day -3 to  0 from LI  Day 0</td>\n<td>LI End Visit  (Screening visit  + 7 to 10 days)  AND  (0 to -2 days  before Day 1) </td>\n<td>Day  1 </td>\n<td>Day  2 </td>\n<td>Day  3 </td>\n<td>Days  4–7 </td>\n<td>Day  8 </td>\n<td>Days  9-14 </td>\n<td>Day  15/  WD   ** </td>\n<td>Day 22 </td>\n<td>Day 22   + 2 days</td>\n<td> Day 29   + 3 days  (Phone call)</td>\n</tr>\n<tr>\n<td>LDL-C, Point of care </td>\n<td>X    * </td>\n<td>X   † </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>LDL-C, Local laboratory </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographic Data </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy Test,if needed </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Drug, Alcohol, Viral screen </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical Exam </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CBC, CMP, lipid profile </td>\n<td>X   </td>\n<td>X   ‡ </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Basic Metabolic Panel </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs </td>\n<td>X </td>\n<td></td>\n<td>X   ‖ </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of Eligibility </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PK Blood Draws</td>\n<td></td>\n<td>X   § </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   ⁋ </td>\n<td></td>\n<td>X   Δ </td>\n<td></td>\n</tr>\n<tr>\n<td>Daily oral atorvastatin  dosing (standard of care). </td>\n<td colspan=\"2\" rowspan=\"1\">X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Resume on  Day 16, if in   sub-study</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Daily IV or SCIMP </td>\n<td></td>\n<td></td>\n<td colspan=\"7\" rowspan=\"1\">X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Single injection SC </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Con Med monitoring </td>\n<td colspan=\"10\" rowspan=\"1\">X </td>\n<td colspan=\"2\" rowspan=\"1\">               X </td>\n</tr>\n<tr>\n<td>Adverse Event monitoring </td>\n<td></td>\n<td colspan=\"9\" rowspan=\"1\">X </td>\n<td colspan=\"2\" rowspan=\"1\">X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03611010_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Phase </td>\n<td>Screen  -ing </td>\n<td colspan=\"3\" rowspan=\"1\">Lead-in </td>\n<td colspan=\"7\" rowspan=\"1\">Treatment </td>\n<td>Follow-up call </td>\n<td colspan=\"2\" rowspan=\"1\">Optional  SUB-STUDY </td>\n</tr>\n<tr>\n<td>Study Day </td>\n<td>Day -3  to 0  from LI  Day 0</td>\n<td>LI  Day  0  </td>\n<td>LI Interim  Visit    (LI Day 28  +/-2 days) </td>\n<td>LI End Visit  (Interim visit +  7 to 10 days  AND  0 to -2 days  before Day 1) </td>\n<td>Day  1 </td>\n<td>Day  2 </td>\n<td>Day  3 </td>\n<td>Days  4–7 </td>\n<td>Day  8 </td>\n<td>Days  9-14 </td>\n<td>Day  15 </td>\n<td>Day 22 </td>\n<td>Day 22  + 2 days</td>\n<td>Day 29  + 3 days  (Phone call)</td>\n</tr>\n<tr>\n<td>LDL-C, Point of care </td>\n<td>X    * </td>\n<td></td>\n<td>X </td>\n<td>X   † </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>LDL-C, Local </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographic Data </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy Test,if </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Drug, Alcohol, Viral </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical Exam </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CBC, CMP, lipid profile </td>\n<td>X   </td>\n<td></td>\n<td></td>\n<td>X   ‡ </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Basic Metabolic Panel </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   ‖ </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of Eligibility </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PK Blood Draws</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   § </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   ⁋ </td>\n<td></td>\n<td>X   Δ </td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense oral </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Daily oral atorvastatin  dosing </td>\n<td></td>\n<td colspan=\"3\" rowspan=\"1\">X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Resume  on Day  16, if in   sub-study</td>\n<td colspan=\"2\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Drug accountability </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\"></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Daily IV or SC IMP </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"7\" rowspan=\"1\">X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Single injection SC </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Con Med monitoring </td>\n<td colspan=\"12\" rowspan=\"1\">X </td>\n<td colspan=\"2\" rowspan=\"1\">               X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03617523_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"2\" rowspan=\"1\">All Subjects </td>\n<td>Subjects Receiving 1 Dose  of Influenza Vaccine </td>\n<td colspan=\"3\" rowspan=\"1\">Subjects Receiving 2 Doses of Influenza Vaccine </td>\n</tr>\n<tr>\n<td>Visit Number </td>\n<td>Visit 1 </td>\n<td>Telephone Contact </td>\n<td>Visit 2 </td>\n<td>Visit 2 </td>\n<td>Telephone Contact </td>\n<td>Visit 3 </td>\n</tr>\n<tr>\n<td>Study Timelines  </td>\n<td>Day 0 </td>\n<td>Visit 1 + 8 days </td>\n<td>Visit 1 + 28 days </td>\n<td>Visit 1 + 28 days </td>\n<td>Visit 2 + 8 days </td>\n<td>Visit 2 + 28 days </td>\n</tr>\n<tr>\n<td>Time Windows  </td>\n<td>-- </td>\n<td>+ 8 to 10 days </td>\n<td>+ 28 to 35 days </td>\n<td>+ 28 to 35 days </td>\n<td>+ 8 to 10 days </td>\n<td>+ 28 to 35 days </td>\n</tr>\n<tr>\n<td>Informed consent/assent   a </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion &amp; Exclusion Criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographic data </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Influenza vaccination history  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>History-directed physical examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Temperature   b </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review contraindications for vaccination </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Allocation of subject number </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample (BL)   c </td>\n<td>BL1 </td>\n<td></td>\n<td>BL2 </td>\n<td></td>\n<td></td>\n<td>BL2 </td>\n</tr>\n<tr>\n<td>Vaccination   d </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Immediate surveillance (20 minutes) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card (DC) provided </td>\n<td>DC1 </td>\n<td></td>\n<td></td>\n<td>DC2 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Telephone contact   e </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card reviewed and collected</td>\n<td></td>\n<td></td>\n<td>DC1 </td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n</tr>\n<tr>\n<td>Interim history </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Termination record   f </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Serious adverse events </td>\n<td colspan=\"6\" rowspan=\"1\">To be reported throughout the study period </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03617523_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit Number  </td>\n<td>Visit 1 </td>\n<td>Telephone Contact </td>\n<td>Visit 2 </td>\n</tr>\n<tr>\n<td>Study Timelines  </td>\n<td>Day 0 </td>\n<td>Visit 1 + 8 days </td>\n<td>Visit 1 + 21 days </td>\n</tr>\n<tr>\n<td>Time Windows  </td>\n<td></td>\n<td>+ 8 to 10 days </td>\n<td>+ 21 to 28 days </td>\n</tr>\n<tr>\n<td>Informed consent  </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographic data </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history  </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Influenza vaccination history (previous season) </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>History-directed physical examination  </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Temperature   a </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine or serum pregnancy test   b </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Allocation of subject number </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sampling (BL)   c </td>\n<td>BL1 </td>\n<td></td>\n<td>BL2 </td>\n</tr>\n<tr>\n<td>Vaccination  </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Immediate surveillance (20 minutes) </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card provided </td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Telephone contact   d </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card reviewed and collected </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Termination record </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Serious adverse events </td>\n<td colspan=\"3\" rowspan=\"1\">To be reported throughout the study period </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03619213_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit</td>\n<td>1 Enrolment</td>\n<td>2 Randomisation</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7 – onwards</td>\n<td>Premature Treatment Discontinuation Visit</td>\n<td>Study Closure Visit</td>\n<td>For details see Section:</td>\n</tr>\n<tr>\n<td>Day/Month</td>\n<td>Day -21 to Day -1</td>\n<td>Day 1</td>\n<td>Day 30 (±7)</td>\n<td>Day 120 (±7)</td>\n<td>Day 240 (±7)</td>\n<td>Day 360 (±7)</td>\n<td>Day 480 -onwards (every 120 days ±14 days)</td>\n<td></td>\n<td>≤ 6 weeks after PACD</td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X   6 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>5.1, A 3</td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>5.1, 5.2</td>\n</tr>\n<tr>\n<td>Demographics</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>5.1</td>\n</tr>\n<tr>\n<td>Medical history</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>5.1</td>\n</tr>\n<tr>\n<td>Concomitant medication</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>6.5</td>\n</tr>\n<tr>\n<td>Cardiac and HF related procedures</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>8.5.1.3</td>\n</tr>\n<tr>\n<td>Physical exam</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>8.4.1</td>\n</tr>\n<tr>\n<td>Systolic and diastolic BP</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X   3 </td>\n<td>X   3 </td>\n<td>X</td>\n<td>X</td>\n<td>5.2, 8.4.2</td>\n</tr>\n<tr>\n<td>Pulse</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X   3 </td>\n<td>X   3 </td>\n<td>X</td>\n<td>X</td>\n<td>5.2, 8.4.2</td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   3 </td>\n<td>X   3 </td>\n<td>X</td>\n<td>X</td>\n<td>8.4.6.1</td>\n</tr>\n<tr>\n<td>Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>8.4.6.1</td>\n</tr>\n<tr>\n<td>NYHA classification</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>5.1, Appendix I</td>\n</tr>\n<tr>\n<td>12-lead ECG</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>8.4.3</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03619213_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit</td>\n<td>1 Enrolment</td>\n<td>2 Randomisation</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7 – onwards</td>\n<td>Premature Treatment Discontinuation Visit</td>\n<td>Study Closure Visit</td>\n<td>For details see Section:</td>\n</tr>\n<tr>\n<td>Day/Month</td>\n<td>Day -21 to Day -1</td>\n<td>Day 1</td>\n<td>Day 30 (±7)</td>\n<td>Day 120 (±7)</td>\n<td>Day 240 (±7)</td>\n<td>Day 360 (±7)</td>\n<td>Day 480 -onwards (every 120 days ±14 days)</td>\n<td></td>\n<td>≤ 6 weeks after PACD</td>\n<td></td>\n</tr>\n<tr>\n<td>C-lab NT-proBNP</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>5.1</td>\n</tr>\n<tr>\n<td>C-lab eGFR (creatinine)</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X   3 </td>\n<td>X   3 </td>\n<td></td>\n<td></td>\n<td>5.2, 8.4.4</td>\n</tr>\n<tr>\n<td>C-lab HbA1c</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>6.3.1.1</td>\n</tr>\n<tr>\n<td>Sample for genetic research, if applicable   5 </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Appendix D</td>\n</tr>\n<tr>\n<td>KCCQ</td>\n<td></td>\n<td>X   4 </td>\n<td>X   4 </td>\n<td>X   4 </td>\n<td>X   4 </td>\n<td></td>\n<td></td>\n<td>X   4 </td>\n<td>X   4 </td>\n<td>8.3.3.1</td>\n</tr>\n<tr>\n<td>PGIS</td>\n<td></td>\n<td>X   4 </td>\n<td>X   4 </td>\n<td>X   4 </td>\n<td>X   4 </td>\n<td></td>\n<td></td>\n<td>X   4 </td>\n<td>X   4 </td>\n<td>8.3.3.2</td>\n</tr>\n<tr>\n<td>EQ-5D-5L</td>\n<td></td>\n<td>X    4 </td>\n<td></td>\n<td></td>\n<td>X   4 </td>\n<td></td>\n<td></td>\n<td>X   4 </td>\n<td>X   4 </td>\n<td>8.3.3.3</td>\n</tr>\n<tr>\n<td>Local pregnancy test (female patients with childbearing potential only)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>5.1</td>\n</tr>\n<tr>\n<td>Randomisation</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>8.2.1</td>\n</tr>\n<tr>\n<td>Dispense investigational product (IP)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>6</td>\n</tr>\n<tr>\n<td>Collect unused IP; check IP compliance</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>6</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03619213_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit</td>\n<td>1 Enrolment</td>\n<td>2 Randomisation</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7 – onwards</td>\n<td>Premature Treatment Discontinuation Visit</td>\n<td>Study Closure Visit</td>\n<td>For details see Section:</td>\n</tr>\n<tr>\n<td>Day/Month</td>\n<td>Day -21 to Day -1</td>\n<td>Day 1</td>\n<td>Day 30 (±7)</td>\n<td>Day 120 (±7)</td>\n<td>Day 240 (±7)</td>\n<td>Day 360 (±7)</td>\n<td>Day 480 -onwards (every 120 days ±14 days)</td>\n<td></td>\n<td>≤ 6 weeks after PACD</td>\n<td></td>\n</tr>\n<tr>\n<td>Efficacy events (death and worsening heart failure)    1 </td>\n<td></td>\n<td>    X,1 </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>8.3</td>\n</tr>\n<tr>\n<td>Safety events   2,7 </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>8.4</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03620747_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study periods </td>\n<td>Start-of-Treatment</td>\n<td>Treatment Period   (144 weeks) </td>\n<td>End-of-Treatment /  End-of-Study </td>\n</tr>\n<tr>\n<td>Week (W)</td>\n<td>W0</td>\n<td>W12-W132 (Visit every 12 weeks) </td>\n<td>W144</td>\n</tr>\n<tr>\n<td> VISIT</td>\n<td>V1   a </td>\n<td>V2–V12   b </td>\n<td>V13   c </td>\n</tr>\n<tr>\n<td>Enrollment</td>\n<td></td>\n<td colspan=\"2\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Patient demography </td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Eligibility criteria </td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"4\" rowspan=\"1\">Treatment</td>\n</tr>\n<tr>\n<td>Contact IRT </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>IMP dispensation/administration   d </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>IMP accountability  </td>\n<td>X </td>\n<td>X </td>\n<td>X</td>\n</tr>\n<tr>\n<td>Injection training/technique observation   e </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense home-dosing diary   f </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"4\" rowspan=\"1\">Safety</td>\n</tr>\n<tr>\n<td>Clinical laboratory   g </td>\n<td>X   h </td>\n<td>X </td>\n<td>X  </td>\n</tr>\n<tr>\n<td>Adverse event reporting </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Symptom-driven physical examination and vital signs </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Concomitant medications </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03622658_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening  (Up to 28 Days  before Day 1)  [1]</td>\n<td colspan=\"4\" rowspan=\"1\">Treatment Period  [2]</td>\n<td>EoT/ ET  Visit </td>\n<td>FU Phone  Contact  [3]</td>\n<td>Follow-up </td>\n</tr>\n<tr>\n<td>Visit Number </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td></td>\n<td>7 </td>\n</tr>\n<tr>\n<td>Study Week </td>\n<td>-4 to -1 </td>\n<td>0 </td>\n<td>2 </td>\n<td>6 </td>\n<td>10 </td>\n<td>12 </td>\n<td></td>\n<td>28 </td>\n</tr>\n<tr>\n<td>Study Day/Window </td>\n<td>-28 to -8 </td>\n<td>1 </td>\n<td>15/±2</td>\n<td>43/±2</td>\n<td>71/±2</td>\n<td>85/±2</td>\n<td></td>\n<td>197/±4 </td>\n</tr>\n<tr>\n<td>Screening </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion and exclusion criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demography </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Past and current medical conditions </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Safety Assessments </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Full physical examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Height </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   4 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Clinical laboratory assessments  (haematology, chemistry including  CRP and ESR, urinalysis) </td>\n<td>X </td>\n<td>X </td>\n<td>X   5 </td>\n<td>X </td>\n<td>X   5 </td>\n<td>X </td>\n<td></td>\n<td>X   5 </td>\n</tr>\n<tr>\n<td>Serum pregnancy test (WOCBP only)   6 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine pregnancy test (WOCBP only)   6 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>HIV testing </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serology (Hep B and C) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>QuantiFERON-TB (or equivalent test) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Lung function tests   7 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pulse oximetry </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>MRC breathlessness scale </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Chest x-ray   8 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Adverse events </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Concomitant medication </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03622658_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening  (Up to 28 Days  before Day 1)  [1]</td>\n<td colspan=\"4\" rowspan=\"1\">Treatment Period  [2]</td>\n<td>EoT/ ET  Visit </td>\n<td>FU Phone  Contact  [3]</td>\n<td>Follow-up </td>\n</tr>\n<tr>\n<td>Visit Number </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td></td>\n<td>7 </td>\n</tr>\n<tr>\n<td>Study Week </td>\n<td>-4 to -1 </td>\n<td>0 </td>\n<td>2 </td>\n<td>6 </td>\n<td>10 </td>\n<td>12 </td>\n<td></td>\n<td>28 </td>\n</tr>\n<tr>\n<td>Study Day/Window </td>\n<td>-28 to -8 </td>\n<td>1 </td>\n<td>15/±2</td>\n<td>43/±2</td>\n<td>71/±2</td>\n<td>85/±2</td>\n<td></td>\n<td>197/±4 </td>\n</tr>\n<tr>\n<td>Efficacy Assessments </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Subject’s Global Assessment of  Disease Status </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Subject’s assessment of spinal pain </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>BASFI </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>BASDAI </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MRI </td>\n<td>X   9 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   10 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ASDAS-CRP assessment </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Neuropathic pain score  (painDETECT™) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Joint count, tendon swelling, and  enthesitis </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PK/PD Assessments   11 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample saved for Total GM-CSF  (namilumab/GM-CSF complexes),  namilumab serum concentration,  immunogenicity and immunology   12,13 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Saliva sample for DNA (optional) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for biomarkers and  immunophenotyping </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Blood sample for HLA-B27   14 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Stool sample for calprotectin </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Stool sample for microbiome analysis </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>IMP administration </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomisation </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Subcutaneous dosing of IMP </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03624881_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Pre-Procedure </td>\n<td></td>\n<td></td>\n<td>Phone  Call </td>\n<td colspan=\"4\" rowspan=\"1\">Follow-Up Visits </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Screening /  Baseline </td>\n<td>Ablation  Procedure  1 </td>\n<td>Discharge  1 </td>\n<td>7-9  Days </td>\n<td>1 Month  +/- 1 wks  </td>\n<td>3 Month  +/- 1 wks  </td>\n<td>6 Month  +/- 2 wks  </td>\n<td>12  Month   +/- 4 wks  </td>\n<td>Unsched uled Visit </td>\n</tr>\n<tr>\n<td>Visit no. </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n</tr>\n<tr>\n<td>Informed consent   1 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion &amp; exclusion  criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   10 </td>\n<td>X   10 </td>\n<td>X   10 </td>\n<td>X   10 </td>\n<td>X   10 </td>\n<td>X   10 </td>\n</tr>\n<tr>\n<td>Physical Exam </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Arrhythmias </td>\n<td>X   history  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>ECG </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>NYHA </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>QOL assessment   2 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test   3 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>LA thrombus  Imaging   4 </td>\n<td></td>\n<td></td>\n<td>X   4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TTE   5,13 </td>\n<td></td>\n<td>X   5 </td>\n<td></td>\n<td>X   13 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Ablation assessments </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Device deficiency </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant  medications   6 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Health Economic  Data Collection   7 </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   7 </td>\n<td>X   7 </td>\n<td>X   7 </td>\n<td>X   7 </td>\n<td>X   7 </td>\n<td>X   7 </td>\n<td>X   7 </td>\n</tr>\n<tr>\n<td>Adverse events   8,9 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03624881_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Pre-Procedure </td>\n<td></td>\n<td></td>\n<td>Phone  Call </td>\n<td colspan=\"4\" rowspan=\"1\">Follow-Up Visits </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Screening /  Baseline </td>\n<td>Ablation  Procedure  1 </td>\n<td>Discharge  1 </td>\n<td>7-9  Days </td>\n<td>1 Month  +/- 1 wks  </td>\n<td>3 Month  +/- 1 wks  </td>\n<td>6 Month  +/- 2 wks  </td>\n<td>12  Month   +/- 4 wks  </td>\n<td>Unsched uled Visit </td>\n</tr>\n<tr>\n<td>Visit no. </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n</tr>\n<tr>\n<td>TTM monitoring   11 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   11 </td>\n<td>X   11 </td>\n<td>X   11 </td>\n<td>X   11 </td>\n<td></td>\n</tr>\n<tr>\n<td>24 Hour Holter </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>PV stenosis imaging  assessment   12 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   12 </td>\n<td>X   12 </td>\n<td>X   12 </td>\n<td>X   12 </td>\n<td>X   12 </td>\n<td>X   12 </td>\n</tr>\n<tr>\n<td>Subject Completion/  discontinuation form </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   14 </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03627468_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>VISIT </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 – 6  1</td>\n<td>7 – 16  2</td>\n<td>17  3</td>\n</tr>\n<tr>\n<td>Time Point </td>\n<td>Screening  (-31 to 0 Days) </td>\n<td>Baseline  (Day 1) </td>\n<td>Weeks  2, 4, 6, 8 ±3 days </td>\n<td>Q4 Weeks  (Weeks 12 – 48)±5 days </td>\n<td>End of Study   Week 52 ±5 days </td>\n</tr>\n<tr>\n<td colspan=\"6\" rowspan=\"1\">PROCEDURE </td>\n</tr>\n<tr>\n<td>Informed Consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical Hx, Demog </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>I/E Criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PE </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Vitals (BP, HR, RR,  Temp) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>HDSM-Ax </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PGI-S   4 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PGI-C   5 </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>DLQI   6 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>HidroQoL   7 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Local Tolerability   8 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Adverse Events   8 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>UPT (FOCBP)   9 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>IP Dispensation/ Return/  Resupply   10 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>IP Weight   10 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Compliance  Training/Evaluation </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Safety Labs (heme.,  chem., urine)   11 </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Conmeds </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03629184_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"6\" rowspan=\"1\">Treatment Period</td>\n<td colspan=\"5\" rowspan=\"1\">Follow-Up Period</td>\n</tr>\n<tr>\n<td>Day(s)</td>\n<td colspan=\"2\" rowspan=\"1\">D1</td>\n<td>D2</td>\n<td>D3</td>\n<td>D4</td>\n<td>D5</td>\n<td>D6</td>\n<td>D7-9</td>\n<td>D10</td>\n<td>D15</td>\n<td>D29 or ET</td>\n</tr>\n<tr>\n<td>Visits</td>\n<td>V1  Screening</td>\n<td>V1 Post-dose</td>\n<td>V2</td>\n<td>OpV1   a </td>\n<td>V3</td>\n<td></td>\n<td>V4</td>\n<td></td>\n<td>V5</td>\n<td>OpV2   a </td>\n<td>V6</td>\n</tr>\n<tr>\n<td>Visit Window (days)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>1</td>\n<td></td>\n<td>1</td>\n<td></td>\n<td>2</td>\n<td>3</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Written informed consent/assent</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history   b </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Study drug administration   c </td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Patient diary: </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Body temperature measurement   d </td>\n<td colspan=\"4\" rowspan=\"1\">Four times daily</td>\n<td colspan=\"4\" rowspan=\"1\">Twice daily</td>\n<td colspan=\"2\" rowspan=\"1\">Once daily</td>\n<td></td>\n</tr>\n<tr>\n<td>Assessment of influenza symptoms   e </td>\n<td colspan=\"8\" rowspan=\"1\">Twice daily</td>\n<td colspan=\"2\" rowspan=\"1\">Once daily</td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>x   f </td>\n<td></td>\n<td>x   f </td>\n<td>(x)   f </td>\n<td>x   f </td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>(x )  g </td>\n<td>x   f </td>\n</tr>\n<tr>\n<td>Vital signs measurement</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>(x)</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>(x )  g </td>\n<td>x   h </td>\n</tr>\n<tr>\n<td>Adverse event assessment</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>(x)</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>(x )  g </td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant therapies assessment</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>(x)</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>(x )  g </td>\n<td>x</td>\n</tr>\n<tr>\n<td>Interview for meal consumption</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td>(x )  g </td>\n<td>(x )  g </td>\n</tr>\n<tr>\n<td>Nasal/nasopharyngeal swabs  (virology test)   i </td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>(x )  g </td>\n<td>(x )  g </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03629184_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"6\" rowspan=\"1\">Treatment Period</td>\n<td colspan=\"5\" rowspan=\"1\">Follow-Up Period</td>\n</tr>\n<tr>\n<td>Day(s)</td>\n<td colspan=\"2\" rowspan=\"1\">D1</td>\n<td>D2</td>\n<td>D3</td>\n<td>D4</td>\n<td>D5</td>\n<td>D6</td>\n<td>D7-9</td>\n<td>D10</td>\n<td>D15</td>\n<td>D29 or ET</td>\n</tr>\n<tr>\n<td>Visits</td>\n<td>V1  Screening</td>\n<td>V1 Post-dose</td>\n<td>V2</td>\n<td>OpV1   a </td>\n<td>V3</td>\n<td></td>\n<td>V4</td>\n<td></td>\n<td>V5</td>\n<td>OpV2   a </td>\n<td>V6</td>\n</tr>\n<tr>\n<td>Sparse PK samples   j </td>\n<td></td>\n<td>x</td>\n<td>(x)   j </td>\n<td></td>\n<td>(x)   j </td>\n<td></td>\n<td colspan=\"3\" rowspan=\"1\">x   j </td>\n<td colspan=\"2\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Intensive PK samples   k </td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td colspan=\"3\" rowspan=\"1\">x   k </td>\n<td colspan=\"2\" rowspan=\"1\"></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03630705_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit /  Telephone Call </td>\n<td>Visit 1 </td>\n<td>TC1   *</td>\n<td>Visit 2 </td>\n<td>Visit 3 </td>\n<td>TC2   *</td>\n<td>Visit 4 </td>\n<td>TC3† </td>\n<td>Visit 5 </td>\n<td>TC4   *</td>\n<td>Visit 6 </td>\n</tr>\n<tr>\n<td>Approximate Subject Age </td>\n<td>2 months‡ </td>\n<td>- </td>\n<td>4 months </td>\n<td>6 months </td>\n<td>- </td>\n<td>7 months </td>\n<td>- </td>\n<td>12 months </td>\n<td>- </td>\n<td>13 months </td>\n</tr>\n<tr>\n<td>Trial timelines (days, months) </td>\n<td>D0 </td>\n<td>V01  +8 days</td>\n<td>V01 +  60 days </td>\n<td>V02 +  60 days </td>\n<td>V03 +  8 days </td>\n<td>V03 +  30 days </td>\n<td>V05  -14 days</td>\n<td>V04  +5 months</td>\n<td>V05  +8 days</td>\n<td>V05 +  30 days </td>\n</tr>\n<tr>\n<td>Time windows (days) </td>\n<td>NA </td>\n<td>+2 days</td>\n<td>+14 days</td>\n<td>+14 days</td>\n<td>+2 days</td>\n<td>+14 days</td>\n<td>+2 days</td>\n<td>+14 days</td>\n<td>+2 days</td>\n<td>+14 days</td>\n</tr>\n<tr>\n<td>Informed consent form signed and dated </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of demographic data </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history§ (including history of maternal  immunization against tetanus) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination and temperature </td>\n<td>X    ** </td>\n<td></td>\n<td>X†† </td>\n<td>X†† </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X†† </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of temporary contraindications for blood  sampling (BL) ‡‡§§</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>BL (6 mL) </td>\n<td>BL0001 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>BL0002 </td>\n<td></td>\n<td></td>\n<td></td>\n<td>BL0003 </td>\n</tr>\n<tr>\n<td>Review of warnings and precautions and / or  contraindications for vaccinations </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review conditions for withdrawal    *** </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for randomization / allocation of  subject number / vaccine assignment </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for vaccine dose number for all  vaccines to be given </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccination with MenACYW conjugate vaccine </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Prevnar 13® vaccination††† </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03630705_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit /  Telephone Call </td>\n<td>Visit 1 </td>\n<td>TC1   *</td>\n<td>Visit 2 </td>\n<td>Visit 3 </td>\n<td>TC2   *</td>\n<td>Visit 4 </td>\n<td>TC3† </td>\n<td>Visit 5 </td>\n<td>TC4   *</td>\n<td>Visit 6 </td>\n</tr>\n<tr>\n<td>Approximate Subject Age </td>\n<td>2 months‡ </td>\n<td>- </td>\n<td>4 months </td>\n<td>6 months </td>\n<td>- </td>\n<td>7 months </td>\n<td>- </td>\n<td>12 months </td>\n<td>- </td>\n<td>13 months </td>\n</tr>\n<tr>\n<td>RotaTeq® vaccination††† </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hexacima® vaccination†††  </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>M-M-R®II vaccinations††† </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Immediate surveillance (30 min) </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary Card (DC):   </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Provided </td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td>DC3 </td>\n<td></td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Reviewed </td>\n<td></td>\n<td></td>\n<td>DC1 </td>\n<td>DC2 </td>\n<td></td>\n<td>DC3 </td>\n<td></td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n</tr>\n<tr>\n<td> Collected </td>\n<td></td>\n<td></td>\n<td>DC1 </td>\n<td>DC2 </td>\n<td></td>\n<td>DC3 </td>\n<td></td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n</tr>\n<tr>\n<td>Telephone call </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of solicited injection site and systemic  reactions </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of unsolicited AEs  </td>\n<td></td>\n<td colspan=\"9\" rowspan=\"1\">Reported from D0 to D30 after each vaccination visit </td>\n</tr>\n<tr>\n<td>Reporting of SAEs / AESIs‡‡‡ </td>\n<td colspan=\"10\" rowspan=\"1\">To be reported throughout the study period </td>\n</tr>\n<tr>\n<td>Collection of reportable concomitant medications </td>\n<td colspan=\"10\" rowspan=\"1\">To be reported throughout the study period </td>\n</tr>\n<tr>\n<td>Trial termination record </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03630705_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit /   Telephone Call (TC) </td>\n<td>Visit 1 </td>\n<td>TC1   *</td>\n<td>Visit 2 </td>\n<td>TC2   *</td>\n<td>Visit 3 </td>\n<td>TC3   *</td>\n<td>Visit 4 </td>\n<td>TC4† </td>\n<td>Visit 5 </td>\n<td>TC5   *</td>\n<td>Visit 6 </td>\n</tr>\n<tr>\n<td>Approximate Subject Age </td>\n<td>2 months‡ </td>\n<td>- </td>\n<td>4 months </td>\n<td>- </td>\n<td>6 months </td>\n<td>- </td>\n<td>7 months </td>\n<td>- </td>\n<td>12 months </td>\n<td>- </td>\n<td>13 months  </td>\n</tr>\n<tr>\n<td>Trial timelines (days, months) </td>\n<td>D0 </td>\n<td>V01  +8 days </td>\n<td>V01+60  days </td>\n<td>V02  +8 days </td>\n<td>V02 +60  days </td>\n<td>V03 +8  days </td>\n<td>V03 +30  days </td>\n<td>V05   -14 days </td>\n<td>V04  +5 months </td>\n<td>V05   +8 days </td>\n<td>V05 +30  days </td>\n</tr>\n<tr>\n<td>Time windows (days) </td>\n<td>NA </td>\n<td>+2 days </td>\n<td>+14 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n</tr>\n<tr>\n<td>Informed consent form signed and dated </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of demographic data </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history§ </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination and temperature </td>\n<td>X    ** </td>\n<td></td>\n<td>X†† </td>\n<td></td>\n<td>X†† </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X†† </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of temporary contraindications for blood  sampling (BL) ‡‡ §§</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>BL (6 mL) </td>\n<td>BL0001 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>BL0002 </td>\n<td></td>\n<td></td>\n<td></td>\n<td>BL0003 </td>\n</tr>\n<tr>\n<td>Review of warnings and precautions and / or  contraindications for vaccinations </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review conditions for withdrawal    *** </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for randomization / allocation of  subject number / vaccine assignment </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for vaccine dose number for all  vaccines to be given </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccination with Menveo®</td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03630705_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit /   Telephone Call (TC) </td>\n<td>Visit 1 </td>\n<td>TC1   *</td>\n<td>Visit 2 </td>\n<td>TC2   *</td>\n<td>Visit 3 </td>\n<td>TC3   *</td>\n<td>Visit 4 </td>\n<td>TC4† </td>\n<td>Visit 5 </td>\n<td>TC5   *</td>\n<td>Visit 6 </td>\n</tr>\n<tr>\n<td>Approximate Subject Age </td>\n<td>2 months‡ </td>\n<td>- </td>\n<td>4 months </td>\n<td>- </td>\n<td>6 months </td>\n<td>- </td>\n<td>7 months </td>\n<td>- </td>\n<td>12 months </td>\n<td>- </td>\n<td>13 months  </td>\n</tr>\n<tr>\n<td>Prevnar 13® vaccination††† </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>RotaTeq® vaccination††† </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hexacima® vaccination††† </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>M-M-R®II vaccinations†††  </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Immediate surveillance  (30 min)  </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary Card (DC): </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Provided </td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td></td>\n<td>DC3 </td>\n<td></td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Reviewed </td>\n<td></td>\n<td></td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td></td>\n<td>DC3 </td>\n<td></td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n</tr>\n<tr>\n<td> Collected </td>\n<td></td>\n<td></td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td></td>\n<td>DC3 </td>\n<td></td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n</tr>\n<tr>\n<td>Telephone call </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of solicited injection site and systemic  reactions </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of unsolicited AEs </td>\n<td colspan=\"11\" rowspan=\"1\">Collected from D0 to D30 after each vaccination visit </td>\n</tr>\n<tr>\n<td>Reporting of SAEs / AESIs§§§ </td>\n<td colspan=\"11\" rowspan=\"1\">To be reported throughout the study period </td>\n</tr>\n<tr>\n<td>Collection of reportable concomitant medications </td>\n<td colspan=\"11\" rowspan=\"1\">To be reported throughout the study period </td>\n</tr>\n<tr>\n<td>Trial termination record </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03630705_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit /   Telephone Call </td>\n<td>V0 </td>\n<td>V01 </td>\n<td>TC1   *</td>\n<td>V02 </td>\n<td>TC2   *</td>\n<td>V03 </td>\n<td>V04 </td>\n<td>TC3   *</td>\n<td>V05 </td>\n<td>TC4†</td>\n<td>V06 </td>\n<td>TC5   *</td>\n<td>V07 </td>\n</tr>\n<tr>\n<td>Approximate  Subject Age </td>\n<td>2 months‡</td>\n<td>2 months</td>\n<td>- </td>\n<td>3 months </td>\n<td>- </td>\n<td>4.5  months </td>\n<td>6 months </td>\n<td>- </td>\n<td>7  months </td>\n<td>- </td>\n<td>12 months </td>\n<td>- </td>\n<td>13 months </td>\n</tr>\n<tr>\n<td>Trial timeline  (days, months) </td>\n<td></td>\n<td>Day 0 +  1 day </td>\n<td>V01  +8 days </td>\n<td>V01   +30 days </td>\n<td>V02   +8 days </td>\n<td>V02  +45 days </td>\n<td>V03  +45 days </td>\n<td>V04  +8 days </td>\n<td>V04   +30 days </td>\n<td>V06   -14 days </td>\n<td>V05  +5 months </td>\n<td>V06  +8 days  </td>\n<td>V06   +30 days </td>\n</tr>\n<tr>\n<td>Time windows  (days) </td>\n<td> NA </td>\n<td>+4 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n<td>+14 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n<td>+2 days  </td>\n<td>+14 days </td>\n<td>+ 2 days </td>\n<td>+14 days </td>\n</tr>\n<tr>\n<td>Informed consent  form signed and  dated </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion / exclusion  criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of  demographic data </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history§ </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine Sample,  (8 mL)    ** </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Physical  examination &amp;  temperature </td>\n<td>X </td>\n<td>X†† </td>\n<td></td>\n<td>X‡‡</td>\n<td></td>\n<td>X‡‡</td>\n<td>X‡‡</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X‡‡</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of temporary  contraindications for  Blood Sampling  (BL)§§    *** </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03630705_SOA_table_5.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit /   Telephone Call </td>\n<td>V0 </td>\n<td>V01 </td>\n<td>TC1   *</td>\n<td>V02 </td>\n<td>TC2   *</td>\n<td>V03 </td>\n<td>V04 </td>\n<td>TC3   *</td>\n<td>V05 </td>\n<td>TC4†</td>\n<td>V06 </td>\n<td>TC5   *</td>\n<td>V07 </td>\n</tr>\n<tr>\n<td>Approximate  Subject Age </td>\n<td>2 months‡</td>\n<td>2 months</td>\n<td>- </td>\n<td>3 months </td>\n<td>- </td>\n<td>4.5  months </td>\n<td>6 months </td>\n<td>- </td>\n<td>7  months </td>\n<td>- </td>\n<td>12 months </td>\n<td>- </td>\n<td>13 months </td>\n</tr>\n<tr>\n<td>BL </td>\n<td>BL0001  6 mL††† </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>BL0002  6 mL‡‡‡ </td>\n<td></td>\n<td></td>\n<td></td>\n<td>BL0003  6 mL††† </td>\n</tr>\n<tr>\n<td>Review of warnings  and precautions and /  or contraindications  to vaccinations </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review conditions  for withdrawal§§§</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system  for randomization /  allocation of subject  number / vaccine  assignment </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system  for vaccine dose  number for all  vaccines to be given </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccination with  MenACYW  conjugate vaccine </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ENGERIX  B® ††††   vaccination   **** </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Prevnar 13® vaccination†††† </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pentaxim® vaccination†††† </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MMR  vaccination†††† </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03630705_SOA_table_6.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit /   Telephone Call </td>\n<td>V0 </td>\n<td>V01 </td>\n<td>TC1   *</td>\n<td>V02 </td>\n<td>TC2   *</td>\n<td>V03 </td>\n<td>V04 </td>\n<td>TC3   *</td>\n<td>V05 </td>\n<td>TC4†</td>\n<td>V06 </td>\n<td>TC5   *</td>\n<td>V07 </td>\n</tr>\n<tr>\n<td>Approximate  Subject Age </td>\n<td>2 months‡</td>\n<td>2 months</td>\n<td>- </td>\n<td>3 months </td>\n<td>- </td>\n<td>4.5  months </td>\n<td>6 months </td>\n<td>- </td>\n<td>7  months </td>\n<td>- </td>\n<td>12 months </td>\n<td>- </td>\n<td>13 months </td>\n</tr>\n<tr>\n<td>Immediate  surveillance  (30 minutes) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Telephone Call  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Diary Card (DC): </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Provided </td>\n<td></td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td></td>\n<td>DC3 </td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n<td></td>\n<td>DC6 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Reviewed </td>\n<td></td>\n<td></td>\n<td></td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td>DC3 </td>\n<td></td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n<td></td>\n<td>DC6 </td>\n</tr>\n<tr>\n<td> Collected </td>\n<td></td>\n<td></td>\n<td></td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td>DC3 </td>\n<td></td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n<td></td>\n<td>DC6 </td>\n</tr>\n<tr>\n<td>Collection of  reportable  medications </td>\n<td>To be reported throughout the study period </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of  solicited injection-site and systemic  reactions </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of  unsolicited AEs  </td>\n<td>Collected from D0 to D30 after each vaccination visit </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Reporting of SAEs /  AESIs‡‡‡‡</td>\n<td>To be reported throughout the study period </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Trial Termination </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03630705_SOA_table_7.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Telephone Call  </td>\n<td>V0 </td>\n<td>V01 </td>\n<td>TC1   *</td>\n<td>V02 </td>\n<td>TC2   *</td>\n<td>V03 </td>\n<td>V04 </td>\n<td>TC3   *</td>\n<td>V05 </td>\n<td>TC4   *</td>\n<td>V06 </td>\n<td>TC5†</td>\n<td>V07 </td>\n</tr>\n<tr>\n<td>Approximate Subject Age </td>\n<td>2 months‡ </td>\n<td>2 months </td>\n<td>- </td>\n<td>3  months </td>\n<td>- </td>\n<td>4.5  months </td>\n<td>6  months </td>\n<td></td>\n<td>7  months </td>\n<td>- </td>\n<td>12  months </td>\n<td>- </td>\n<td>13  months </td>\n</tr>\n<tr>\n<td>Trial timeline  (days, months) </td>\n<td></td>\n<td>Day 0 +  1 day </td>\n<td>V01  +8 days </td>\n<td>V01   +30 days </td>\n<td>V02   +8 days </td>\n<td>V02  +45 days </td>\n<td>V03  +45 days </td>\n<td>V04   +8 days </td>\n<td>V04  +30 days </td>\n<td>V06   -14  days </td>\n<td>V05  +5 months </td>\n<td>V06   +8 days </td>\n<td>V06   +30 days </td>\n</tr>\n<tr>\n<td>Time windows (days) </td>\n<td>NA </td>\n<td>+4 days</td>\n<td>+2 days</td>\n<td>+14 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n<td>+14 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n<td>+2 days </td>\n<td>+14 days </td>\n</tr>\n<tr>\n<td>Informed consent form signed  and dated </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion / exclusion criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of demographic data </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history§ </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine Sample (8mL)    ** </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Physical examination &amp;  temperature </td>\n<td>X </td>\n<td>X†† </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X‡‡</td>\n<td>X‡‡</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X‡‡</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of temporary  contraindications for Blood  Sampling (BL)§§    *** </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>BL </td>\n<td>BL0001  6 mL††† </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>BL0002  6 mL‡‡‡ </td>\n<td></td>\n<td></td>\n<td></td>\n<td>BL0003  6 mL††† </td>\n</tr>\n<tr>\n<td>Review of warnings and  precautions and / or  contraindications to vaccinations </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review conditions for  withdrawal§§§ </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for  randomization / allocation of  subject number / vaccine  assignment </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03630705_SOA_table_8.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Telephone Call  </td>\n<td>V0 </td>\n<td>V01 </td>\n<td>TC1   *</td>\n<td>V02 </td>\n<td>TC2   *</td>\n<td>V03 </td>\n<td>V04 </td>\n<td>TC3   *</td>\n<td>V05 </td>\n<td>TC4   *</td>\n<td>V06 </td>\n<td>TC5†</td>\n<td>V07 </td>\n</tr>\n<tr>\n<td>Approximate Subject Age </td>\n<td>2 months‡ </td>\n<td>2 months </td>\n<td>- </td>\n<td>3  months </td>\n<td>- </td>\n<td>4.5  months </td>\n<td>6  months </td>\n<td></td>\n<td>7  months </td>\n<td>- </td>\n<td>12  months </td>\n<td>- </td>\n<td>13  months </td>\n</tr>\n<tr>\n<td>Contact IRT system for vaccine  dose number for all vaccines to  be given </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ENGERIX B® vaccination ††††   **** </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Prevnar 13® vaccination†††† </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pentaxim® vaccination†††† </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MMR vaccination†††† </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Immediate surveillance   (30 minutes) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Telephone Call  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Diary Card(DC): </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Provided </td>\n<td></td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td></td>\n<td>DC3 </td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n<td></td>\n<td>DC6 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Reviewed </td>\n<td></td>\n<td></td>\n<td></td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td>DC3 </td>\n<td></td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n<td></td>\n<td>DC6 </td>\n</tr>\n<tr>\n<td> Collected </td>\n<td></td>\n<td></td>\n<td></td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td>DC3 </td>\n<td></td>\n<td>DC4 </td>\n<td></td>\n<td>DC5 </td>\n<td></td>\n<td>DC6 </td>\n</tr>\n<tr>\n<td>Collection of reportable  concomitant medications </td>\n<td colspan=\"13\" rowspan=\"1\">To be reported throughout the study period. </td>\n</tr>\n<tr>\n<td>Recording of solicited injection  and systemic reactions </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of Unsolicited AEs </td>\n<td colspan=\"13\" rowspan=\"1\">Collected from D0 to D30 after each vaccination visit </td>\n</tr>\n<tr>\n<td>Reporting of   SAEs / AESIs‡‡‡‡</td>\n<td colspan=\"13\" rowspan=\"1\">To be reported throughout the study period </td>\n</tr>\n<tr>\n<td>Trial Termination </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03632720_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit </td>\n<td>Visit 1 </td>\n<td>Telephone  Call (TC) 1   *</td>\n<td>Visit 2 </td>\n<td>TC2   *</td>\n<td>Visit 3 </td>\n<td>TC3   *</td>\n<td>Visit 4† </td>\n<td>TC4   *</td>\n<td>Visit 5‡ </td>\n</tr>\n<tr>\n<td>Approximate age of subjects </td>\n<td>2 months </td>\n<td>- </td>\n<td>3 months </td>\n<td>- </td>\n<td>4 months </td>\n<td></td>\n<td>12-13  months </td>\n<td>- </td>\n<td>13-14  months </td>\n</tr>\n<tr>\n<td>Trial timelines (days) </td>\n<td>Day 0 </td>\n<td>Visit 1 +  8 days </td>\n<td>Visit 1 +  30 days </td>\n<td>Visit 2 +  8 days </td>\n<td>Visit 2 +  30 days </td>\n<td>Visit 3 +  8 days </td>\n<td>- </td>\n<td>Visit 4 +  8 days </td>\n<td>Visit 4 +  30 days </td>\n</tr>\n<tr>\n<td>Time windows (days)  </td>\n<td>- </td>\n<td></td>\n<td>+14 days </td>\n<td></td>\n<td> +14 days </td>\n<td></td>\n<td></td>\n<td></td>\n<td>+21 days </td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of demographic data </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history (including maternal prenatal  pertussis vaccination) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination§</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X    ** </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Measurement of temperature†† </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for randomization,  allocation of subject number, and vaccine  assignment </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for vaccine assignment </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of temporary contraindications for  blood sampling‡‡ </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Blood sampling (BL)§§  </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>BL1  (3 mL)    *** </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>BL2  (3 mL)    *** </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\">BL3 (6 mL) </td>\n</tr>\n<tr>\n<td></td>\n<td>BL1   (3 mL)†††</td>\n<td>BL2   (3 mL)†††</td>\n</tr>\n<tr>\n<td>Review of warning and precautions to  vaccinations </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of contraindications to subsequent  vaccinations and conditions for withdrawal‡‡‡ </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccination with MenACYW conjugate  vaccine  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccination with Bexsero®</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03632720_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit </td>\n<td>Visit 1 </td>\n<td>Telephone  Call (TC) 1   *</td>\n<td>Visit 2 </td>\n<td>TC2   *</td>\n<td>Visit 3 </td>\n<td>TC3   *</td>\n<td>Visit 4† </td>\n<td>TC4   *</td>\n<td>Visit 5‡ </td>\n</tr>\n<tr>\n<td>Approximate age of subjects </td>\n<td>2 months </td>\n<td>- </td>\n<td>3 months </td>\n<td>- </td>\n<td>4 months </td>\n<td></td>\n<td>12-13  months </td>\n<td>- </td>\n<td>13-14  months </td>\n</tr>\n<tr>\n<td>Trial timelines (days) </td>\n<td>Day 0 </td>\n<td>Visit 1 +  8 days </td>\n<td>Visit 1 +  30 days </td>\n<td>Visit 2 +  8 days </td>\n<td>Visit 2 +  30 days </td>\n<td>Visit 3 +  8 days </td>\n<td>- </td>\n<td>Visit 4 +  8 days </td>\n<td>Visit 4 +  30 days </td>\n</tr>\n<tr>\n<td>Time windows (days)  </td>\n<td>- </td>\n<td></td>\n<td>+14 days </td>\n<td></td>\n<td> +14 days </td>\n<td></td>\n<td></td>\n<td></td>\n<td>+21 days </td>\n</tr>\n<tr>\n<td>Vaccination with routine pediatric  vaccines§§§ </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Immediate surveillance (30 minutes) and  recording of any immediate unsolicited AEs  </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card (DC) provided   **** </td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Telephone call </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card reviewed and collected </td>\n<td></td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n</tr>\n<tr>\n<td>Recording of solicited injection site &amp; systemic  reactions </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of unsolicited AEs </td>\n<td colspan=\"9\" rowspan=\"1\">From Day0 to Day30 after each vaccination </td>\n</tr>\n<tr>\n<td>Reporting of serious adverse events (SAEs,  including AESIs)†††† </td>\n<td colspan=\"9\" rowspan=\"1\">To be reported throughout the trial </td>\n</tr>\n<tr>\n<td>Collection of reportable concomitant  medications </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Trial termination record </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03632720_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit </td>\n<td>Visit 1 </td>\n<td>Telephone  Call (TC) 1   *</td>\n<td>Visit 2 </td>\n<td>TC2   *</td>\n<td>Visit 3 </td>\n<td>TC3   *</td>\n<td>Visit 4† </td>\n<td>TC4   *</td>\n<td>Visit 5‡ </td>\n</tr>\n<tr>\n<td>Approximate age of subjects </td>\n<td>2 months </td>\n<td>- </td>\n<td>3 months </td>\n<td>- </td>\n<td>4 months </td>\n<td></td>\n<td>12-13 months </td>\n<td>- </td>\n<td>13-14  months </td>\n</tr>\n<tr>\n<td>Trial timelines (days) </td>\n<td>Day 0 </td>\n<td>Visit 1 +  8 days </td>\n<td>Visit 1 +  30 days </td>\n<td>Visit 2 +  8 days </td>\n<td>Visit 2 +  30 days </td>\n<td>Visit 3 +  8 days </td>\n<td>- </td>\n<td>Visit 4 +  8 days </td>\n<td>Visit 4 +  30 days </td>\n</tr>\n<tr>\n<td>Time windows (days)  </td>\n<td>- </td>\n<td></td>\n<td>+14 days </td>\n<td></td>\n<td>+14 days </td>\n<td></td>\n<td></td>\n<td></td>\n<td>+21 days </td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of demographic data </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history (including maternal prenatal  pertussis vaccination) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination §</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X    ** </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Measurement of temperature†† </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for randomization,  allocation of subject number, and vaccine  assignment  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for vaccine assignment </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of temporary contraindications for  blood sampling‡‡ </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Blood sampling (BL)§§ </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>BL1  (3 mL)    *** </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>BL2  (3 mL)    *** </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>BL3 (6 mL) </td>\n</tr>\n<tr>\n<td></td>\n<td>BL1   (3 mL)†††</td>\n<td>BL2   (3 mL)†††</td>\n<td></td>\n</tr>\n<tr>\n<td>Review of warning and precautions to  vaccinations </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of contraindications to subsequent  vaccinations and conditions for withdrawal‡‡‡ </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccination with MenACYW conjugate  vaccine  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccination with Bexsero®</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03632720_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit </td>\n<td>Visit 1 </td>\n<td>Telephone  Call (TC) 1   *</td>\n<td>Visit 2 </td>\n<td>TC2   *</td>\n<td>Visit 3 </td>\n<td>TC3   *</td>\n<td>Visit 4† </td>\n<td>TC4   *</td>\n<td>Visit 5‡ </td>\n</tr>\n<tr>\n<td>Approximate age of subjects </td>\n<td>2 months </td>\n<td>- </td>\n<td>3 months </td>\n<td>- </td>\n<td>4 months </td>\n<td></td>\n<td>12-13 months </td>\n<td>- </td>\n<td>13-14  months </td>\n</tr>\n<tr>\n<td>Trial timelines (days) </td>\n<td>Day 0 </td>\n<td>Visit 1 +  8 days </td>\n<td>Visit 1 +  30 days </td>\n<td>Visit 2 +  8 days </td>\n<td>Visit 2 +  30 days </td>\n<td>Visit 3 +  8 days </td>\n<td>- </td>\n<td>Visit 4 +  8 days </td>\n<td>Visit 4 +  30 days </td>\n</tr>\n<tr>\n<td>Time windows (days)  </td>\n<td>- </td>\n<td></td>\n<td>+14 days </td>\n<td></td>\n<td>+14 days </td>\n<td></td>\n<td></td>\n<td></td>\n<td>+21 days </td>\n</tr>\n<tr>\n<td>Vaccination with routine pediatric  vaccines§§§ </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Immediate surveillance (30 minutes) and  recording of any immediate unsolicited AEs </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card (DC) provided   **** </td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Telephone call </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card reviewed and collected </td>\n<td></td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n</tr>\n<tr>\n<td>Recording of solicited injection site &amp; systemic  reactions </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of unsolicited AEs </td>\n<td colspan=\"9\" rowspan=\"1\">From Day0 to Day30 after each vaccination  </td>\n</tr>\n<tr>\n<td>Reporting of serious adverse events (SAEs,  including AESIs)†††† </td>\n<td colspan=\"9\" rowspan=\"1\">To be reported throughout the trial </td>\n</tr>\n<tr>\n<td>Collection of reportable concomitant  medications </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Trial termination record </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03632720_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit </td>\n<td>Visit 1 </td>\n<td>Telephone  Call (TC) 1   *</td>\n<td>Visit 2 </td>\n<td>TC2   *</td>\n<td>Visit 3 </td>\n<td>TC3   *</td>\n<td>Visit 4† </td>\n<td>TC4   *</td>\n<td>Visit 5‡ </td>\n</tr>\n<tr>\n<td>Approximate age of subjects </td>\n<td>2 months </td>\n<td>- </td>\n<td>3 months </td>\n<td>- </td>\n<td>4 months </td>\n<td></td>\n<td>12-13  months </td>\n<td>- </td>\n<td>13-14 months </td>\n</tr>\n<tr>\n<td>Trial timelines (days) </td>\n<td>Day 0 </td>\n<td>Visit 1 +  8 days </td>\n<td>Visit 1 +  30 days </td>\n<td>Visit 2 +  8 days </td>\n<td>Visit 2 +  30 days </td>\n<td>Visit 3 +  8 days </td>\n<td>- </td>\n<td>Visit 4 +  8 days </td>\n<td>Visit 4 +  30 days </td>\n</tr>\n<tr>\n<td>Time windows (days)  </td>\n<td>- </td>\n<td></td>\n<td>+14 days </td>\n<td></td>\n<td>+14 days </td>\n<td></td>\n<td></td>\n<td></td>\n<td>+21 days </td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of demographic data </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history (including maternal prenatal  pertussis vaccination) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination§</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X    ** </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Measurement of temperature†† </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for randomization,  allocation of subject number, and vaccine  assignment </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT system for vaccine assignment </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of temporary contraindications for  blood sampling‡‡ </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Blood sampling (BL)§§ </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>BL1 (3 mL) </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>BL2 (3 mL) </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>BL3 (6 mL) </td>\n</tr>\n<tr>\n<td></td>\n<td>BL1 (3  mL)    *** </td>\n<td>BL2 (3  mL)    *** </td>\n<td></td>\n</tr>\n<tr>\n<td>Review of warning and precautions to  vaccinations </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of contraindications to subsequent  vaccinations and conditions for withdrawal††† </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccination with Bexsero®</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccination with routine pediatric  vaccines‡‡‡ </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Immediate surveillance (30 minutes) and  recording of any immediate unsolicited AEs </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card (DC) provided§§§</td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03632720_SOA_table_5.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit </td>\n<td>Visit 1 </td>\n<td>Telephone  Call (TC) 1   *</td>\n<td>Visit 2 </td>\n<td>TC2   *</td>\n<td>Visit 3 </td>\n<td>TC3   *</td>\n<td>Visit 4† </td>\n<td>TC4   *</td>\n<td>Visit 5‡ </td>\n</tr>\n<tr>\n<td>Approximate age of subjects </td>\n<td>2 months </td>\n<td>- </td>\n<td>3 months </td>\n<td>- </td>\n<td>4 months </td>\n<td></td>\n<td>12-13  months </td>\n<td>- </td>\n<td>13-14 months </td>\n</tr>\n<tr>\n<td>Trial timelines (days) </td>\n<td>Day 0 </td>\n<td>Visit 1 +  8 days </td>\n<td>Visit 1 +  30 days </td>\n<td>Visit 2 +  8 days </td>\n<td>Visit 2 +  30 days </td>\n<td>Visit 3 +  8 days </td>\n<td>- </td>\n<td>Visit 4 +  8 days </td>\n<td>Visit 4 +  30 days </td>\n</tr>\n<tr>\n<td>Time windows (days)  </td>\n<td>- </td>\n<td></td>\n<td>+14 days </td>\n<td></td>\n<td>+14 days </td>\n<td></td>\n<td></td>\n<td></td>\n<td>+21 days </td>\n</tr>\n<tr>\n<td>Telephone call </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card reviewed and collected </td>\n<td></td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n<td></td>\n<td>DC </td>\n</tr>\n<tr>\n<td>Recording of solicited injection site &amp; systemic  reactions </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of unsolicited AEs </td>\n<td colspan=\"9\" rowspan=\"1\">From Day0 to Day30 after each vaccination  </td>\n</tr>\n<tr>\n<td>Reporting of serious adverse events (SAEs,  including AESIs)    **** </td>\n<td colspan=\"9\" rowspan=\"1\">To be reported throughout the trial </td>\n</tr>\n<tr>\n<td>Collection of reportable concomitant  medications </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Trial termination record </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03633396_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening  period</td>\n<td colspan=\"14\" rowspan=\"1\"> Treatment Period</td>\n<td colspan=\"3\" rowspan=\"1\">Follow-up Period</td>\n</tr>\n<tr>\n<td>Procedure</td>\n<td>Screening (Up to 48 days  prior to  Day 1)</td>\n<td>    D1 W 0</td>\n<td>    D3 W 1</td>\n<td>    D8 W 1</td>\n<td>    D15 W2  (±1  day) </td>\n<td>  D2 2 W3  (±1  day) </td>\n<td>D29 W4  (±1  day) </td>\n<td>D36 W5  (±2  days) </td>\n<td>D43 W6  (±2  days) </td>\n<td>D5 0 W 7  (±2  days  ) </td>\n<td>D57 W8  (±2  days) </td>\n<td>D64 W9  (±2  days) </td>\n<td>D71 W1 0 (±2  days) </td>\n<td>D78 W11  (±2  days) </td>\n<td>D85 W12 (±2  days) </td>\n<td>D 113 W16  (±2  days) </td>\n<td>D 141 W20  (±2  days) </td>\n<td>EOS/  D169 W24/ET   (±2 days)   l </td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion and  exclusion criteria </td>\n<td> X</td>\n<td> X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Height and  weight   a </td>\n<td> X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>PPPASI, PPSI,  PPPIGA   b </td>\n<td> X</td>\n<td> X </td>\n<td> X</td>\n<td> X</td>\n<td> X</td>\n<td> X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PPPQLI, Patient  Assessment of  Palmoplantar  Pustulosis Disease  Activity, DLQI   b </td>\n<td>   X</td>\n<td>   X </td>\n<td>   X</td>\n<td>   X</td>\n<td>   X</td>\n<td>   X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PASI (plaque  psoriasis subjects  only)   b </td>\n<td> X</td>\n<td> X </td>\n<td> X</td>\n<td> X</td>\n<td> X</td>\n<td> X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Total affected  BSA (for subjects  with plaque  psoriasis and/or  pustular psoriasis  at non-acral  sites)   b </td>\n<td>    X</td>\n<td>    X </td>\n<td>    X</td>\n<td>    X</td>\n<td>    X</td>\n<td>    X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03633396_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening  period</td>\n<td colspan=\"14\" rowspan=\"1\"> Treatment Period</td>\n<td colspan=\"3\" rowspan=\"1\">Follow-up Period</td>\n</tr>\n<tr>\n<td>Procedure</td>\n<td>Screening (Up to 48 days  prior to  Day 1)</td>\n<td>    D1 W 0</td>\n<td>    D3 W 1</td>\n<td>    D8 W 1</td>\n<td>    D15 W2  (±1  day) </td>\n<td>  D2 2 W3  (±1  day) </td>\n<td>D29 W4  (±1  day) </td>\n<td>D36 W5  (±2  days) </td>\n<td>D43 W6  (±2  days) </td>\n<td>D5 0 W 7  (±2  days  ) </td>\n<td>D57 W8  (±2  days) </td>\n<td>D64 W9  (±2  days) </td>\n<td>D71 W1 0 (±2  days) </td>\n<td>D78 W11  (±2  days) </td>\n<td>D85 W12 (±2  days) </td>\n<td>D 113 W16  (±2  days) </td>\n<td>D 141 W20  (±2  days) </td>\n<td>EOS/  D169 W24/ET   (±2 days)   l </td>\n</tr>\n<tr>\n<td>Fresh and total  pustule count on  palms and soles </td>\n<td> X</td>\n<td> X </td>\n<td> X</td>\n<td> X</td>\n<td> X</td>\n<td> X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Complete  physical  examination   c </td>\n<td> X</td>\n<td> X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-Lead ECG   d </td>\n<td>X</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Chest X-ray   e </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   f </td>\n<td>X</td>\n<td>X </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Hematology and  biochemistry   g </td>\n<td> X</td>\n<td> X </td>\n<td> X</td>\n<td> X</td>\n<td> X</td>\n<td> X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urinalysis   g </td>\n<td>X</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>TB screening  (QuantiFERON®-TB Gold test)   g </td>\n<td> X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Virology   g </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum pregnancy  test (WOCBP  only)   g </td>\n<td> X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urine pregnancy  test  (WOCBP only)   g </td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03633396_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening  period</td>\n<td colspan=\"14\" rowspan=\"1\"> Treatment Period</td>\n<td colspan=\"3\" rowspan=\"1\">Follow-up Period</td>\n</tr>\n<tr>\n<td>Procedure</td>\n<td>Screening (Up to 48 days  prior to  Day 1)</td>\n<td>    D1 W 0</td>\n<td>    D3 W 1</td>\n<td>    D8 W 1</td>\n<td>    D15 W2  (±1  day) </td>\n<td>  D2 2 W3  (±1  day) </td>\n<td>D29 W4  (±1  day) </td>\n<td>D36 W5  (±2  days) </td>\n<td>D43 W6  (±2  days) </td>\n<td>D5 0 W 7  (±2  days  ) </td>\n<td>D57 W8  (±2  days) </td>\n<td>D64 W9  (±2  days) </td>\n<td>D71 W1 0 (±2  days) </td>\n<td>D78 W11  (±2  days) </td>\n<td>D85 W12 (±2  days) </td>\n<td>D 113 W16  (±2  days) </td>\n<td>D 141 W20  (±2  days) </td>\n<td>EOS/  D169 W24/ET   (±2 days)   l </td>\n</tr>\n<tr>\n<td>FSH (Postmenopausal woman with at least 1 year of amenorrhea only)g</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Samples for PKh</td>\n<td></td>\n<td>Xh</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Samples for ADA</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Skin biopsiesi</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Photography</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Telephone contactm</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ANB019/placebo administration</td>\n<td></td>\n<td>Xj</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Xj</td>\n<td></td>\n<td></td>\n<td></td>\n<td>Xj</td>\n<td></td>\n<td></td>\n<td></td>\n<td>Xj</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>AE/SAE review</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medication review</td>\n<td>Xk</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03638258_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Procedure</td>\n<td>Screen</td>\n<td>Baseline  Day 1</td>\n<td> Wk 2   Day 15</td>\n<td> Wk 4  Day 29</td>\n<td> Wk 6  Day 43 </td>\n<td> Wk 8  Day 57</td>\n<td> Wk 12  Day 85  </td>\n<td> Wk 16  Day 113 </td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5 </td>\n<td>6</td>\n<td>7</td>\n<td>8 </td>\n</tr>\n<tr>\n<td>Visit Window </td>\n<td>-35  days </td>\n<td></td>\n<td>+/- 3  days </td>\n<td>+/- 5  days </td>\n<td>+/- 5  days </td>\n<td>+/- 5  days </td>\n<td>+/- 7 days </td>\n<td>+/- 7  days </td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination   a </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>I/E criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology, Serum  Chemistries, and Urine  Analysis   b </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs, height, weight   c </td>\n<td>X</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>IGA , BSA , mPASI   d,d,d </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Intertriginous area IGA  (I-IGA)   e </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>WI-NRS , Fatigue NRS ,  WPAI , Itch-related sleep loss  and DLQI   f,g,h,i </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td> X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Local Tolerability Assessments   j </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS, PHQ-8  </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>PSD </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Optional Photography   k </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Urine pregnancy test   l </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>PK draws   m </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>IP application in clinic   n </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Assign study medication kit   o </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense/review diary </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Weigh study medication tubes   p </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Compliance calculation   p </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse event assessment   q </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Concomitant medications </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Study Exit   r </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03645421_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Pre-dose</td>\n<td colspan=\"7\" rowspan=\"1\">Treatment period </td>\n<td>Follow-up  </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"> V2 </td>\n<td colspan=\"2\" rowspan=\"1\">Dose Level 1 </td>\n<td>Dose Level 2</td>\n<td>Dose Level 3</td>\n<td colspan=\"3\" rowspan=\"1\">Dose Level 4 </td>\n<td colspan=\"1\" rowspan=\"2\"> V13 </td>\n</tr>\n<tr>\n<td>V3 </td>\n<td>V4-7 </td>\n<td>V8 </td>\n<td>V9 </td>\n<td>V10 </td>\n<td>V11 </td>\n<td>V12  / Withdrawal    o </td>\n</tr>\n<tr>\n<td>Study Day </td>\n<td>-1 </td>\n<td>1 </td>\n<td>2-5 </td>\n<td>6 </td>\n<td>13 </td>\n<td>20 </td>\n<td>34 </td>\n<td>48 </td>\n<td>7-14 Days  Post Last  Dose </td>\n</tr>\n<tr>\n<td>Allowance </td>\n<td>-1 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>+1 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Procedure</td>\n</tr>\n<tr>\n<td>Verify eligibility criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Targeted physical examination </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Body weight    a </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Randomization </td>\n<td>X    b </td>\n<td>X    b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Collect blood for:</td>\n</tr>\n<tr>\n<td>Hematology panel (predose) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Serum chemistry panel  (predose) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Pancreatic amylase and lipase  (predose) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Lactate (predose) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>HbA1c (predose) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Fructosamine   (predose) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Fasting lipid profile (before  breakfast and predose as  applicable) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Optional future genetic  research    c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>(X) </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03645421_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Pre-dose</td>\n<td colspan=\"7\" rowspan=\"1\">Treatment period </td>\n<td>Follow-up  </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"> V2 </td>\n<td colspan=\"2\" rowspan=\"1\">Dose Level 1 </td>\n<td>Dose Level 2</td>\n<td>Dose Level 3</td>\n<td colspan=\"3\" rowspan=\"1\">Dose Level 4 </td>\n<td colspan=\"1\" rowspan=\"2\"> V13 </td>\n</tr>\n<tr>\n<td>V3 </td>\n<td>V4-7 </td>\n<td>V8 </td>\n<td>V9 </td>\n<td>V10 </td>\n<td>V11 </td>\n<td>V12  / Withdrawal    o </td>\n</tr>\n<tr>\n<td>Study Day </td>\n<td>-1 </td>\n<td>1 </td>\n<td>2-5 </td>\n<td>6 </td>\n<td>13 </td>\n<td>20 </td>\n<td>34 </td>\n<td>48 </td>\n<td>7-14 Days  Post Last  Dose </td>\n</tr>\n<tr>\n<td>Allowance </td>\n<td>-1 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>+1 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Collect urine sample for:</td>\n</tr>\n<tr>\n<td>Urinalysis (dipstick) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Pregnancy test (only for  premenopausal women)  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>ECG    d </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs (BP, pulse, body  temperature, RR)    e </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>24-hour ABPM    f </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Subject completes  Daily Diary    g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Staff review Daily Diary with  subject </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Train subject on self-administration </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Train subject on at-home dose  preparation </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Staff train subject in Daily Diary  completion </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP administration by staff </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP administration by subject </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>IP dispense </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03645421_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Pre-dose</td>\n<td colspan=\"7\" rowspan=\"1\">Treatment period </td>\n<td>Follow-up  </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"> V2 </td>\n<td colspan=\"2\" rowspan=\"1\">Dose Level 1 </td>\n<td>Dose Level 2</td>\n<td>Dose Level 3</td>\n<td colspan=\"3\" rowspan=\"1\">Dose Level 4 </td>\n<td colspan=\"1\" rowspan=\"2\"> V13 </td>\n</tr>\n<tr>\n<td>V3 </td>\n<td>V4-7 </td>\n<td>V8 </td>\n<td>V9 </td>\n<td>V10 </td>\n<td>V11 </td>\n<td>V12  / Withdrawal    o </td>\n</tr>\n<tr>\n<td>Study Day </td>\n<td>-1 </td>\n<td>1 </td>\n<td>2-5 </td>\n<td>6 </td>\n<td>13 </td>\n<td>20 </td>\n<td>34 </td>\n<td>48 </td>\n<td>7-14 Days  Post Last  Dose </td>\n</tr>\n<tr>\n<td>Allowance </td>\n<td>-1 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>+1 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PK for MEDI0382    h </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>MMT    i </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Blood samples for glucose and  insulin    i </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Blood samples for pro insulin  and c peptide, GLP-1, and  glucagon    i </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>CGM    j </td>\n<td></td>\n<td>X (D1 to D5) </td>\n<td></td>\n<td>X   (D6 to D12)</td>\n<td>X   (D13 to D19)</td>\n<td></td>\n<td></td>\n<td>X   (D41 to D47) </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"10\" rowspan=\"1\">CGM sensor  application/change    k </td>\n</tr>\n<tr>\n<td>ADA    l </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>AEs/SAEs    m </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Injection site assessment    n </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medications </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03650400_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Period</td>\n<td>Screening</td>\n<td colspan=\"8\" rowspan=\"1\">Treatment  [1]</td>\n<td>Safety Follow-up</td>\n</tr>\n<tr>\n<td>Visit Name</td>\n<td>Screening</td>\n<td>Treatment</td>\n<td colspan=\"7\" rowspan=\"1\">End of Treatment</td>\n<td>Follow-up   2 </td>\n</tr>\n<tr>\n<td>Days</td>\n<td>up to -14</td>\n<td>1</td>\n<td colspan=\"7\" rowspan=\"1\">4 to 8</td>\n<td>34 to 38</td>\n</tr>\n<tr>\n<td>Time (post-dose)</td>\n<td>-</td>\n<td>-</td>\n<td>0h  3 </td>\n<td>0.5h  3 </td>\n<td>1h</td>\n<td>2h</td>\n<td>3h</td>\n<td>5h</td>\n<td>8h</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demography</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion /  Exclusion criteria</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical  history/current  medical conditions</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant  medications  (including Asthma)</td>\n<td colspan=\"10\" rowspan=\"1\">X   4 </td>\n</tr>\n<tr>\n<td>Prior and  concomitant non-drug therapies-procedures</td>\n<td colspan=\"10\" rowspan=\"1\">X   4 </td>\n</tr>\n<tr>\n<td>Current medication  review/adjust</td>\n<td>S</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical  Examination</td>\n<td>S</td>\n<td>S</td>\n<td>S  4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Body Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Body Weight</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs</td>\n<td>X</td>\n<td>X</td>\n<td>X   4 </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical Chemistry</td>\n<td>X</td>\n<td></td>\n<td>X   4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td>X</td>\n<td></td>\n<td>X   4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine dipstick</td>\n<td>S</td>\n<td></td>\n<td>S  4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>S  5</td>\n<td></td>\n</tr>\n<tr>\n<td>PK blood collection</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03650400_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Period</td>\n<td>Screening</td>\n<td colspan=\"8\" rowspan=\"1\">Treatment  [1]</td>\n<td>Safety Follow-up</td>\n</tr>\n<tr>\n<td>Visit Name</td>\n<td>Screening</td>\n<td>Treatment</td>\n<td colspan=\"7\" rowspan=\"1\">End of Treatment</td>\n<td>Follow-up   2 </td>\n</tr>\n<tr>\n<td>Days</td>\n<td>up to -14</td>\n<td>1</td>\n<td colspan=\"7\" rowspan=\"1\">4 to 8</td>\n<td>34 to 38</td>\n</tr>\n<tr>\n<td>Time (post-dose)</td>\n<td>-</td>\n<td>-</td>\n<td>0h  3 </td>\n<td>0.5h  3 </td>\n<td>1h</td>\n<td>2h</td>\n<td>3h</td>\n<td>5h</td>\n<td>8h</td>\n<td>-</td>\n</tr>\n<tr>\n<td>PK urine  collection   5 </td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"6\" rowspan=\"1\">X</td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy and  assessments of  fertility</td>\n<td>S</td>\n<td>S</td>\n<td>S  4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Electrocardiogram  (ECG)</td>\n<td>X</td>\n<td></td>\n<td>X   4 </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense patient  diary card</td>\n<td></td>\n<td>S</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Drug dispensation</td>\n<td></td>\n<td>S</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse Events</td>\n<td colspan=\"10\" rowspan=\"1\">X   4 </td>\n</tr>\n<tr>\n<td>Asthma  Exacerbation  Episodes</td>\n<td colspan=\"10\" rowspan=\"1\">X   4 </td>\n</tr>\n<tr>\n<td>Serious Adverse  Events</td>\n<td colspan=\"10\" rowspan=\"1\">X   4 </td>\n</tr>\n<tr>\n<td>Study drug  administration at  visit</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record/interruption  changes in study  drug  administrations to  assess compliance</td>\n<td></td>\n<td>X</td>\n<td>X   4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record time of  study drug taken  one day prior to  end of treatment</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03650400_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Period</td>\n<td>Screening</td>\n<td colspan=\"8\" rowspan=\"1\">Treatment  [1]</td>\n<td>Safety Follow-up</td>\n</tr>\n<tr>\n<td>Visit Name</td>\n<td>Screening</td>\n<td>Treatment</td>\n<td colspan=\"7\" rowspan=\"1\">End of Treatment</td>\n<td>Follow-up   2 </td>\n</tr>\n<tr>\n<td>Days</td>\n<td>up to -14</td>\n<td>1</td>\n<td colspan=\"7\" rowspan=\"1\">4 to 8</td>\n<td>34 to 38</td>\n</tr>\n<tr>\n<td>Time (post-dose)</td>\n<td>-</td>\n<td>-</td>\n<td>0h  3 </td>\n<td>0.5h  3 </td>\n<td>1h</td>\n<td>2h</td>\n<td>3h</td>\n<td>5h</td>\n<td>8h</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Disposition  (Treatment/Study  disposition)</td>\n<td colspan=\"10\" rowspan=\"1\">X</td>\n</tr>\n<tr>\n<td>Reconcile study  medication</td>\n<td></td>\n<td></td>\n<td>S  4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collect unused  study medication</td>\n<td></td>\n<td></td>\n<td>S  4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collect patient  diary card</td>\n<td></td>\n<td></td>\n<td>S  4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03656744_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\">Protocol  Section(s) </td>\n<td colspan=\"1\" rowspan=\"2\">SCR </td>\n<td colspan=\"6\" rowspan=\"1\">Double-Blind Treatment </td>\n<td colspan=\"1\" rowspan=\"2\">ET </td>\n<td colspan=\"1\" rowspan=\"2\">Follow-up </td>\n</tr>\n<tr>\n<td>Baseline </td>\n<td>WK 2 </td>\n<td>WK 6 </td>\n<td>WK 10 </td>\n<td>WK 14 </td>\n<td>WK 18 </td>\n</tr>\n<tr>\n<td>Visit Day </td>\n<td colspan=\"1\" rowspan=\"2\">- </td>\n<td>-28 to -1 </td>\n<td>0 </td>\n<td>14 </td>\n<td>42 </td>\n<td>70 </td>\n<td>98 </td>\n<td>126 </td>\n<td colspan=\"1\" rowspan=\"2\">- </td>\n<td>+30d </td>\n</tr>\n<tr>\n<td>Procedure / Window </td>\n<td>- </td>\n<td>- </td>\n<td>±3d </td>\n<td>±3d </td>\n<td>±3d </td>\n<td>±3d </td>\n<td>±3d </td>\n<td>+7d </td>\n</tr>\n<tr>\n<td colspan=\"11\" rowspan=\"1\">Administrative Procedures </td>\n</tr>\n<tr>\n<td>Clinic visit </td>\n<td>5.1 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>10.1 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Eligibility criteria </td>\n<td>3.3.1, 3.3.2 </td>\n<td>X </td>\n<td>X   a </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics </td>\n<td>6.1.1 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history </td>\n<td>6.1.1 </td>\n<td>X </td>\n<td>X   a </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization </td>\n<td>6.1.2 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense study drug </td>\n<td>6.1.2 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Return study drug </td>\n<td>6.1.2 </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Study discharge </td>\n<td>5.1.4, 5.1.5 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Telephone contact </td>\n<td>5.1.6 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td colspan=\"11\" rowspan=\"1\">Clinical Assessments </td>\n</tr>\n<tr>\n<td>Comprehensive physical  examination </td>\n<td>6.3.1 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Targeted physical examination   b </td>\n<td>6.3.1 </td>\n<td></td>\n<td>X   a </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs </td>\n<td>6.3.2 </td>\n<td>X </td>\n<td>X   a </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Weight </td>\n<td>6.3.2 </td>\n<td>X </td>\n<td>X   a </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Height </td>\n<td>6.3.2 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ECG </td>\n<td>6.3.3 </td>\n<td>X </td>\n<td>X   a </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"11\" rowspan=\"1\">Laboratory Assessments </td>\n</tr>\n<tr>\n<td>Serum chemistry panel   c </td>\n<td>6.2.2, 6.3.4</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Lipid panel   c </td>\n<td>6.2.2, 6.3.4</td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology with differential   c </td>\n<td>6.3.4</td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Coagulation panel   c </td>\n<td>6.3.4</td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03656744_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\">Protocol  Section(s) </td>\n<td colspan=\"1\" rowspan=\"2\">SCR </td>\n<td colspan=\"6\" rowspan=\"1\">Double-Blind Treatment </td>\n<td colspan=\"1\" rowspan=\"2\">ET </td>\n<td colspan=\"1\" rowspan=\"2\">Follow-up </td>\n</tr>\n<tr>\n<td>Baseline </td>\n<td>WK 2 </td>\n<td>WK 6 </td>\n<td>WK 10 </td>\n<td>WK 14 </td>\n<td>WK 18 </td>\n</tr>\n<tr>\n<td>Visit Day </td>\n<td colspan=\"1\" rowspan=\"2\">- </td>\n<td>-28 to -1 </td>\n<td>0 </td>\n<td>14 </td>\n<td>42 </td>\n<td>70 </td>\n<td>98 </td>\n<td>126 </td>\n<td colspan=\"1\" rowspan=\"2\">- </td>\n<td>+30d </td>\n</tr>\n<tr>\n<td>Procedure / Window </td>\n<td>- </td>\n<td>- </td>\n<td>±3d </td>\n<td>±3d </td>\n<td>±3d </td>\n<td>±3d </td>\n<td>±3d </td>\n<td>+7d </td>\n</tr>\n<tr>\n<td>HbA1c </td>\n<td>6.2.2</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>HOMA-IR </td>\n<td>6.2.2</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>HIV and Hepatitis B/C </td>\n<td>6.3.4</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>G6PD </td>\n<td>6.3.4</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test   e </td>\n<td>6.3.4</td>\n<td>X </td>\n<td>X   a,e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>FSH test   e </td>\n<td>6.3.4 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine drug test </td>\n<td>6.3.4</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"11\" rowspan=\"1\">Imaging and Biomarker Assessments </td>\n</tr>\n<tr>\n<td>MRI-PDFF </td>\n<td>6.2.1 </td>\n<td colspan=\"2\" rowspan=\"1\">X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Corrected T1 and T2    * </td>\n<td>6.2.1 </td>\n<td colspan=\"2\" rowspan=\"1\">X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pro-C3 </td>\n<td>6.2.2 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>ELF test </td>\n<td>6.2.2 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Bile acid panel   c </td>\n<td>6.2.2 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"11\" rowspan=\"1\">Safety Assessments </td>\n</tr>\n<tr>\n<td>Adverse event monitoring </td>\n<td>6.3.5, 7.0</td>\n<td>X </td>\n<td>X   a </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Prior and concomitant medications </td>\n<td>4.5, 4.6,  6.3.6</td>\n<td>X </td>\n<td>X   a </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03661983_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"15\" rowspan=\"1\">Table 3.7-1 Schedule of Assessments - Screening and Open-label Stabilization Phase</td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessments/Procedures</td>\n<td colspan=\"1\" rowspan=\"2\">Screening and  Washout  Period (Days −42 to −3)</td>\n<td colspan=\"13\" rowspan=\"1\">Open-label Stabilization Phase Visits - Week (Day)   a </td>\n</tr>\n<tr>\n<td>Baseline (Day 1)</td>\n<td>1 (8 ± 2)</td>\n<td>2 (15 ± 2)</td>\n<td>3 (22 ± 2)</td>\n<td>4 (29 ± 2)</td>\n<td>6 (43 ± 3)</td>\n<td>8 (57 ± 3)</td>\n<td>10 (71 ± 3)</td>\n<td>12 (85 ± 3)</td>\n<td>14 (99 ± 3)</td>\n<td>16 (113 ± 3 )</td>\n<td>18 (127 ± 3 )</td>\n<td>20 (141 ± 3 )/ EOP or  ET   b </td>\n</tr>\n<tr>\n<td>Screening/Eligibility</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed Consent/Assent   c </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Confirmation of diagnosis  of TD by DSM-5   d </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>K-SADS-PL   e </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CY-BOCS   f </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demography</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Psychiatric history</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record current  psychotropic therapy   g </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Washout of prohibited  medications, including  psychotropics   g </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Trial Assessments</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>YGTSS   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CGI-TS Severity   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CGI-TS Improvement   f </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS (children’s version)   f,h </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03661983_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"15\" rowspan=\"1\">Table 3.7-1 Schedule of Assessments - Screening and Open-label Stabilization Phase</td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessments/Procedures</td>\n<td colspan=\"1\" rowspan=\"2\">Screening and  Washout  Period (Days −42 to −3)</td>\n<td colspan=\"13\" rowspan=\"1\">Open-label Stabilization Phase Visits - Week (Day)   a </td>\n</tr>\n<tr>\n<td>Baseline (Day 1)</td>\n<td>1 (8 ± 2)</td>\n<td>2 (15 ± 2)</td>\n<td>3 (22 ± 2)</td>\n<td>4 (29 ± 2)</td>\n<td>6 (43 ± 3)</td>\n<td>8 (57 ± 3)</td>\n<td>10 (71 ± 3)</td>\n<td>12 (85 ± 3)</td>\n<td>14 (99 ± 3)</td>\n<td>16 (113 ± 3 )</td>\n<td>18 (127 ± 3 )</td>\n<td>20 (141 ± 3 )/ EOP or  ET   b </td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Height</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Waist circumference</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   j </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead ECG   k </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests  (hematology, serum  chemistry, and urinalysis)   l </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Glycosylated hemoglobin,  prolactin  (blinded),TSH   l,m </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urine pregnancy test   n </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Documentation of birth  control status   o </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urine drug and blood  alcohol screen   p </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>SAS   f </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>AIMS   f </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>BARS   f </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Adverse Events   q </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03661983_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"15\" rowspan=\"1\">Table 3.7-1 Schedule of Assessments - Screening and Open-label Stabilization Phase</td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessments/Procedures</td>\n<td colspan=\"1\" rowspan=\"2\">Screening and  Washout  Period (Days −42 to −3)</td>\n<td colspan=\"13\" rowspan=\"1\">Open-label Stabilization Phase Visits - Week (Day)   a </td>\n</tr>\n<tr>\n<td>Baseline (Day 1)</td>\n<td>1 (8 ± 2)</td>\n<td>2 (15 ± 2)</td>\n<td>3 (22 ± 2)</td>\n<td>4 (29 ± 2)</td>\n<td>6 (43 ± 3)</td>\n<td>8 (57 ± 3)</td>\n<td>10 (71 ± 3)</td>\n<td>12 (85 ± 3)</td>\n<td>14 (99 ± 3)</td>\n<td>16 (113 ± 3 )</td>\n<td>18 (127 ± 3 )</td>\n<td>20 (141 ± 3 )/ EOP or  ET   b </td>\n</tr>\n<tr>\n<td>Prior and Concomitant  Medications   r </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Trial Management</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense IMP</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X   s </td>\n<td></td>\n<td>X   s </td>\n<td></td>\n<td>X   s </td>\n<td></td>\n<td>X   t </td>\n</tr>\n<tr>\n<td>Assess eligibility for  treatment</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Assess stabilization  criteria</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Randomization of stable  subjects</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   u </td>\n<td>X   u </td>\n<td>X   u </td>\n<td>X   t </td>\n</tr>\n<tr>\n<td>Drug accountability</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Phone call to assess if  titration is needed in-clinic</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03661983_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Table 3.7-2 Schedule of Assessments - Double-blind Randomized Withdrawal Phase</td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessments/Procedures</td>\n<td colspan=\"8\" rowspan=\"1\">Double-blind Randomized Withdrawal Phase   a </td>\n<td colspan=\"1\" rowspan=\"2\">Follow-up  Period  30 Days  (+ 3 days)</td>\n</tr>\n<tr>\n<td>Week 1 (± 2 days)</td>\n<td>Week 2 (± 2 days)</td>\n<td>Week 3 (± 2 days)</td>\n<td>Week 4 (± 2 days)</td>\n<td>Week 6 (± 3 days)</td>\n<td>Week 8 (± 3 days)</td>\n<td>Week 10 (± 3 days)</td>\n<td>Week 12  (± 3 days)/  ET</td>\n</tr>\n<tr>\n<td>Trial Assessments</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record current psychotropic  therapy</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>YGTSS   b </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>CGI-TS Severity   b </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>CGI-TS Improvement   b </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS (children’s version)   b </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Height</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Body weight</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Waist circumference</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   c </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical laboratory tests  (hematology, serum chemistry,  urinalysis)   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Glycosylated hemoglobin,  prolactin (blinded), TSH   e,f </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Urine pregnancy test   g </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Documentation of birth control  status   h </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Urine drug and blood alcohol  screen   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>SAS   b </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03661983_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"10\" rowspan=\"1\">Table 3.7-2 Schedule of Assessments - Double-blind Randomized Withdrawal Phase</td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessments/Procedures</td>\n<td colspan=\"8\" rowspan=\"1\">Double-blind Randomized Withdrawal Phase   a </td>\n<td colspan=\"1\" rowspan=\"2\">Follow-up  Period  30 Days  (+ 3 days)</td>\n</tr>\n<tr>\n<td>Week 1 (± 2 days)</td>\n<td>Week 2 (± 2 days)</td>\n<td>Week 3 (± 2 days)</td>\n<td>Week 4 (± 2 days)</td>\n<td>Week 6 (± 3 days)</td>\n<td>Week 8 (± 3 days)</td>\n<td>Week 10 (± 3 days)</td>\n<td>Week 12  (± 3 days)/  ET</td>\n</tr>\n<tr>\n<td>AIMS   b </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>BARS   b </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse Events   j </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Prior and Concomitant  Medications   k </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Trial Management</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense IMP</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Drug accountability</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03669549_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period: </td>\n<td colspan=\"3\" rowspan=\"1\">Screening  2-14 Weeks </td>\n<td colspan=\"2\" rowspan=\"1\">Baseline  2-8 Weeks </td>\n<td colspan=\"13\" rowspan=\"1\">Treatment  16 Weeks </td>\n<td>Follow-up  4 Weeks </td>\n</tr>\n<tr>\n<td>Target Study Day:   a </td>\n<td>-56 </td>\n<td>-42 </td>\n<td>-28 </td>\n<td>-14 </td>\n<td>-8 </td>\n<td>1 </td>\n<td>15 </td>\n<td>22 </td>\n<td>29 </td>\n<td>&lt;43 </td>\n<td>50 </td>\n<td>57 </td>\n<td>&lt;71 </td>\n<td>78 </td>\n<td>85 </td>\n<td>&lt;99 </td>\n<td>106 </td>\n<td>113 </td>\n<td>141 </td>\n</tr>\n<tr>\n<td>Study Week:   a </td>\n<td>-8 </td>\n<td>-6 </td>\n<td>-4 </td>\n<td>-2 </td>\n<td>-1 </td>\n<td>1 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>15 </td>\n<td>16 </td>\n<td>17 </td>\n<td>21 </td>\n</tr>\n<tr>\n<td>Visit:   a,b </td>\n<td>S1 </td>\n<td>tel </td>\n<td>S2   a </td>\n<td>B1 </td>\n<td></td>\n<td>T1 </td>\n<td>tel </td>\n<td></td>\n<td>T2 </td>\n<td>tel </td>\n<td></td>\n<td>T3 </td>\n<td>tel </td>\n<td></td>\n<td>T4 </td>\n<td>tel </td>\n<td></td>\n<td>T5/EoT </td>\n<td>F1/EoS </td>\n</tr>\n<tr>\n<td>Informed Consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/ Exclusion Criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History &amp; Demographics </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs, Height and Weight   c </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Physical Examination   d </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology &amp; Chemistry </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PT, aPTT, INR </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Viral Screen</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum 17-OHP, P, and Cortisol   e </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Other Blood Hormones (A4, ACTH,   total T, and 11-ketoT)   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Salivary 17-OHP, P, and Cortisol   e,f </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Salivary 17-OHP Profile   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Urine Drug Screen </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy Test   g </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Start Date of Last Menstrual  Period   g,h </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>GC Dose Adjustment (if needed)   i </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>eDiary Instruction/Review   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Enrollment </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense and Dose Study Drug   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X   b </td>\n<td></td>\n</tr>\n<tr>\n<td>Dose Titration Assessment   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Study Drug Compliance </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Dose GC and MC at Site   b </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Plasma PK and Serum Storage   k </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X   b </td>\n<td></td>\n</tr>\n<tr>\n<td>Medications and Adverse Events   l </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03670810_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Visit 1  Screening [a]</td>\n<td>Visit 2 Baseline (at site)</td>\n<td colspan=\"3\" rowspan=\"1\">Treatment Attack 1-4  All attacks:  Mod/sev within 4 hrs of onset Attack 2:  ≥48 hrs after dosing Attack 1 Attack 3:  ≥48 hrs after dosing Attack 2 Attack 4:  ≥48 hrs after dosing Attack 3 [b]</td>\n<td>Visit 6 EoS  (at site) or EDC  [c]</td>\n<td>Notes</td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td>V1+3-30 days (pending  lab  results)</td>\n<td>Visit 3  Phone Call  1 after  Attack 1 or at 1 mo ±1  wk after V2  d </td>\n<td>Visit 4  Site Visit at +2 mos±1  wk after V2 </td>\n<td>Visit 5  Phone Call 2  at 3 mos±1  wk after V2</td>\n<td>≥7 days after  last treated  attack (=last  dose) OR at 4 mos±2 wks after  V2</td>\n<td></td>\n</tr>\n<tr>\n<td>Obtain informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion and exclusion</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Introduce eDiary (V1) including assess patient  capability to use eDiary</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>Temperature, BP, pulse.  BP/pulse measured sitting before blood draws, dosing.   Use local BP equipment.</td>\n</tr>\n<tr>\n<td>Weight </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Menstrual cycle status</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Females asked to provide dates  and durations of menstrual  period; table included in paper  journal to record between visits.</td>\n</tr>\n<tr>\n<td>Review migraine history  including prior treatment</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review medical history and  concomitant medication</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Neurological exam</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03670810_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Document migraine  characteristics per IHS criteria </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Complete MIDAS </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS - BL/screening  version   e </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS - since last visit  version   e </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>   Self-Harm Supplement Form</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>   Self-Harm Follow-up Form    f </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Patients must be supine for 5 to  10 min before ECG collection  and remain supine but awake  during collection.</td>\n</tr>\n<tr>\n<td>Clinical laboratory  (hematology, serum chemistry,  urinalysis)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>Hepatic algorithm triggered in  cases of hepatic abnormalities  identified by laboratory testing.</td>\n</tr>\n<tr>\n<td>Serum pregnancy test or FSH</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>Pregnancy tests assessed in  WOCBP (serum as indicated;  urine more frequently if  mandated by local regulations);  FSH assessed as appropriate  (details in Inclusion Criterion  #7)</td>\n</tr>\n<tr>\n<td>Urine drug screen</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Can be repeated once if result is  positive.</td>\n</tr>\n<tr>\n<td>Pharmacogenetic sample  (genetic sample/DNA)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Confirm eligibility </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Patient training video</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense study drug</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Provide study eDiary and  provide detailed instructions and complete EQ-5D-5L</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03670810_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Migraine attack (eDiary) documentation by patient</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>Patients enter data in eDiary  during attacks (Appendix 7) and from V2 to EoS, will be  reminded daily to record AEs  and new conmeds in paper  journal.</td>\n</tr>\n<tr>\n<td>mTOQ-6</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HCRU</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Employment status</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Assessment of driving  accidents/violations</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment Satisfaction</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Verify any eDiary or study drug issues, assess compliance  all procedures, provide  instructions if needed</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Determine compliance study  drug</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Documentation of  rescue/recurrence medication </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Documentation of AEs and concomitant medication</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Collect unused/empty study  drug pack and eDiary</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03698279_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit/Contact </td>\n<td>V01 </td>\n<td>V02 </td>\n<td>V03 </td>\n<td>V04 </td>\n<td>V05 </td>\n<td>Telephone  Call</td>\n</tr>\n<tr>\n<td>Study timelines (days) </td>\n<td>D0 </td>\n<td>D8 </td>\n<td>D28 </td>\n<td>8 days  after V03 </td>\n<td>28 days  after V03 </td>\n<td>180 days  after V03 </td>\n</tr>\n<tr>\n<td>Time windows (days) </td>\n<td></td>\n<td>+3 </td>\n<td>+7 </td>\n<td>+3 </td>\n<td>+7 </td>\n<td>+14 </td>\n</tr>\n<tr>\n<td>Informed consent form / assent form (if  applicable ) signed and dated  *</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion / exclusion criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of demographic data </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>History of seasonal influenza vaccination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of reportable concomitant  medications </td>\n<td colspan=\"5\" rowspan=\"1\">D0-D56 </td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination† </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization / allocation of subject  number and unique dose number‡ </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Allocation of unique dose number  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Temporary and definitive  contraindications </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sampling (BL), 5 mL </td>\n<td>BL0001§ </td>\n<td></td>\n<td>BL0002§ </td>\n<td></td>\n<td>BL0003 </td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccination </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Immediate surveillance (30 min) </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>DC provided§   **</td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>DC reviewed and recorded†† </td>\n<td></td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>DC collected </td>\n<td></td>\n<td></td>\n<td>DC1 </td>\n<td></td>\n<td>DC2 </td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of solicited injection site and  systemic reactions </td>\n<td colspan=\"2\" rowspan=\"1\">D0-D7 </td>\n<td colspan=\"2\" rowspan=\"1\">D28-D35 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of unsolicited adverse events </td>\n<td colspan=\"3\" rowspan=\"1\">D0-D28 </td>\n<td colspan=\"2\" rowspan=\"1\">D28-D56 </td>\n<td></td>\n</tr>\n<tr>\n<td>MA provided‡‡ </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Study active phase termination record </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Follow-up telephone call§§ </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Reporting of serious adverse events  (SAEs) (including AESIs)   ***</td>\n<td colspan=\"6\" rowspan=\"1\">To be reported at any time during the study </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03710889_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Procedure </td>\n<td>Visit 1 </td>\n<td>Visit 2  (±4 days) </td>\n<td>Visit 3  (+4 days) </td>\n<td>Visit 4  (±4 days) </td>\n<td>Visit 5  (±4 days) </td>\n<td>Visit 6  (±7 days) </td>\n</tr>\n<tr>\n<td>Screening  (30 Days) </td>\n<td>Pre-treatment </td>\n<td>Day 1 </td>\n<td>Month 1 </td>\n<td>Month 3 </td>\n<td>Month 4 </td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Verification of entry criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of medical history     a </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Physical examination     b </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Symptom directed physical examination </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Vital signs     c </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Weight and height measurements     d </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>12-lead Electrocardiogram     e </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urinalysis (dipstick)     f </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Chemistry blood collection     g </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology blood collection </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Coagulation (PT and PTT) blood collection </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>PTH (1-84) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>25-hydroxyvitamin D level </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>1,25-dihydroxy vitamin D level </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FSH </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Thyroid stimulating hormone </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Injection training for subjects </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense calcium and vitamin D supplements   n </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03710889_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Procedure </td>\n<td>Visit 1 </td>\n<td>Visit 2  (±4 days) </td>\n<td>Visit 3  (+4 days) </td>\n<td>Visit 4  (±4 days) </td>\n<td>Visit 5  (±4 days) </td>\n<td>Visit 6  (±7 days) </td>\n</tr>\n<tr>\n<td>Screening  (30 Days) </td>\n<td>Pre-treatment </td>\n<td>Day 1 </td>\n<td>Month 1 </td>\n<td>Month 3 </td>\n<td>Month 4 </td>\n</tr>\n<tr>\n<td>Study medication (abaloparatide) administration </td>\n<td></td>\n<td></td>\n<td colspan=\"3\" rowspan=\"1\">Daily abaloparatide administration until  and including the day of bone biopsy </td>\n<td></td>\n</tr>\n<tr>\n<td>Demeclocycline (dispense and administration) </td>\n<td></td>\n<td>X h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tetracycline (dispense and administration) </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X i </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Transiliac crest bone biopsy j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Serum markers of bone metabolism (PINP and  CTX) </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>AP and lateral lumbar and thoracic spine  radiographs </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical assessment of new fractures k </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Collect blood for immunogenicity testing </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>BMD of lumbar spine, total hip, and femoral  neck </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Investigator assessment of local tolerance  (dermal reactions assessment) </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Subject diary review l </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Document AEs and concomitant medications m </td>\n<td colspan=\"6\" rowspan=\"1\">At any time, question subject at each visit </td>\n</tr>\n<tr>\n<td>Drug supply/resupply/accountability </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03710889_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Procedure </td>\n<td>Visit 1 </td>\n<td>Visit 2 (±4  days) </td>\n<td>Visit 3  (+4 days) </td>\n<td>Visit 4  (±4 days) </td>\n<td>Visit 5  (±4 days) </td>\n<td>Visit 6  (±4 days) </td>\n<td>Visit 7  (±4 days) </td>\n<td>Visit 8  (±7 days) </td>\n</tr>\n<tr>\n<td>Screening  (30 Days) </td>\n<td>Pretreatment </td>\n<td>Day 1 </td>\n<td>Month 1 </td>\n<td>Month 3 </td>\n<td>Month 4 </td>\n<td>Month 6 </td>\n<td>Month 7 </td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Verification of entry criteria </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of medical history   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Physical examination   b </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Symptom directed physical examination </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   c </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Weight and height measurements   d </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead Electrocardiogram   e </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urinalysis (dipstick)   f </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Chemistry blood collection   g </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology blood collection </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Coagulation (PT and PTT) blood collection </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PTH (1-84) </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>25-hydroxyvitamin D level </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>1,25-dihydroxy vitamin D level </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FSH </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Thyroid stimulating hormone </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Injection training for subjects </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense calcium and vitamin D  supplements   n </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Study medication (abaloparatide)  administration </td>\n<td></td>\n<td></td>\n<td colspan=\"6\" rowspan=\"1\">Daily abaloparatide administration </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03710889_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Procedure </td>\n<td>Visit 1 </td>\n<td>Visit 2 (±4  days) </td>\n<td>Visit 3  (+4 days) </td>\n<td>Visit 4  (±4 days) </td>\n<td>Visit 5  (±4 days) </td>\n<td>Visit 6  (±4 days) </td>\n<td>Visit 7  (±4 days) </td>\n<td>Visit 8  (±7 days) </td>\n</tr>\n<tr>\n<td>Screening  (30 Days) </td>\n<td>Pretreatment </td>\n<td>Day 1 </td>\n<td>Month 1 </td>\n<td>Month 3 </td>\n<td>Month 4 </td>\n<td>Month 6 </td>\n<td>Month 7 </td>\n</tr>\n<tr>\n<td>Demeclocycline (dispense and  administration) </td>\n<td></td>\n<td>X   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tetracycline (dispense and administration) </td>\n<td></td>\n<td></td>\n<td></td>\n<td>Xi </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Transiliac crest bone biopsy   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum markers of bone metabolism (PINP  and CTX) </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>AP and lateral lumbar and thoracic spine  radiographs </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Peripheral quantitative computed  tomography (pQCT) of the forearm and tibiae </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical assessment of new fractures   k </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Collect blood for immunogenicity testing </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>BMD of lumbar spine, total hip, and femoral  neck </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Investigator assessment of local tolerance  (dermal reactions assessment) </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Subject diary review   l </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Document AEs and concomitant  medications   m </td>\n<td colspan=\"8\" rowspan=\"1\">At any time, question subject at each visit </td>\n</tr>\n<tr>\n<td>Drug supply/resupply/accountability </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"14\" rowspan=\"1\">Year 1</td>\n</tr>\n<tr>\n<td>Dose 1</td>\n<td>Dose  2</td>\n<td>Dose  3</td>\n<td>Dose  4</td>\n<td>Dose  5</td>\n<td>Dose  6</td>\n<td>Dose  7</td>\n<td>Dose  8</td>\n<td>Dose  9</td>\n<td>Dose  10</td>\n<td>Dose  11</td>\n<td>Dose  12</td>\n<td>Dose  13</td>\n<td>Dose  14</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Day 1/ Baseline</td>\n<td>Wk  4</td>\n<td>Wk  8</td>\n<td>Wk  12</td>\n<td>Wk  16</td>\n<td>Wk  20</td>\n<td>Wk  24</td>\n<td>Wk  28</td>\n<td>Wk  32</td>\n<td>Wk  36</td>\n<td>Wk  40</td>\n<td>Wk  44</td>\n<td>Wk  48</td>\n<td>Wk  52</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   f </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   g </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Dose</td>\n<td colspan=\"14\" rowspan=\"1\">Year 1</td>\n</tr>\n<tr>\n<td></td>\n<td>Dose 1</td>\n<td>Dose  2</td>\n<td>Dose  3</td>\n<td>Dose  4</td>\n<td>Dose  5</td>\n<td>Dose  6</td>\n<td>Dose  7</td>\n<td>Dose  8</td>\n<td>Dose  9</td>\n<td>Dose  10</td>\n<td>Dose  11</td>\n<td>Dose  12</td>\n<td>Dose  13</td>\n<td>Dose  14</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Day 1/ Baseline</td>\n<td>Wk  4</td>\n<td>Wk  8</td>\n<td>Wk  12</td>\n<td>Wk  16</td>\n<td>Wk  20</td>\n<td>Wk  24</td>\n<td>Wk  28</td>\n<td>Wk  32</td>\n<td>Wk  36</td>\n<td>Wk  40</td>\n<td>Wk  44</td>\n<td>Wk  48</td>\n<td>Wk  52</td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CDR   h </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>RBANS   h </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   h </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   h </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   e,h </td>\n<td>X   d </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications review   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_10.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"14\" rowspan=\"1\">Year 1</td>\n</tr>\n<tr>\n<td>Dose 1</td>\n<td>Dose  2</td>\n<td>Dose  3</td>\n<td>Dose  4</td>\n<td>Dose  5</td>\n<td>Dose  6</td>\n<td>Dose  7</td>\n<td>Dose  8</td>\n<td>Dose  9</td>\n<td>Dose  10</td>\n<td>Dose  11</td>\n<td>Dose  12</td>\n<td>Dose  13</td>\n<td>Dose  14</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Day 1/ Baseline</td>\n<td>Wk  4</td>\n<td>Wk  8</td>\n<td>Wk  12</td>\n<td>Wk  16</td>\n<td>Wk  20</td>\n<td>Wk  24</td>\n<td>Wk  28</td>\n<td>Wk  32</td>\n<td>Wk  36</td>\n<td>Wk  40</td>\n<td>Wk  44</td>\n<td>Wk  48</td>\n<td>Wk 52</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Retinal imaging scan   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   g </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_11.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"14\" rowspan=\"1\">Year 1</td>\n</tr>\n<tr>\n<td>Dose 1</td>\n<td>Dose  2</td>\n<td>Dose  3</td>\n<td>Dose  4</td>\n<td>Dose  5</td>\n<td>Dose  6</td>\n<td>Dose  7</td>\n<td>Dose  8</td>\n<td>Dose  9</td>\n<td>Dose  10</td>\n<td>Dose  11</td>\n<td>Dose  12</td>\n<td>Dose  13</td>\n<td>Dose  14</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Day 1/ Baseline</td>\n<td>Wk  4</td>\n<td>Wk  8</td>\n<td>Wk  12</td>\n<td>Wk  16</td>\n<td>Wk  20</td>\n<td>Wk  24</td>\n<td>Wk  28</td>\n<td>Wk  32</td>\n<td>Wk  36</td>\n<td>Wk  40</td>\n<td>Wk  44</td>\n<td>Wk  48</td>\n<td>Wk 52</td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   h </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CDR   i </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>RBANS   i </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   i </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   i </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   f,i </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Digital measurements of cognition,  actigraphy, and sleep   j </td>\n<td>X   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   j </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medications review   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_12.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 2</td>\n</tr>\n<tr>\n<td>Dose 15</td>\n<td>Dose  16</td>\n<td>Dose  17</td>\n<td>Dose  18</td>\n<td>Dose  19</td>\n<td>Dose  20</td>\n<td>Dose  21</td>\n<td>Dose  22</td>\n<td>Dose  23</td>\n<td>Dose  24</td>\n<td>Dose  25</td>\n<td>Dose  26</td>\n<td>Dose  27</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 56</td>\n<td>Wk 60</td>\n<td>Wk 64</td>\n<td>Wk 68</td>\n<td>Wk 72</td>\n<td>Wk 76</td>\n<td>Wk 80</td>\n<td>Wk 84</td>\n<td>Wk 88</td>\n<td>Wk 92</td>\n<td>Wk 96</td>\n<td>Wk 100</td>\n<td>Wk 104</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Retinal imaging scan   e </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_13.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 2</td>\n</tr>\n<tr>\n<td>Dose 15</td>\n<td>Dose  16</td>\n<td>Dose  17</td>\n<td>Dose  18</td>\n<td>Dose  19</td>\n<td>Dose  20</td>\n<td>Dose  21</td>\n<td>Dose  22</td>\n<td>Dose  23</td>\n<td>Dose  24</td>\n<td>Dose  25</td>\n<td>Dose  26</td>\n<td>Dose  27</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 56</td>\n<td>Wk 60</td>\n<td>Wk 64</td>\n<td>Wk 68</td>\n<td>Wk 72</td>\n<td>Wk 76</td>\n<td>Wk 80</td>\n<td>Wk 84</td>\n<td>Wk 88</td>\n<td>Wk 92</td>\n<td>Wk 96</td>\n<td>Wk 100</td>\n<td>Wk 104</td>\n</tr>\n<tr>\n<td>CDR   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>RBANS   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   f,i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Digital measurements of cognition, actigraphy, and  sleep   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   j </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medications review   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_14.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 3</td>\n</tr>\n<tr>\n<td>Dose  28</td>\n<td>Dose  29</td>\n<td>Dose  30</td>\n<td>Dose  31</td>\n<td>Dose  32</td>\n<td>Dose  33</td>\n<td>Dose  34</td>\n<td>Dose  35</td>\n<td>Dose  36</td>\n<td>Dose  37</td>\n<td>Dose  38</td>\n<td>Dose  39</td>\n<td>Dose  40</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 108</td>\n<td>Wk 112</td>\n<td>Wk 116</td>\n<td>Wk 120</td>\n<td>Wk 124</td>\n<td>Wk 128</td>\n<td>Wk 132</td>\n<td>Wk 136</td>\n<td>Wk 140</td>\n<td>Wk 144</td>\n<td>Wk 148</td>\n<td>Wk 152</td>\n<td>Wk 156</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Retinal imaging scan   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_15.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 3</td>\n</tr>\n<tr>\n<td>Dose  28</td>\n<td>Dose  29</td>\n<td>Dose  30</td>\n<td>Dose  31</td>\n<td>Dose  32</td>\n<td>Dose  33</td>\n<td>Dose  34</td>\n<td>Dose  35</td>\n<td>Dose  36</td>\n<td>Dose  37</td>\n<td>Dose  38</td>\n<td>Dose  39</td>\n<td>Dose  40</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 108</td>\n<td>Wk 112</td>\n<td>Wk 116</td>\n<td>Wk 120</td>\n<td>Wk 124</td>\n<td>Wk 128</td>\n<td>Wk 132</td>\n<td>Wk 136</td>\n<td>Wk 140</td>\n<td>Wk 144</td>\n<td>Wk 148</td>\n<td>Wk 152</td>\n<td>Wk 156</td>\n</tr>\n<tr>\n<td>CDR   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>RBANS   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   f,i </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Digital measurements of cognition, actigraphy,  and sleep   j </td>\n<td></td>\n<td></td>\n<td>X   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medications review   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_16.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 4</td>\n</tr>\n<tr>\n<td>Dose 41</td>\n<td>Dose 42</td>\n<td>Dose 43</td>\n<td>Dose 44</td>\n<td>Dose 45</td>\n<td>Dose 46</td>\n<td>Dose 47</td>\n<td>Dose 48</td>\n<td>Dose 49</td>\n<td>Dose 50</td>\n<td>Dose 51</td>\n<td>Dose 52</td>\n<td>Dose 53</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  160</td>\n<td>Wk  164</td>\n<td>Wk  168</td>\n<td>Wk  172</td>\n<td>Wk  176</td>\n<td>Wk  180</td>\n<td>Wk  184</td>\n<td>Wk  188</td>\n<td>Wk  192</td>\n<td>Wk  196</td>\n<td>Wk  200</td>\n<td>Wk  204</td>\n<td>Wk  208</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Retinal imaging scan   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_17.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 4</td>\n</tr>\n<tr>\n<td>Dose 41</td>\n<td>Dose 42</td>\n<td>Dose 43</td>\n<td>Dose 44</td>\n<td>Dose 45</td>\n<td>Dose 46</td>\n<td>Dose 47</td>\n<td>Dose 48</td>\n<td>Dose 49</td>\n<td>Dose 50</td>\n<td>Dose 51</td>\n<td>Dose 52</td>\n<td>Dose 53</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  160</td>\n<td>Wk  164</td>\n<td>Wk  168</td>\n<td>Wk  172</td>\n<td>Wk  176</td>\n<td>Wk  180</td>\n<td>Wk  184</td>\n<td>Wk  188</td>\n<td>Wk  192</td>\n<td>Wk  196</td>\n<td>Wk  200</td>\n<td>Wk  204</td>\n<td>Wk  208</td>\n</tr>\n<tr>\n<td>CDR   i </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>RBANS   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   f,i </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Digital measurements of cognition, actigraphy,  and sleep   i </td>\n<td></td>\n<td>X   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medications review   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_18.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"14\" rowspan=\"1\">Year 5</td>\n</tr>\n<tr>\n<td>Dose  54</td>\n<td>Dose  55</td>\n<td>Dose  56</td>\n<td>Dose  57</td>\n<td>Dose  58</td>\n<td>Dose  59</td>\n<td>Dose  60</td>\n<td>Dose  61</td>\n<td>Dose  62</td>\n<td>Dose  63</td>\n<td>Dose  64</td>\n<td>Dose  65</td>\n<td>Wk 260/ Study  Completion  PD Visit</td>\n<td>20 Wk Post-Last  Dose Follow-Up Visit  k </td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  212</td>\n<td>Wk  216</td>\n<td>Wk  220</td>\n<td>Wk  224</td>\n<td>Wk  228</td>\n<td>Wk  232</td>\n<td>Wk  236</td>\n<td>Wk  240</td>\n<td>Wk  244</td>\n<td>Wk  248</td>\n<td>Wk  252</td>\n<td>Wk  256</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Retinal imaging scan   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Brain MRI </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for  ABBV-8E12 assay </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker  sample</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_19.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"14\" rowspan=\"1\">Year 5</td>\n</tr>\n<tr>\n<td>Dose  54</td>\n<td>Dose  55</td>\n<td>Dose  56</td>\n<td>Dose  57</td>\n<td>Dose  58</td>\n<td>Dose  59</td>\n<td>Dose  60</td>\n<td>Dose  61</td>\n<td>Dose  62</td>\n<td>Dose  63</td>\n<td>Dose  64</td>\n<td>Dose  65</td>\n<td>Wk 260/ Study  Completion  PD Visit</td>\n<td>20 Wk Post-Last  Dose Follow-Up Visit  k </td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  212</td>\n<td>Wk  216</td>\n<td>Wk  220</td>\n<td>Wk  224</td>\n<td>Wk  228</td>\n<td>Wk  232</td>\n<td>Wk  236</td>\n<td>Wk  240</td>\n<td>Wk  244</td>\n<td>Wk  248</td>\n<td>Wk  252</td>\n<td>Wk  256</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA  sample   h </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CDR   i </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>RBANS   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>EQ-5D-5L   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   f,i </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Digital measurements of  cognition, actigraphy, and  sleep   j </td>\n<td>X   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   j </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   j </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medications  review   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 2</td>\n</tr>\n<tr>\n<td>Dose 15</td>\n<td>Dose  16</td>\n<td>Dose  17</td>\n<td>Dose  18</td>\n<td>Dose  19</td>\n<td>Dose  20</td>\n<td>Dose  21</td>\n<td>Dose  22</td>\n<td>Dose  23</td>\n<td>Dose  24</td>\n<td>Dose  25</td>\n<td>Dose  26</td>\n<td>Dose  27</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 56</td>\n<td>Wk 60</td>\n<td>Wk 64</td>\n<td>Wk 68</td>\n<td>Wk 72</td>\n<td>Wk 76</td>\n<td>Wk 80</td>\n<td>Wk 84</td>\n<td>Wk 88</td>\n<td>Wk 92</td>\n<td>Wk 96</td>\n<td>Wk 100</td>\n<td>Wk 104</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>O</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CDR   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_20.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"14\" rowspan=\"1\">Year 1</td>\n</tr>\n<tr>\n<td>Dose 1</td>\n<td>Dose  2</td>\n<td>Dose  3</td>\n<td>Dose  4</td>\n<td>Dose  5</td>\n<td>Dose  6</td>\n<td>Dose  7</td>\n<td>Dose  8</td>\n<td>Dose  9</td>\n<td>Dose  10</td>\n<td>Dose  11</td>\n<td>Dose  12</td>\n<td>Dose  13</td>\n<td>Dose  14</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Day 1/ Baseline</td>\n<td>Wk  4</td>\n<td>Wk  8</td>\n<td>Wk  12</td>\n<td>Wk  16</td>\n<td>Wk  20</td>\n<td>Wk  24</td>\n<td>Wk  28</td>\n<td>Wk  32</td>\n<td>Wk  36</td>\n<td>Wk  40</td>\n<td>Wk  44</td>\n<td>Wk  48</td>\n<td>Wk  52</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   f </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   g </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_21.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"14\" rowspan=\"1\">Year 1</td>\n</tr>\n<tr>\n<td>Dose 1</td>\n<td>Dose  2</td>\n<td>Dose  3</td>\n<td>Dose  4</td>\n<td>Dose  5</td>\n<td>Dose  6</td>\n<td>Dose  7</td>\n<td>Dose  8</td>\n<td>Dose  9</td>\n<td>Dose  10</td>\n<td>Dose  11</td>\n<td>Dose  12</td>\n<td>Dose  13</td>\n<td>Dose  14</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Day 1/ Baseline</td>\n<td>Wk  4</td>\n<td>Wk  8</td>\n<td>Wk  12</td>\n<td>Wk  16</td>\n<td>Wk  20</td>\n<td>Wk  24</td>\n<td>Wk  28</td>\n<td>Wk  32</td>\n<td>Wk  36</td>\n<td>Wk  40</td>\n<td>Wk  44</td>\n<td>Wk  48</td>\n<td>Wk  52</td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CDR   h </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>RBANS   h </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   h </td>\n<td>X   d </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   h </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   e,h </td>\n<td>X   d </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications review   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_22.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 2</td>\n</tr>\n<tr>\n<td>Dose 15</td>\n<td>Dose  16</td>\n<td>Dose  17</td>\n<td>Dose  18</td>\n<td>Dose  19</td>\n<td>Dose  20</td>\n<td>Dose  21</td>\n<td>Dose  22</td>\n<td>Dose  23</td>\n<td>Dose  24</td>\n<td>Dose  25</td>\n<td>Dose  26</td>\n<td>Dose  27</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 56</td>\n<td>Wk 60</td>\n<td>Wk 64</td>\n<td>Wk 68</td>\n<td>Wk 72</td>\n<td>Wk 76</td>\n<td>Wk 80</td>\n<td>Wk 84</td>\n<td>Wk 88</td>\n<td>Wk 92</td>\n<td>Wk 96</td>\n<td>Wk 100</td>\n<td>Wk 104</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>O</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CDR   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_23.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 2</td>\n</tr>\n<tr>\n<td>Dose 15</td>\n<td>Dose  16</td>\n<td>Dose  17</td>\n<td>Dose  18</td>\n<td>Dose  19</td>\n<td>Dose  20</td>\n<td>Dose  21</td>\n<td>Dose  22</td>\n<td>Dose  23</td>\n<td>Dose  24</td>\n<td>Dose  25</td>\n<td>Dose  26</td>\n<td>Dose  27</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 56</td>\n<td>Wk 60</td>\n<td>Wk 64</td>\n<td>Wk 68</td>\n<td>Wk 72</td>\n<td>Wk 76</td>\n<td>Wk 80</td>\n<td>Wk 84</td>\n<td>Wk 88</td>\n<td>Wk 92</td>\n<td>Wk 96</td>\n<td>Wk 100</td>\n<td>Wk 104</td>\n</tr>\n<tr>\n<td>RBANS   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   e,h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications review   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_24.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 3</td>\n</tr>\n<tr>\n<td>Dose  28</td>\n<td>Dose  29</td>\n<td>Dose  30</td>\n<td>Dose  31</td>\n<td>Dose  32</td>\n<td>Dose  33</td>\n<td>Dose  34</td>\n<td>Dose  35</td>\n<td>Dose  36</td>\n<td>Dose  37</td>\n<td>Dose  38</td>\n<td>Dose  39</td>\n<td>Dose  40</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 108</td>\n<td>Wk 112</td>\n<td>Wk 116</td>\n<td>Wk 120</td>\n<td>Wk 124</td>\n<td>Wk 128</td>\n<td>Wk 132</td>\n<td>Wk 136</td>\n<td>Wk 140</td>\n<td>Wk 144</td>\n<td>Wk 148</td>\n<td>Wk 152</td>\n<td>Wk 156</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI </td>\n<td></td>\n<td></td>\n<td></td>\n<td>O</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CDR   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_25.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 3</td>\n</tr>\n<tr>\n<td>Dose  28</td>\n<td>Dose  29</td>\n<td>Dose  30</td>\n<td>Dose  31</td>\n<td>Dose  32</td>\n<td>Dose  33</td>\n<td>Dose  34</td>\n<td>Dose  35</td>\n<td>Dose  36</td>\n<td>Dose  37</td>\n<td>Dose  38</td>\n<td>Dose  39</td>\n<td>Dose  40</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 108</td>\n<td>Wk 112</td>\n<td>Wk 116</td>\n<td>Wk 120</td>\n<td>Wk 124</td>\n<td>Wk 128</td>\n<td>Wk 132</td>\n<td>Wk 136</td>\n<td>Wk 140</td>\n<td>Wk 144</td>\n<td>Wk 148</td>\n<td>Wk 152</td>\n<td>Wk 156</td>\n</tr>\n<tr>\n<td>RBANS   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   e,h </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications review   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_26.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 4</td>\n</tr>\n<tr>\n<td>Dose 41</td>\n<td>Dose 42</td>\n<td>Dose 43</td>\n<td>Dose 44</td>\n<td>Dose 45</td>\n<td>Dose 46</td>\n<td>Dose 47</td>\n<td>Dose 48</td>\n<td>Dose 49</td>\n<td>Dose 50</td>\n<td>Dose 51</td>\n<td>Dose 52</td>\n<td>Dose 53</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  160</td>\n<td>Wk  164</td>\n<td>Wk  168</td>\n<td>Wk  172</td>\n<td>Wk  176</td>\n<td>Wk  180</td>\n<td>Wk  184</td>\n<td>Wk  188</td>\n<td>Wk  192</td>\n<td>Wk  196</td>\n<td>Wk  200</td>\n<td>Wk  204</td>\n<td>Wk  208</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI</td>\n<td></td>\n<td></td>\n<td>O</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   g </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CDR   h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_27.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 4</td>\n</tr>\n<tr>\n<td>Dose 41</td>\n<td>Dose 42</td>\n<td>Dose 43</td>\n<td>Dose 44</td>\n<td>Dose 45</td>\n<td>Dose 46</td>\n<td>Dose 47</td>\n<td>Dose 48</td>\n<td>Dose 49</td>\n<td>Dose 50</td>\n<td>Dose 51</td>\n<td>Dose 52</td>\n<td>Dose 53</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  160</td>\n<td>Wk  164</td>\n<td>Wk  168</td>\n<td>Wk  172</td>\n<td>Wk  176</td>\n<td>Wk  180</td>\n<td>Wk  184</td>\n<td>Wk  188</td>\n<td>Wk  192</td>\n<td>Wk  196</td>\n<td>Wk  200</td>\n<td>Wk  204</td>\n<td>Wk  208</td>\n</tr>\n<tr>\n<td>RBANS   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   e,h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications review   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_28.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 4</td>\n<td></td>\n</tr>\n<tr>\n<td>Dose 41</td>\n<td>Dose 42</td>\n<td>Dose 43</td>\n<td>Dose 44</td>\n<td>Dose 45</td>\n<td>Dose 46</td>\n<td>Dose 47</td>\n<td>Dose 48</td>\n<td>Dose 49</td>\n<td>Dose 50</td>\n<td>Dose 51</td>\n<td>Dose 52</td>\n<td>Dose 53</td>\n<td></td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  160</td>\n<td>Wk  164</td>\n<td>Wk  168</td>\n<td>Wk  172</td>\n<td>Wk  176</td>\n<td>Wk  180</td>\n<td>Wk  184</td>\n<td>Wk  188</td>\n<td>Wk  192</td>\n<td>Wk  196</td>\n<td>Wk  200</td>\n<td>Wk  204</td>\n<td>Wk  208</td>\n<td></td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Body weight   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI</td>\n<td></td>\n<td></td>\n<td>O</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   g </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_29.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 4</td>\n<td></td>\n</tr>\n<tr>\n<td>Dose 41</td>\n<td>Dose 42</td>\n<td>Dose 43</td>\n<td>Dose 44</td>\n<td>Dose 45</td>\n<td>Dose 46</td>\n<td>Dose 47</td>\n<td>Dose 48</td>\n<td>Dose 49</td>\n<td>Dose 50</td>\n<td>Dose 51</td>\n<td>Dose 52</td>\n<td>Dose 53</td>\n<td></td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  160</td>\n<td>Wk  164</td>\n<td>Wk  168</td>\n<td>Wk  172</td>\n<td>Wk  176</td>\n<td>Wk  180</td>\n<td>Wk  184</td>\n<td>Wk  188</td>\n<td>Wk  192</td>\n<td>Wk  196</td>\n<td>Wk  200</td>\n<td>Wk  204</td>\n<td>Wk  208</td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>CDR   h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>RBANS   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>EQ-5D-5L   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS   e,h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medications review   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>AE assessment   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 2</td>\n</tr>\n<tr>\n<td>Dose 15</td>\n<td>Dose  16</td>\n<td>Dose  17</td>\n<td>Dose  18</td>\n<td>Dose  19</td>\n<td>Dose  20</td>\n<td>Dose  21</td>\n<td>Dose  22</td>\n<td>Dose  23</td>\n<td>Dose  24</td>\n<td>Dose  25</td>\n<td>Dose  26</td>\n<td>Dose  27</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 56</td>\n<td>Wk 60</td>\n<td>Wk 64</td>\n<td>Wk 68</td>\n<td>Wk 72</td>\n<td>Wk 76</td>\n<td>Wk 80</td>\n<td>Wk 84</td>\n<td>Wk 88</td>\n<td>Wk 92</td>\n<td>Wk 96</td>\n<td>Wk 100</td>\n<td>Wk 104</td>\n</tr>\n<tr>\n<td>RBANS   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   e,h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications review   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 3</td>\n</tr>\n<tr>\n<td>Dose  28</td>\n<td>Dose  29</td>\n<td>Dose  30</td>\n<td>Dose  31</td>\n<td>Dose  32</td>\n<td>Dose  33</td>\n<td>Dose  34</td>\n<td>Dose  35</td>\n<td>Dose  36</td>\n<td>Dose  37</td>\n<td>Dose  38</td>\n<td>Dose  39</td>\n<td>Dose  40</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 108</td>\n<td>Wk 112</td>\n<td>Wk 116</td>\n<td>Wk 120</td>\n<td>Wk 124</td>\n<td>Wk 128</td>\n<td>Wk 132</td>\n<td>Wk 136</td>\n<td>Wk 140</td>\n<td>Wk 144</td>\n<td>Wk 148</td>\n<td>Wk 152</td>\n<td>Wk 156</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI </td>\n<td></td>\n<td></td>\n<td></td>\n<td>O</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CDR   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_5.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 3</td>\n</tr>\n<tr>\n<td>Dose  28</td>\n<td>Dose  29</td>\n<td>Dose  30</td>\n<td>Dose  31</td>\n<td>Dose  32</td>\n<td>Dose  33</td>\n<td>Dose  34</td>\n<td>Dose  35</td>\n<td>Dose  36</td>\n<td>Dose  37</td>\n<td>Dose  38</td>\n<td>Dose  39</td>\n<td>Dose  40</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk 108</td>\n<td>Wk 112</td>\n<td>Wk 116</td>\n<td>Wk 120</td>\n<td>Wk 124</td>\n<td>Wk 128</td>\n<td>Wk 132</td>\n<td>Wk 136</td>\n<td>Wk 140</td>\n<td>Wk 144</td>\n<td>Wk 148</td>\n<td>Wk 152</td>\n<td>Wk 156</td>\n</tr>\n<tr>\n<td>RBANS   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   e,h </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications review   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_6.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 4</td>\n</tr>\n<tr>\n<td>Dose 41</td>\n<td>Dose 42</td>\n<td>Dose 43</td>\n<td>Dose 44</td>\n<td>Dose 45</td>\n<td>Dose 46</td>\n<td>Dose 47</td>\n<td>Dose 48</td>\n<td>Dose 49</td>\n<td>Dose 50</td>\n<td>Dose 51</td>\n<td>Dose 52</td>\n<td>Dose 53</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  160</td>\n<td>Wk  164</td>\n<td>Wk  168</td>\n<td>Wk  172</td>\n<td>Wk  176</td>\n<td>Wk  180</td>\n<td>Wk  184</td>\n<td>Wk  188</td>\n<td>Wk  192</td>\n<td>Wk  196</td>\n<td>Wk  200</td>\n<td>Wk  204</td>\n<td>Wk  208</td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brain MRI</td>\n<td></td>\n<td></td>\n<td>O</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for ABBV-8E12 assay </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker sample</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA sample   g </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CDR   h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_7.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"13\" rowspan=\"1\">Year 4</td>\n</tr>\n<tr>\n<td>Dose 41</td>\n<td>Dose 42</td>\n<td>Dose 43</td>\n<td>Dose 44</td>\n<td>Dose 45</td>\n<td>Dose 46</td>\n<td>Dose 47</td>\n<td>Dose 48</td>\n<td>Dose 49</td>\n<td>Dose 50</td>\n<td>Dose 51</td>\n<td>Dose 52</td>\n<td>Dose 53</td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  160</td>\n<td>Wk  164</td>\n<td>Wk  168</td>\n<td>Wk  172</td>\n<td>Wk  176</td>\n<td>Wk  180</td>\n<td>Wk  184</td>\n<td>Wk  188</td>\n<td>Wk  192</td>\n<td>Wk  196</td>\n<td>Wk  200</td>\n<td>Wk  204</td>\n<td>Wk  208</td>\n</tr>\n<tr>\n<td>RBANS   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   e,h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications review   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_8.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"14\" rowspan=\"1\">Year 5</td>\n</tr>\n<tr>\n<td>Dose  54</td>\n<td>Dose  55</td>\n<td>Dose  56</td>\n<td>Dose  57</td>\n<td>Dose  58</td>\n<td>Dose  59</td>\n<td>Dose  60</td>\n<td>Dose  61</td>\n<td>Dose  62</td>\n<td>Dose  63</td>\n<td>Dose  64</td>\n<td>Dose  65</td>\n<td>Wk 260/ Study  Completion  PD Visit</td>\n<td>20 Wk Post-Last  Dose Follow-Up Visit  i </td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  212</td>\n<td>Wk  216</td>\n<td>Wk  220</td>\n<td>Wk  224</td>\n<td>Wk  228</td>\n<td>Wk  232</td>\n<td>Wk  236</td>\n<td>Wk  240</td>\n<td>Wk  244</td>\n<td>Wk  248</td>\n<td>Wk  252</td>\n<td>Wk  256</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Subject/study partner ICF   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history update   c </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment assignment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Neurological examination</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical laboratory tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Brain MRI </td>\n<td></td>\n<td>O</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Optional LP/CSF collection</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Tau PET   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for  ABBV-8E12 assay </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>ADA sample</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Plasma and serum biomarker  sample</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Optional PG DNA and RNA  sample   g </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03712787_SOA_table_9.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Dose</td>\n<td colspan=\"14\" rowspan=\"1\">Year 5</td>\n</tr>\n<tr>\n<td>Dose  54</td>\n<td>Dose  55</td>\n<td>Dose  56</td>\n<td>Dose  57</td>\n<td>Dose  58</td>\n<td>Dose  59</td>\n<td>Dose  60</td>\n<td>Dose  61</td>\n<td>Dose  62</td>\n<td>Dose  63</td>\n<td>Dose  64</td>\n<td>Dose  65</td>\n<td>Wk 260/ Study  Completion  PD Visit</td>\n<td>20 Wk Post-Last  Dose Follow-Up Visit  i </td>\n</tr>\n<tr>\n<td>Visits &amp; Procedures   a </td>\n<td>Wk  212</td>\n<td>Wk  216</td>\n<td>Wk  220</td>\n<td>Wk  224</td>\n<td>Wk  228</td>\n<td>Wk  232</td>\n<td>Wk  236</td>\n<td>Wk  240</td>\n<td>Wk  244</td>\n<td>Wk  248</td>\n<td>Wk  252</td>\n<td>Wk  256</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IV study drug   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CDR   h </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>RBANS   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>ADCS-MCI-ADL-24   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>EQ-5D-5L   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS   e,h </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications  review   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>AE assessment   e </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03713632_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"8\" rowspan=\"1\">Treatment Period 1</td>\n<td colspan=\"13\" rowspan=\"1\">Treatment Period 2</td>\n<td>Post-Treatment  Follow-Up</td>\n</tr>\n<tr>\n<td>Visit Name</td>\n<td>Screening  1</td>\n<td>Screening  2</td>\n<td>Baseline</td>\n<td>Week 1</td>\n<td>Week 2</td>\n<td>Week 3</td>\n<td>Week 4</td>\n<td>Week 8</td>\n<td>Week 12</td>\n<td>Week 16 /  EOT1</td>\n<td>Week 17</td>\n<td>Week 18</td>\n<td>Week 19</td>\n<td>Week 20</td>\n<td>Week 24</td>\n<td>Week 28</td>\n<td>Week 32</td>\n<td>Week 36</td>\n<td>Week 40</td>\n<td>Week 44</td>\n<td>Week 48</td>\n<td>UNS 1 to 3</td>\n<td>Week 52 /  EOT2</td>\n<td>Week 60 / F8</td>\n</tr>\n<tr>\n<td>Days</td>\n<td>-28 to -14</td>\n<td>-13 to -1</td>\n<td>1</td>\n<td>8</td>\n<td>15</td>\n<td>22</td>\n<td>29</td>\n<td>57</td>\n<td>85</td>\n<td>113</td>\n<td>120</td>\n<td>127</td>\n<td>134</td>\n<td>141</td>\n<td>169</td>\n<td>197</td>\n<td>225</td>\n<td>253</td>\n<td>281</td>\n<td>309</td>\n<td>337</td>\n<td></td>\n<td>365</td>\n<td>421</td>\n</tr>\n<tr>\n<td>Obtain informed  consent (ICF)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demography</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion / Exclusion  criteria   1 </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Washout evaluation /  instruction</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Relevant medical  history / current  medical condition</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HS medical history  and previous therapies </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Smoking history</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hurley stage</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Prior / concomitant  medications   2 </td>\n<td>X</td>\n<td colspan=\"23\" rowspan=\"1\">Update as necessary</td>\n</tr>\n<tr>\n<td>Adverse Events   3 </td>\n<td>X</td>\n<td colspan=\"23\" rowspan=\"1\">Update as necessary</td>\n</tr>\n<tr>\n<td>Physical Examination   1 </td>\n<td></td>\n<td></td>\n<td>S</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>S</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>S</td>\n<td>S</td>\n</tr>\n<tr>\n<td>Body Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Body Weight</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Tuberculosis test</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03713632_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"8\" rowspan=\"1\">Treatment Period 1</td>\n<td colspan=\"13\" rowspan=\"1\">Treatment Period 2</td>\n<td>Post-Treatment  Follow-Up</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Name</td>\n<td>Screening  1</td>\n<td>Screening  2</td>\n<td>Baseline</td>\n<td>Week 1</td>\n<td>Week 2</td>\n<td>Week 3</td>\n<td>Week 4</td>\n<td>Week 8</td>\n<td>Week 12</td>\n<td>Week 16 /  EOT1</td>\n<td>Week 17</td>\n<td>Week 18</td>\n<td>Week 19</td>\n<td>Week 20</td>\n<td>Week 24</td>\n<td>Week 28</td>\n<td>Week 32</td>\n<td>Week 36</td>\n<td>Week 40</td>\n<td>Week 44</td>\n<td>Week 48</td>\n<td>UNS 1 to 3</td>\n<td>Week 52 /  EOT2</td>\n<td>Week 60 / F8</td>\n<td></td>\n</tr>\n<tr>\n<td>Days</td>\n<td>-28 to -14</td>\n<td>-13 to -1</td>\n<td>1</td>\n<td>8</td>\n<td>15</td>\n<td>22</td>\n<td>29</td>\n<td>57</td>\n<td>85</td>\n<td>113</td>\n<td>120</td>\n<td>127</td>\n<td>134</td>\n<td>141</td>\n<td>169</td>\n<td>197</td>\n<td>225</td>\n<td>253</td>\n<td>281</td>\n<td>309</td>\n<td>337</td>\n<td></td>\n<td>365</td>\n<td>421</td>\n<td></td>\n</tr>\n<tr>\n<td>Lesion count  (physician)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Flare assessment   4 </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Numerical Rating  Scale for pain  assessment   5 </td>\n<td colspan=\"10\" rowspan=\"1\">Completed daily in the eDiary</td>\n<td colspan=\"14\" rowspan=\"1\">Completed weekly in the eDiary</td>\n<td></td>\n</tr>\n<tr>\n<td>Modified Hidradenitis  Suppurativa Score  (mHSS)</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HS-Physician's Global  Assessment</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Patient's Lesion Count</td>\n<td colspan=\"24\" rowspan=\"1\">Completed weekly in the eDiary</td>\n<td></td>\n</tr>\n<tr>\n<td>DLQI</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>EQ5D</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Patient Global  Impression of severity  (PGI-s)</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Patient Global  Impression of change  (PGI-c)</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Work productivity  Activity Impairment  (WPAI)</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HS Symptom Diary   6 </td>\n<td colspan=\"10\" rowspan=\"1\">Completed daily in the eDiary</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical Chemistry</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03713632_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"8\" rowspan=\"1\">Treatment Period 1</td>\n<td colspan=\"13\" rowspan=\"1\">Treatment Period 2</td>\n<td>Post-Treatment  Follow-Up</td>\n</tr>\n<tr>\n<td>Visit Name</td>\n<td>Screening  1</td>\n<td>Screening  2</td>\n<td>Baseline</td>\n<td>Week 1</td>\n<td>Week 2</td>\n<td>Week 3</td>\n<td>Week 4</td>\n<td>Week 8</td>\n<td>Week 12</td>\n<td>Week 16 /  EOT1</td>\n<td>Week 17</td>\n<td>Week 18</td>\n<td>Week 19</td>\n<td>Week 20</td>\n<td>Week 24</td>\n<td>Week 28</td>\n<td>Week 32</td>\n<td>Week 36</td>\n<td>Week 40</td>\n<td>Week 44</td>\n<td>Week 48</td>\n<td>UNS 1 to 3</td>\n<td>Week 52 /  EOT2</td>\n<td>Week 60 / F8</td>\n</tr>\n<tr>\n<td>Days</td>\n<td>-28 to -14</td>\n<td>-13 to -1</td>\n<td>1</td>\n<td>8</td>\n<td>15</td>\n<td>22</td>\n<td>29</td>\n<td>57</td>\n<td>85</td>\n<td>113</td>\n<td>120</td>\n<td>127</td>\n<td>134</td>\n<td>141</td>\n<td>169</td>\n<td>197</td>\n<td>225</td>\n<td>253</td>\n<td>281</td>\n<td>309</td>\n<td>337</td>\n<td></td>\n<td>365</td>\n<td>421</td>\n</tr>\n<tr>\n<td>Fasting lipid panel</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum pregnancy test</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine pregnancy test</td>\n<td></td>\n<td></td>\n<td>S</td>\n<td></td>\n<td></td>\n<td></td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td></td>\n<td></td>\n<td></td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n</tr>\n<tr>\n<td>Blood sample for  pharmacokinetics</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Blood sample for  immunogenicity</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Biomarker serum</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Optional biopsy  sample   7 </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Optional DNA  sampling   8 </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contact IRT</td>\n<td>S</td>\n<td></td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td>S</td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Drug dispensation   9 </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dose administration   10 </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Period  completion/disposition  form</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Health care resource  utilization</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Trial Feedback  Questionnaire  (optional)</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03713632_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Period</td>\n<td colspan=\"2\" rowspan=\"1\">Screening</td>\n<td colspan=\"8\" rowspan=\"1\">Treatment Period 1</td>\n<td colspan=\"13\" rowspan=\"1\">Treatment Period 2</td>\n<td>Post-Treatment  Follow-Up</td>\n</tr>\n<tr>\n<td>Visit Name</td>\n<td>Screening  1</td>\n<td>Screening  2</td>\n<td>Baseline</td>\n<td>Week 1</td>\n<td>Week 2</td>\n<td>Week 3</td>\n<td>Week 4</td>\n<td>Week 8</td>\n<td>Week 12</td>\n<td>Week 16 /  EOT1</td>\n<td>Week 17</td>\n<td>Week 18</td>\n<td>Week 19</td>\n<td>Week 20</td>\n<td>Week 24</td>\n<td>Week 28</td>\n<td>Week 32</td>\n<td>Week 36</td>\n<td>Week 40</td>\n<td>Week 44</td>\n<td>Week 48</td>\n<td>UNS 1 to 3</td>\n<td>Week 52 /  EOT2</td>\n<td>Week 60 / F8</td>\n</tr>\n<tr>\n<td>Days</td>\n<td>-28 to -14</td>\n<td>-13 to -1</td>\n<td>1</td>\n<td>8</td>\n<td>15</td>\n<td>22</td>\n<td>29</td>\n<td>57</td>\n<td>85</td>\n<td>113</td>\n<td>120</td>\n<td>127</td>\n<td>134</td>\n<td>141</td>\n<td>169</td>\n<td>197</td>\n<td>225</td>\n<td>253</td>\n<td>281</td>\n<td>309</td>\n<td>337</td>\n<td></td>\n<td>365</td>\n<td>421</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03713684_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening   (2 weeks) </td>\n<td colspan=\"8\" rowspan=\"1\">Double-blind, placebo-controlled Core Treatment  Period   (30 weeks) </td>\n<td colspan=\"4\" rowspan=\"1\">Double-blind, placebo-controlled Treatment  Extension Period  (26 weeks) </td>\n<td>Post-treatment  Follow-up  Period  (6 weeks) </td>\n<td>Notes </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>R </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>EOT </td>\n<td>EOS </td>\n<td></td>\n</tr>\n<tr>\n<td>Week </td>\n<td>-2 </td>\n<td>0  Baseline</td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>18 </td>\n<td>24 </td>\n<td>30   a </td>\n<td>36 </td>\n<td>43 </td>\n<td>50 </td>\n<td>56 </td>\n<td>Last IMP+  6weeks </td>\n<td></td>\n</tr>\n<tr>\n<td>Acceptable range  (days) </td>\n<td>-14 to   -11</td>\n<td>1 </td>\n<td>14  (±3) </td>\n<td>28  (±3) </td>\n<td>56  (±3) </td>\n<td>84  (±3) </td>\n<td>126  (±3) </td>\n<td>168  (±3) </td>\n<td>210  (±3) </td>\n<td>252  (±5) </td>\n<td>301  (±5) </td>\n<td>350  (±5) </td>\n<td>392  (±5) </td>\n<td>434   (±7) </td>\n<td></td>\n</tr>\n<tr>\n<td>Injection of weekly dose  on the day of visit </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Participant will self-administer the  injection only after blood samples have  been drawn at the respective visit </td>\n</tr>\n<tr>\n<td>Injection of weekly dose  may be on a different  day than visit </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>See Table 2 for details of dosing windows </td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Informed consent taken prior to any  study-related procedures being  performed </td>\n</tr>\n<tr>\n<td>Inclusion and exclusion  criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Check eligibility before randomization </td>\n</tr>\n<tr>\n<td>Demography,  medical/surgical history </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Includes diabetes complications,  cardiovascular (CV) and allergy history,  alcohol and smoking habits </td>\n</tr>\n<tr>\n<td>Physical examination </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>BP and HR in sitting position after at least  5 minutes of rest </td>\n</tr>\n<tr>\n<td>Height </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Body weight </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03713684_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening   (2 weeks) </td>\n<td colspan=\"8\" rowspan=\"1\">Double-blind, placebo-controlled Core Treatment  Period   (30 weeks) </td>\n<td colspan=\"4\" rowspan=\"1\">Double-blind, placebo-controlled Treatment  Extension Period  (26 weeks) </td>\n<td>Post-treatment  Follow-up  Period  (6 weeks) </td>\n<td>Notes </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>R </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>EOT </td>\n<td>EOS </td>\n<td></td>\n</tr>\n<tr>\n<td>Week </td>\n<td>-2 </td>\n<td>0  Baseline</td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>18 </td>\n<td>24 </td>\n<td>30   a </td>\n<td>36 </td>\n<td>43 </td>\n<td>50 </td>\n<td>56 </td>\n<td>Last IMP+  6weeks </td>\n<td></td>\n</tr>\n<tr>\n<td>Acceptable range  (days) </td>\n<td>-14 to   -11</td>\n<td>1 </td>\n<td>14  (±3) </td>\n<td>28  (±3) </td>\n<td>56  (±3) </td>\n<td>84  (±3) </td>\n<td>126  (±3) </td>\n<td>168  (±3) </td>\n<td>210  (±3) </td>\n<td>252  (±5) </td>\n<td>301  (±5) </td>\n<td>350  (±5) </td>\n<td>392  (±5) </td>\n<td>434   (±7) </td>\n<td></td>\n</tr>\n<tr>\n<td>Waist circumference </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>See Section 8.1.4</td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>The 12-lead ECG recording should be  obtained in supine position prior to IMP  dose administration (see Section 8.2.3). </td>\n</tr>\n<tr>\n<td>Transition from prestudy  insulin glargine 100 U/mL  to Lantus </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>See Section 6.1.2.1 of NIMPs. </td>\n</tr>\n<tr>\n<td>IMP injection  training/retraining with  prefilled syringe if needed </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>See Section 6.1.1. </td>\n</tr>\n<tr>\n<td>Review of injection sites </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Diary dispensation </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary collection </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Review of SMPG and  Lantus dose adjustments </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Glucose meter  dispensation and training </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Will include training for hypoglycemia  awareness and management. </td>\n</tr>\n<tr>\n<td>Diet and lifestyle  counselling </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>As per current practice, to be  documented (Section5.3.1). </td>\n</tr>\n<tr>\n<td>IRT contact </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Lantus dispensation </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Lantus collection and  accounting </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03713684_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening   (2 weeks) </td>\n<td colspan=\"8\" rowspan=\"1\">Double-blind, placebo-controlled Core Treatment  Period   (30 weeks) </td>\n<td colspan=\"4\" rowspan=\"1\">Double-blind, placebo-controlled Treatment  Extension Period  (26 weeks) </td>\n<td>Post-treatment  Follow-up  Period  (6 weeks) </td>\n<td>Notes </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>R </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>EOT </td>\n<td>EOS </td>\n<td></td>\n</tr>\n<tr>\n<td>Week </td>\n<td>-2 </td>\n<td>0  Baseline</td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>18 </td>\n<td>24 </td>\n<td>30   a </td>\n<td>36 </td>\n<td>43 </td>\n<td>50 </td>\n<td>56 </td>\n<td>Last IMP+  6weeks </td>\n<td></td>\n</tr>\n<tr>\n<td>Acceptable range  (days) </td>\n<td>-14 to   -11</td>\n<td>1 </td>\n<td>14  (±3) </td>\n<td>28  (±3) </td>\n<td>56  (±3) </td>\n<td>84  (±3) </td>\n<td>126  (±3) </td>\n<td>168  (±3) </td>\n<td>210  (±3) </td>\n<td>252  (±5) </td>\n<td>301  (±5) </td>\n<td>350  (±5) </td>\n<td>392  (±5) </td>\n<td>434   (±7) </td>\n<td></td>\n</tr>\n<tr>\n<td>IMP dispensation </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IMP collection and  accounting </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Compliance </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>SMPG, IMP, Lantus, diary </td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Efficacy:  </td>\n</tr>\n<tr>\n<td>HbA1c </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FPG </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>For these visits, participants need to  come in fasting conditions as described  in Section 5.3.1 and Section 8.1.2. </td>\n</tr>\n<tr>\n<td>C-peptide (fasting) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>For these visits, participants need to  come in fasting conditions as described  in Section 5.3.1.</td>\n</tr>\n<tr>\n<td>7-point SMPG profiles (on  at least 1 day in the week  prior to the visit)</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>Performed on at least 1 day in the week  prior to clinical visits indicated. See  Section8.1.5 for complete details. </td>\n</tr>\n<tr>\n<td>Fasting (prebreakfast)  SMPG </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>Daily within first 8 weeks after  randomization and at least 3 days in the  other weeks, prior to visits indicated. See  Section8.1.5. </td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Safety: </td>\n</tr>\n<tr>\n<td>Hematology </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>See Appendix 2 (Section 10.2) </td>\n</tr>\n<tr>\n<td>Clinical chemistry </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>See Appendix 2 (Section 10.2) </td>\n</tr>\n<tr>\n<td>Calcitonin </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>See Appendix 2 (Section 10.2) </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03713684_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening   (2 weeks) </td>\n<td colspan=\"8\" rowspan=\"1\">Double-blind, placebo-controlled Core Treatment  Period   (30 weeks) </td>\n<td colspan=\"4\" rowspan=\"1\">Double-blind, placebo-controlled Treatment  Extension Period  (26 weeks) </td>\n<td>Post-treatment  Follow-up  Period  (6 weeks) </td>\n<td>Notes </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>R </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>EOT </td>\n<td>EOS </td>\n<td></td>\n</tr>\n<tr>\n<td>Week </td>\n<td>-2 </td>\n<td>0  Baseline</td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>18 </td>\n<td>24 </td>\n<td>30   a </td>\n<td>36 </td>\n<td>43 </td>\n<td>50 </td>\n<td>56 </td>\n<td>Last IMP+  6weeks </td>\n<td></td>\n</tr>\n<tr>\n<td>Acceptable range  (days) </td>\n<td>-14 to   -11</td>\n<td>1 </td>\n<td>14  (±3) </td>\n<td>28  (±3) </td>\n<td>56  (±3) </td>\n<td>84  (±3) </td>\n<td>126  (±3) </td>\n<td>168  (±3) </td>\n<td>210  (±3) </td>\n<td>252  (±5) </td>\n<td>301  (±5) </td>\n<td>350  (±5) </td>\n<td>392  (±5) </td>\n<td>434   (±7) </td>\n<td></td>\n</tr>\n<tr>\n<td>Lipid profile </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>See Appendix 2 (Section 10.2) </td>\n</tr>\n<tr>\n<td>Urinalysis </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>See Appendix 2 (Section 10.2) </td>\n</tr>\n<tr>\n<td>Pregnancy test (for  women of childbearing  potential) </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>Serum pregnancy testing (β-HCG) at  screening for WOCBP (Appendix 4   Section10.4 ), urine pregnancy testing  subsequently (at on-site visits and  monthly at home in between visits). If the  urine test is positive, serum β-HCG  should be tested for confirmation of the  pregnancy. </td>\n</tr>\n<tr>\n<td>Serum FSH and estradiol </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>For women of nonchildbearing potential.  In case the definition of postmenopausal  or premenopausal cannot be satisfied.  See Appendix 4 (Section 10.4). </td>\n</tr>\n<tr>\n<td>ADA  </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>Participants positive for ADAs at the end  of study, and who experienced severe  injection site or hypersensitivity reaction  at any time during the study will be asked  to provide samples for anti-efpeglenatide  antibodies assessments 4 and 6 months  after the end of the treatment or as soon  as possible after study database lock  whichever comes later. </td>\n</tr>\n<tr>\n<td>IMP concentration (PK)  </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>All participants will have 1 blood sample  </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03713684_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening   (2 weeks) </td>\n<td colspan=\"8\" rowspan=\"1\">Double-blind, placebo-controlled Core Treatment  Period   (30 weeks) </td>\n<td colspan=\"4\" rowspan=\"1\">Double-blind, placebo-controlled Treatment  Extension Period  (26 weeks) </td>\n<td>Post-treatment  Follow-up  Period  (6 weeks) </td>\n<td>Notes </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>R </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>EOT </td>\n<td>EOS </td>\n<td></td>\n</tr>\n<tr>\n<td>Week </td>\n<td>-2 </td>\n<td>0  Baseline</td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>18 </td>\n<td>24 </td>\n<td>30   a </td>\n<td>36 </td>\n<td>43 </td>\n<td>50 </td>\n<td>56 </td>\n<td>Last IMP+  6weeks </td>\n<td></td>\n</tr>\n<tr>\n<td>Acceptable range  (days) </td>\n<td>-14 to   -11</td>\n<td>1 </td>\n<td>14  (±3) </td>\n<td>28  (±3) </td>\n<td>56  (±3) </td>\n<td>84  (±3) </td>\n<td>126  (±3) </td>\n<td>168  (±3) </td>\n<td>210  (±3) </td>\n<td>252  (±5) </td>\n<td>301  (±5) </td>\n<td>350  (±5) </td>\n<td>392  (±5) </td>\n<td>434   (±7) </td>\n<td></td>\n</tr>\n<tr>\n<td>Sampling</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>collected just before their weekly injection  (and at least 6 days after last IMP dose  administration) for the predose serum  concentration (Ctrough) of efpeglenatide at  selected clinical visits.  For participants who consent, at least  1 additional postdose sample will be  taken 3 days (±1 day) after  administration of IMP, preferably between  Week 8 and Week 12. See Section 8.5. </td>\n</tr>\n<tr>\n<td>Rescue therapy  assessment </td>\n<td></td>\n<td colspan=\"12\" rowspan=\"1\">Continuous assessment and recording during treatment periods </td>\n<td></td>\n<td>After randomization, the need of rescue  therapy should be assessed by the  Investigator via fasting SMPG performed  by the participants and the central  laboratory alerts received on FPG and on  HbA1c (from Week 12 onwards).  Participants must have an unscheduled  in-person visit prior to rescue therapy  initiation, with the assessments normally  planned for EOT visit.  See Section 6.1.2.2. </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03713684_SOA_table_5.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening   (2 weeks) </td>\n<td colspan=\"8\" rowspan=\"1\">Double-blind, placebo-controlled Core Treatment  Period   (30 weeks) </td>\n<td colspan=\"4\" rowspan=\"1\">Double-blind, placebo-controlled Treatment  Extension Period  (26 weeks) </td>\n<td>Post-treatment  Follow-up  Period  (6 weeks) </td>\n<td>Notes </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>R </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>EOT </td>\n<td>EOS </td>\n<td></td>\n</tr>\n<tr>\n<td>Week </td>\n<td>-2 </td>\n<td>0  Baseline</td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>18 </td>\n<td>24 </td>\n<td>30   a </td>\n<td>36 </td>\n<td>43 </td>\n<td>50 </td>\n<td>56 </td>\n<td>Last IMP+  6weeks </td>\n<td></td>\n</tr>\n<tr>\n<td>Acceptable range  (days) </td>\n<td>-14 to   -11</td>\n<td>1 </td>\n<td>14  (±3) </td>\n<td>28  (±3) </td>\n<td>56  (±3) </td>\n<td>84  (±3) </td>\n<td>126  (±3) </td>\n<td>168  (±3) </td>\n<td>210  (±3) </td>\n<td>252  (±5) </td>\n<td>301  (±5) </td>\n<td>350  (±5) </td>\n<td>392  (±5) </td>\n<td>434   (±7) </td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medication  review </td>\n<td colspan=\"14\" rowspan=\"3\">Continuous assessment and recording throughout the study </td>\n<td></td>\n</tr>\n<tr>\n<td>AE/SAE recording </td>\n<td></td>\n</tr>\n<tr>\n<td>Reporting hypoglycemia  (symptoms, SMPG) </td>\n<td>Hypoglycemia eCRF page must be filled  in for all SMPG ≤70 mg/dL (3.9 mmol/L)  and/or in case of symptoms suggesting  hypoglycemia. </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03715998_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening  a</td>\n<td>Inclusion  a</td>\n<td>Safety check  b</td>\n<td>Titration </td>\n<td>Treatment </td>\n<td>EOT  c</td>\n<td>Follow-up  m</td>\n</tr>\n<tr>\n<td>Visit </td>\n<td>Visit 1 </td>\n<td>Visit 2 </td>\n<td>On-site or via  Telephone Call </td>\n<td>Visit 3 </td>\n<td>Visit 4 </td>\n<td>Visit 5 </td>\n<td>Visit 6 </td>\n</tr>\n<tr>\n<td>Study Day  Assessment </td>\n<td>Day -2 to   Day 1 </td>\n<td>Day 1 </td>\n<td>Day 3 </td>\n<td>Day 14  (±2 days) </td>\n<td>Day 42  (±2 days) </td>\n<td>Day 84  (±3 days) </td>\n<td>Day 114   (±3 days) or  30 Days after  Treatment  Discontinuation </td>\n</tr>\n<tr>\n<td>Written informed consent   d </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical examination   e </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG   f </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Blood pressure and HR measurement   g </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Capture of troponin peak</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CMRI   h </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Blood samples for local laboratory  assessment (hematology and clinical  chemistry)   i,j </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>assessment (biomarkers)   k </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X   l </td>\n<td>X   l </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense IP   n </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Discontinue IP </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>IP compliance check</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>AEs </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03726658_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\">Double-blind Treatment Period</td>\n<td>Safety Follow-up  Period</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>Screening (1)</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6/ET   a </td>\n<td>7</td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>up to –14 days</td>\n<td>1</td>\n<td>2</td>\n<td>8</td>\n<td>9</td>\n<td>15</td>\n<td>22</td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical (surgical, neurologic) and psychiatric  histories</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Prior medication history</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization assessment</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical laboratory determinations   b </td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Urine drug screen</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum pregnancy test</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Pharmacogenomics consent and sample   c </td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   d </td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>ECG</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>SCID</td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MADRS</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>CGI-S</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03726658_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\">Double-blind Treatment Period</td>\n<td>Safety Follow-up  Period</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>Screening (1)</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6/ET   a </td>\n<td>7</td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>up to –14 days</td>\n<td>1</td>\n<td>2</td>\n<td>8</td>\n<td>9</td>\n<td>15</td>\n<td>22</td>\n</tr>\n<tr>\n<td>BPRS+</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>CADSS</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>HAM-A   e </td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n</tr>\n<tr>\n<td>AEs</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n</tr>\n<tr>\n<td>Study treatment administration in the clinic</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Study treatment compliance</td>\n<td></td>\n<td>x</td>\n<td></td>\n<td>x</td>\n<td>x</td>\n<td>x</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03726658_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\">OutPt</td>\n<td colspan=\"33\" rowspan=\"1\">Inpatient</td>\n<td colspan=\"6\" rowspan=\"1\">Outpatient</td>\n</tr>\n<tr>\n<td></td>\n<td colspan=\"36\" rowspan=\"1\">Double-Blind Treatment</td>\n<td>Safety  Follow-Up   a </td>\n<td></td>\n</tr>\n<tr>\n<td>Visit   b </td>\n<td>V1 Screeni ng</td>\n<td>V2 Base -line</td>\n<td colspan=\"5\" rowspan=\"1\">V3</td>\n<td colspan=\"5\" rowspan=\"1\">V4</td>\n<td colspan=\"5\" rowspan=\"1\">V5</td>\n<td colspan=\"5\" rowspan=\"1\">V6</td>\n<td colspan=\"4\" rowspan=\"1\">V7</td>\n<td colspan=\"4\" rowspan=\"1\">V8</td>\n<td colspan=\"4\" rowspan=\"1\">V9</td>\n<td colspan=\"2\" rowspan=\"1\">V10 Dis-charge</td>\n<td>V1 1</td>\n<td>V12/ ET   c,d </td>\n<td>V13</td>\n<td>V1 4</td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>Up to  14 days</td>\n<td>D –1 Adm it</td>\n<td colspan=\"5\" rowspan=\"1\">D1 (First Day of  Dosing)</td>\n<td colspan=\"5\" rowspan=\"1\">D2</td>\n<td colspan=\"5\" rowspan=\"1\">D3 </td>\n<td colspan=\"5\" rowspan=\"1\">D4</td>\n<td colspan=\"4\" rowspan=\"1\">D5</td>\n<td colspan=\"4\" rowspan=\"1\">D6</td>\n<td colspan=\"4\" rowspan=\"1\">D7</td>\n<td colspan=\"2\" rowspan=\"1\">D8</td>\n<td>D1 1</td>\n<td>D14/ ET</td>\n<td>D18</td>\n<td>D2 1</td>\n</tr>\n<tr>\n<td>Assessment Time  Relative to Morning  Dose (hours)   e </td>\n<td></td>\n<td></td>\n<td>P r e</td>\n<td>1 &amp; 2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>1  &amp; 2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>1 &amp; 2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>1 &amp; 2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>4</td>\n<td colspan=\"4\" rowspan=\"1\">N/A</td>\n</tr>\n<tr>\n<td>ICF</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MedHx/PsyHx</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Prior &amp; ConMed</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Physical Exam</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Incl/Excl</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs    f </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Randomize</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>SCID</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Likert Patient  Depressive Symptom  Scales </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>MADRS</td>\n<td>X</td>\n<td>X</td>\n<td>X g</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CGI-S </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>CADSS</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>BPRS+</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ECG </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical Laboratory  Determinations   h,i </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Hepatitis Serology</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine Drug Screen   j </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Serum Pregnancy  Test   k </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pharmacogenetic  Consent and  Sampling (Opt.)   l </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03726658_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\">OutPt</td>\n<td colspan=\"33\" rowspan=\"1\">Inpatient</td>\n<td colspan=\"6\" rowspan=\"1\">Outpatient</td>\n</tr>\n<tr>\n<td></td>\n<td colspan=\"36\" rowspan=\"1\">Double-Blind Treatment</td>\n<td>Safety  Follow-Up   a </td>\n<td></td>\n</tr>\n<tr>\n<td>Visit   b </td>\n<td>V1 Screeni ng</td>\n<td>V2 Base -line</td>\n<td colspan=\"5\" rowspan=\"1\">V3</td>\n<td colspan=\"5\" rowspan=\"1\">V4</td>\n<td colspan=\"5\" rowspan=\"1\">V5</td>\n<td colspan=\"5\" rowspan=\"1\">V6</td>\n<td colspan=\"4\" rowspan=\"1\">V7</td>\n<td colspan=\"4\" rowspan=\"1\">V8</td>\n<td colspan=\"4\" rowspan=\"1\">V9</td>\n<td colspan=\"2\" rowspan=\"1\">V10 Dis-charge</td>\n<td>V1 1</td>\n<td>V12/ ET   c,d </td>\n<td>V13</td>\n<td>V1 4</td>\n</tr>\n<tr>\n<td>Study Day</td>\n<td>Up to  14 days</td>\n<td>D –1 Adm it</td>\n<td colspan=\"5\" rowspan=\"1\">D1 (First Day of  Dosing)</td>\n<td colspan=\"5\" rowspan=\"1\">D2</td>\n<td colspan=\"5\" rowspan=\"1\">D3 </td>\n<td colspan=\"5\" rowspan=\"1\">D4</td>\n<td colspan=\"4\" rowspan=\"1\">D5</td>\n<td colspan=\"4\" rowspan=\"1\">D6</td>\n<td colspan=\"4\" rowspan=\"1\">D7</td>\n<td colspan=\"2\" rowspan=\"1\">D8</td>\n<td>D1 1</td>\n<td>D14/ ET</td>\n<td>D18</td>\n<td>D2 1</td>\n</tr>\n<tr>\n<td>Assessment Time  Relative to Morning  Dose (hours)   e </td>\n<td></td>\n<td></td>\n<td>P r e</td>\n<td>1 &amp; 2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>1  &amp; 2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>1 &amp; 2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>1 &amp; 2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>P r e</td>\n<td>4</td>\n<td colspan=\"4\" rowspan=\"1\">N/A</td>\n</tr>\n<tr>\n<td>HVLT-R   m </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>KSS/qEEG/ERP  (mid-day)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>KSS/qEEG/ERP  (afternoon)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>KSS/qEEG/ERP    n,o </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>CSF Pre-Dose  Consent and  Sampling (Opt. 1x per pt.)   p </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CSF Post-Dose  Consent and  Sampling (Opt. 1x per pt.)    p </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse Event</td>\n<td></td>\n<td></td>\n<td colspan=\"38\" rowspan=\"1\">X</td>\n</tr>\n<tr>\n<td>Rescue Med (Sleep/ Benzo)    q </td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"37\" rowspan=\"1\">PRN (withhold 12 hours prior to scale assessments and qEEG/ERPs)</td>\n</tr>\n<tr>\n<td>Provide Patient Diary</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Return &amp; Review  Diary</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Assign/Dispense study treatment</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Study Treatment Compliance (Return)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Discharge Pt   r </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03728933_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"4\"></td>\n<td colspan=\"1\" rowspan=\"2\">Screening  Period  (+1 day) </td>\n<td colspan=\"1\" rowspan=\"2\">Rand  (+3  days) </td>\n<td colspan=\"3\" rowspan=\"2\">Titration Period  (±1 day)     a</td>\n<td colspan=\"1\" rowspan=\"2\">EOT/  SOM  </td>\n<td colspan=\"2\" rowspan=\"2\">Maintenance Period  (±2 days)   a</td>\n<td colspan=\"2\" rowspan=\"1\">Taper Period (4 days)  a</td>\n<td colspan=\"1\" rowspan=\"2\">Safety  Follow-Up  (30 ±5  days)  a</td>\n<td colspan=\"1\" rowspan=\"2\">Un-scheduled  Visit  b</td>\n</tr>\n<tr>\n<td>End of  Maintenance / WD Visit   a </td>\n<td>End of  Taper  </td>\n</tr>\n<tr>\n<td></td>\n<td colspan=\"8\" rowspan=\"1\">Telemedicine Calls  </td>\n<td>Telemedicine  Call </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>V1 </td>\n<td>V2/BL</td>\n<td>V3</td>\n<td>V4 </td>\n<td>V5 </td>\n<td>V6 </td>\n<td>V7 </td>\n<td>V8 </td>\n<td>V9 </td>\n<td>V10 </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td>Assessment </td>\n<td>Day -28  to Day -1 </td>\n<td>Day   0 </td>\n<td>Day  1 </td>\n<td>Day  8 </td>\n<td>Day  15 </td>\n<td>Day  22 </td>\n<td>Day  50 </td>\n<td>Day  78 </td>\n<td>Day  106 </td>\n<td>Day   110 </td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demography </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Eligibility criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Withdrawal criteria </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Randomization </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>General medical/  procedures history </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Lifestyle </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Reproductive  potential and birth  control </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td> P</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brief physical  examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Neurological  examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>C-SSRS </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X   c </td>\n</tr>\n<tr>\n<td>Vital signs </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Body weight, height,  and BMI  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Safety laboratory  tests </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urine drug screen </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Pregnancy  Test  (hCG)   d </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03728933_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"4\"></td>\n<td colspan=\"1\" rowspan=\"2\">Screening  Period  (+1 day) </td>\n<td colspan=\"1\" rowspan=\"2\">Rand  (+3  days) </td>\n<td colspan=\"3\" rowspan=\"2\">Titration Period  (±1 day)     a</td>\n<td colspan=\"1\" rowspan=\"2\">EOT/  SOM  </td>\n<td colspan=\"2\" rowspan=\"2\">Maintenance Period  (±2 days)   a</td>\n<td colspan=\"2\" rowspan=\"1\">Taper Period (4 days)  a</td>\n<td colspan=\"1\" rowspan=\"2\">Safety  Follow-Up  (30 ±5  days)  a</td>\n<td colspan=\"1\" rowspan=\"2\">Un-scheduled  Visit  b</td>\n</tr>\n<tr>\n<td>End of  Maintenance / WD Visit   a </td>\n<td>End of  Taper  </td>\n</tr>\n<tr>\n<td></td>\n<td colspan=\"8\" rowspan=\"1\">Telemedicine Calls  </td>\n<td>Telemedicine  Call </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>V1 </td>\n<td>V2/BL</td>\n<td>V3</td>\n<td>V4 </td>\n<td>V5 </td>\n<td>V6 </td>\n<td>V7 </td>\n<td>V8 </td>\n<td>V9 </td>\n<td>V10 </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td>Assessment </td>\n<td>Day -28  to Day -1 </td>\n<td>Day   0 </td>\n<td>Day  1 </td>\n<td>Day  8 </td>\n<td>Day  15 </td>\n<td>Day  22 </td>\n<td>Day  50 </td>\n<td>Day  78 </td>\n<td>Day  106 </td>\n<td>Day   110 </td>\n</tr>\n<tr>\n<td>Hormone status </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PK sampling   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IRLS </td>\n<td>X </td>\n<td>X   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CGI </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>RLS-6  </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>mMIDI </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Menstrual function   d </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Subject Quality of  Life Questionnaire </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X  U</td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of  medication and  procedures </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X  P</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Adverse event  assessment </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Contact IRT </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Dispense study  medication </td>\n<td></td>\n<td></td>\n<td>X   g </td>\n<td></td>\n<td></td>\n<td>X   g </td>\n<td>X   g </td>\n<td>X   g </td>\n<td>X   g </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Return unused study  medication </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03732807_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Protocol Activity</td>\n<td>Screening  Period</td>\n<td colspan=\"12\" rowspan=\"1\">Treatment Period</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td colspan=\"3\" rowspan=\"1\">Loading Phase</td>\n<td colspan=\"4\" rowspan=\"1\">Maintenance Phase</td>\n<td colspan=\"5\" rowspan=\"1\">Extension Phase</td>\n<td>F/U   b </td>\n<td>ET   c </td>\n</tr>\n<tr>\n<td>Visit Identifier</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Day   a </td>\n<td>Day -35  to -1</td>\n<td>Day 1</td>\n<td>Day 15</td>\n<td>Day 29</td>\n<td>Day  57</td>\n<td>Day  85</td>\n<td>Day  127</td>\n<td>Day  169</td>\n<td>Day 183</td>\n<td>Day 197</td>\n<td>Day  239</td>\n<td>Day 281</td>\n<td>Day 337</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Week</td>\n<td>N/A</td>\n<td></td>\n<td>W2</td>\n<td>W4</td>\n<td>W8</td>\n<td>W12</td>\n<td>W18</td>\n<td>W24</td>\n<td>W26</td>\n<td>W28</td>\n<td>W34</td>\n<td>W40</td>\n<td>W48/EOT</td>\n<td>EOS</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Window</td>\n<td colspan=\"2\" rowspan=\"1\">N/A</td>\n<td colspan=\"2\" rowspan=\"1\">±3 Days based on  Day 1 visit</td>\n<td colspan=\"4\" rowspan=\"1\">±7 Days based on  Day 1 visit</td>\n<td colspan=\"2\" rowspan=\"1\">±3 Days based on  Day 1 visit</td>\n<td colspan=\"3\" rowspan=\"1\">±7 Days based on  Day 1 visit</td>\n<td>+7  Days</td>\n<td></td>\n</tr>\n<tr>\n<td>Enrollment procedure</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent and if applicable  assent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/Exclusion criteria</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history and AA disease  history   d </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical procedures</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Complete physical examination   e </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Targeted physical examination   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs   g </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-Lead ECG   h </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Height &amp; Weight   i </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Chest radiographs   j </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Audiological Evaluation   k </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Laboratory</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology &amp; Serum Chemistry   l </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Fasting lipid Panel   m </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urinalysis   n </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Serum FSH   o </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03732807_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Protocol Activity</td>\n<td>Screening  Period</td>\n<td colspan=\"12\" rowspan=\"1\">Treatment Period</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td colspan=\"3\" rowspan=\"1\">Loading Phase</td>\n<td colspan=\"4\" rowspan=\"1\">Maintenance Phase</td>\n<td colspan=\"5\" rowspan=\"1\">Extension Phase</td>\n<td>F/U   b </td>\n<td>ET   c </td>\n</tr>\n<tr>\n<td>Visit Identifier</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Day   a </td>\n<td>Day -35  to -1</td>\n<td>Day 1</td>\n<td>Day 15</td>\n<td>Day 29</td>\n<td>Day  57</td>\n<td>Day  85</td>\n<td>Day  127</td>\n<td>Day  169</td>\n<td>Day 183</td>\n<td>Day 197</td>\n<td>Day  239</td>\n<td>Day 281</td>\n<td>Day 337</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Week</td>\n<td>N/A</td>\n<td></td>\n<td>W2</td>\n<td>W4</td>\n<td>W8</td>\n<td>W12</td>\n<td>W18</td>\n<td>W24</td>\n<td>W26</td>\n<td>W28</td>\n<td>W34</td>\n<td>W40</td>\n<td>W48/EOT</td>\n<td>EOS</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Window</td>\n<td colspan=\"2\" rowspan=\"1\">N/A</td>\n<td colspan=\"2\" rowspan=\"1\">±3 Days based on  Day 1 visit</td>\n<td colspan=\"4\" rowspan=\"1\">±7 Days based on  Day 1 visit</td>\n<td colspan=\"2\" rowspan=\"1\">±3 Days based on  Day 1 visit</td>\n<td colspan=\"3\" rowspan=\"1\">±7 Days based on  Day 1 visit</td>\n<td>+7  Days</td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test (WOCBP only)   p </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>HIV testing   q </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hep B and Hep C Screening   r </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBVDNA (applicable countries)   s </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Varicella-zoster virus  immunoglobulin G antibody (VZV  IgG Ab) (adolescents only, if  applicable)   t </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collection of baseline sample for  potential viral screen   u </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tuberculosis test   v </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Laboratory Pharmacodynamics</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP-10 (CXCL10)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FACS-TBNK </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Immunoglobulins (IgA, IgG, IgM)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Trial treatment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Impala registration</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Investigational product dispensing</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Investigational product  administration   w </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Investigational product  accountability</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical assessments</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>SALT</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>ELA and EBA</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Photography   x </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Assessment of Fingernails  Affected by AA   y </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>CGI-AA</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS  Patient reported outcome  z </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03732807_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Protocol Activity</td>\n<td>Screening  Period</td>\n<td colspan=\"12\" rowspan=\"1\">Treatment Period</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td colspan=\"3\" rowspan=\"1\">Loading Phase</td>\n<td colspan=\"4\" rowspan=\"1\">Maintenance Phase</td>\n<td colspan=\"5\" rowspan=\"1\">Extension Phase</td>\n<td>F/U   b </td>\n<td>ET   c </td>\n</tr>\n<tr>\n<td>Visit Identifier</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Day   a </td>\n<td>Day -35  to -1</td>\n<td>Day 1</td>\n<td>Day 15</td>\n<td>Day 29</td>\n<td>Day  57</td>\n<td>Day  85</td>\n<td>Day  127</td>\n<td>Day  169</td>\n<td>Day 183</td>\n<td>Day 197</td>\n<td>Day  239</td>\n<td>Day 281</td>\n<td>Day 337</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Week</td>\n<td>N/A</td>\n<td></td>\n<td>W2</td>\n<td>W4</td>\n<td>W8</td>\n<td>W12</td>\n<td>W18</td>\n<td>W24</td>\n<td>W26</td>\n<td>W28</td>\n<td>W34</td>\n<td>W40</td>\n<td>W48/EOT</td>\n<td>EOS</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Window</td>\n<td colspan=\"2\" rowspan=\"1\">N/A</td>\n<td colspan=\"2\" rowspan=\"1\">±3 Days based on  Day 1 visit</td>\n<td colspan=\"4\" rowspan=\"1\">±7 Days based on  Day 1 visit</td>\n<td colspan=\"2\" rowspan=\"1\">±3 Days based on  Day 1 visit</td>\n<td colspan=\"3\" rowspan=\"1\">±7 Days based on  Day 1 visit</td>\n<td>+7  Days</td>\n<td></td>\n</tr>\n<tr>\n<td>Patient reported outcome</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>AAPPO</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>PGI-C and P-Sat</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>PHQ-8   z </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HADS</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>SF36v2 Acute</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L (adults) or EQ-5D-Y  (adolescents)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>AARU</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>WPAI: AA (adults only)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pharmacokinetic</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Predose PK sampling   aa </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Full PK sampling (including  predose sampling)   bb </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X   bb </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Banked Biospecimen Collection </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Genomic banked Biospecimen:  Prep D1   cc </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Other banked biospecimen:  Prep B1</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Other banked biospecimen:  Prep B2</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Other banked biospecimen:  Prep R1</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Other</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Prior and current concomitant  treatment(s) monitoring </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Adverse event monitoring</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Contraception check, as applicable </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Check for initiation of menarche  (for premenarchal females only)   dd </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03732807_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Protocol Activity</td>\n<td>Screening  Period</td>\n<td colspan=\"12\" rowspan=\"1\">Treatment Period</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td colspan=\"3\" rowspan=\"1\">Loading Phase</td>\n<td colspan=\"4\" rowspan=\"1\">Maintenance Phase</td>\n<td colspan=\"5\" rowspan=\"1\">Extension Phase</td>\n<td>F/U   b </td>\n<td>ET   c </td>\n</tr>\n<tr>\n<td>Visit Identifier</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Day   a </td>\n<td>Day -35  to -1</td>\n<td>Day 1</td>\n<td>Day 15</td>\n<td>Day 29</td>\n<td>Day  57</td>\n<td>Day  85</td>\n<td>Day  127</td>\n<td>Day  169</td>\n<td>Day 183</td>\n<td>Day 197</td>\n<td>Day  239</td>\n<td>Day 281</td>\n<td>Day 337</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Week</td>\n<td>N/A</td>\n<td></td>\n<td>W2</td>\n<td>W4</td>\n<td>W8</td>\n<td>W12</td>\n<td>W18</td>\n<td>W24</td>\n<td>W26</td>\n<td>W28</td>\n<td>W34</td>\n<td>W40</td>\n<td>W48/EOT</td>\n<td>EOS</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Window</td>\n<td colspan=\"2\" rowspan=\"1\">N/A</td>\n<td colspan=\"2\" rowspan=\"1\">±3 Days based on  Day 1 visit</td>\n<td colspan=\"4\" rowspan=\"1\">±7 Days based on  Day 1 visit</td>\n<td colspan=\"2\" rowspan=\"1\">±3 Days based on  Day 1 visit</td>\n<td colspan=\"3\" rowspan=\"1\">±7 Days based on  Day 1 visit</td>\n<td>+7  Days</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03732807_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Protocol Activity</td>\n<td>Screening  Period</td>\n<td colspan=\"12\" rowspan=\"1\">Treatment Period</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td colspan=\"3\" rowspan=\"1\">Loading Phase</td>\n<td colspan=\"4\" rowspan=\"1\">Maintenance Phase</td>\n<td colspan=\"5\" rowspan=\"1\">Extension Phase</td>\n<td>F/U   b </td>\n<td>ET   c </td>\n</tr>\n<tr>\n<td>Visit Identifier</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Day   a </td>\n<td>Day -35  to -1</td>\n<td>Day 1</td>\n<td>Day 15</td>\n<td>Day 29</td>\n<td>Day  57</td>\n<td>Day  85</td>\n<td>Day  127</td>\n<td>Day  169</td>\n<td>Day 183</td>\n<td>Day 197</td>\n<td>Day  239</td>\n<td>Day 281</td>\n<td>Day 337</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Week</td>\n<td>N/A</td>\n<td></td>\n<td>W2</td>\n<td>W4</td>\n<td>W8</td>\n<td>W12</td>\n<td>W18</td>\n<td>W24</td>\n<td>W26</td>\n<td>W28</td>\n<td>W34</td>\n<td>W40</td>\n<td>W48/EOT</td>\n<td>EOS</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Window</td>\n<td colspan=\"2\" rowspan=\"1\">N/A</td>\n<td colspan=\"2\" rowspan=\"1\">±3 Days based on  Day 1 visit</td>\n<td colspan=\"4\" rowspan=\"1\">±7 Days based on  Day 1 visit</td>\n<td colspan=\"2\" rowspan=\"1\">±3 Days based on  Day 1 visit</td>\n<td colspan=\"3\" rowspan=\"1\">±7 Days based on  Day 1 visit</td>\n<td>+7  Days</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03733301_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>Screening</td>\n<td colspan=\"7\" rowspan=\"1\">Double-Blind, Placebo-Controlled</td>\n<td>Post-treatment  Follow-up</td>\n</tr>\n<tr>\n<td>Period 1</td>\n<td colspan=\"7\" rowspan=\"1\">Period 2</td>\n<td>Period 3</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from Randomization</td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16 or ET</td>\n<td></td>\n</tr>\n<tr>\n<td>Days from Randomization</td>\n<td></td>\n<td>0</td>\n<td>7</td>\n<td>14</td>\n<td>28</td>\n<td>56</td>\n<td>84</td>\n<td>112</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Tolerance Interval (days)</td>\n<td>-8 to -35</td>\n<td></td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>28 ± 4 after last  dose</td>\n</tr>\n<tr>\n<td>Procedure</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion and exclusion review</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical Assessments</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Substance Use (alcohol, tobacco use)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Previous and current AD treatments</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Height</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs (BP and pulse rate)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Symptom-directed physical examination   b </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead ECG (single)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chest x-ray (posterior–anterior view)  c </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TB test   d </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Read PPD if applicable (48-72 hours post  PPD)</td>\n<td>X   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pre-existing Conditions</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse Events</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant Medication</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>ePRO (patient diary) dispensed</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X   g </td>\n<td></td>\n</tr>\n<tr>\n<td>ePRO (patient diary) returned   f </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X   g </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03733301_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>Screening</td>\n<td colspan=\"7\" rowspan=\"1\">Double-Blind, Placebo-Controlled</td>\n<td>Post-treatment  Follow-up</td>\n</tr>\n<tr>\n<td>Period 1</td>\n<td colspan=\"7\" rowspan=\"1\">Period 2</td>\n<td>Period 3</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from Randomization</td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16 or ET</td>\n<td></td>\n</tr>\n<tr>\n<td>Days from Randomization</td>\n<td></td>\n<td>0</td>\n<td>7</td>\n<td>14</td>\n<td>28</td>\n<td>56</td>\n<td>84</td>\n<td>112</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Tolerance Interval (days)</td>\n<td>-8 to -35</td>\n<td></td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>28 ± 4 after last  dose</td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IWRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>IP dispensed</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP returned and compliance assessed </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense background TCS   h </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Weigh (tube with cap) and record returned  background TCS   h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Scales</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IGA</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>EASI</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>SCORAD</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Health Outcome Measures and Other  Questionnaires   i </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>POEM</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>DLQI</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>HADS</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>EQ-5D-5L</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>WPAI-AD</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Itch NRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Skin Pain NRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>ADSS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PGI-S-AD</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PIQ – General   j </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PIQ – Activity and Clothing   j </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PIQ – Mood and Sleep   j </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PIQ – Scratching Behavior   j </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03733301_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>Screening</td>\n<td colspan=\"7\" rowspan=\"1\">Double-Blind, Placebo-Controlled</td>\n<td>Post-treatment  Follow-up</td>\n</tr>\n<tr>\n<td>Period 1</td>\n<td colspan=\"7\" rowspan=\"1\">Period 2</td>\n<td>Period 3</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>801   a </td>\n</tr>\n<tr>\n<td>Weeks from Randomization</td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16 or ET</td>\n<td></td>\n</tr>\n<tr>\n<td>Days from Randomization</td>\n<td></td>\n<td>0</td>\n<td>7</td>\n<td>14</td>\n<td>28</td>\n<td>56</td>\n<td>84</td>\n<td>112</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit Tolerance Interval (days)</td>\n<td>-8 to -35</td>\n<td></td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>28 ± 4 after last  dose</td>\n</tr>\n<tr>\n<td>PROMIS – Sleep-Related Impairment   j </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neuro-QoL – Cognitive Function   j </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Patient Benefit Index   j </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS /Self-Harm Supplement Form  k </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Self-Harm Follow-up Form   l </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Laboratory Assessment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical Chemistry   m </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Lipids (fasting)   n </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X   o </td>\n<td>X</td>\n</tr>\n<tr>\n<td>Serum Pregnancy   p </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FSH   q </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TSH</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HIV</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HCV antibody   r </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV testing</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV DNA   s </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urine Pregnancy   p </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pharmacogenetics:  blood</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum immunoglobulins</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Exploratory storage samples (serum and plasma)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>RNA and biomarkers:  blood</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03733925_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"10\" rowspan=\"1\">Schedule of events </td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>Screening </td>\n<td>Week 0 </td>\n<td>Week 4 </td>\n<td>Week 8 </td>\n<td>Week 12 </td>\n<td>Week  14 </td>\n<td>Week 16 </td>\n<td>Week 20 </td>\n<td>Week 24 </td>\n<td>Week 32   k </td>\n<td></td>\n</tr>\n<tr>\n<td>Visit  Day</td>\n<td>Visit 1  Day (-7 to -1)  (±4 days) </td>\n<td>Visit 2  Day 1  (±4 days) </td>\n<td>Visit 3  Day 28  (±4 days) </td>\n<td>Visit 4  Day 56  (±4 days) </td>\n<td>Visit 5  Day 84  (±4 days) </td>\n<td>Visit 6  Day 98  (±4  days) </td>\n<td>Visit 7  Day 112  (±4 days) </td>\n<td>Visit 8  Day 140  (±4 days) </td>\n<td>Visit 9  Day 168  (±4 days) </td>\n<td>Visit 10  Day 224  (±4 days) </td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td>Approximatel y start of  Month 1 </td>\n<td>Approximatel y start of  Month 2 </td>\n<td>Approximatel y start of  Month 3 </td>\n<td>Approximatel y start of  Month 4 </td>\n<td></td>\n<td>Approximatel y start of  Month 5 </td>\n<td>Approximatel y start of  Month 6 </td>\n<td>Approximatel y end of  Month 6 </td>\n<td>Approxim ately end  of Month 8 </td>\n<td></td>\n</tr>\n<tr>\n<td>Assessment/Study  Procedure   a </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed Consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical  Examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Height and  Weight </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chest X-ray   b </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum Pregnancy  Test</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine Pregnancy  Test </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HLA B-27 Status   c </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HIV, HBV and  HCV test   d </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ECG </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TB Suspicion &amp;  Evaluation   e </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>QuantiFeron - TB  Gold Test </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tuberculin Skin  Test  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review of  Eligibility Criteria </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Study Drug  Injection </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03733925_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Drug  Injection-site  Evaluation   f </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>ASAS20 Response  Evaluation   g </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>BASDAI  Evaluation (NRS) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>BASFI Evaluation  (NRS) </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Total and Night  Spinal Pain  Assessment (NRS) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Patient Global  Assessment (NRS) </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>ACR20 Response  Evaluation   h </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>HAQ </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>CRP (quantitative  mg/L) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>ESR </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Routine  Laboratory  Analyses   i </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant  Medication  Review </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>AE/SAE Review   j </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03828617_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Visit Description</td>\n<td>Vaccination</td>\n<td>Follow-up After  Vaccination</td>\n<td>6-Month Safety  Collection</td>\n</tr>\n<tr>\n<td>Visit Type</td>\n<td>Clinic Visit</td>\n<td>Clinic Visit</td>\n<td>Telephone Contact</td>\n</tr>\n<tr>\n<td>Visit Window (Days)</td>\n<td>Day 1</td>\n<td>28 to 42 Days After Vaccination</td>\n<td>168 to 196 Days  After Vaccination</td>\n</tr>\n<tr>\n<td>Obtain informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Assign subject number</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record demography</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Conduct clinical assessment, including collecting medical history data and smoking history</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record nonstudy vaccinations and concomitant medications   a </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Measure height and weight  </td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Measure prevaccination oral temperature</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Contraception check, if applicable   b </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Perform urine pregnancy test for female subjects of childbearing potential </td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review inclusion and exclusion criteria</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review temporary delay criteria</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Review continued eligibility</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Assign randomization number</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Obtain blood sample for immunogenicity (~30 mL)</td>\n<td>X   c </td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Administer investigational product(s)</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Assess and record acute (immediate) reactions for at least 30 minutes after investigational product  administration</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Provide subject with an e-diary, thermometer, and measuring device and instruct how to collect  prompted local reactions, systemic events, and use of pain/antipyretic medications   d </td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review e-diary   e </td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Collect e-diary </td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03828617_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Visit Description</td>\n<td>Vaccination</td>\n<td>Follow-up After  Vaccination</td>\n<td>6-Month Safety  Collection</td>\n</tr>\n<tr>\n<td>Visit Type</td>\n<td>Clinic Visit</td>\n<td>Clinic Visit</td>\n<td>Telephone Contact</td>\n</tr>\n<tr>\n<td>Visit Window (Days)</td>\n<td>Day 1</td>\n<td>28 to 42 Days After Vaccination</td>\n<td>168 to 196 Days  After Vaccination</td>\n</tr>\n<tr>\n<td>Record and report adverse events</td>\n<td colspan=\"2\" rowspan=\"1\">X</td>\n<td></td>\n</tr>\n<tr>\n<td>Record and report serious adverse events and newly diagnosed chronic medical conditions   f </td>\n<td colspan=\"3\" rowspan=\"1\">X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03830281_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Procedure</td>\n<td>Study Screening</td>\n<td colspan=\"2\" rowspan=\"1\">Lead-in Period</td>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Safety Follow-up</td>\n<td>ED</td>\n</tr>\n<tr>\n<td>eCRF Vist Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5  a</td>\n<td>6</td>\n<td>7  a</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>801</td>\n<td>ED  b</td>\n</tr>\n<tr>\n<td>Vist Window(+- days)</td>\n<td></td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td></td>\n</tr>\n<tr>\n<td>Time on Study Relative to First Active Treatment Dose(weeks)</td>\n<td>-3</td>\n<td>-2</td>\n<td>-1</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>6</td>\n<td>8</td>\n<td>12</td>\n<td>14</td>\n<td>16</td>\n<td>20</td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Study Logistics</td>\n</tr>\n<tr>\n<td>Informed consent signed</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IWRS</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Patient eligibility review</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization  c</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Clinical Assesments</td>\n</tr>\n<tr>\n<td>Patient demographics</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history and preexisting conditions</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination/height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medication</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Adverse events and product complaints</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Body weight  d</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs: blood pressure/pulse rate   e</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>ECG  f (12-lead)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Patient Education and Management</td>\n</tr>\n<tr>\n<td>Diabetes and nutritional counseling</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Transfer to Humalog   g</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record model of pump used in eCRF</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record use of low glucose suspend  h</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record low senssor glucose alert limit(s)</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Record model of infusion set type used in the eCRF\n</td>\n<td>X   i</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03830281_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Procedure</td>\n<td>Study Screening</td>\n<td colspan=\"2\" rowspan=\"1\">Lead-in Period</td>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Safety Follow-up</td>\n<td>ED</td>\n</tr>\n<tr>\n<td>eCRF Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5  a</td>\n<td>6</td>\n<td>7  a</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>801</td>\n<td>ED  b</td>\n</tr>\n<tr>\n<td>Visit Window(± days)</td>\n<td></td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td></td>\n</tr>\n<tr>\n<td>Time on Study Relative to First Active Treatment Dose(weeks)</td>\n<td>-3</td>\n<td>-2</td>\n<td>-1</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>6</td>\n<td>8</td>\n<td>12</td>\n<td>14</td>\n<td>16</td>\n<td>20</td>\n<td></td>\n</tr>\n<tr>\n<td>Record pump bolus delivery speed in the eCRF: 630G and 640G (standard or quick speed); 530G, Paradigm Revel, and Paradigm Veo (only standard speed)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Train on routinely changing the reservoir and infusion set every 3 days (may repeat as needed)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Patient Education and Management</td>\n</tr>\n<tr>\n<td>Assist patient to connect the study BG meter to their pump and select the option \"Always\" send BG results to pump</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Assist patient to set a pump reminder to prompt for a reservoir and infusion set change every 3 days</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Site staff to verify synchronization of the dates and times of pump and BG meter</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Change infusion set and reservoir at investigative site j</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Remind patients to change infusion set and reservoir the evening prior to MMTT</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review pump basal rates and bolus calculation factors and adjust as needed k</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Train on collecting glucose (4-,7-, and 10-point) profiles l</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review 4-point glucose profiles m</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Remind patient of 7-point glucose profilesn</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review 7-point glucose profiles m</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03830281_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Procedure</td>\n<td>Study Screening</td>\n<td colspan=\"2\" rowspan=\"1\">Lead-in Period</td>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Safety Follow-up</td>\n<td>ED</td>\n</tr>\n<tr>\n<td>eCRF Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5  a</td>\n<td>6</td>\n<td>7  a</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>801</td>\n<td>ED  b</td>\n</tr>\n<tr>\n<td>Visit Window(+- days)</td>\n<td></td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td></td>\n</tr>\n<tr>\n<td>Time on Study Relative to First Active Treatment Dose(weeks)</td>\n<td>-3</td>\n<td>-2</td>\n<td>-1</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>6</td>\n<td>8</td>\n<td>12</td>\n<td>14</td>\n<td>16</td>\n<td>20</td>\n<td></td>\n</tr>\n<tr>\n<td>Remind patient of 10-point SMBG profile requirements o</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review 10-point SMBG</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Train/remind patient on CGM to record date and start time of all meals and bedtime snack, if consumed, in patient diary during blinded CGM sessions</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Insert CGM sensor, attach transmitter and pair with receiverP</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Site staff to verify the date and time of the Dexcom G5 Receiver; adjust if needed</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Remind patient to change CGM sensor every 7 days</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Patient Education and Management</td>\n</tr>\n<tr>\n<td>Remove CGM sensor and detach transmitter</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X  q</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X  q</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Remind patient to avoid the use of acetaminophen/paracetamol during CGM use</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Upload CGM data to Study Management Suite r</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Start nonstudy rapid-acting insulin and reset pump to basal rates and bolus calculator settings used at randomization</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Dispense Study Diary</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X s</td>\n<td></td>\n<td>X  s</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review and collect study diary for clinical decision making</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">IP and Ancillary Supplies</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03830281_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Procedure</td>\n<td>Study Screening</td>\n<td colspan=\"2\" rowspan=\"1\">Lead-in Period</td>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Safety Follow-up</td>\n<td>ED</td>\n</tr>\n<tr>\n<td>eCRF Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5  a</td>\n<td>6</td>\n<td>7  a</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>801</td>\n<td>ED  b</td>\n</tr>\n<tr>\n<td>Visit Window(+- days)</td>\n<td></td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td></td>\n</tr>\n<tr>\n<td>Time on Study Relative to First Active Treatment Dose(weeks)</td>\n<td>-3</td>\n<td>-2</td>\n<td>-1</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>6</td>\n<td>8</td>\n<td>12</td>\n<td>14</td>\n<td>16</td>\n<td>20</td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense blood glucose meter and complete training 1</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense blood glucose meter supplies t</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense pump infusion sets, reservoirs and other ancillary supplies</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense CGM sensors to complete 14-day sessions (2x)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense IP</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Drug accountability</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Collect used and unused study drug</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Return CGM transmitter and receiver</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Transfer Diary Data to eCRF and Discuss with Patient u</td>\n</tr>\n<tr>\n<td>Hypoglycemia events</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>10-point SMBG</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X v</td>\n</tr>\n<tr>\n<td>Unplanned infusion set changes with noted reason(s)</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Planned infusion set changes</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urine Ketone results if available</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Recorded dates and start times of meals and bedtime snacks (if consumed) during blinded CGM sessions</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Transfer Pump Data to eCRF</td>\n</tr>\n<tr>\n<td>Total daily basal and total diary bolus insulin doses ( 3 days prior to vists)</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Bolus calculator settings: ISF, CR, AIT</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03830281_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Procedure</td>\n<td>Study Screening</td>\n<td colspan=\"2\" rowspan=\"1\">Lead-in Period</td>\n<td colspan=\"10\" rowspan=\"1\">Treatment Period</td>\n<td>Safety Follow-up</td>\n<td>ED</td>\n</tr>\n<tr>\n<td>eCRF Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5  a</td>\n<td>6</td>\n<td>7  a</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>801</td>\n<td>ED  b</td>\n</tr>\n<tr>\n<td>Visit Window(+- days)</td>\n<td></td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>3</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td>7</td>\n<td></td>\n</tr>\n<tr>\n<td>Time on Study Relative to First Active Treatment Dose(weeks)</td>\n<td>-3</td>\n<td>-2</td>\n<td>-1</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>6</td>\n<td>8</td>\n<td>12</td>\n<td>14</td>\n<td>16</td>\n<td>20</td>\n<td></td>\n</tr>\n<tr>\n<td>Number of each bolus type used: normal, square or dual wave during the 7 days prior to visit</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Laboratory Assessments</td>\n</tr>\n<tr>\n<td>Patient fasts prior to visit</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MMTT w</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record the basal rate at the start of  the MMTT and if it changes during the MMTT</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis panel</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test x</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Follicle-stimulating hormone test y</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chemistry panel</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>eGFR</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>1.5-Anhydroglucitol</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Laboratory Assessments</td>\n</tr>\n<tr>\n<td>Hemoglobin A1c</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Anti-insulin lispro antibodies</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td colspan=\"16\" rowspan=\"1\">Health Outcomes Questionnairesz</td>\n</tr>\n<tr>\n<td>ITSQ</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>EQ-5D-5L</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03831191_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening</td>\n<td colspan=\"7\" rowspan=\"1\">Induction Period</td>\n<td colspan=\"9\" rowspan=\"1\">Maintenance Period</td>\n<td>Posttreatment  Follow-Up</td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1</td>\n<td colspan=\"7\" rowspan=\"1\">Period 2</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3</td>\n<td>Period 4</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>801</td>\n</tr>\n<tr>\n<td>Weeks from  randomization</td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>28</td>\n<td>32</td>\n<td>36</td>\n<td>40</td>\n<td>44</td>\n<td>48</td>\n<td>52 or  ET</td>\n<td>60</td>\n</tr>\n<tr>\n<td>Days from  randomization</td>\n<td></td>\n<td>0</td>\n<td>7</td>\n<td>14</td>\n<td>28</td>\n<td>56</td>\n<td>84</td>\n<td>112</td>\n<td>140</td>\n<td>168</td>\n<td>196</td>\n<td>224</td>\n<td>252</td>\n<td>280</td>\n<td>308</td>\n<td>336</td>\n<td>364</td>\n<td>420</td>\n</tr>\n<tr>\n<td>Visit tolerance interval  (days)</td>\n<td>-8 to -35</td>\n<td></td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n</tr>\n<tr>\n<td>Procedure</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion and exclusion  review</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical assessments</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Previous and current AD  treatments</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Height</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs (BP and  Pulse)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Complete physical  examination</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Symptom-directed  physical examination   a </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medication</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>ePRO (patient diary)  dispensed</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03831191_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening</td>\n<td colspan=\"7\" rowspan=\"1\">Induction Period</td>\n<td colspan=\"9\" rowspan=\"1\">Maintenance Period</td>\n<td>Posttreatment  Follow-Up</td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1</td>\n<td colspan=\"7\" rowspan=\"1\">Period 2</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3</td>\n<td>Period 4</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>801</td>\n</tr>\n<tr>\n<td>Weeks from  randomization</td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>28</td>\n<td>32</td>\n<td>36</td>\n<td>40</td>\n<td>44</td>\n<td>48</td>\n<td>52 or  ET</td>\n<td>60</td>\n</tr>\n<tr>\n<td>Days from  randomization</td>\n<td></td>\n<td>0</td>\n<td>7</td>\n<td>14</td>\n<td>28</td>\n<td>56</td>\n<td>84</td>\n<td>112</td>\n<td>140</td>\n<td>168</td>\n<td>196</td>\n<td>224</td>\n<td>252</td>\n<td>280</td>\n<td>308</td>\n<td>336</td>\n<td>364</td>\n<td>420</td>\n</tr>\n<tr>\n<td>Visit tolerance interval  (days)</td>\n<td>-8 to -35</td>\n<td></td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n</tr>\n<tr>\n<td>ePRO (patient diary)  returned</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IWRS entry</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>IP SC injections</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Investigator Scales</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IGA   c </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>EASI   c </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>SCORAD   c </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Health Outcome  Measures and Other  Questionnaires</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>POEM   c,d </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>DLQI   c,d </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Itch NRS   e </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Skin Pain NRS   e </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS  “Baseline/Screening”</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS  “Since Last Visit”</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Self-Harm Supplement  Form</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Self-Harm Follow-up  Form  Laboratory Assessment  f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03831191_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening</td>\n<td colspan=\"7\" rowspan=\"1\">Induction Period</td>\n<td colspan=\"9\" rowspan=\"1\">Maintenance Period</td>\n<td>Posttreatment  Follow-Up</td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1</td>\n<td colspan=\"7\" rowspan=\"1\">Period 2</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3</td>\n<td>Period 4</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>801</td>\n</tr>\n<tr>\n<td>Weeks from  randomization</td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>28</td>\n<td>32</td>\n<td>36</td>\n<td>40</td>\n<td>44</td>\n<td>48</td>\n<td>52 or  ET</td>\n<td>60</td>\n</tr>\n<tr>\n<td>Days from  randomization</td>\n<td></td>\n<td>0</td>\n<td>7</td>\n<td>14</td>\n<td>28</td>\n<td>56</td>\n<td>84</td>\n<td>112</td>\n<td>140</td>\n<td>168</td>\n<td>196</td>\n<td>224</td>\n<td>252</td>\n<td>280</td>\n<td>308</td>\n<td>336</td>\n<td>364</td>\n<td>420</td>\n</tr>\n<tr>\n<td>Visit tolerance interval  (days)</td>\n<td>-8 to -35</td>\n<td></td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n</tr>\n<tr>\n<td>Laboratory Assessment</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG (single)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chest x-ray (posterior– anterior and lateral  views)  g </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TB test   h </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Read PPD if applicable  (48–72 hours post-PPD)   i </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Skin punch biopsies  (lesional, nonlesional)  j </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical chemistry</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Lipids (fasting)   k </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum pregnancy   l </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FSH   m </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HIV, HCV, HBV  screening tests  n </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV DNA   o </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urinalysis</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Urine pregnancy   l </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pharmacogenetics sample</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum IgE (total)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Serum IgE (allergen </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03831191_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening</td>\n<td colspan=\"7\" rowspan=\"1\">Induction Period</td>\n<td colspan=\"9\" rowspan=\"1\">Maintenance Period</td>\n<td>Posttreatment  Follow-Up</td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1</td>\n<td colspan=\"7\" rowspan=\"1\">Period 2</td>\n<td colspan=\"9\" rowspan=\"1\">Period 3</td>\n<td>Period 4</td>\n</tr>\n<tr>\n<td>Visit Number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>801</td>\n</tr>\n<tr>\n<td>Weeks from  randomization</td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>28</td>\n<td>32</td>\n<td>36</td>\n<td>40</td>\n<td>44</td>\n<td>48</td>\n<td>52 or  ET</td>\n<td>60</td>\n</tr>\n<tr>\n<td>Days from  randomization</td>\n<td></td>\n<td>0</td>\n<td>7</td>\n<td>14</td>\n<td>28</td>\n<td>56</td>\n<td>84</td>\n<td>112</td>\n<td>140</td>\n<td>168</td>\n<td>196</td>\n<td>224</td>\n<td>252</td>\n<td>280</td>\n<td>308</td>\n<td>336</td>\n<td>364</td>\n<td>420</td>\n</tr>\n<tr>\n<td>Visit tolerance interval  (days)</td>\n<td>-8 to -35</td>\n<td></td>\n<td>±2</td>\n<td>±2</td>\n<td>±2</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±4</td>\n<td>±5</td>\n</tr>\n<tr>\n<td>specif)p</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Exploratory long-term storage samples (serum, plasma EDTA)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Exploratory long-term storage samples: RNA and DNA (epigenetic)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>LY3375880 PK sample q</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Immunogeneticity sample q</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Target engagement samples (Total IL-33)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>IL-19, TARC, Periostin</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Flow cytometry sample</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03836716_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Baseline   [a]</td>\n<td colspan=\"4\" rowspan=\"1\">Open-label treatment   [b]</td>\n<td>Safety Follow Up </td>\n</tr>\n<tr>\n<td>Visit name </td>\n<td>Baseline    c </td>\n<td>In-person visits    c </td>\n<td>In-person  visits </td>\n<td>Remote visits  (telephone calls) </td>\n<td>End of trial   (in person)   d </td>\n<td>Safety Follow Up   (telephone call)   e </td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>1 </td>\n<td>2, 4, 6, 8, 11, 14  and 17 </td>\n<td>3, 5, 7, </td>\n<td>9, 10, 12, 13, 15, 16, 18 and  19 </td>\n<td>20 </td>\n<td>21 </td>\n</tr>\n<tr>\n<td>Time in relation to Baseline </td>\n<td>Day 1 </td>\n<td>Weeks 4, 12, 20,  28, 40, 52, 64  </td>\n<td>8, 16, 24 </td>\n<td>Weeks 32, 36, 44, 48, 56, 60,  68 and 72  </td>\n<td>Week 76   (or early  termination) </td>\n<td>2 weeks after treatment discontinuation </td>\n</tr>\n<tr>\n<td>Visit window, days </td>\n<td></td>\n<td>± 7 days </td>\n<td></td>\n<td>± 7 days </td>\n<td>± 7 days </td>\n<td>± 7 days </td>\n</tr>\n<tr>\n<td>SUBJECTS</td>\n<td colspan=\"6\" rowspan=\"1\"></td>\n</tr>\n<tr>\n<td>Written Informed Consent </td>\n<td>X    r </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/Exclusion Criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics    f </td>\n<td>(X) </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History   g </td>\n<td>(X) </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Respiratory rate </td>\n<td>(X) </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Diary instruction    h </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary completion    h </td>\n<td colspan=\"5\" rowspan=\"1\">X</td>\n<td></td>\n</tr>\n<tr>\n<td>Collect diary and record diary  data in eCRF    h </td>\n<td>(X) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant Medication </td>\n<td>(X) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td colspan=\"7\" rowspan=\"1\">EFFICACY</td>\n</tr>\n<tr>\n<td>Survival (PAV/ tracheostomy/  death) </td>\n<td colspan=\"6\" rowspan=\"1\">X</td>\n</tr>\n<tr>\n<td>ALSFRS-R   i </td>\n<td>(X) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>SVC </td>\n<td>(X) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"7\" rowspan=\"1\">SAFETY</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03836716_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Baseline   [a]</td>\n<td colspan=\"4\" rowspan=\"1\">Open-label treatment   [b]</td>\n<td>Safety Follow Up </td>\n</tr>\n<tr>\n<td>Visit name </td>\n<td>Baseline    c </td>\n<td>In-person visits    c </td>\n<td>In-person  visits </td>\n<td>Remote visits  (telephone calls) </td>\n<td>End of trial   (in person)   d </td>\n<td>Safety Follow Up   (telephone call)   e </td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>1 </td>\n<td>2, 4, 6, 8, 11, 14  and 17 </td>\n<td>3, 5, 7, </td>\n<td>9, 10, 12, 13, 15, 16, 18 and  19 </td>\n<td>20 </td>\n<td>21 </td>\n</tr>\n<tr>\n<td>Time in relation to Baseline </td>\n<td>Day 1 </td>\n<td>Weeks 4, 12, 20,  28, 40, 52, 64  </td>\n<td>8, 16, 24 </td>\n<td>Weeks 32, 36, 44, 48, 56, 60,  68 and 72  </td>\n<td>Week 76   (or early  termination) </td>\n<td>2 weeks after treatment discontinuation </td>\n</tr>\n<tr>\n<td>Visit window, days </td>\n<td></td>\n<td>± 7 days </td>\n<td></td>\n<td>± 7 days </td>\n<td>± 7 days </td>\n<td>± 7 days </td>\n</tr>\n<tr>\n<td>Physical Examination </td>\n<td>(X) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Vital Signs </td>\n<td>(X) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Body Weight    j </td>\n<td>(X) </td>\n<td>X (Week 52 only) </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS    k </td>\n<td>(X) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>ECG </td>\n<td>(X) </td>\n<td>X (Weeks 20 and  52 only) </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>AEs </td>\n<td>(X) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X    l </td>\n</tr>\n<tr>\n<td>Pregnancy Test    m </td>\n<td>(X) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical Safety Laboratory Test    n p </td>\n<td>(X) </td>\n<td>X </td>\n<td>X   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03836716_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Baseline   [a]</td>\n<td colspan=\"4\" rowspan=\"1\">Open-label treatment   [b]</td>\n<td>Safety Follow Up </td>\n</tr>\n<tr>\n<td>Visit name </td>\n<td>Baseline    c </td>\n<td>In-person visits    c </td>\n<td>In-person  visits </td>\n<td>Remote visits  (telephone calls) </td>\n<td>End of trial   (in person)   d </td>\n<td>Safety Follow Up   (telephone call)   e </td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>1 </td>\n<td>2, 4, 6, 8, 11, 14  and 17 </td>\n<td>3, 5, 7, </td>\n<td>9, 10, 12, 13, 15, 16, 18 and  19 </td>\n<td>20 </td>\n<td>21 </td>\n</tr>\n<tr>\n<td>Time in relation to Baseline </td>\n<td>Day 1 </td>\n<td>Weeks 4, 12, 20,  28, 40, 52, 64  </td>\n<td>8, 16, 24 </td>\n<td>Weeks 32, 36, 44, 48, 56, 60,  68 and 72  </td>\n<td>Week 76   (or early  termination) </td>\n<td>2 weeks after treatment discontinuation </td>\n</tr>\n<tr>\n<td>Visit window, days </td>\n<td></td>\n<td>± 7 days </td>\n<td></td>\n<td>± 7 days </td>\n<td>± 7 days </td>\n<td>± 7 days </td>\n</tr>\n<tr>\n<td colspan=\"7\" rowspan=\"1\">HEALTH-RELATED QUALITY OF LIFE</td>\n</tr>\n<tr>\n<td>EQ-5D-5L</td>\n<td>(X) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"7\" rowspan=\"1\">BIOLOGICAL SAMPLE COLLECTION </td>\n</tr>\n<tr>\n<td colspan=\"7\" rowspan=\"1\">BIOREPOSITORY </td>\n</tr>\n<tr>\n<td>Blood collection </td>\n<td>(X) </td>\n<td>X (Weeks 20 and  52 only) </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Urine collection  </td>\n<td>(X) </td>\n<td>X (Weeks 20 and  52 only) </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"7\" rowspan=\"1\">PHARMACOKINETICS </td>\n</tr>\n<tr>\n<td>Blood sampling (arimoclomol)   o </td>\n<td></td>\n<td>X (Weeks 20 and  52 only) </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"7\" rowspan=\"1\">INVESTIGATIONAL MEDICINAL PRODUCT </td>\n</tr>\n<tr>\n<td>Dispensing of IMP </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Drug Accountability </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03841331_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Examination </td>\n<td>Screening </td>\n<td>Mid-Screening  (-3 days)  TC</td>\n<td>Baseline  (+3 days)  1</td>\n<td>Week 1  (±  3 days)  TC</td>\n<td>Week 2 (-3  /+1 days) </td>\n<td>Week 4 (±  3 days) </td>\n<td>Week 6 (±  3 days) </td>\n<td>Week 8  (± 3 days)  TC</td>\n<td>Week 10  (+ 3  days) </td>\n<td>F/U  2</td>\n</tr>\n<tr>\n<td>Demographics </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Paper WI-NRS   3 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>WI-VAS  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>ESS  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>sPGA </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PGIC </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>ECG </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Vital signs </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Medical history (and prior medications)  </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical exam   4 </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Concomitant medications </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Labs   5 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urine pregnancy test   6 </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PK blood draw  </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Review of I/E criteria </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense/collect eDiary  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X  </td>\n</tr>\n<tr>\n<td>eDiary review/compliance   7 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Dispense and/or collect study drug </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Review study drug compliance </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>AEs/SAEs   8 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03841526_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment </td>\n<td>Visit 1 </td>\n<td>Visit 2 </td>\n<td>Visit 3  CRC 1  o</td>\n<td>Visit 4  CRC 2  o</td>\n<td>Visits 5 to 10  Outpatient Phase </td>\n<td colspan=\"1\" rowspan=\"2\">Visit 11   Follow-up  /ET   f</td>\n</tr>\n<tr>\n<td>Screening  Day–28 to  –3 </td>\n<td>CGM  Placement  Day –2 to –1 </td>\n<td>Treatment  Period 1  (Days 1 )   a,b,c </td>\n<td>Treatment  Period 2  Day 3 to 29   d </td>\n<td>Treatment  Period 3  Day 4 to 113   e </td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History/  Demographics </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion  criteria </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant  medications (including  insulin pump data) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Height, weight and  physical examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Vital signs </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urine pregnancy test </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urine drug screen </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Clinical chemistry </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>HbA1c </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Plasma Glucose </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>C-peptide </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Immunogenicity   g </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>CGM </td>\n<td></td>\n<td>X   d </td>\n<td>X   h </td>\n<td>X   h </td>\n<td>X   h </td>\n<td>X   h </td>\n</tr>\n<tr>\n<td>Exercise   i,o </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>BGM   k </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X   j </td>\n<td>X   j </td>\n<td>X   j </td>\n</tr>\n<tr>\n<td>Study drug  administration </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X   l </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Wearable Activity  Monitors  (Fitbit Ionic and Polar  Beat H10) </td>\n<td></td>\n<td></td>\n<td>X   m </td>\n<td>X   m </td>\n<td>X   n </td>\n<td>X   n </td>\n</tr>\n<tr>\n<td>HBV, HCV, HIV  Screen  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03841526_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessment </td>\n<td>Visit 1 </td>\n<td>Visit 2 </td>\n<td>Visit 3  CRC 1  o</td>\n<td>Visit 4  CRC 2  o</td>\n<td>Visits 5 to 10  Outpatient Phase </td>\n<td colspan=\"1\" rowspan=\"2\">Visit 11   Follow-up  /ET   f</td>\n</tr>\n<tr>\n<td>Screening  Day–28 to  –3 </td>\n<td>CGM  Placement  Day –2 to –1 </td>\n<td>Treatment  Period 1  (Days 1 )   a,b,c </td>\n<td>Treatment  Period 2  Day 3 to 29   d </td>\n<td>Treatment  Period 3  Day 4 to 113   e </td>\n</tr>\n<tr>\n<td>Outpatient Study  Training </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary   i </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Glucose Tabs Log</td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Randomization </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>8-Hour fast </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Venous blood glucose  (YSI)</td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>BAPAD-1  Questionnaire </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Draize Scale </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HFS </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Hypoglycemia  Confidence Scale </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Injection Site  Discomfort Description  and Duration  Questionnaire </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse event review </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03843541_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>ACTIVITIES (See sections 9 &amp; 10 for details)</td>\n<td>Visit 1 Screening</td>\n<td>Visit 2 Randomisation</td>\n<td></td>\n<td>Visit 3</td>\n<td></td>\n<td></td>\n<td>Visit 4 End of Treatment (EOT)</td>\n<td>Follow-up phone call or Visit</td>\n<td>Unscheduled deterioration visit</td>\n<td>Premature dicontinuation visit)</td>\n</tr>\n<tr>\n<td></td>\n<td> Within 7 days  of Visit 2</td>\n<td>Day 1</td>\n<td>Day 2</td>\n<td> Day 3</td>\n<td>Day 4</td>\n<td>Day 5 &amp; 6</td>\n<td>Day 7</td>\n<td>2 weeks ± 3 days  after  EoT or  DV</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Verification of  eligibility for  randomization</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical  history/demography</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Previous/concomitan medications</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead ECG</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Blood sample for  haematology and  clinical chemistry</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Assessment of  expectoration  difficulty, sputum  viscosity, sputum  colour and cough by  means of the 4-point  ordinal scales  provided</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>24-h sputum  collection (to be  collected and  measured the  following day)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>IMP dispensation</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Accountability of IMP</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03847896_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening (run-in)    b</td>\n<td colspan=\"5\" rowspan=\"1\">Double-blind Treatment Period</td>\n<td colspan=\"1\" rowspan=\"4\">PDV  (if  applicable)    d</td>\n<td colspan=\"1\" rowspan=\"4\">Safety Follow-up TC  (2 weeks [±4 days] after  treatment discontinuation)  </td>\n</tr>\n<tr>\n<td> Visit   a</td>\n<td> 1 (1/1a) </td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6  c</td>\n</tr>\n<tr>\n<td>Week </td>\n<td>-4 to -2</td>\n<td>0</td>\n<td>1</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n</tr>\n<tr>\n<td>Day </td>\n<td>-28 to -14</td>\n<td>1</td>\n<td>7±2 </td>\n<td>28±2 </td>\n<td>56±2 </td>\n<td>84±2 c</td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Eligibility criteria</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"9\" rowspan=\"1\">Routine clinical procedures</td>\n</tr>\n<tr>\n<td>Medical/surgical history (including any on-study medical/surgical procedures)    e</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"1\" rowspan=\"5\">X</td>\n</tr>\n<tr>\n<td>Demography</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination   f</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>SABA reversibility test   g</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"9\" rowspan=\"1\">Safety measurements</td>\n</tr>\n<tr>\n<td>Vital signs (HR and BP only)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td colspan=\"1\" rowspan=\"5\">X</td>\n</tr>\n<tr>\n<td>12-lead ECG</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pregnancy test   h</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Safety laboratory assessments (clinical chemistry, hematology)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03847896_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening (run-in)    b</td>\n<td colspan=\"5\" rowspan=\"1\">Double-blind Treatment Period</td>\n<td colspan=\"1\" rowspan=\"4\">PDV  (if  applicable)    d</td>\n<td colspan=\"1\" rowspan=\"4\">Safety Follow-up TC  (2 weeks [±4 days] after  treatment discontinuation)  </td>\n</tr>\n<tr>\n<td> Visit   a</td>\n<td> 1 (1/1a) </td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6  c</td>\n</tr>\n<tr>\n<td>Week </td>\n<td>-4 to -2</td>\n<td>0</td>\n<td>1</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n</tr>\n<tr>\n<td>Day </td>\n<td>-28 to -14</td>\n<td>1</td>\n<td>7±2 </td>\n<td>28±2 </td>\n<td>56±2 </td>\n<td>84±2 c</td>\n</tr>\n<tr>\n<td colspan=\"9\" rowspan=\"1\">Efficacy measurements</td>\n</tr>\n<tr>\n<td>Spirometry (FEV1)   i</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>ACQ-5</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>ACQ-7</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>AQLQ+12/PAQLQ</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Review of PEF, use of Ventolintherapy, asthma daytime/night-time symptoms, night-time awakenings due to asthma symptoms</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense/collect eDiary (AM3+)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Review compliance with eDiary</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"9\" rowspan=\"1\">Investigational product administration</td>\n</tr>\n<tr>\n<td>IP compliance</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP (dispense/collect)k</td>\n<td> d</td>\n<td>c/d   k</td>\n<td>c/d</td>\n<td>c/d</td>\n<td>c/d</td>\n<td>c/d   n</td>\n<td>c/d   n</td>\n<td></td>\n</tr>\n<tr>\n<td>Ventolin (collect/dispense)</td>\n<td>d</td>\n<td>c/d   l</td>\n<td>c/d   l</td>\n<td>c/d   l</td>\n<td>c/d   l</td>\n<td>c</td>\n<td>c</td>\n<td></td>\n</tr>\n<tr>\n<td>Ventolin administration (recorded in MasterScope)</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP administration (recorded in MasterScope)    m</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03870880_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening</td>\n<td>Baseline</td>\n<td colspan=\"12\" rowspan=\"1\">Treatment Period (Double-Blind) </td>\n<td>Follow  -up </td>\n</tr>\n<tr>\n<td>Study Visit Number:</td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7   1 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14   2 </td>\n<td>15   3 </td>\n</tr>\n<tr>\n<td>Study Day :  4 </td>\n<td>-8 to -1   5 </td>\n<td>1 </td>\n<td>3 </td>\n<td>4 </td>\n<td>8 </td>\n<td>15 </td>\n<td>22 </td>\n<td>29 </td>\n<td>31 </td>\n<td>43 </td>\n<td>57 </td>\n<td>59 </td>\n<td>71 </td>\n<td>85 </td>\n<td>99 </td>\n</tr>\n<tr>\n<td>Treatment Week:</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td></td>\n<td>6 </td>\n<td>8 </td>\n<td></td>\n<td>10 </td>\n<td>12 </td>\n<td></td>\n</tr>\n<tr>\n<td>Overall Dosing Sequence:</td>\n<td></td>\n<td>1 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>2 </td>\n<td></td>\n<td></td>\n<td>3 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Screening assessments   6 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Eligibility criteria review   7 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inpatient study unit   8 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>(X)</td>\n<td>(X)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>(Test oral risperidone)   9 </td>\n<td>(X)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization   10 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inject IM study drug   11 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Efficacy scales 12 :</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>  PANSS   </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td> CGI-S</td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>CGI-I  </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Socio-demographic  information   </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td> HRU data collection –  center</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>HRU data collection –  patient</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Health outcome scales 13 :</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PSP (clinician  administered)  </td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>SWN-20 (patient  reported)</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Safety assessments : </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> AEs   14</td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Concomitant meds  15</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Physical examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Height  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight and body mass  index  </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs  16</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>ECG  17</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td> Injection site evaluation 18</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Injection site pain VAS  18</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Safety scales 12 :  </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>AIMS </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n<td> X </td>\n<td></td>\n<td> X </td>\n<td> X </td>\n<td></td>\n<td> X </td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>BARS       </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>SAS</td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS</td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Ophthalmological  examination   19 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for:  </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology panel   20 </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td> X </td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03870880_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening</td>\n<td>Baseline</td>\n<td colspan=\"12\" rowspan=\"1\">Treatment Period (Double-Blind) </td>\n<td>Follow  -up </td>\n</tr>\n<tr>\n<td>Study Visit Number:</td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7   1 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14   2 </td>\n<td>15   3 </td>\n</tr>\n<tr>\n<td>Study Day :  4 </td>\n<td>-8 to -1   5 </td>\n<td>1 </td>\n<td>3 </td>\n<td>4 </td>\n<td>8 </td>\n<td>15 </td>\n<td>22 </td>\n<td>29 </td>\n<td>31 </td>\n<td>43 </td>\n<td>57 </td>\n<td>59 </td>\n<td>71 </td>\n<td>85 </td>\n<td>99 </td>\n</tr>\n<tr>\n<td>Treatment Week:</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td></td>\n<td>6 </td>\n<td>8 </td>\n<td></td>\n<td>10 </td>\n<td>12 </td>\n<td></td>\n</tr>\n<tr>\n<td>Overall Dosing Sequence:</td>\n<td></td>\n<td>1 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>2 </td>\n<td></td>\n<td></td>\n<td>3 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chemistry panel  21</td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Prolactin   </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Pharmacokinetics  22</td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X   23 </td>\n<td>X  23,23 </td>\n<td>X23</td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Genotype  24</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serology panel  25</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test (serum)   </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine sample for:</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test  26</td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis  27</td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Drug screen   28 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>(X) </td>\n<td>(X) </td>\n<td></td>\n<td>(X) </td>\n<td></td>\n<td>(X)</td>\n<td>(X)</td>\n<td></td>\n<td>(X) </td>\n<td>(X) </td>\n<td>ical</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03870880_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Extension  Baseline </td>\n<td colspan=\"13\" rowspan=\"1\">Extension Segment Treatment Period (Open-Label) </td>\n<td>Extension  Follow-up </td>\n</tr>\n<tr>\n<td>Extension Visit Number:</td>\n<td>   1   1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11</td>\n<td>12</td>\n<td>13  2 </td>\n<td>142</td>\n<td>15   3 </td>\n</tr>\n<tr>\n<td>Extension Study Day :  4 </td>\n<td>   1   5 </td>\n<td>29 </td>\n<td>57 </td>\n<td>85</td>\n<td>113</td>\n<td>141</td>\n<td>169</td>\n<td>197</td>\n<td>225</td>\n<td>253</td>\n<td>281</td>\n<td>309</td>\n<td>337</td>\n<td>365</td>\n<td>393 </td>\n</tr>\n<tr>\n<td>Extension Treatment Week:</td>\n<td></td>\n<td>4 </td>\n<td>8 </td>\n<td>12</td>\n<td>16</td>\n<td>20 </td>\n<td>24</td>\n<td>28</td>\n<td>32 </td>\n<td>36 </td>\n<td>40</td>\n<td>44</td>\n<td>48 </td>\n<td>52 </td>\n<td>56 </td>\n</tr>\n<tr>\n<td>Extension Dosing Sequence:</td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11</td>\n<td>12</td>\n<td>13 </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent   6 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Eligibility criteria review   7 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inject Risperidone ISM   8 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Efficacy scales :</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>  PANSS   </td>\n<td>  X   9 </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td> CGI-S</td>\n<td> X   9 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>CGI-I  10</td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Socio-demographic  information   </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> HRU data collection –  center</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HRU data collection –  patient</td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Health outcome scales 11 :</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PSP (clinician  administered)  </td>\n<td></td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>SWN-20 (patient  reported)</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Safety assessments : </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> AEs   12</td>\n<td>  X   9 </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n</tr>\n<tr>\n<td>Concomitant meds  13</td>\n<td> X   9 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Physical examination </td>\n<td> X   9 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Weight and body mass  index  </td>\n<td> X   9 </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs  14</td>\n<td>X   8 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>ECG  15</td>\n<td>X   8 </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td> Injection site evaluation 16</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Injection site pain VAS  16</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Safety scales :  </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>AIMS </td>\n<td>  X   9 </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>BARS       </td>\n<td> X   9 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>SAS</td>\n<td> X   9 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS</td>\n<td> X   9 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for:</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Hematology panel  17</td>\n<td>  X   9 </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>Chemistry panel  18</td>\n<td> X   9 </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Prolactin  </td>\n<td> X   9 </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test  (serum)   19 </td>\n<td>(X) </td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td></td>\n</tr>\n<tr>\n<td>Urine sample for: </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test  20</td>\n<td>  X   9 </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis  21</td>\n<td> X   9 </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Drug screen   22 </td>\n<td>(X) </td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03870880_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening</td>\n<td>Baseline</td>\n<td colspan=\"13\" rowspan=\"1\">Extension Segment Treatment Period (Open-Label) </td>\n<td>Extension  Follow-up </td>\n</tr>\n<tr>\n<td>Extension Visit Number:</td>\n<td>0 </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10  1 </td>\n<td>11  1 </td>\n<td>12  1 </td>\n<td>13  1 </td>\n<td>141</td>\n<td>15 </td>\n</tr>\n<tr>\n<td>Extension Study Day :  2 </td>\n<td>-8 to -1   3 </td>\n<td>1 </td>\n<td>29</td>\n<td>57</td>\n<td>85</td>\n<td>113</td>\n<td>141</td>\n<td>169</td>\n<td>197</td>\n<td>225</td>\n<td>253</td>\n<td>281</td>\n<td>309</td>\n<td>337</td>\n<td>365</td>\n<td>393 </td>\n</tr>\n<tr>\n<td>Extension Treatment  Week:</td>\n<td></td>\n<td></td>\n<td>4 </td>\n<td>8 </td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>28</td>\n<td>32</td>\n<td>36</td>\n<td>40</td>\n<td>44</td>\n<td>48</td>\n<td>52</td>\n<td>56 </td>\n</tr>\n<tr>\n<td>Extension Dosing Sequence:</td>\n<td></td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent   4 </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Screening assessment   * </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Eligibility criteria review   2 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Arm assignment   5 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inject Risperidone ISM   3 </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Efficacy scales: </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PANSS </td>\n<td> X </td>\n<td>  X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td> CGI-S  </td>\n<td>X </td>\n<td> X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>CGI-I </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Socio-demographic  information   </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> HRU data collection –  center</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HRU data collection –  patient</td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Health outcome scales 6 :</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PSP (clinician  administered)  </td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>SWN-20 (patient  reported)</td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Safety assessments : </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> AEs   7</td>\n<td> X </td>\n<td>  X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n</tr>\n<tr>\n<td>Concomitant meds  8</td>\n<td>X </td>\n<td> X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Physical examination </td>\n<td>X </td>\n<td> X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Weight and body mass  index  </td>\n<td>X </td>\n<td> X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs  9</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>ECG  10</td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td> Injection site evaluation 9</td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Injection site pain VAS  11</td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Safety scales :  </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>AIMS </td>\n<td> X </td>\n<td>  X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>BARS       </td>\n<td>X </td>\n<td> X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>SAS</td>\n<td>X </td>\n<td> X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS</td>\n<td>X </td>\n<td> X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Blood sample for:</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Hematology panel  12</td>\n<td> X </td>\n<td>  X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n<td></td>\n<td></td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>Chemistry panel  13</td>\n<td>X </td>\n<td> X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Prolactin  </td>\n<td>X </td>\n<td> X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Serology panel **</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test  (serum)   14</td>\n<td>X </td>\n<td>(X) </td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03870880_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening</td>\n<td>Baseline</td>\n<td colspan=\"13\" rowspan=\"1\">Extension Segment Treatment Period (Open-Label) </td>\n<td>Extension  Follow-up </td>\n</tr>\n<tr>\n<td>Extension Visit Number:</td>\n<td>0 </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10  1 </td>\n<td>11  1 </td>\n<td>12  1 </td>\n<td>13  1 </td>\n<td>141</td>\n<td>15 </td>\n</tr>\n<tr>\n<td>Extension Study Day :  2 </td>\n<td>-8 to -1   3 </td>\n<td>1 </td>\n<td>29</td>\n<td>57</td>\n<td>85</td>\n<td>113</td>\n<td>141</td>\n<td>169</td>\n<td>197</td>\n<td>225</td>\n<td>253</td>\n<td>281</td>\n<td>309</td>\n<td>337</td>\n<td>365</td>\n<td>393 </td>\n</tr>\n<tr>\n<td>Extension Treatment  Week:</td>\n<td></td>\n<td></td>\n<td>4 </td>\n<td>8 </td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>28</td>\n<td>32</td>\n<td>36</td>\n<td>40</td>\n<td>44</td>\n<td>48</td>\n<td>52</td>\n<td>56 </td>\n</tr>\n<tr>\n<td>Extension Dosing Sequence:</td>\n<td></td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine sample for: </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy test  15</td>\n<td></td>\n<td>  X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis  16</td>\n<td>X </td>\n<td> X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Drug screen   17</td>\n<td>X </td>\n<td>X </td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td>(X)</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03872453_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening Visit  [1]</td>\n<td>Baseline/  Randomization  Visit (Day 1)  [2]</td>\n<td>Onset of moderate or  severe migraine  [3]</td>\n<td>Post Study Medication  Administration:  15, 30, 45, 60 and 90 minutes  2, 3, 4, 6, 8, 24 and 48 hours </td>\n<td>End of Treatment  Visit  [14]</td>\n</tr>\n<tr>\n<td colspan=\"6\" rowspan=\"1\">Eligibility Assessments</td>\n</tr>\n<tr>\n<td>Informed Consent </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/  Exclusion Criteria </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Migraine History  Assessment   (signs/ symptoms/ prior  treatment/ frequency/  intensity) </td>\n<td> X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Rescue Medication paper  diary, Concomitant  Medication paper diary   4 </td>\n<td> X</td>\n<td> X</td>\n<td> X </td>\n<td> X </td>\n<td> X </td>\n</tr>\n<tr>\n<td>Randomize subject in  IWRS   5 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"6\" rowspan=\"1\">Safety Assessments  </td>\n</tr>\n<tr>\n<td>Physical Examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Nasal Inspection   6 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Vital Signs/ Physical  Measurements   7 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Adverse Event and Serious  Adverse Event  Assessment   8 </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X  </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Sheehan Suicidality  Tracking Scale   (S-STS)   9 </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>ECG </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Clinical Safety Laboratory  Testing</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03872453_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening Visit  [1]</td>\n<td>Baseline/  Randomization  Visit (Day 1)  [2]</td>\n<td>Onset of moderate or  severe migraine  [3]</td>\n<td>Post Study Medication  Administration:  15, 30, 45, 60 and 90 minutes  2, 3, 4, 6, 8, 24 and 48 hours </td>\n<td>End of Treatment  Visit  [14]</td>\n</tr>\n<tr>\n<td>Liver Function Tests  (LFTs) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Lipid Panel </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>FSH, if applicable, to  determine WOCBP status </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy Test   10 </td>\n<td>X (Serum)</td>\n<td>X (Urine) </td>\n<td>X (Urine) </td>\n<td></td>\n<td>X (Serum) </td>\n</tr>\n<tr>\n<td>Urinalysis </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urine drug screen for  drugs of abuse </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td colspan=\"6\" rowspan=\"1\">Clinical Drug Supplies/Study Supplies</td>\n</tr>\n<tr>\n<td>eCOA Handheld device  assigned  </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense study  medication   11 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer study  medication </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Patient Education:  Dose  Administration </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Patient Education: eCOA  Handheld </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Enter use of study  medication in eCOA  Handheld device  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Return used or unused  study medication  </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>eCOA Handheld returned/  reviewed for  completeness   12 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td> X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03872453_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Procedure </td>\n<td>Screening Visit  [1]</td>\n<td>Baseline/  Randomization  Visit (Day 1)  [2]</td>\n<td>Onset of moderate or  severe migraine  [3]</td>\n<td>Post Study Medication  Administration:  15, 30, 45, 60 and 90 minutes  2, 3, 4, 6, 8, 24 and 48 hours </td>\n<td>End of Treatment  Visit  [14]</td>\n</tr>\n<tr>\n<td colspan=\"6\" rowspan=\"1\">Efficacy Assessments   12 </td>\n</tr>\n<tr>\n<td>Assessment of migraine  pain   13 </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Assessment of Migraine  Symptoms (photophobia,  phonophobia, and  nausea)   13 </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Functional Disability  Scale   13 </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>MQoL (Migraine Quality  of Life Questionnaire)   13 </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X (24-hour assessment) </td>\n<td></td>\n</tr>\n<tr>\n<td>Preference of Medication  (PoM)   13 </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X (24-hour assessment) </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03877224_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit</td>\n<td colspan=\"1\" rowspan=\"2\">1 Enrolment</td>\n<td colspan=\"2\" rowspan=\"1\">2 Randomisation</td>\n<td colspan=\"1\" rowspan=\"2\">3</td>\n<td colspan=\"1\" rowspan=\"2\">4   Telephone  call [b]</td>\n<td colspan=\"1\" rowspan=\"2\">5 Final visit</td>\n<td colspan=\"1\" rowspan=\"2\">Early  Withdrawal  Visit OR Early  Treatment  Discontinuation  Visit   [c]</td>\n<td colspan=\"1\" rowspan=\"2\">Details in CSP  section or  Appendix</td>\n<td></td>\n</tr>\n<tr>\n<td>2a Randomisation  A</td>\n<td>2b   Randomisation  B  a </td>\n<td></td>\n</tr>\n<tr>\n<td>Week</td>\n<td>-2 (±1)</td>\n<td>0</td>\n<td>0</td>\n<td>8 (±1)</td>\n<td>14 (±1)</td>\n<td>16 (±1)</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Day (visit window  ±days )</td>\n<td>-14 (±7)</td>\n<td>1</td>\n<td>1</td>\n<td>56 (±7)</td>\n<td>98 (±7)</td>\n<td>112 (±7)</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 5.1</td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Sections 5.1 and  5.2</td>\n<td></td>\n</tr>\n<tr>\n<td>Demography</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 5.1</td>\n<td></td>\n</tr>\n<tr>\n<td>Medical and surgical history</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 5.1</td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 6.5</td>\n<td></td>\n</tr>\n<tr>\n<td>Kansas City Cardiomyopathy  Questionnaire   d </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n<td></td>\n</tr>\n<tr>\n<td>Patient global impression of  severity in HF symptoms    d </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n<td></td>\n</tr>\n<tr>\n<td>Patient global impression of  change in HF symptoms    d </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n<td></td>\n</tr>\n<tr>\n<td>Patient global impression of  change in walking ability    d </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n<td></td>\n</tr>\n<tr>\n<td>Dyspnoea, fatigue    d </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n<td></td>\n</tr>\n<tr>\n<td>EQ-5D-5L    d </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n<td></td>\n</tr>\n<tr>\n<td>Overall treatment benefit    d </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.2.1</td>\n<td></td>\n</tr>\n<tr>\n<td>NYHA functional classification</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.5</td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 8.2.2</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03877224_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit</td>\n<td colspan=\"1\" rowspan=\"2\">1 Enrolment</td>\n<td colspan=\"2\" rowspan=\"1\">2 Randomisation</td>\n<td colspan=\"1\" rowspan=\"2\">3</td>\n<td colspan=\"1\" rowspan=\"2\">4   Telephone  call [b]</td>\n<td colspan=\"1\" rowspan=\"2\">5 Final visit</td>\n<td colspan=\"1\" rowspan=\"2\">Early  Withdrawal  Visit OR Early  Treatment  Discontinuation  Visit   [c]</td>\n<td colspan=\"1\" rowspan=\"2\">Details in CSP  section or  Appendix</td>\n<td></td>\n</tr>\n<tr>\n<td>2a Randomisation  A</td>\n<td>2b   Randomisation  B  a </td>\n<td></td>\n</tr>\n<tr>\n<td>Week</td>\n<td>-2 (±1)</td>\n<td>0</td>\n<td>0</td>\n<td>8 (±1)</td>\n<td>14 (±1)</td>\n<td>16 (±1)</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Day (visit window  ±days )</td>\n<td>-14 (±7)</td>\n<td>1</td>\n<td>1</td>\n<td>56 (±7)</td>\n<td>98 (±7)</td>\n<td>112 (±7)</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs: Systolic and  diastolic blood pressure</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.2.3</td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs: Pulse rate</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.2.3</td>\n<td></td>\n</tr>\n<tr>\n<td>Body weight</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.2.4</td>\n<td></td>\n</tr>\n<tr>\n<td>Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 8.2.4</td>\n<td></td>\n</tr>\n<tr>\n<td>Waist circumference</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.2.4</td>\n<td></td>\n</tr>\n<tr>\n<td>6-minute walking test    e, f, g </td>\n<td>X    h </td>\n<td>X    i </td>\n<td>X    j </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.1</td>\n<td></td>\n</tr>\n<tr>\n<td>Central laboratory NT-proBNP,  sodium, potassium,  creatinine/eGFR, haematocrit,  HbA1c</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Sections 8.1.2 &amp;  8.2.5</td>\n<td></td>\n</tr>\n<tr>\n<td>Sample for genetic research (if  consented)</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 8.7;  Appendix D</td>\n<td></td>\n</tr>\n<tr>\n<td>Local pregnancy test using  urine β-hCG (female patients of  child-bearing potential only)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 8.2.5</td>\n<td></td>\n</tr>\n<tr>\n<td>Randomisation</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense IP</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IP dose in clinic for  PK assessment</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X    k </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03877224_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit</td>\n<td colspan=\"1\" rowspan=\"2\">1 Enrolment</td>\n<td colspan=\"2\" rowspan=\"1\">2 Randomisation</td>\n<td colspan=\"1\" rowspan=\"2\">3</td>\n<td colspan=\"1\" rowspan=\"2\">4   Telephone  call [b]</td>\n<td colspan=\"1\" rowspan=\"2\">5 Final visit</td>\n<td colspan=\"1\" rowspan=\"2\">Early  Withdrawal  Visit OR Early  Treatment  Discontinuation  Visit   [c]</td>\n<td colspan=\"1\" rowspan=\"2\">Details in CSP  section or  Appendix</td>\n<td></td>\n</tr>\n<tr>\n<td>2a Randomisation  A</td>\n<td>2b   Randomisation  B  a </td>\n<td></td>\n</tr>\n<tr>\n<td>Week</td>\n<td>-2 (±1)</td>\n<td>0</td>\n<td>0</td>\n<td>8 (±1)</td>\n<td>14 (±1)</td>\n<td>16 (±1)</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Day (visit window  ±days )</td>\n<td>-14 (±7)</td>\n<td>1</td>\n<td>1</td>\n<td>56 (±7)</td>\n<td>98 (±7)</td>\n<td>112 (±7)</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PK blood sampling    l </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X    k </td>\n<td>Section 8.5</td>\n<td></td>\n</tr>\n<tr>\n<td>Wearable activity monitor  dispensed, if applicable    m </td>\n<td>X (Monitor  B #1  dispensed for  immediate  use)</td>\n<td></td>\n<td></td>\n<td>X (Monitor  B #2  dispensed  for  immediate  use; Monitor  B #3  dispensed  for delayed  use at Week  14)</td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 8.1.3</td>\n<td></td>\n</tr>\n<tr>\n<td>Collect wearable activity  monitor, if applicable    m </td>\n<td></td>\n<td>X (Monitor B #1)</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X (Monitors  B #2 &amp;  #3)</td>\n<td>X (any monitors)</td>\n<td>Section 8.1.3</td>\n<td></td>\n</tr>\n<tr>\n<td>Telephone call b reminding patient to wear activity monitor  B #3 and return it at Visit 5  (Final Visit); and to hold IP in  the morning of visit 5 (Final  visit). IP at visit 5 (Final visit)  will be taken at clinic.</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03877224_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit</td>\n<td colspan=\"1\" rowspan=\"2\">1 Enrolment</td>\n<td colspan=\"2\" rowspan=\"1\">2 Randomisation</td>\n<td colspan=\"1\" rowspan=\"2\">3</td>\n<td colspan=\"1\" rowspan=\"2\">4   Telephone  call [b]</td>\n<td colspan=\"1\" rowspan=\"2\">5 Final visit</td>\n<td colspan=\"1\" rowspan=\"2\">Early  Withdrawal  Visit OR Early  Treatment  Discontinuation  Visit   [c]</td>\n<td colspan=\"1\" rowspan=\"2\">Details in CSP  section or  Appendix</td>\n<td></td>\n</tr>\n<tr>\n<td>2a Randomisation  A</td>\n<td>2b   Randomisation  B  a </td>\n<td></td>\n</tr>\n<tr>\n<td>Week</td>\n<td>-2 (±1)</td>\n<td>0</td>\n<td>0</td>\n<td>8 (±1)</td>\n<td>14 (±1)</td>\n<td>16 (±1)</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Day (visit window  ±days )</td>\n<td>-14 (±7)</td>\n<td>1</td>\n<td>1</td>\n<td>56 (±7)</td>\n<td>98 (±7)</td>\n<td>112 (±7)</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Check IP compliance</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collect unused IP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>AEs    n </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Sections 8.3 &amp;  8.4</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03877237_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit</td>\n<td colspan=\"1\" rowspan=\"2\">1 Enrolment</td>\n<td colspan=\"2\" rowspan=\"1\">2 Randomisation</td>\n<td colspan=\"1\" rowspan=\"2\">3</td>\n<td colspan=\"1\" rowspan=\"2\">4   Telephone  call b</td>\n<td colspan=\"1\" rowspan=\"2\">5 Final visit</td>\n<td colspan=\"1\" rowspan=\"2\">Early  Withdrawal  Visit OR Early  Treatment  Discontinuation  Visit   c</td>\n<td colspan=\"1\" rowspan=\"2\">Details in CSP  section or  Appendix</td>\n</tr>\n<tr>\n<td>2a Randomisation  A</td>\n<td>2b   Randomisation  B  a </td>\n</tr>\n<tr>\n<td>Week</td>\n<td>-2 (±1)</td>\n<td>0</td>\n<td>0</td>\n<td>8 (±1)</td>\n<td>14 (±1)</td>\n<td>16 (±1)</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Day (visit window  ±days )</td>\n<td>-14 (±7)</td>\n<td>1</td>\n<td>1</td>\n<td>56 (±7)</td>\n<td>98 (±7)</td>\n<td>112 (±7)</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 5.1</td>\n</tr>\n<tr>\n<td>Inclusion/exclusion criteria</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Sections 5.1 and  5.2</td>\n</tr>\n<tr>\n<td>Demography</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 5.1</td>\n</tr>\n<tr>\n<td>Medical and surgical history</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 5.1</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Section 6.5</td>\n</tr>\n<tr>\n<td>Kansas City Cardiomyopathy  Questionnaire   d </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n</tr>\n<tr>\n<td>Patient global impression of  severity in HF symptoms    d </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n</tr>\n<tr>\n<td>Patient global impression of  change in HF symptoms    d </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n</tr>\n<tr>\n<td>Patient global impression of  change in walking ability    d </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n</tr>\n<tr>\n<td>Dyspnoea, fatigue    d </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n</tr>\n<tr>\n<td>EQ-5D-5L    d </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n</tr>\n<tr>\n<td>Overall treatment benefit    d </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.2</td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.2.1</td>\n</tr>\n<tr>\n<td>NYHA functional classification</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.5</td>\n</tr>\n<tr>\n<td>12-lead ECG </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 8.2.2</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03877237_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit</td>\n<td colspan=\"1\" rowspan=\"2\">1 Enrolment</td>\n<td colspan=\"2\" rowspan=\"1\">2 Randomisation</td>\n<td colspan=\"1\" rowspan=\"2\">3</td>\n<td colspan=\"1\" rowspan=\"2\">4   Telephone  call b</td>\n<td colspan=\"1\" rowspan=\"2\">5 Final visit</td>\n<td colspan=\"1\" rowspan=\"2\">Early  Withdrawal  Visit OR Early  Treatment  Discontinuation  Visit   c</td>\n<td colspan=\"1\" rowspan=\"2\">Details in CSP  section or  Appendix</td>\n</tr>\n<tr>\n<td>2a Randomisation  A</td>\n<td>2b   Randomisation  B  a </td>\n</tr>\n<tr>\n<td>Week</td>\n<td>-2 (±1)</td>\n<td>0</td>\n<td>0</td>\n<td>8 (±1)</td>\n<td>14 (±1)</td>\n<td>16 (±1)</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Day (visit window  ±days )</td>\n<td>-14 (±7)</td>\n<td>1</td>\n<td>1</td>\n<td>56 (±7)</td>\n<td>98 (±7)</td>\n<td>112 (±7)</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs: Systolic and  diastolic blood pressure</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.2.3</td>\n</tr>\n<tr>\n<td>Vital signs: Pulse rate</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.2.3</td>\n</tr>\n<tr>\n<td>Body weight</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.2.4</td>\n</tr>\n<tr>\n<td>Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 8.2.4</td>\n</tr>\n<tr>\n<td>Waist circumference</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.2.4</td>\n</tr>\n<tr>\n<td>6-minute walking test    e, f, g </td>\n<td>X    h </td>\n<td>X    i </td>\n<td>X    j </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Section 8.1.1.1</td>\n</tr>\n<tr>\n<td>Central laboratory NT-proBNP,  sodium, potassium,  creatinine/eGFR, haematocrit,  HbA1c</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>Sections 8.1.2 &amp;  8.2.5</td>\n</tr>\n<tr>\n<td>Sample for genetic research (if  consented)</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 8.7;  Appendix D</td>\n</tr>\n<tr>\n<td>Local pregnancy test using  urine β-hCG (female patients of  child-bearing potential only)</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 8.2.5</td>\n</tr>\n<tr>\n<td>Randomisation</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense IP</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Administer IP dose in clinic for  PK assessment</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X    k </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03877237_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit</td>\n<td colspan=\"1\" rowspan=\"2\">1 Enrolment</td>\n<td colspan=\"2\" rowspan=\"1\">2 Randomisation</td>\n<td colspan=\"1\" rowspan=\"2\">3</td>\n<td colspan=\"1\" rowspan=\"2\">4   Telephone  call b</td>\n<td colspan=\"1\" rowspan=\"2\">5 Final visit</td>\n<td colspan=\"1\" rowspan=\"2\">Early  Withdrawal  Visit OR Early  Treatment  Discontinuation  Visit   c</td>\n<td colspan=\"1\" rowspan=\"2\">Details in CSP  section or  Appendix</td>\n</tr>\n<tr>\n<td>2a Randomisation  A</td>\n<td>2b   Randomisation  B  a </td>\n</tr>\n<tr>\n<td>Week</td>\n<td>-2 (±1)</td>\n<td>0</td>\n<td>0</td>\n<td>8 (±1)</td>\n<td>14 (±1)</td>\n<td>16 (±1)</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Day (visit window  ±days )</td>\n<td>-14 (±7)</td>\n<td>1</td>\n<td>1</td>\n<td>56 (±7)</td>\n<td>98 (±7)</td>\n<td>112 (±7)</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PK blood sampling    l </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X    k </td>\n<td>Section 8.5</td>\n</tr>\n<tr>\n<td>Wearable activity monitor  dispensed, if applicable    m </td>\n<td>X (Monitor  B #1  dispensed for  immediate  use)</td>\n<td></td>\n<td></td>\n<td>X (Monitor  B #2  dispensed  for  immediate  use; Monitor  B #3  dispensed  for delayed  use at Week  14)</td>\n<td></td>\n<td></td>\n<td></td>\n<td>Section 8.1.3</td>\n</tr>\n<tr>\n<td>Collect wearable activity  monitor, if applicable    m </td>\n<td></td>\n<td>X (Monitor B #1)</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X (Monitors  B #2 &amp;  #3)</td>\n<td>X (any monitors)</td>\n<td>Section 8.1.3</td>\n</tr>\n<tr>\n<td>Telephone call reminding  patient to wear activity monitor  B #3 and return it at Visit 5  (Final Visit); and hold IP dose  until at Visit 5 (Final Visit)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Check IP compliance</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Collect unused IP</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03877237_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Visit</td>\n<td colspan=\"1\" rowspan=\"2\">1 Enrolment</td>\n<td colspan=\"2\" rowspan=\"1\">2 Randomisation</td>\n<td colspan=\"1\" rowspan=\"2\">3</td>\n<td colspan=\"1\" rowspan=\"2\">4   Telephone  call b</td>\n<td colspan=\"1\" rowspan=\"2\">5 Final visit</td>\n<td colspan=\"1\" rowspan=\"2\">Early  Withdrawal  Visit OR Early  Treatment  Discontinuation  Visit   c</td>\n<td colspan=\"1\" rowspan=\"2\">Details in CSP  section or  Appendix</td>\n</tr>\n<tr>\n<td>2a Randomisation  A</td>\n<td>2b   Randomisation  B  a </td>\n</tr>\n<tr>\n<td>Week</td>\n<td>-2 (±1)</td>\n<td>0</td>\n<td>0</td>\n<td>8 (±1)</td>\n<td>14 (±1)</td>\n<td>16 (±1)</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Day (visit window  ±days )</td>\n<td>-14 (±7)</td>\n<td>1</td>\n<td>1</td>\n<td>56 (±7)</td>\n<td>98 (±7)</td>\n<td>112 (±7)</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>AEs    n </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>Sections 8.3 &amp;  8.4</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03882970_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Study Period I</td>\n<td colspan=\"20\" rowspan=\"1\">Study Period  II</td>\n<td>Study Period III</td>\n</tr>\n<tr>\n<td>Screening Lead  in</td>\n<td></td>\n<td colspan=\"20\" rowspan=\"1\">Treatment Period</td>\n<td>Safety F/U</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3   a </td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>ET    b </td>\n<td>801</td>\n</tr>\n<tr>\n<td>Week of Treatment</td>\n<td>-3</td>\n<td>-2</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>10</td>\n<td>12</td>\n<td>14</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>46</td>\n<td>52</td>\n<td></td>\n<td>4 weeks Post  End of Tx</td>\n</tr>\n<tr>\n<td>Allowable Deviation  (days)   c </td>\n<td>-</td>\n<td>±3</td>\n<td>±7</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td></td>\n<td>±7</td>\n</tr>\n<tr>\n<td>Fasting Visit   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Telephone Visit</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"24\" rowspan=\"1\">Clinical Assessments</td>\n</tr>\n<tr>\n<td>Medical history   e </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight   f </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Waist circumference</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Electrocardiogram</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs (2 sitting  BP and HR)   g </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Dilated Fundoscopic  Examination   h </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant  medications</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Review hypoglycemic  events collected in  diary</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03882970_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Study Period I</td>\n<td colspan=\"20\" rowspan=\"1\">Study Period  II</td>\n<td>Study Period III</td>\n</tr>\n<tr>\n<td>Screening Lead  in</td>\n<td></td>\n<td colspan=\"20\" rowspan=\"1\">Treatment Period</td>\n<td>Safety F/U</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3   a </td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>ET    b </td>\n<td>801</td>\n</tr>\n<tr>\n<td>Week of Treatment</td>\n<td>-3</td>\n<td>-2</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>10</td>\n<td>12</td>\n<td>14</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>46</td>\n<td>52</td>\n<td></td>\n<td>4 weeks Post  End of Tx</td>\n</tr>\n<tr>\n<td>Allowable Deviation  (days)   c </td>\n<td>-</td>\n<td>±3</td>\n<td>±7</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td></td>\n<td>±7</td>\n</tr>\n<tr>\n<td>Fasting Visit   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Telephone Visit</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"24\" rowspan=\"1\">Patient Education</td>\n</tr>\n<tr>\n<td>Diabetes education   i,j </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>BG meter, SMBG  training   j </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense BG  meter/supplies, as  needed</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Study drug injection  training   j </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hand out diary,  instruct in use   j </td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Remind patients  about 7-point SMBG   k </td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review 7-point  SMBG values  collected in diary</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense study drug</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Observe patient  administer  LY3298176   l </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Patient returns study  drugs and injection </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03882970_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Study Period I</td>\n<td colspan=\"20\" rowspan=\"1\">Study Period  II</td>\n<td>Study Period III</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Screening Lead  in</td>\n<td></td>\n<td colspan=\"20\" rowspan=\"1\">Treatment Period</td>\n<td>Safety F/U</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3   a </td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>ET    b </td>\n<td>801</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Week of Treatment</td>\n<td>-3</td>\n<td>-2</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>10</td>\n<td>12</td>\n<td>14</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>46</td>\n<td>52</td>\n<td></td>\n<td>4 weeks Post  End of Tx</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Allowable Deviation  (days)   c </td>\n<td>-</td>\n<td>±3</td>\n<td>±7</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td></td>\n<td>±7</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Fasting Visit   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Telephone Visit</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"24\" rowspan=\"1\">supplies</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Assess study drug  compliance</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Review insulin dose  and adjustment per  TTT algorithm   m </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Assess compliance  with insulin dose  adjustment TTT  algorithm   n </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03882970_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Study Period I</td>\n<td colspan=\"20\" rowspan=\"1\">Study Period  II</td>\n<td>Study Period III</td>\n</tr>\n<tr>\n<td>Screening Lead  in</td>\n<td></td>\n<td colspan=\"20\" rowspan=\"1\">Treatment Period</td>\n<td>Safety F/U</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3   a </td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>ET    b </td>\n<td>801</td>\n</tr>\n<tr>\n<td>Week of Treatment</td>\n<td>-3</td>\n<td>-2</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>10</td>\n<td>12</td>\n<td>14</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>46</td>\n<td>52</td>\n<td></td>\n<td>4 weeks Post  End of Tx</td>\n</tr>\n<tr>\n<td>Allowable Deviation  (days)   c </td>\n<td>-</td>\n<td>±3</td>\n<td>±7</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td></td>\n<td>±7</td>\n</tr>\n<tr>\n<td>Fasting Visit   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Telephone Visit</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"24\" rowspan=\"1\">Laboratory Tests</td>\n</tr>\n<tr>\n<td>Serum pregnancy test   o </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine pregnancy test   p </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Follicle-stimulating  hormone test   q </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chemistry panel</td>\n<td>X   r </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Fasting serum glucose</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Lipid panel</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urinary albumin/ creatinine ratio</td>\n<td>X   r </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Serum creatinine, eGFR  (CKD-EPI)   s </td>\n<td>X   r </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Calcitonin</td>\n<td>X   r </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td>X   r </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>HbA1c</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pancreatic amylase,  lipase</td>\n<td>X   r </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Immunogenicity   t </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PK sample for  Immunogenicity   u </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Anti-GAD antibody</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"24\" rowspan=\"1\">Stored samples</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03882970_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Study Period I</td>\n<td colspan=\"20\" rowspan=\"1\">Study Period  II</td>\n<td>Study Period III</td>\n</tr>\n<tr>\n<td>Screening Lead  in</td>\n<td></td>\n<td colspan=\"20\" rowspan=\"1\">Treatment Period</td>\n<td>Safety F/U</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3   a </td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n<td>20</td>\n<td>21</td>\n<td>ET    b </td>\n<td>801</td>\n</tr>\n<tr>\n<td>Week of Treatment</td>\n<td>-3</td>\n<td>-2</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>10</td>\n<td>12</td>\n<td>14</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td>46</td>\n<td>52</td>\n<td></td>\n<td>4 weeks Post  End of Tx</td>\n</tr>\n<tr>\n<td>Allowable Deviation  (days)   c </td>\n<td>-</td>\n<td>±3</td>\n<td>±7</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±3</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td>±7</td>\n<td></td>\n<td>±7</td>\n</tr>\n<tr>\n<td>Fasting Visit   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Telephone Visit</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pharmacogenetic stored  sample</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Nonpharmacogenetic  stored samples: EDTA plasma, Serum, P800 plasma-2.0 ml</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"24\" rowspan=\"1\">Patient Reported Outcomes   v </td>\n</tr>\n<tr>\n<td>APPADL</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>EQ-5D-5L</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>IW-SP</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>DTSQs</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>DTSQc</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"4\" rowspan=\"1\">Open-label PK Lead-in </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td colspan=\"4\" rowspan=\"1\">Period 2 </td>\n<td colspan=\"11\" rowspan=\"1\">Period 4 </td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td colspan=\"1\" rowspan=\"14\">Patient  Transitions  Directly to  Visit 9  (Period 4) </td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19 </td>\n</tr>\n<tr>\n<td>Weeks from initiation  of baricitinib  treatment </td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>12</td>\n<td>16</td>\n<td>28</td>\n<td>40</td>\n<td>52</td>\n<td>64</td>\n<td>76</td>\n<td>88</td>\n<td>100</td>\n<td>112</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion and exclusion  criteria review </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed  consent/Assent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical assessments  and general study  procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Substance Use  (alcohol, tobacco use  for patients ≥10 years) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Previous and current  AD treatments </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Height   b </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Vital signs (BP and  Pulse)   b </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Occipital frontal  circumference  measurement in  patients &lt;3 years old </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Physical examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"4\" rowspan=\"1\">Open-label PK Lead-in </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td colspan=\"4\" rowspan=\"1\">Period 2 </td>\n<td colspan=\"11\" rowspan=\"1\">Period 4 </td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td colspan=\"1\" rowspan=\"2\">Patient  Transitions  Directly to  Visit 9  (Period 4) </td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19 </td>\n</tr>\n<tr>\n<td>Weeks from initiation  of baricitinib  treatment </td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>12</td>\n<td>16</td>\n<td>28</td>\n<td>40</td>\n<td>52</td>\n<td>64</td>\n<td>76</td>\n<td>88</td>\n<td>100</td>\n<td>112</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td></td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tanner Staging in  patients ≥8 years old  (see Section 9.4.4.1.) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Symptom-directed  physical exam   c </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>12-lead ECG (single) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TB test   d </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Read PPD if applicable  (48–72 hours post PPD)   e </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pre-existing Conditions </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse Events </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Concomitant  Medication </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>ePRO (patient diary)  dispensed </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ePRO (patient diary)  returned </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Begin treatment with  open-label baricitinib </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IWRS </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>IP tablets dispensed  (patients ≥10 years old) </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>IP suspension  dispensed (patients &lt;10  years old) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_10.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"7\" rowspan=\"1\">Double-blinded Treatment </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment  </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td>Period 3 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period 4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td>15 </td>\n<td>16 </td>\n<td>17 </td>\n<td>18 </td>\n<td>19 </td>\n</tr>\n<tr>\n<td>Weeks from  randomization </td>\n<td></td>\n<td>0 </td>\n<td>1 </td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>16 </td>\n<td>20 </td>\n<td>24 </td>\n<td>28 </td>\n<td>40 </td>\n<td>52 </td>\n<td>64 </td>\n<td>76 </td>\n<td>88 </td>\n<td>100 </td>\n<td>112 </td>\n<td>124 </td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days) </td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tanner Staging in  patients ≥8 years old  (see Section 9.4.4.1.) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Symptom-directed  physical exam   c </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>12-lead ECG (single) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TB test   d </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Read PPD if applicable  (48–72 hours post  PPD)   e </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pre-existing  Conditions </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse Events </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Concomitant  Medication </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>ePRO (patient diary)  dispensed </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ePRO (patient diary)  returned </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IWRS </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>IP tablets dispensed  (patients ≥10 years old) </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>IP suspension  dispensed (patients &lt;10  years old) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>IP returned and  compliance assessed  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_11.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"7\" rowspan=\"1\">Double-blinded Treatment </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment  </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td>Period 3 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period 4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td>15 </td>\n<td>16 </td>\n<td>17 </td>\n<td>18 </td>\n<td>19 </td>\n</tr>\n<tr>\n<td>Weeks from  randomization </td>\n<td></td>\n<td>0 </td>\n<td>1 </td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>16 </td>\n<td>20 </td>\n<td>24 </td>\n<td>28 </td>\n<td>40 </td>\n<td>52 </td>\n<td>64 </td>\n<td>76 </td>\n<td>88 </td>\n<td>100 </td>\n<td>112 </td>\n<td>124 </td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days) </td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense and weigh  (tube with cap) TCS   f </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Weigh (tube with cap)  and record returned  TCS   f </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Scales </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>vIGA-AD </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>EASI </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>SCORAD </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Health Outcomes  Measures and Other  Questionnaires </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>POEM   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>CDLQI /IDQOL   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>DFI   g </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PROMIS-Depression   g </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PROMIS-Anxiety   g </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>EQ-5D-Y   g </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>WPAI-AD-CG   g </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Missed School Days  for school age  children   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PRISM   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Itch NRS   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Skin Pain NRS   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADSS   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PGI-S-AD   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TCS Use   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_12.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"7\" rowspan=\"1\">Double-blinded Treatment </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment  </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td>Period 3 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period 4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td>15 </td>\n<td>16 </td>\n<td>17 </td>\n<td>18 </td>\n<td>19 </td>\n</tr>\n<tr>\n<td>Weeks from  randomization </td>\n<td></td>\n<td>0 </td>\n<td>1 </td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>16 </td>\n<td>20 </td>\n<td>24 </td>\n<td>28 </td>\n<td>40 </td>\n<td>52 </td>\n<td>64 </td>\n<td>76 </td>\n<td>88 </td>\n<td>100 </td>\n<td>112 </td>\n<td>124 </td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days) </td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS and Self-Harm Supplement   h </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Self-Harm Follow-up  Form   i </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Laboratory  Assessments </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical chemistry   j, q </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Hematology   q </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Lipids (fasting)   k, q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>IGF-1 and IGFBP-3   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Left hand x-ray (see  Section 9.4.9.3 for  ongoing patients)   l </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>X-ray of the knee (see  Section 9.4.9.3 for  ongoing patients)   l </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Gonadal hormones  (patients 8 to &lt;18 years  old)   m, q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Serum Pregnancy   n </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TSH </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HIV </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HCV antibody   o </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV testing </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV DNA   p </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urinalysis   q </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urine Pregnancy   n, q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_13.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"7\" rowspan=\"1\">Double-blinded Treatment </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment  </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td>Period 3 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period 4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td>15 </td>\n<td>16 </td>\n<td>17 </td>\n<td>18 </td>\n<td>19 </td>\n</tr>\n<tr>\n<td>Weeks from  randomization </td>\n<td></td>\n<td>0 </td>\n<td>1 </td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>16 </td>\n<td>20 </td>\n<td>24 </td>\n<td>28 </td>\n<td>40 </td>\n<td>52 </td>\n<td>64 </td>\n<td>76 </td>\n<td>88 </td>\n<td>100 </td>\n<td>112 </td>\n<td>124 </td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days) </td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pharmacogenetics:   blood   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum IgE   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Exploratory storage  samples (serum and  plasma)   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>RNA and biomarkers:   blood   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Baricitinib plasma  concentration (PK  sample)   r </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Antipneumococcal IgG  multianalyte Ab assay    * </td>\n<td></td>\n<td></td>\n<td>At relevant visits for prevaccination, 4 weeks post vaccination, and 12 weeks post vaccination  based on the vaccination schedule of each patient.     If patients are eligible for vaccination with tetanus, diphtheria, and pertussis (TDaP) and/or  pneumococcal conjugate vaccine according to local recommended schedule of vaccination, IgG  titers for eligible vaccine will be evaluated at prevaccination, 4 weeks post vaccination, and  12 weeks post vaccination.   * </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Anti-tetanus toxoid IgG,  anti-diphtheria toxoid,  and anti-pertussis toxoid  Ab assay    * </td>\n<td></td>\n<td></td>\n<td>At relevant visits for prevaccination, 4 weeks post vaccination, and 12 weeks post vaccination  based on the vaccination schedule of each patient     If patients are eligible for vaccination with tetanus, diphtheria, and pertussis (TDaP) and/or  pneumococcal conjugate vaccine according to local recommended schedule of vaccination, IgG  titers for eligible vaccine will be evaluated at prevaccination, 4 weeks post vaccination, and  12 weeks post vaccination.   * </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_14.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"12\" rowspan=\"1\">Long-term Extension Treatment  </td>\n<td>PTF/U </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>Period 4 – Extended   (Patients Randomized to Double-Blind Treatment at Visit 2) </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period  5 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>20 </td>\n<td>21 </td>\n<td>22 </td>\n<td>23 </td>\n<td>24 </td>\n<td>25 </td>\n<td>26 </td>\n<td>27   s </td>\n<td>28   s </td>\n<td>29   s </td>\n<td>30   s </td>\n<td>31 /  ET   s,a </td>\n<td>801 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weeks from randomization </td>\n<td>136 </td>\n<td>148 </td>\n<td>160 </td>\n<td>172 </td>\n<td>184 </td>\n<td>196 </td>\n<td>208 </td>\n<td>220 </td>\n<td>232 </td>\n<td>244 </td>\n<td>256 </td>\n<td>268 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance interval (days) </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ±4  after  last  dose </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Height   b </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs (BP and Pulse)   b </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Occipital frontal circumference  measurement in patients &lt;3  years old </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Symptom-directed physical  exam   c </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse Events </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant Medication </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IWRS </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP tablets dispensed (patients  ≥10 years old) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP suspension dispensed  (patients &lt;10 years old) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP returned and compliance  assessed  </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense and weigh (tube with  cap) TCS   f </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weigh (tube with cap) and  record returned TCS   f </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Scales </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>vIGA-AD </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>EASI </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>SCORAD  </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_15.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"12\" rowspan=\"1\">Long-term Extension Treatment  </td>\n<td>PTF/U </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>Period 4 – Extended   (Patients Randomized to Double-Blind Treatment at Visit 2) </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period  5 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>20 </td>\n<td>21 </td>\n<td>22 </td>\n<td>23 </td>\n<td>24 </td>\n<td>25 </td>\n<td>26 </td>\n<td>27   s </td>\n<td>28   s </td>\n<td>29   s </td>\n<td>30   s </td>\n<td>31 /  ET   s,a </td>\n<td>801 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weeks from randomization </td>\n<td>136 </td>\n<td>148 </td>\n<td>160 </td>\n<td>172 </td>\n<td>184 </td>\n<td>196 </td>\n<td>208 </td>\n<td>220 </td>\n<td>232 </td>\n<td>244 </td>\n<td>256 </td>\n<td>268 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance interval (days) </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ±4  after  last  dose </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Health Outcomes Measures and  Other Questionnaires </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>POEM   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CDLQI /IDQOL   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>DFI   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PROMIS-Depression   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PROMIS-Anxiety   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>EQ-5D-Y   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>WPAI-AD-CG   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS and Self-Harm  Supplement   h </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Self-Harm Follow-up Form   i </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Laboratory Assessments </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical chemistry   j </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hematology </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Lipids (fasting)   k </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IGF-1 and IGFBP-3 </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Left hand x-ray (see Section  9.4.9.3 for ongoing patients)   l </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>X-ray of the knee (see Section  9.4.9.3 for ongoing patients)   l </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Gonadal hormones (patients 8  to &lt;18 years old)   m </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV DNA   p </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urinalysis </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_16.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"12\" rowspan=\"1\">Long-term Extension Treatment  </td>\n<td>PTF/U </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 4 – Extended   (Patients Randomized to Double-Blind Treatment at Visit 2) </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period  5 </td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>20 </td>\n<td>21 </td>\n<td>22 </td>\n<td>23 </td>\n<td>24 </td>\n<td>25 </td>\n<td>26 </td>\n<td>27   s </td>\n<td>28   s </td>\n<td>29   s </td>\n<td>30   s </td>\n<td>31 /  ET   s,a </td>\n<td>801 </td>\n</tr>\n<tr>\n<td>Weeks from randomization </td>\n<td>136 </td>\n<td>148 </td>\n<td>160 </td>\n<td>172 </td>\n<td>184 </td>\n<td>196 </td>\n<td>208 </td>\n<td>220 </td>\n<td>232 </td>\n<td>244 </td>\n<td>256 </td>\n<td>268 </td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance interval (days) </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ±4  after  last  dose </td>\n</tr>\n<tr>\n<td>Urine Pregnancy   n </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Serum IgE </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Baricitinib plasma  concentration (PK sample)   r </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Antipneumococcal IgG  multianalyte Ab assay    * </td>\n<td>At relevant visits for prevaccination, 4 weeks post vaccination, and 12 weeks post vaccination based on the  vaccination schedule of each patient.     If patients are eligible for vaccination with tetanus, diphtheria, and pertussis (TDaP) and/or pneumococcal  conjugate vaccine according to local recommended schedule of vaccination, IgG titers for eligible vaccine will  be evaluated at prevaccination, 4 weeks post vaccination, and 12 weeks post vaccination.   * </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Anti-tetanus toxoid IgG, anti-diphtheria toxoid, and anti-pertussis toxoid Ab assay    * </td>\n<td>At relevant visits for prevaccination, 4 weeks post vaccination, and 12 weeks post vaccination based on the  vaccination schedule of each patient.     If patients are eligible for vaccination with tetanus, diphtheria, and pertussis (TDaP) and/or pneumococcal  conjugate vaccine according to local recommended schedule of vaccination, IgG titers for eligible vaccine will  be evaluated at prevaccination, 4 weeks post vaccination, and 12 weeks post vaccination.   * </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_17.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"4\" rowspan=\"1\">Open-label PK Lead-in </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment </td>\n<td>PTF/U </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td>Period 2 </td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period 4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period  5 </td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>Patient  Transitions  Directly to  Visit 9  (Period 4) </td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19/  ET   a </td>\n<td>801</td>\n</tr>\n<tr>\n<td>Weeks from initiation  of baricitinib  treatment </td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td></td>\n<td>4</td>\n<td>12</td>\n<td>16</td>\n<td>28</td>\n<td>40</td>\n<td>52</td>\n<td>64</td>\n<td>76</td>\n<td>88</td>\n<td>10 0</td>\n<td>112</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td></td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ±4  after last  dose </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IWRS </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>IP tablets dispensed  (patients ≥10 years old)     The bottle dispensed  at Visit 2 should be re-dispensed at Visit 3 and  4 (Study Period 2).   * </td>\n<td></td>\n<td>X </td>\n<td>X    * </td>\n<td>X    * </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP suspension  dispensed (patients &lt;10  years old) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_18.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"4\" rowspan=\"1\">Open-label PK Lead-in </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment </td>\n<td>PTF/U </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td colspan=\"4\" rowspan=\"1\">Period 2 </td>\n<td colspan=\"11\" rowspan=\"1\">Period 4 </td>\n<td>Period  5 </td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td colspan=\"1\" rowspan=\"3\">Patient  Transitions  Directly to  Visit 9  (Period 4) </td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19/  ET  [a]</td>\n<td>801</td>\n</tr>\n<tr>\n<td>Weeks from initiation  of baricitinib  treatment </td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>12</td>\n<td>16</td>\n<td>28</td>\n<td>40</td>\n<td>52</td>\n<td>64</td>\n<td>76</td>\n<td>88</td>\n<td>10 0</td>\n<td>112</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ±4  after last  dose </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> TB test  QuantiFERON®-TB  Gold test or T-SPOT® TB test are preferred   d</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Read PPD if applicable  (48–72 hours post  PPD)   PPD test may be used  only for patients  without BCG  vaccination AND for  whom blood volume  restrictions apply.    e</td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_19.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"7\" rowspan=\"1\">Double-blinded Treatment </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment  </td>\n<td>PTF/U </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td>Period 3 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period 4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period 5 </td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td>15 </td>\n<td>16 </td>\n<td>17 </td>\n<td>18 </td>\n<td>19/  ET   a </td>\n<td>801 </td>\n</tr>\n<tr>\n<td>Weeks from  randomization </td>\n<td></td>\n<td>0 </td>\n<td>1 </td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>16 </td>\n<td>20 </td>\n<td>24 </td>\n<td>28 </td>\n<td>40 </td>\n<td>52 </td>\n<td>64 </td>\n<td>76 </td>\n<td>88 </td>\n<td>100 </td>\n<td>112 </td>\n<td>124 </td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days) </td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ±4 after  last dose </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> TB test  QuantiFERON®-TB  Gold test or T-SPOT® TB test are preferred    d </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td> Read PPD if applicable  (48–72 hours post  PPD)   PPD test may be used  only for patients  without BCG  vaccination AND for  whom blood volume  restrictions apply.     e </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"4\" rowspan=\"1\">Open-label PK Lead-in </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td colspan=\"4\" rowspan=\"1\">Period 2 </td>\n<td colspan=\"11\" rowspan=\"1\">Period 4 </td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td colspan=\"1\" rowspan=\"22\">Patient  Transitions  Directly to  Visit 9  (Period 4) </td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19 </td>\n</tr>\n<tr>\n<td>Weeks from initiation  of baricitinib  treatment </td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>12</td>\n<td>16</td>\n<td>28</td>\n<td>40</td>\n<td>52</td>\n<td>64</td>\n<td>76</td>\n<td>88</td>\n<td>100</td>\n<td>112</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP returned and  compliance assessed  </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Dispense and weigh  (tube with cap) TCS   f </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Weigh (tube with cap)  and record returned  TCS   f </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Scales </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>vIGA-AD </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>EASI </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>SCORAD </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Health Outcomes  Measures and Other  Questionnaires</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>POEM   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>CDLQI /IDQOL   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>DFI   g </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PROMIS-Depression   g </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>PROMIS-Anxiety   g </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>EQ-5D-Y   g </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>WPAI-AD-CG   g </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Missed School Days  for school age  children   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PRISM   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Itch NRS   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_20.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening</td>\n<td colspan=\"7\" rowspan=\"1\">Double-blinded Treatment</td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1</td>\n<td>Period 3</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period 4</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19</td>\n</tr>\n<tr>\n<td>Weeks from  randomization</td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>8</td>\n<td>12</td>\n<td>16</td>\n<td>20</td>\n<td>24</td>\n<td>28</td>\n<td>40</td>\n<td>52</td>\n<td>64</td>\n<td>76</td>\n<td>88</td>\n<td>100</td>\n<td>112</td>\n<td>124</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Laboratory  Assessments </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum Pregnancy   n </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_21.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"12\" rowspan=\"1\">Long-term Extension Treatment  </td>\n<td>PTF/U </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>Period 4 – Extended   (Patients Randomized to Double-Blind Treatment at Visit 2) </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period 5 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>20 </td>\n<td>21 </td>\n<td>22 </td>\n<td>23 </td>\n<td>24 </td>\n<td>25 </td>\n<td>26 </td>\n<td>27   s </td>\n<td>28   s </td>\n<td>29   s </td>\n<td>30   s </td>\n<td>31 /ET   s,a </td>\n<td>801 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weeks from randomization </td>\n<td>136 </td>\n<td>148 </td>\n<td>160 </td>\n<td>172 </td>\n<td>184 </td>\n<td>196 </td>\n<td>208 </td>\n<td>220 </td>\n<td>232 </td>\n<td>244 </td>\n<td>256 </td>\n<td>268 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance interval (days) </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ±4 after  last dose </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination   u </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>12-lead ECG (single) </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Left hand x-ray   l </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tibial length measurement </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>MRI of the knee (or x-ray of the knee if  MRI is not possible)   l, t </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"4\" rowspan=\"1\">Open-label PK Lead-in </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td colspan=\"4\" rowspan=\"1\">Period 2 </td>\n<td colspan=\"11\" rowspan=\"1\">Period 4 </td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td colspan=\"1\" rowspan=\"20\">Patient  Transitions  Directly to  Visit 9  (Period 4) </td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19 </td>\n</tr>\n<tr>\n<td>Weeks from initiation  of baricitinib  treatment </td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>4</td>\n<td>12</td>\n<td>16</td>\n<td>28</td>\n<td>40</td>\n<td>52</td>\n<td>64</td>\n<td>76</td>\n<td>88</td>\n<td>100</td>\n<td>112</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Skin Pain NRS   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ADSS   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PGI-S-AD   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TCS Use   g </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Palatability and  Acceptability </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X   g </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS and Self-Harm  Supplement   h </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Self-Harm Follow-up  Form   i </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Laboratory  Assessments </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical chemistry   j, q </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Hematology   q </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Lipids (fasting)   k, q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>IGF-1 and IGFBP-3   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Left hand x-ray (see  Section 9.4.9.3 for  ongoing patients)   l </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>X-ray of the knee  (see Section 9.4.9.3 for  ongoing patients)   l </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Gonadal hormones  (patients 8 to &lt;18 years  old)   m, q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n</tr>\n<tr>\n<td>Serum Pregnancy   n </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"4\" rowspan=\"1\">Open-label PK Lead-in </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td colspan=\"4\" rowspan=\"1\">Period 2 </td>\n<td colspan=\"11\" rowspan=\"1\">Period 4 </td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n<td>Patient  Transitions  Directly to  Visit 9  (Period 4) </td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>15</td>\n<td>16</td>\n<td>17</td>\n<td>18</td>\n<td>19 </td>\n</tr>\n<tr>\n<td>Weeks from initiation  of baricitinib  treatment </td>\n<td></td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td></td>\n<td>4</td>\n<td>12</td>\n<td>16</td>\n<td>28</td>\n<td>40</td>\n<td>52</td>\n<td>64</td>\n<td>76</td>\n<td>88</td>\n<td>100</td>\n<td>112</td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days)</td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td></td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>TSH </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HIV </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HCV antibody   o </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV testing </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV DNA   p </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urinalysis   q </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urine Pregnancy   n, q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Pharmacogenetics:   blood   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum IgE   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Exploratory storage  samples (serum and  plasma)   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>RNA and biomarkers:   blood   q </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Baricitinib plasma  concentration (PK  sample)   r </td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Antipneumococcal IgG  multianalyte Ab assay    * </td>\n<td></td>\n<td></td>\n<td colspan=\"14\" rowspan=\"1\">At relevant visits for prevaccination, 4 weeks post vaccination, and 12 weeks post vaccination based on  the vaccination schedule of each patient.     If patients are eligible for vaccination with tetanus, diphtheria, and pertussis (TDaP) and/or  pneumococcal conjugate vaccine according to local recommended schedule of vaccination, IgG titers  for eligible vaccine will be evaluated at prevaccination, 4 weeks post vaccination, and 12 weeks post  vaccination.   * </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_5.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"12\" rowspan=\"1\">Long-term Extension Treatment </td>\n<td>PTF/U </td>\n</tr>\n<tr>\n<td></td>\n<td colspan=\"12\" rowspan=\"1\">Period 4 – Extended (PK Lead-in Patients) </td>\n<td>Period  5 </td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>20</td>\n<td>21</td>\n<td>22</td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27   s </td>\n<td>28   s </td>\n<td>29   s </td>\n<td>30   s </td>\n<td>31 /  ET   s,a </td>\n<td>801</td>\n</tr>\n<tr>\n<td>Weeks from initiation of baricitinib treatment </td>\n<td>124</td>\n<td>136 </td>\n<td>148 </td>\n<td>160 </td>\n<td>172 </td>\n<td>184 </td>\n<td>196 </td>\n<td>208 </td>\n<td>220 </td>\n<td>232 </td>\n<td>244 </td>\n<td>256 </td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance interval (days)</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ± 4  after last  dose </td>\n</tr>\n<tr>\n<td>Clinical assessments and general study  procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Height   b </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs (BP and Pulse)   b </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Occipital frontal circumference measurement in  patients &lt;3 years old </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Symptom-directed physical exam   c </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Adverse Events </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_6.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"12\" rowspan=\"1\">Long-term Extension Treatment </td>\n<td>PTF/U </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td>Period 4 – Extended (PK Lead-in Patients) </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period  5 </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>20</td>\n<td>21</td>\n<td>22</td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27   s </td>\n<td>28   s </td>\n<td>29   s </td>\n<td>30   s </td>\n<td>31 /  ET   s,a </td>\n<td>801</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weeks from initiation of baricitinib treatment </td>\n<td>124</td>\n<td>136 </td>\n<td>148 </td>\n<td>160 </td>\n<td>172 </td>\n<td>184 </td>\n<td>196 </td>\n<td>208 </td>\n<td>220 </td>\n<td>232 </td>\n<td>244 </td>\n<td>256 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance interval (days)</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ± 4  after last  dose </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical assessments and general study  procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Concomitant Medication </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IWRS </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP tablets dispensed (patients ≥10 years old) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP suspension dispensed (patients &lt;10 years old) </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>IP returned and compliance assessed  </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense and weigh (tube with cap) TCS   f </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weigh (tube with cap) and record returned TCS   f </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Scales </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>vIGA-AD </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>EASI </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>SCORAD </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Health Outcomes Measures and Other  Questionnaires</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>POEM   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CDLQI /IDQOL   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>DFI   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PROMIS-Depression   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>PROMIS-Anxiety   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>EQ-5D-Y   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>WPAI-AD-CG   g </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>C-SSRS and Self-Harm Supplement   h </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Self-Harm Follow-up Form    i </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_7.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"12\" rowspan=\"1\">Long-term Extension Treatment </td>\n<td>PTF/U </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 4 – Extended (PK Lead-in Patients) </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period  5 </td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>20</td>\n<td>21</td>\n<td>22</td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27   s </td>\n<td>28   s </td>\n<td>29   s </td>\n<td>30   s </td>\n<td>31 /  ET   s,a </td>\n<td>801</td>\n</tr>\n<tr>\n<td>Weeks from initiation of baricitinib treatment </td>\n<td>124</td>\n<td>136 </td>\n<td>148 </td>\n<td>160 </td>\n<td>172 </td>\n<td>184 </td>\n<td>196 </td>\n<td>208 </td>\n<td>220 </td>\n<td>232 </td>\n<td>244 </td>\n<td>256 </td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance interval (days)</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ± 4  after last  dose </td>\n</tr>\n<tr>\n<td>Clinical assessments and general study  procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Laboratory Assessments</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical chemistry   j </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Hematology </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Lipids (fasting)   k </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n</tr>\n<tr>\n<td>IGF-1 and IGFBP-3 </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Left hand x-ray (see Section 9.4.9.3 for ongoing  patients)   l </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>X-ray of the knee  (see Section 9.4.9.3 for ongoing patients)   l </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Gonadal hormones (patients 8 to &lt;18 years old)   m </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>HBV DNA   p </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urinalysis </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td>X  </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Urine Pregnancy   n </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Serum IgE </td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Antipneumococcal IgG multianalyte Ab assay    * </td>\n<td>At relevant visits for prevaccination, 4 weeks post vaccination, and 12 weeks post vaccination  based on the vaccination schedule of each patient.     If patients are eligible for vaccination with tetanus, diphtheria, and pertussis (TDaP) and/or  pneumococcal conjugate vaccine according to local recommended schedule of vaccination,  IgG titers for eligible vaccine will be evaluated at prevaccination, 4 weeks post vaccination,  and 12 weeks post vaccination.   * </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_8.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"12\" rowspan=\"1\">Long-term Extension Treatment </td>\n<td>PTF/U </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 4 – Extended (PK Lead-in Patients) </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period  5 </td>\n</tr>\n<tr>\n<td>Visit number</td>\n<td>20</td>\n<td>21</td>\n<td>22</td>\n<td>23</td>\n<td>24</td>\n<td>25</td>\n<td>26</td>\n<td>27   s </td>\n<td>28   s </td>\n<td>29   s </td>\n<td>30   s </td>\n<td>31 /  ET   s,a </td>\n<td>801</td>\n</tr>\n<tr>\n<td>Weeks from initiation of baricitinib treatment </td>\n<td>124</td>\n<td>136 </td>\n<td>148 </td>\n<td>160 </td>\n<td>172 </td>\n<td>184 </td>\n<td>196 </td>\n<td>208 </td>\n<td>220 </td>\n<td>232 </td>\n<td>244 </td>\n<td>256 </td>\n<td></td>\n</tr>\n<tr>\n<td>Visit tolerance interval (days)</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>28 ± 4  after last  dose </td>\n</tr>\n<tr>\n<td>Clinical assessments and general study  procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Anti-tetanus toxoid IgG, anti-diphtheria toxoid, and  anti-pertussis toxoid Ab assay    * </td>\n<td>At relevant visits for prevaccination, 4 weeks post vaccination, and 12 weeks post vaccination  based on the vaccination schedule of each patient.     If patients are eligible for vaccination with tetanus, diphtheria, and pertussis (TDaP) and/or  pneumococcal conjugate vaccine according to local recommended schedule of vaccination,  IgG titers for eligible vaccine will be evaluated at prevaccination, 4 weeks post vaccination,  and 12 weeks post vaccination.   * </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03952559_SOA_table_9.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td>Screening </td>\n<td colspan=\"7\" rowspan=\"1\">Double-blinded Treatment </td>\n<td colspan=\"11\" rowspan=\"1\">Long-term Extension Treatment  </td>\n</tr>\n<tr>\n<td></td>\n<td>Period 1 </td>\n<td>Period 3 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>Period 4 </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Visit number </td>\n<td>1 </td>\n<td>2 </td>\n<td>3 </td>\n<td>4 </td>\n<td>5 </td>\n<td>6 </td>\n<td>7 </td>\n<td>8 </td>\n<td>9 </td>\n<td>10 </td>\n<td>11 </td>\n<td>12 </td>\n<td>13 </td>\n<td>14 </td>\n<td>15 </td>\n<td>16 </td>\n<td>17 </td>\n<td>18 </td>\n<td>19 </td>\n</tr>\n<tr>\n<td>Weeks from  randomization </td>\n<td></td>\n<td>0 </td>\n<td>1 </td>\n<td>2 </td>\n<td>4 </td>\n<td>8 </td>\n<td>12 </td>\n<td>16 </td>\n<td>20 </td>\n<td>24 </td>\n<td>28 </td>\n<td>40 </td>\n<td>52 </td>\n<td>64 </td>\n<td>76 </td>\n<td>88 </td>\n<td>100 </td>\n<td>112 </td>\n<td>124 </td>\n</tr>\n<tr>\n<td>Visit tolerance  interval (days) </td>\n<td>-8 to -35 </td>\n<td></td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±2 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±4 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7</td>\n<td>±7 </td>\n<td>±7 </td>\n<td>±7 </td>\n</tr>\n<tr>\n<td>Procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion and  exclusion criteria  review </td>\n<td>X </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed  consent/Assent </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinical assessments  and general study  procedures </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics  </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical History </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Substance Use  (alcohol, tobacco use  for patients ≥10 years  old) </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Previous and current  AD treatments </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Height   b </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Vital signs (BP and  Pulse)   b </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Occipital frontal  circumference  measurement in  patients &lt;3 years old </td>\n<td></td>\n<td>X </td>\n<td></td>\n<td></td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n<td>X </td>\n</tr>\n<tr>\n<td>Physical examination </td>\n<td>X </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03954743_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Age </td>\n<td>6-12  weeks </td>\n<td>3-5  months </td>\n<td>4-7  months </td>\n<td>9-11  months </td>\n<td>Notes </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Epoch </td>\n<td colspan=\"4\" rowspan=\"1\">Epoch 001</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Type of contact </td>\n<td>Visit 1 </td>\n<td>Visit 2 </td>\n<td>Visit 3 /   [*,**]</td>\n<td>ESFU </td>\n<td colspan=\"1\" rowspan=\"2\">Refer to Section 8.4 for study procedures to be considered during  special circumstances (Amended 30 March 2020)</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Timepoints </td>\n<td>Day 1</td>\n<td>Month 1-2</td>\n<td>Month 2-4</td>\n<td>Month 7-8</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent </td>\n<td>●</td>\n<td></td>\n<td></td>\n<td></td>\n<td>(See Section 12.2.3 for details)  </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Check inclusion/exclusion criteria </td>\n<td>●</td>\n<td></td>\n<td></td>\n<td></td>\n<td>Recheck clinical status before randomization and/or first dose of study  treatment (See Section 6.1 and 6.2 for inclusion and exclusion criteria) </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Collect demographic data </td>\n<td>●</td>\n<td></td>\n<td></td>\n<td></td>\n<td>(See Section 8.2.1 for more information) </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record gestational age at birth </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history </td>\n<td>●</td>\n<td></td>\n<td></td>\n<td></td>\n<td>(See Section 8.2.2 for more information) </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination </td>\n<td>●</td>\n<td></td>\n<td></td>\n<td></td>\n<td>Physical examination at each study visit subsequent to the first vaccination  visit, will be performed only if the subjects’ parent(s)/LAR(s) indicates  during questioning that there might be some underlying pathology(ies) or if  deemed necessary by the investigator or delegate. Physical examination  information will not be captured in the eCRF for study visits subsequent to  the first vaccination visit. (See Section 8.2.3 for more information) </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>History of previous vaccination history from birth </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td></td>\n<td>(See Section 8.2.2 for more information)  </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pre-vaccination body temperature </td>\n<td>● </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td>(See Section 8.2.4 for more information) </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Measure/record length and weight </td>\n<td>●</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"6\" rowspan=\"1\">Vaccines</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Check criteria for temporary delay for enrollment and  vaccination </td>\n<td>O </td>\n<td>O </td>\n<td></td>\n<td></td>\n<td>(See Section 6.3 for more information) </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td></td>\n<td>(See Section 7.2.2.2.1 for more information) </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Treatment number allocation for subsequent doses  </td>\n<td></td>\n<td>● </td>\n<td></td>\n<td></td>\n<td>(See Section 7.2.2.2.2 for more information) </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Check contraindications and warnings and precautions </td>\n<td>● </td>\n<td>●</td>\n<td></td>\n<td></td>\n<td>(See Section 7.6 and 7.7 for more information) </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of administered treatment number </td>\n<td>● </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccine administration </td>\n<td>● </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td>Two oral doses of the study vaccines will be administered at 1-month to 2-months interval to subjects. (See Section 7.1 for more information) </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Record regurgitation/vomiting </td>\n<td>● </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td>Any regurgitation or vomiting by the subjects after study vaccine  administration should be recorded in the eCRF. </td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03954743_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Age </td>\n<td>6-12  weeks </td>\n<td>3-5  months </td>\n<td>4-7  months </td>\n<td>9-11  months </td>\n<td>Notes </td>\n<td></td>\n</tr>\n<tr>\n<td>Epoch </td>\n<td colspan=\"4\" rowspan=\"1\">Epoch 001</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Type of contact </td>\n<td>Visit 1 </td>\n<td>Visit 2 </td>\n<td>Visit 3 /   [*,**]</td>\n<td>ESFU </td>\n<td colspan=\"1\" rowspan=\"2\">Refer to Section 8.4 for study procedures to be considered during  special circumstances (Amended 30 March 2020)</td>\n<td></td>\n</tr>\n<tr>\n<td>Timepoints </td>\n<td>Day 1</td>\n<td>Month 1-2</td>\n<td>Month 2-4</td>\n<td>Month 7-8</td>\n<td></td>\n</tr>\n<tr>\n<td>Vaccine replacement dose administration in case of  regurgitation/vomiting </td>\n<td>● </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td>If regurgitation or vomiting, which may have impaired vaccine take, occurs  within 30 minutes after vaccination, a single replacement dose may be  given at the same vaccination visit at the discretion of the investigator.  This information should be recorded in the eCRF. The subject should  continue to participate in the study. </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"6\" rowspan=\"1\">Safety assessments</td>\n<td></td>\n</tr>\n<tr>\n<td>Record any concomitant medications/vaccinations </td>\n<td>● </td>\n<td>● </td>\n<td>● </td>\n<td></td>\n<td>Concomitant administration of routine pediatric vaccines will be allowed  according to the local immunization practices in each participating country.  All concomitant vaccinations given during the study period will be recorded  in the eCRF (See Section 7.5 for more information) </td>\n<td></td>\n</tr>\n<tr>\n<td>Distribution of diary cards</td>\n<td>O </td>\n<td>O </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of solicited AEs within 8 days after each  vaccination (Day 1-Day 8) by subjects’ parent(s)/LAR(s) in  diary card </td>\n<td>● </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td>(See Section 12.3.6 for more information) </td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of non-serious unsolicited AEs within 31 days  after each vaccination (Day 1-Day 31) by subjects’  parent(s)/LAR(s) in diary card.</td>\n<td>● </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td>(See Section 12.3.6 for more information) </td>\n<td></td>\n</tr>\n<tr>\n<td>Return of diary cards</td>\n<td></td>\n<td>O </td>\n<td>O </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diary card transcription by the investigator or designee </td>\n<td></td>\n<td>● </td>\n<td>● </td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of AEs/SAEs leading to withdrawal from study</td>\n<td>● </td>\n<td>● </td>\n<td>● </td>\n<td>● </td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of SAEs </td>\n<td>● </td>\n<td>● </td>\n<td>● </td>\n<td>● </td>\n<td>(See Section 12.3.6 for more information) </td>\n<td></td>\n</tr>\n<tr>\n<td>Recording of SAEs related to study participation, or to a  concurrent GSK medication/vaccine </td>\n<td>● </td>\n<td>● </td>\n<td>● </td>\n<td>● </td>\n<td>(See Section 12.3.6 for more information) </td>\n<td></td>\n</tr>\n<tr>\n<td>Safety contact </td>\n<td></td>\n<td></td>\n<td></td>\n<td>● </td>\n<td>A safety follow-up contact will be done by a telephone call or any other  convenient procedure to collect information on SAEs and medication taken  for treatment of SAEs. </td>\n<td></td>\n</tr>\n<tr>\n<td>Study conclusion </td>\n<td></td>\n<td></td>\n<td></td>\n<td>● </td>\n<td>(See Section 5.4 for more information) </td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03954743_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Study activity </td>\n<td colspan=\"1\" rowspan=\"2\">Pre-V  *</td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>V1  Dose 1 </td>\n<td>7 days  Post-V1 </td>\n<td>30  days   Post-V1 </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>V2  Dose 2 </td>\n<td>7 days  Post-V2 </td>\n<td>30  days   Post-V2 </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td>V3 (30  days after  the last  dose) </td>\n<td></td>\n<td>ESFU (Study  conclusion) </td>\n</tr>\n<tr>\n<td>Day 1 </td>\n<td></td>\n<td></td>\n<td>Month 1-2</td>\n<td></td>\n<td></td>\n<td>Month 2-4</td>\n<td></td>\n<td>Month 7-8 </td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Solicited general  AEs </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td></td>\n<td></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td></td>\n<td></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Unsolicited AEs </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td></td>\n<td></td>\n<td></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">AEs/SAEs  leading to  withdrawal </td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>SAEs  </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">SAEs related to  study participation or  GSK concurrent  medication/vaccine </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03954834_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Study Period I</td>\n<td colspan=\"13\" rowspan=\"1\">Study Period II</td>\n<td>Study Period III</td>\n</tr>\n<tr>\n<td>Screening/leading</td>\n<td></td>\n<td colspan=\"13\" rowspan=\"1\">Treatment Period</td>\n<td>Safety F/U</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3    a</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>ET   b</td>\n<td>801</td>\n</tr>\n<tr>\n<td>Week of Treatment</td>\n<td>-3</td>\n<td>-2</td>\n<td>0</td>\n<td>4</td>\n<td>7</td>\n<td>8</td>\n<td>12</td>\n<td>15</td>\n<td>16</td>\n<td>20</td>\n<td>23</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td></td>\n<td>4 weeks post end of tx</td>\n</tr>\n<tr>\n<td>Allowable Deviations(days)  c</td>\n<td></td>\n<td>± 3</td>\n<td>± 7</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 7</td>\n<td>± 7</td>\n<td></td>\n<td>± 7</td>\n</tr>\n<tr>\n<td>Fasting Vist   d</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PK Specific Vist    e</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Randomization</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"17\" rowspan=\"1\">Clinical Assessments</td>\n</tr>\n<tr>\n<td>Medical history   f</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Physical</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight   g</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Waist cirumference</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Electrocardiogram   h</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs(2 sitting BP and HR)   i</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Dilated fundoscopic Examination   i</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Review hypoglycemic events collected in the diaries</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03954834_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Study Period I</td>\n<td colspan=\"13\" rowspan=\"1\">Study Period II</td>\n<td>Study Period III</td>\n</tr>\n<tr>\n<td>Screening/leading</td>\n<td></td>\n<td colspan=\"13\" rowspan=\"1\">Treatment Period</td>\n<td>Safety F/U</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3    a</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>ET   b</td>\n<td>801</td>\n</tr>\n<tr>\n<td>Week of Treatment</td>\n<td>-3</td>\n<td>-2</td>\n<td>0</td>\n<td>4</td>\n<td>7</td>\n<td>8</td>\n<td>12</td>\n<td>15</td>\n<td>16</td>\n<td>20</td>\n<td>23</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td></td>\n<td>4 weeks post end of tx</td>\n</tr>\n<tr>\n<td>Allowable Deviations(days)  c</td>\n<td></td>\n<td>± 3</td>\n<td>± 7</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 7</td>\n<td>± 7</td>\n<td></td>\n<td>± 7</td>\n</tr>\n<tr>\n<td>Fasting Vist   d</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PK Specific Vist    e</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diabetes education   k,l</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>BG meter, SMBG training   m</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense BG meter/supplies as needed</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Study drug injection training with demo device</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hand out diaries, instruct in use  l</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Remind patients about 7-point SMBG  m</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Review 7-point SMBG values collected in the diaries</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03954834_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Study Period I</td>\n<td colspan=\"13\" rowspan=\"1\">Study Period II</td>\n<td>Study Period III</td>\n</tr>\n<tr>\n<td>Screening/leading</td>\n<td></td>\n<td colspan=\"13\" rowspan=\"1\">Treatment Period</td>\n<td>Safety F/U</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3    a</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>ET   b</td>\n<td>801</td>\n</tr>\n<tr>\n<td>Week of Treatment</td>\n<td>-3</td>\n<td>-2</td>\n<td>0</td>\n<td>4</td>\n<td>7</td>\n<td>8</td>\n<td>12</td>\n<td>15</td>\n<td>16</td>\n<td>20</td>\n<td>23</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td></td>\n<td>4 weeks post end of tx</td>\n</tr>\n<tr>\n<td>Allowable Deviations(days)  c</td>\n<td></td>\n<td>± 3</td>\n<td>± 7</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 7</td>\n<td>± 7</td>\n<td></td>\n<td>± 7</td>\n</tr>\n<tr>\n<td>Fasting Vist   d</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PK Specific Vist    e</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Diespense study drug</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Observe patient adiminister study drug</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>patient returns study drugs and injection supplies</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Assess study drug compliance</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03954834_SOA_table_3.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Study Period I</td>\n<td colspan=\"13\" rowspan=\"1\">Study Period II</td>\n<td>Study Period III</td>\n</tr>\n<tr>\n<td>Screening/leading</td>\n<td></td>\n<td colspan=\"13\" rowspan=\"1\">Treatment Period</td>\n<td>Safety F/U</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3    a</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>ET   b</td>\n<td>801</td>\n</tr>\n<tr>\n<td>Week of Treatment</td>\n<td>-3</td>\n<td>-2</td>\n<td>0</td>\n<td>4</td>\n<td>7</td>\n<td>8</td>\n<td>12</td>\n<td>15</td>\n<td>16</td>\n<td>20</td>\n<td>23</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td></td>\n<td>4 weeks post end of tx</td>\n</tr>\n<tr>\n<td>Allowable Deviations(days)  c</td>\n<td></td>\n<td>± 3</td>\n<td>± 7</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 7</td>\n<td>± 7</td>\n<td></td>\n<td>± 7</td>\n</tr>\n<tr>\n<td>Fasting Vist   d</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PK Specific Vist    e</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Laboratory Tests</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Serum pregnancy test   o</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine pregnancy test    p</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Folicle-stimulating hormone test, estradiol     q</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Chemistry pannel</td>\n<td>X  r</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Fasting serum glucose</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Fasting insulin</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Fasting glucagon</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Fasting C-peptide</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Lipid panel</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urinary albumin/creatinine ratio</td>\n<td>X  r</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Serum creatinine, eGFR (CKD-EPI)    s</td>\n<td>X  r</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Calcitonin</td>\n<td>X  r</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td>X  r</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>HbA1c</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Pancreatic amylase, lipase</td>\n<td>X  r</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Immunogenicity    t</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PK sample for immunogenicity   u</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03954834_SOA_table_4.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\"></td>\n<td colspan=\"2\" rowspan=\"1\">Study Period I</td>\n<td colspan=\"13\" rowspan=\"1\">Study Period II</td>\n<td>Study Period III</td>\n</tr>\n<tr>\n<td>Screening/leading</td>\n<td></td>\n<td colspan=\"13\" rowspan=\"1\">Treatment Period</td>\n<td>Safety F/U</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3    a</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>7</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11</td>\n<td>12</td>\n<td>13</td>\n<td>14</td>\n<td>ET   b</td>\n<td>801</td>\n</tr>\n<tr>\n<td>Week of Treatment</td>\n<td>-3</td>\n<td>-2</td>\n<td>0</td>\n<td>4</td>\n<td>7</td>\n<td>8</td>\n<td>12</td>\n<td>15</td>\n<td>16</td>\n<td>20</td>\n<td>23</td>\n<td>24</td>\n<td>32</td>\n<td>40</td>\n<td></td>\n<td>4 weeks post end of tx</td>\n</tr>\n<tr>\n<td>Allowable Deviations(days)  c</td>\n<td></td>\n<td>± 3</td>\n<td>± 7</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 3</td>\n<td>-</td>\n<td>± 3</td>\n<td>± 7</td>\n<td>± 7</td>\n<td></td>\n<td>± 7</td>\n</tr>\n<tr>\n<td>Fasting Vist   d</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PK Specific Vist    e</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Stored Example</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Tirzepatide PK   v</td>\n<td></td>\n<td></td>\n<td>X   w</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X  x</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Pharmacogenetic stored sample</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Nonpharmacogenetic stored sample EDTA plasma-2.0 mL</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Patient-Reported Outcomes   y</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>APPADL</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>EQ-5D-5L</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>IW-SP</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03961204_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessments &amp; Procedures</td>\n<td>Screening</td>\n<td>Study Visit 1</td>\n<td>Study Visit 2</td>\n<td>Notes</td>\n</tr>\n<tr>\n<td></td>\n<td>Within 2 weeks of Screening                        (in case of relapse: 4 weeks to 3 months)</td>\n<td>Within 3 months of Study Visit 1 a</td>\n<td></td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion and exclusion criteria</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Sociodemographic and clinical characteristics\n</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">Prospective data collection</td>\n</tr>\n<tr>\n<td>Physical examination including vital signs</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Expanded Disability Status Scale (EDSS): In-person (clinic vist) or telephone (remote visit only) b</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03961204_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessments &amp; Procedures</td>\n<td>Screening</td>\n<td>Study Visit 1</td>\n<td>Study Visit 2</td>\n<td>Notes</td>\n</tr>\n<tr>\n<td></td>\n<td>Within 2 weeks of Screening                        (in case of relapse: 4 weeks to 3 months)</td>\n<td>Within 3 months of Study Visit 1 a</td>\n<td></td>\n</tr>\n<tr>\n<td>EuroQoL-5 Dimensions (EQ-5D-3L)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Brief Visuospatial Memory Test Revised (BVMT-R)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Symbol Digit Modalities Test (SDMT)</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Optional blood sample for pharmacogenetic testing</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse events and concomitant medications</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>End of study form c</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td colspan=\"4\" rowspan=\"1\">Retrospective data collection (based on chart review)</td>\n</tr>\n<tr>\n<td>Medical and disease history</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>EDSS from end of parent study to Study Visit 1</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Details of subsequent Disease Modifying Drugs (DMDs), including physician questions on treatment decisions</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Date of first use of an ambulatory device or wheelchair</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03961204_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Assessments &amp; Procedures</td>\n<td>Screening</td>\n<td>Study Visit 1</td>\n<td colspan=\"2\" rowspan=\"1\">Study Visit 2</td>\n<td>Notes</td>\n</tr>\n<tr>\n<td></td>\n<td>Within 2 weeks of Screening                        (in case of relapse: 4 weeks to 3 months)</td>\n<td colspan=\"2\" rowspan=\"1\">Within 3 months of Study Visit 1 a</td>\n<td></td>\n</tr>\n<tr>\n<td>Date of first time bedridden</td>\n<td></td>\n<td>X</td>\n<td colspan=\"2\" rowspan=\"1\"></td>\n<td></td>\n</tr>\n<tr>\n<td>Relapse history from end of parent study to Study Visit 1</td>\n<td></td>\n<td>X</td>\n<td colspan=\"2\" rowspan=\"1\"></td>\n<td></td>\n</tr>\n<tr>\n<td>Secondary Progressive Multiple Sclerosis (SPMS) diagnosis</td>\n<td></td>\n<td>X</td>\n<td colspan=\"2\" rowspan=\"1\"></td>\n<td></td>\n</tr>\n<tr>\n<td>Clinically Definite Multiple Sclerosis (CDMS) conversion</td>\n<td></td>\n<td>X</td>\n<td colspan=\"2\" rowspan=\"1\"></td>\n<td></td>\n</tr>\n<tr>\n<td>Primary Progressive Multiple Sclerosis (PPMS) diagnosis</td>\n<td></td>\n<td>X</td>\n<td colspan=\"2\" rowspan=\"1\"></td>\n<td></td>\n</tr>\n<tr>\n<td>Adverse drug reactions related to Cladribine Tablets</td>\n<td></td>\n<td>X</td>\n<td colspan=\"2\" rowspan=\"1\"></td>\n<td></td>\n</tr>\n<tr>\n<td></td>\n<td colspan=\"5\" rowspan=\"1\">MRI sub-study</td>\n</tr>\n<tr>\n<td>Urine pregnancy test</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Magnetic Resources Imaging (MRI) assessment</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03961529_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td></td>\n<td colspan=\"8\" rowspan=\"1\">Table 3.7-1 Schedule of Assessments</td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"2\">Evaluation </td>\n<td>Screening period  (2–30 days)</td>\n<td></td>\n<td>Assessment period  (52 weeks)</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Screening  examination</td>\n<td>Baseline  examination</td>\n<td>Week 2  examination</td>\n<td>Week 4, 8, 12,  16, 20, 28, 32,  36, 40, 44, and  48 examination</td>\n<td>Week 24  examination</td>\n<td>Week 52  examination Withdrawal  examination   a </td>\n<td>Unscheduled  visit</td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Acceptable window</td>\n<td>−</td>\n<td>−</td>\n<td>±3 days</td>\n<td>±7 days</td>\n<td></td>\n<td></td>\n<td>−</td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Informed consent </td>\n<td>  ○   b </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Inclusion and exclusion criteria</td>\n<td>○</td>\n<td>○</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Subject demographics</td>\n<td>○</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Physical examination</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○   c </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Vital signs, height, and body weight</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○   c </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Clinical laboratory tests</td>\n<td>  ○   d </td>\n<td>○   e </td>\n<td></td>\n<td></td>\n<td></td>\n<td>○</td>\n<td>○   c </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Pregnancy test   f </td>\n<td>○</td>\n<td>○</td>\n<td></td>\n<td></td>\n<td></td>\n<td>○</td>\n<td>○   c </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">IGA </td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○   c </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">EASI</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○   c </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">POEM</td>\n<td></td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○   c </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Affected BSA </td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Treatment area </td>\n<td></td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td></td>\n<td>○   c </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Administration diary</td>\n<td></td>\n<td colspan=\"6\" rowspan=\"1\">  ○   g </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Severity of AD</td>\n<td>○</td>\n<td>○</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Status of IMP administration</td>\n<td></td>\n<td></td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td>○</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Prescription and collection of IMP</td>\n<td></td>\n<td>○   h </td>\n<td>○   i </td>\n<td>○</td>\n<td>○</td>\n<td>  ○   j </td>\n<td>○   i </td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">IMP administration</td>\n<td></td>\n<td colspan=\"7\" rowspan=\"1\">○   k </td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">AEs</td>\n<td></td>\n<td colspan=\"6\" rowspan=\"1\"></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Concomitant medications and  therapies </td>\n<td></td>\n<td colspan=\"6\" rowspan=\"1\"></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"2\" rowspan=\"1\">Patch test   l </td>\n<td></td>\n<td colspan=\"6\" rowspan=\"1\"></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03963232_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period (SP)</td>\n<td>SP I-Screening</td>\n<td>SP II-Prospective  Baseline</td>\n<td colspan=\"5\" rowspan=\"1\">SP III Double-Blind Treatment</td>\n</tr>\n<tr>\n<td>(Target) Interval (days)  since previous visit</td>\n<td></td>\n<td></td>\n<td>30-45</td>\n<td>14</td>\n<td>16</td>\n<td>30</td>\n<td>30</td>\n</tr>\n<tr>\n<td>Allowable range (days) between visits</td>\n<td>3-45 </td>\n<td>30-40   a </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Interval allowance (days)</td>\n<td></td>\n<td></td>\n<td></td>\n<td>+/- 5</td>\n<td>+/- 2</td>\n<td>+/- 2</td>\n<td>+/- 2</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4   b </td>\n<td>5   1</td>\n<td>6</td>\n<td>7</td>\n</tr>\n<tr>\n<td>Month</td>\n<td></td>\n<td></td>\n<td>0</td>\n<td>0.5</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n</tr>\n<tr>\n<td colspan=\"8\" rowspan=\"1\">Assessments and Procedures</td>\n</tr>\n<tr>\n<td>Informed consent</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Inclusion/exclusion</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Demographics</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Physical examination</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Neurological examination   c </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Height</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Weight</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Medical history </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Prespecified  migraine history   d </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ECG   e </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   f </td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>ePRO and headache medication log training</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>ePRO diary daily patient entries</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Headache medication log</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03963232_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period (SP)</td>\n<td>SP I-Screening</td>\n<td>SP II-Prospective  Baseline</td>\n<td colspan=\"5\" rowspan=\"1\">SP III Double-Blind Treatment</td>\n</tr>\n<tr>\n<td>(Target) Interval (days)  since previous visit</td>\n<td></td>\n<td></td>\n<td>30-45</td>\n<td>14</td>\n<td>16</td>\n<td>30</td>\n<td>30</td>\n</tr>\n<tr>\n<td>Allowable range (days) between visits</td>\n<td>3-45 </td>\n<td>30-40   a </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Interval allowance (days)</td>\n<td></td>\n<td></td>\n<td></td>\n<td>+/- 5</td>\n<td>+/- 2</td>\n<td>+/- 2</td>\n<td>+/- 2</td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4   b </td>\n<td>5   1</td>\n<td>6</td>\n<td>7</td>\n</tr>\n<tr>\n<td>Month</td>\n<td></td>\n<td></td>\n<td>0</td>\n<td>0.5</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n</tr>\n<tr>\n<td colspan=\"8\" rowspan=\"1\">Clinical Laboratory Tests and Sampling Schedules</td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical chemistry</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>HbA1c</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urinalysis</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Serum Pregnancy (for women of childbearing  potential) or FSH at Visit 1 (all other female  patients)   g </td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Urine pregnancy   g </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Immunogenicity   h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>PK blood sample   h </td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Study drug administered   i </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X   j </td>\n</tr>\n<tr>\n<td colspan=\"8\" rowspan=\"1\">Scales, Questionnaires, and Outcome Measures</td>\n</tr>\n<tr>\n<td>MIDAS</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>MSQ v2.1</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>MIBS-4</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PGI-S</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>GAD-7</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>PHQ-9</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03963232_SOA_table_2.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td>Study Period (SP)</td>\n<td colspan=\"3\" rowspan=\"1\">SP IV Open-Label\n</td>\n<td colspan=\"3\" rowspan=\"1\">SP V Post-treatment\n</td>\n</tr>\n<tr>\n<td>(Target) Interval (days) since previous visit</td>\n<td>30</td>\n<td>30</td>\n<td>30</td>\n<td>60</td>\n<td>60</td>\n<td>ET   K </td>\n</tr>\n<tr>\n<td>Interval allowance (days)</td>\n<td>+/- 2</td>\n<td>+/- 2</td>\n<td>+/- 2</td>\n<td>+/- 5</td>\n<td>+/- 5</td>\n<td></td>\n</tr>\n<tr>\n<td>Visit</td>\n<td>8</td>\n<td>9</td>\n<td>10</td>\n<td>11   b </td>\n<td>12</td>\n<td></td>\n</tr>\n<tr>\n<td>Month</td>\n<td>4</td>\n<td>5</td>\n<td>6</td>\n<td>8</td>\n<td>10</td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"7\" rowspan=\"1\">Assessments and Procedures</td>\n</tr>\n<tr>\n<td>Weight</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Neurological examination   c </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>ECG   e </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Vital signs   f </td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Adverse events</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Concomitant medications</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>ePRO diary daily patient entries</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Headache medication log</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td colspan=\"7\" rowspan=\"1\">Clinical Laboratory Tests and Sampling Schedule</td>\n</tr>\n<tr>\n<td>Hematology</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Clinical chemistry</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>HbA1c</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urinalysis</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Serum Pregnancy (for women of childbearing potential)   g </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Urine pregnancy   g </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Immunogenicity   h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PK blood sample   h </td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Study drug administered   i </td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td colspan=\"7\" rowspan=\"1\">Scales, Questionnaires, and Outcome Measures</td>\n</tr>\n<tr>\n<td>MIDAS</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>MSQv2.1</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>MIBS-4</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PGI-S</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>GAD-7</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>PHQ-9</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03980938_SOA_table_0.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Evaluation</td>\n<td>Screening[*]</td>\n<td colspan=\"4\" rowspan=\"1\">Treatment Period 1</td>\n<td>Washout (8 to 12 weeks)</td>\n<td colspan=\"4\" rowspan=\"1\">Treatment Period 2</td>\n<td>ET Visit #</td>\n<td colspan=\"1\" rowspan=\"2\">Final Study Visit[#]</td>\n</tr>\n<tr>\n<td>Within 21 days of D1</td>\n<td>W0  b</td>\n<td>W4 (±4 d)</td>\n<td>W8 (±4 d)</td>\n<td>W10 (±2 d)</td>\n<td>2 wks (±3 d) of last dose in Period 1</td>\n<td>W4 (±4 d)</td>\n<td>W8 (±4 d)</td>\n<td>W10 (±2 d)</td>\n<td>Within 3 d after last dose</td>\n<td>2 wks (±3 d) of last dose</td>\n</tr>\n<tr>\n<td>Informed Consent</td>\n<td>X *</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Medical history review</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Pregnancy testing</td>\n<td>X f</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>Physical examination c</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>C-SSRS</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Hospital Anxiety and Depression Scale</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>UHDRS</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>CANTAB</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>MWM</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n</tr>\n<tr>\n<td>Vital signs</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Prior/concomitant medication</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Adverse events recording a</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n</tr>\n<tr>\n<td>Hematology and chemistry e</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n</tr>\n<tr>\n<td>12-lead electrocardiogram d</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
{"images": "/Users/charlie.gong/Documents/GitHub/mlx-vlm/data/protocols_max1000px/nct03980938_SOA_table_1.jpg", "messages": [{"role": "user", "content": "Here is a table image <image>. Convert it to HTML."}, {"role": "assistant", "content": "<table frame=\"hsides\" rules=\"groups\">\n<tr>\n<td colspan=\"1\" rowspan=\"2\">Evaluation</td>\n<td>Screening[*]</td>\n<td colspan=\"4\" rowspan=\"1\">Treatment Period 1</td>\n<td>Washout (8 to 12 weeks)</td>\n<td colspan=\"4\" rowspan=\"1\">Treatment Period 2</td>\n<td>ET Visit #</td>\n<td colspan=\"1\" rowspan=\"2\">Final Study Visit[#]</td>\n<td></td>\n</tr>\n<tr>\n<td>Within 21 days of D1</td>\n<td>W0  b</td>\n<td>W4 (±4 d)</td>\n<td>W8 (±4 d)</td>\n<td>W10 (±2 d)</td>\n<td>2 wks (±3 d) of last dose in Period 1</td>\n<td>W4 (±4 d)</td>\n<td>W8 (±4 d)</td>\n<td>W10 (±2 d)</td>\n<td>Within 3 d after last dose</td>\n<td>2 wks (±3 d) of last dose</td>\n<td></td>\n</tr>\n<tr>\n<td>Dispense study drug  k</td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Final study drug reconciliation</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td></td>\n<td></td>\n<td></td>\n<td></td>\n<td>X</td>\n<td>X</td>\n<td></td>\n<td></td>\n</tr>\n</table>"}]}
